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Abstract
This thesis explored the association between cannabis use and executive function, with 
a specific focus on the age of onset of cannabis use. Previous research has provided 
some preliminary evidence that early onset cannabis use, namely cannabis initiation 
during the early teenage years or younger, is associated with greater cognitive deficits 
than later onset use. The first study within this thesis included a large battery of 
validated neuropsychological tasks administered to cannabis users, controls and tobacco 
using controls to compare executive function performance. This approach found several 
cognitive domains in which cannabis users performed at significantly lower levels than 
the two controls groups. Further analyses showed that the early onset cannabis users 
(<15 years) were performing at lower levels on some of these tests than late onset users 
(>16 years) when compared to the control groups. While the early onset hypothesis did 
not explain all of the deficits in the cannabis using groups there was a clear pattern for 
early onset users to be impaired at a greater level on some tests. In particular, it 
appeared that the cannabis-related deficits were more pronounced on tests which 
required visual scanning, set switching abilities and visuo-motor coordination. While 
the visuo-motor deficits were quite clear, it could not be determined if visual scanning 
deficits were explaining the performance deficits on the set switching task.
Subsequently an eye-tracking study was conducted to investigate the age of onset of 
cannabis use effects on visual scanning and set switching processes. This study 
suggested that visual scanning was impaired while set switching processes remained 
intact in cannabis users. Furthermore, this study found some support of an age of onset 
effect; two of the dependent variables showed evidence of greater impairments among 
early onset cannabis users relative to the other groups.
In addition this thesis includes a large scale survey which assessed lifestyle predictors of 
the age of onset of cannabis use. Two lifestyle factors were highly associated with 
executive function abilities - other drug use and educational achievement - were 
predictors of the age of onset of cannabis use. As the two quasi-experimental studies 
controlled for these two variables, in addition to other confounding variables, it is 
unlikely they were explaining the pattern of deficits reported.
Based on data presented here and supported by existing multidisciplinary research, it is 
argued that the relationship between cannabis use and cognition reported in this thesis is 
causal. While cannabis may have a causal impact on cognitive performance, such as 
visual search and visuo-motor coordination, the cannabis users still performed at a 
“normal” level. The severity of cognitive impairments does appear to be mediated by 
early onset cannabis use, however not all cognitive processes appear to be at risk for 
these greater impairments. Findings may indicate a developmental vulnerability to 
cannabis use.
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Chapter One. Literature Review
1.1. Cannabis
1.1.1. Terminology
The use of cannabis is so ubiquitous that countless terms have been created to describe 
the drug and the means by which it is used. Jacquette (2010) attempted to collate some 
of these terms in his book on the philosophy of cannabis by alphabetically naming over 
two pages worth of cannabis-related synonyms. Although such an audacious task will 
not be attempted here, the terminology used in the current thesis will briefly be 
described.
For the purposes of this thesis the term cannabis will be used to describe the drug 
derived from the plant cannabis sativa. This term will be used in place of the American 
synonym marijuana and the colloquialisms weed, hash, and skunk, although these are 
not in the strictest sense the same substances. The name of the drug sometimes varies 
dependent on the different growing and manufacturing processes of the plant. The term 
spliff is used to describe a common method of smoking cannabis. A spliff typically 
consists of a cigarette paper filled with cannabis, occasionally tobacco, and rolled into a 
cone shaped ‘cigarette’ to then smoke. For a full description of the various devices used 
to consume cannabis see Appendix A. 1.1.
Regarding cannabis use, the term acute refers to the stage of cannabis use at which 
physiological and psychological effects are occurring shortly after consuming the drug 
and this term can be used interchangeably with the synonym intoxication. The term 
withdrawal refers to the stage of cannabis use during which deleterious physiological 
and psychological effects are associated with the decline in levels of the drug within the 
blood or tissue. The term chronic is used to describe long term drug use, such that 
chronic cannabis use related damage, refers to the damage done by long term cannabis 
use rather than the acute or withdrawal stages.
Other recreational drug use, not including cannabis use, tobacco use or alcohol use, will 
be referred to as other drug use. Examples include ecstasy and amphetamines.
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1.1.2. Cannabinoids
Among the numerous chemical compounds discovered in the cannabis plant, 70 types of 
cannabinoids have been identified (Turner, 1980; Elsohly & Slade, 2005). The main 
groups of cannabinoids include: A9-TetraHydroCannabinol (A9-THC), A8-THC, 
cannabinol, and cannabidiol.
1.1.2.1. Psychoactive Cannabinoids
A9-THC is the primary psychoactive component of cannabis and the central focus of 
numerous studies investigating the many properties of the drug (Kalant, 2001). 
Additional psychoactive cannabinoids include A8-THC and cannabinol. The two 
strongest psychoactive cannabinoids, A9-THC and A8-THC, have a much stronger 
affinity to bind with CBi receptors than the weaker psychoactive cannabinoid, 
cannabinol.
7.7.2.2. Cannabidiol (CBD)
The other salient cannabinoid is CBD, and although it is not psychotropic 
(Grotenhermen, 2003), nor does it bind with CBi receptors, it appears to reduce the 
effects of A9-THC. CBD has been shown to reduce anxiety and subjective intoxication 
induced by A9-THC (Niesink & van Laar, 2013; Zuardi, Shirakawa, Finkelfarb & 
Karniol, 1982) and acute injections of both of these cannabinoids have been shown to 
have opposite functional effects on regional brain activity, namely hypo- vs. 
hyperactivity during cognitive tasks across a range of brain regions (Bhattacharyya et 
al., 2009).
1.1.3. Cannabis Use
1.1.3.1. Recreational Use
Cannabis is the most commonly used illegal drug in the World (United Nations Office 
on Drugs and Crime, 2011). Cannabis use in 2009/10 was reported at 6.6% of the 
population for England and Wales, this figure rises to 7.4% in Northern Ireland and 
8.4% in Scotland (Home Office, 2010). Elsewhere in the world these rates increase for 
the United States of America (USA; 13.4%) and go as high as 24.2% for Palau (United 
Nations Office on Drugs and Crime, 2011). Figure 1.1 highlights several groups at
11
higher risk for the use of cannabis such as males, younger individuals, students, the 
unemployed, and mixed-race ethnicities.
While these figures suggest that cannabis use is quite high this does not describe the rate 
at which people become addicted to the drug. Epidemiological data has helped answer 
this question by showing that approximately 9% of individuals who use cannabis 
become addicted based on a nationally representative sample located within America 
(Anthony, Warner & Kessler, 1994). This diagnosis was made by use of the DSM-III 
(American Psychiatric Association, 1980) and as the diagnostic criteria has changed 
over the updated DSM versions, any newer findings need to be compared while 
considering the method used to assess addiction or “cannabis use disorder”, as it is 
currently called (DSM-V; American Psychiatric Association, 2013). While these 
estimates typically deal with the percentage of individuals who have used cannabis in 
the year prior to testing or the percentage of individuals who have used cannabis once in 
their lifetimes, this does not differentiate between those who have tried the drug once 
and those who are regular users. In contrast, Compton, Grant, Colliver, Glantz and 
Stinson (2004) also analysed data from two large cohorts of individuals from the USA 
and found that dependence rates were much higher at approximately 30-35%. These 
differences could be due to that Compton et al (2004) used the less strict DSM-IV 
(American Psychiatric Association, 1994) to determine abuse and dependence.
Three main types of cannabis are used within the UK based on police seizures: cannabis 
resin, herbal cannabis, and sinsemilla (Potter, Clark & Brown, 2008). There are varying 
effects of acute cannabis use which are partially dependent on the type of cannabis used; 
as the production, the sex, and the part of the plant which is selected will dictate the 
level of cannabinoids consumed. Within the UK the most popularly consumed variety 
of cannabis is sinsemilla, accounting for 55% of the cannabis seized in 2004/5. 
Colloquially referred to as ‘skunk’, this variety of cannabis refers to the female plant 
grown without contact to the male’s pollen thus leading to a complete lack of seeds.
This variety of the plant boasts high levels of A9-THC and relatively low levels of CBD 
in contrast to its frequently consumed relatives. Seized sinsemilla within the UK has 
shown a A9-THC content of 13.3% whilst its nearest competitor, cannabis resin, 
contains low A9-THC levels at around 3.7%. Additionally, CBD, which has been shown 
to ameliorate some of the effects of THC (Niesink & van Laar, 2013; Zuardi et al, 1982) 
and produces no psychotropic effects of its own, is much more prevalent in resin (4.2%) 
compared to sinsemilla in which the levels are below the detectable threshold of 0.1%.
12
Not all cannabis use is illegal as several regions have decriminalised or legalised the 
recreational use of cannabis. At this point in time the regions which have legalised 
recreational cannabis use are two USA states, Colorado (Amendment 64, 2012) and 
Washington (Initiative 502, 2012), in addition to two countries, Uruguay (Room, 2014) 
and the Netherlands (Caulkins et al., 2011). This is worth considering as the levels of 
cannabinoids in the finished plant and the products used during the manufacturing 
process are likely to differ between the illegal and legal/regulated growing procedures.
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Figure 1.1. A  series of graphs displaying the varying percentages of individuals with the 
UK who have used cannabis in the past year among different groups. Data taken from
13
British Crime Survey, Home Office Statistics (2010). AB = Asian-British; BB = Black 
British; U/E = Unemployed; Hong term or temporarily ill and unable to work.
/. 1.3.2. Cannabis as a Medicine
Medical grade cannabis is now available for prescription in several countries throughout 
the world to treat various ailments. Clinical studies show promising results for the 
analgesic effects of varying cannabis derivatives on a variety of different pains 
(Holdcroft et al., 1997). There is also evidence suggesting it can reduce vomiting and 
nausea symptoms induced from chemotherapy (Tramer et al., 2001), can help reduce 
convulsions associated with epilepsy (Cunha et al., 1980) and help reduce symptoms 
associated with multiple sclerosis (Baker, Jackson & Pryce, 2007). The current research 
programme focussed on recreational cannabis users as opposed to those with prescribed 
medicinal cannabis and therefore this will not be discussed any further.
1.1.3.3. Summary
The recreational and medicinal based use of the drug highlights the prevalence of 
cannabis use throughout the world. This necessitates an investigation into the possible 
adverse effects of chronic cannabis use.
1.1.4. Cannabis and the Brain
1.1.4.1. Cannabinoid receptor sites
The two known binding sites for cannabinoids are the CBi and CB2 receptors. The 
highest densities of CBi receptors are found in the basal ganglia and cerebellum. High 
densities are also found in the hippocampus and throughout the cerebral cortex 
(Herkenham et al., 1990). Eggan and Lewis (2007) examined how CBi receptors are 
distributed throughout the macaque neocortex. Their primary finding was that prefrontal 
cortex CBi density was much greater than sensory or motor cortices. More specifically, 
the DLPFC was the area of the prefrontal cortex with the highest density. Secondary 
findings show support for Herkenham et al. (1990) by displaying the highest densities 
of CBi receptors in the basal ganglia structures, the molecular layer of the cerebellum, 
the dendate gyrus and amygdala. Although there are clear interspecies differences as 
seen in Figure 1.2, Eggan and Lewis (2007) show that prefrontal cortex regions have the 
highest levels of CBi receptors throughout the cortex.
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Figure 1.2. A graph reproduced from Herkenham et al (1990), displaying the varying 
density of CB 1 receptors in different brain regions. SNr = substantia nigra; GPi = 
interntal segment of the globus pallidus; EP = entopendulcular nucleus; GPe = external 
segment of the globus pallidus; Cer Mol Lyr = cerebellum molecular layer; DG Mol Lyr 
= dendate gyrus molecular layer; Cing Cx = cingulate cortex; Hipp CA1 = hippocampal 
field CA1; BL = this abbreviation was not defined by the authors but likely refers to 
either basal lateral or basal regions of the amygdala; Sp Cd SG = substantia gelatinosa 
of spinal cord* only rat measured; Med Hypothal = medial hypothalamus; Ret Form = 
reticular formation; WM(cc) = white matter of the corpus callosum.
Figure 1.3. A lateral view of the left hemisphere of the brain. The red shaded area 
represents the ventromedial prefrontal cortex; the blue represents the inferior frontal 
cortex/gyrus; the olive represents the dorsolateral prefrontal cortex; the purple 
represents the intraparietal sulcus.
Figure 1.4. A sagittal view of the brain. The orange shaded area represents the anterior 
cingulate cortex; the teal represents the approximate area of the amygdala.
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1.1.5. The Effects of Cannabis on the Brain
The current thesis is investigating whether cannabis use has long term detrimental 
effects on cognition. In order to examine a possible mechanism for these effects, the 
impact of cannabinoids on the brain will be discussed here.
1.1.5.1. The Neurotoxic Effects o f Cannabinoids
Animal studies have provided strong evidence for the neurotoxic properties of cannabis. 
Administration of A9-THC to rats over a long timescale was found to cause decreased 
neuronal density in hippocampal neurons (Landfield, Cadwallader & Vinsant, 1988; 
Scallet et al., 1987). These findings have been partially supported by the detection of 
markers of apoptosis in cortical neurons following the administration of similar doses of 
A9-THC to neonatal rats (Downer, Gowran & Campbell, 2007). These findings have 
also been supported by in vitro studies of rat neurons in which A9-THC was associated 
with cell damage (Campbell, 2001; Chan, Hinds, Impey & Storm, 1998; Downer, 
Fogarty & Campbell, 2003).
Potentially contradictory findings have been ever present in this field which suggest that 
cannabinoids, including A9-THC, can also be neuroprotective (e.g. van der Stelt et al., 
2001a; van der Stelt et al., 2001b; Carroll, Zeissler, Hanemann & Zajicek, 2012). Same 
et al (2011) suggest one viable explanation for the apparent contradiction is that 
cannabinoids are neurotoxic to the brain cells, however this damage triggers a 
conditioning mechanism which can help protect against future damage.
The potential toxicity of cannabis in humans is far less clear. Lorenzetti, Lubman, 
Whittle, Solowij and Yucel (2010) provided a review of the literature on the 
relationship between cannabis use and brain structure in humans.
The review showed largely mixed findings with some evidence of volumetric 
differences across cannabis users and controls in specific regions (e.g. Matochik, 
Eldreth, Cadet & Bolla, 2005; Medina et al., 2007; Yucel et al., 2008), some evidence 
of early onset use being associated with greater group differences (Wilson et al., 2000), 
and some which show no differences or even greater regional volumes in cannabis users 
(Block et al. 2000; Medina et al., 2007; Tzilos et al., 2005; Jager et al., 2007). Among 
the studies which did find differences there was a distinct lack of regional consensus 
such that some studies found reductions in hippocampal volume (Matochik et al., 2005; 
Yucel et al., 2008) while another found an increase in hippocampal volume (Medina et
17
al., 2007), and three showed no effect of cannabis on hippocample volume (Block et al., 
2000; Medina et al., 2007; Wilson et al., 2000). Lorenzetti et al (2010) suggest that as 
these studies are so few in number, and that the effects of cannabis on certain brain 
regions are yet to be replicated, it is too early to interpret the findings regarding whether 
or not cannabis leads to morphological changes.
One more recent study used a longitudinal methodology to test whether brain volumes 
which predate cannabis use will later predict cannabis use onset (Cheetham et al., 2012). 
The authors found that orbitofrontal cortex (OPFC) volume at age 12 predicted later 
cannabis use onset, yet regions such as the hippocampus and amygdala which were 
found to have reduced volumes in earlier research (Matochik et al., 2005; Yucel et al., 
2008), were not predictive of later cannabis onset. As this was the first study to address 
the question longitudinally (Cheetham et al., 2012), it cannot be stated as to how brain 
volume and cannabis use are linked and whether there is a more complex and dynamic, 
transactional interplay. A more recent study using a non-longitudinal study confirmed 
this association between cannabis use and OPFC volume (Filbey et al. 2014). In 
particular the authors found that the age of cannabis onset was related to such volume in 
a manner previously reported by Wilson et al (2000). Filbey et al (2014) argue that the 
consensus in the animal literature suggests toxicity is a viable explanation however they 
also highlight that the previous results by Cheetham et al (2012) point to neurological 
differences explaining cannabis use, as opposed to vice versa. Due to the quasi- 
experimental nature of this research it is also possible that a third variable was 
explaining the association.
1.1.5.2. Dopaminergic Dysregulation
Recently Bloomfield et al (2014) used Positron Emission Tomography (PET) to 
examine dopamine synthesis in cannabis users and controls. The authors found that 
dopamine synthesis was reduced within the corpus striatum of cannabis users, and the 
“heavy” cannabis users, users with diagnoses of dependence, and early onset cannabis 
users had the lowest dopamine synthesis. As each of these correlations - cannabis use & 
age of onset with dopamine synthesis -  did not control for the other cannabis use 
variables it is not clear if the early onset relationship is due to greater cannabis use, or 
vice versa. Despite this limitation, this research provides clear findings for a reduction 
in dopamine synthesis among human cannabis users. These findings partially contradict 
earlier research which suggests that dopamine function in the striatum does not differ
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between cannabis users and controls (Urban et al., 2012). There were substantial sample 
differences between the two studies, including cannabis use behaviours, which could 
explain the lack of concordance. Bloomfield et al (2014) suggested the findings reported 
by Urban et al (2012) could be due to a return to normal functioning given the large 
period of abstinence from cannabis; approximately four weeks. Although Urban et al 
(2012) did not find group differences they did also find a relationship between lower 
dopamine release and an early age of cannabis onset, similar to Bloomfield et al’s 
findings. These mixed results suggest that it is not clear how long term cannabis use 
affects dopaminergic function in humans.
Due to the quasi-experimental approach used by these two studies (Bloomfield et al., 
2014; Urban et al., 2012) a causal role of cannabis on dopaminergic function is hard to 
determine however among animal studies, experimental approaches increase the ability 
to infer a causal role of cannabis on such effects. Doses of THC comparable with 
previous studies examining toxicity (e.g. Landfield et al., 1988) were administered over 
14 days to rats which led to significant reductions in prefrontal cortex dopamine 
transmission after a week’s abstinence from the drug (Verrico, Jentsch & Roth, 2003). 
This builds on previous work identifying similar dopaminergic deficits in the prefrontal 
cortex (Jentsch, Verrico, Le & Roth, 1998). The authors suggested that these reductions 
in dopaminergic functioning could be explaining previously found deficits in cognitive 
function in human cannabis users (e.g. Pope & Yurgellun-Todd, 1995).
1.1.5.3. Summary
While there is strong evidence of cannabis induced neurotoxicity in rats the results are 
not clear in human research. The quasi-experimental nature of these studies combined 
with small sample sizes and lack of consistent results make it too early to conclude that 
cannabis causes brain damage in human cannabis users.
There is also a clear effect of dopaminergic dysfunction after long term cannabis 
administration in rats and tentatively in humans. While it is not clear if putative 
neurotoxicity or dopaminergic dysfunction is explaining the cognitive deficits found in 
human cannabis users, it presents a possible mechanism to explain the effects given the 
role of dopamine and neurons in cognitive functioning (e.g. Buckholtz et al., 2010).
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1.1.6. Cannabis Summary
In this section it is clear that cannabis is a widely used substance despite its 
predominantly illegal nature. The exact consequences of using these drugs are unclear, 
yet there is preliminary evidence for neurotoxic effects which could explain reports of 
cognitive deficits in cannabis users. Given that the levels of A9-THC have been 
increasing over the past 20 years within the UK (Potter et al., 2008), the potential risk 
for adverse effects to develop is increasing as time goes by. As the primary binding site 
for A9-THC, CB i receptors, are densely packed in regions involved in executive 
functions, it is these cognitive processes which are at increased risk of damage, and the 
focus of this research.
1.2. Executive Function
The term executive function describes a series of higher order cognitive processes 
involved in the control of behaviour to reach a certain goal (Banich, 2009; Koechlin, 
2014; Miyake et al., 2000). Such behaviours are so crucial for normal functioning in 
society that deficits in executive functioning following trauma predict the likelihood of 
the ability to live independently (Hanks, Rapport, Millis, & Deshpande, 1999).
1.2.1. Theories of Executive Function
The following section describes some influential, theoretical approaches of executive 
function. While the terminology has changed over time, the underlying processes which 
have been described represent early attempts to conceptualise what is now referred to as 
executive function.
1.2.1.1. Attentional Control Model
The model of attention control (Norman & Shallice, 1986) suggests the existence of one
system which selects between conflicting routine actions (the contention scheduling
mechanism) and a second which intervenes when dealing with a complex or novel
situation that requires conscious processing (Supervisory Activating System; SAS).
This has been criticised by assuming that the distinction between executive and other
cognitive processes is merely a control-automatic distinction (Stuss & Alexander,
2000). A direct test of the model by Bayliss and Roodenrys (2000) on individuals with
ADHD found that this dichotomy between control and automatic is insufficient to
explain the pattern of deficits among their participants and concluded that the
fractionation of executive function was necessary.
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1.2.1.2. Working Memory Model
Baddeley & Hitch (1974) proposed a model of working memory, a temporary 
information storage system which contained the first description of "executive" 
processes. The model originally included three components but was subsequently 
updated to include the episodic buffer, in addition to the original visuo-spatial 
sketchpad, the phonological loop, and the central executive (Baddeley & Hitch, 2000). 
This modality-free central executive was suggested to be an attentional control system 
involved in the coordination of the ‘slave’ systems. Baddeley et al (1986) incorporated 
the supervisory activating system (SAS) from the model of attentional control into the 
theory (Baddeley, 1996; Norman & Shallice, 1980). Following a seminal publication by 
Stuss and Benson (1984) which reviewed the structure and function of the frontal lobes, 
Baddeley and Wilson (1988) began to link dysexecutive syndrome with the frontal lobes 
and thus argue for the importance of the frontal lobes in central executive functioning. 
After Parkin’s criticisms of the central executive concept (Parkin, 1988), Baddeley 
developed the explanation of the central executive to include a number of components 
which constitute individual executive functions (Baddeley, 1998). These suggested 
functions were: the capacity to coordinate performance on two different tasks, switch 
between strategies, attend to a stimulus while inhibiting a second, the ability to access 
and manipulate information from long-term memory, and hold information within 
working memory.
1.2.1.3. Hierarchical Feedback-Feedforward Model
Stuss (1992) took the distinction between 'lower' and 'higher' processes and elaborated 
on this in his three level, Hierarchical Feedback-Feedforward model. The second of 
three levels includes the supervisory or executive processes such as plan formulation 
and does not specify that executive function is unitary, unlike earlier models. The model 
highlights that the novel situations which demand executive processes take longer and 
more effort than automatic processes completed on level one. The model links these two 
levels with the third which is involved in metacognition and consciousness. 
Considerations regarding the development of executive function components along with 
biological maturational processes are incorporated into the model. It is also stated that 
executive processes need to be considered more by the hierarchical nature of the 
cognitive processes than by whether or not the process itself is subserved by the frontal 
lobes (Stuss, 1992; Stuss & Alexander, 2000). This is a departure from those who
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suggest that executive function is the cognitive analogue to the prefrontal cortex (e.g. 
Koechlin & Summerfield, 2007). Given the many prefrontal cortex networks with 
cortical and sub-cortical regions of the brain (Middleton & Strick, 2001) there is an 
inherent problem with ascribing executive function to one specific region.
1.2.1.4. Information Processing Model o f Executive Function
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By using information processing theory, Koechlin and Summerfield (2007) attempted to 
quantify executive function. They propose that the key tenet of executive function is the 
selection of action which is determined by information gathered from stimuli. The 
model also includes the division of executive function into sensorimotor (stimuli-motor 
responses), contextual (external context accompany stimuli), and episodic control 
(involving memory & goals). This assertion is supported by fMRI and behavioural data 
taken during a variation of the GO/NO-GO paradigm in which sensorimotor, contextual 
and episodic information was varied (Koechlin, Ody & Kouneiher, 2003). These data 
suggested that each of these three stages map onto separate regions of the frontal lobes, 
the rostral Lateral Prefrontal Cortex (LPFC), the caudal LPFC and the premotor cortex 
are involved in episodic control, context, and sensorimotor responses, respectively. 
Similar to Stuss (1992), Koechlin and Summerfield (2007) present a hierarchical model 
of executive function, which they refer to as the cascade model. This cascade model
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receives support from the time based activation of each brain region during the task, 
with activation moving in an anterior-posterior direction (Koechlin et al., 2003).
« /
Branching
control
Temporal axes of 
cognitive controlEpisodic
control
Past
episode Ongoing
episode
Contextual
controlQ(als)Context
Sensory
control
I (s,a) H<a)
Stimulus
Stimulus s TimeAction aPast event u
Context c
Figure 1.5. An image reproduced from Koechlin & Summerfield (2007) which 
highlights the various stages of the cascade model and the associated neurological 
correlates.
1.2.1.5. The Monoaminergic Modulation o f Executive Function
One aspect of executive function frequently postulated is that it controls other processes 
(e.g. Baddeley & Hitch, 1974; Miller & Cohen, 2001; Norman & Shalice, 1986). It is 
proposed that this 'control' by the prefrontal cortex (PFC) is based on the PFC's ability 
to prolong, alter or diminish neural firing in other brain regions by use of a monoamine 
system (Robbins & Arnsten, 2009). This builds on work on identifying neural networks
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from the PFC to the basal ganglia (Middleton & Strick, 2001), to sensory cortices, and 
to the amygdala (Barbas, Zikiopoulos & Timbie, 2011) highlighting the role of the 
frontal lobes in downstream coordination of emotions, selection of sensory information, 
and the initiation of actions.
This monoaminergic modulation theory also places an emphasis on the projections to 
the PFC, particularly from the amygdala. This explains previous results identifying that 
either insufficient or excessive dopamine or noradrenaline in the PFC, such as that 
which happens during stress, can impair working memory (Birnbaum, Gobeske, 
Auerbach, Taylor & Arnsten, 1999; Zarht, Taylor, Mathew & Arnsten, 1997).
Although much of the work in this area is with rodents and therefore extrapolations to 
humans must be treated cautiously, this theory links cognitive and neurological data 
with neurotransmitter systems and therefore is a crucial part of any potential unified 
theory of executive function.
1.2.1.6. Executive Function as an Emergent Property
A frequently used conceptualisation of executive function is that it is a property which 
accounts for the association between executive function task performance in a manner 
similar to general intelligence (g; Banich, 2009). Early factor analysis research within 
this field found evidence that individual differences in executive function as measured 
by the tasks selected were actually best explained by a three factor model of shifting, 
updating, and inhibition (Miyake et al., 2000). If executive function was unitary then it 
would be expected that a single latent variable would best fit the data however this has 
not occurred. Despite the clear fractionation of executive function identified by these 
methods, the latent variables still are associated with each other which leaves a role of 
executive function (Adrover-Roig, Sese, Barcelo & Palmer, 2012; Friedman et al.,
2006; Miyake et al., 2000; Royall, Chiodo & Polk, 2003; Testa, Bennet & Ponsford, 
2012 ).
Despite these findings (e.g. Miyake et al., 2000) there have been suggestions that the 
general concept of executive function can be abandoned (e.g. Royall & Palmer, 2014). 
The authors also used a factor analytic approach and suggested that there is no evidence 
of executive function beyond the role of g and memory which therefore implies that any 
previously tested association between tests of “executive function” are merely an 
artefact representing g and/or memory. This is supported by other work identifying that
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fluid intelligence accounts for dementia or schizophrenia related impairments in a 
number of frequently used executive function tests (Roca et al., 2013; 2014). In 
contrast, the authors found that fluid intelligence did not account for deficits in 
multitasking and decision making. Furthermore, Friedmann et al (2006) used similar 
methods and found that other executive processes are not related to fluid or crystallised 
intelligence and therefore associations between executive function tasks cannot be 
completely ascribed to intelligence, based on current methods of assessing IQ, and 
therefore there still exists a role for “executive function” to explain the association 
between “executive” tasks.
1.2.1.7. Summary
There is still a considerable amount of controversy surrounding executive function 
despite attempts to develop a unified theory (Banich, 2009). When discussing what 
counts as an “executive subcomponent” or an “executive task”, there is a distinct lack of 
clarity and evidence-based protocol for a conclusion to be made. While Figure 1.6 
suggests a number of executive processes, the authors rarely give evidence for the 
executive name-tag (e.g. Powell et al., 2004) and therefore it is difficult to come to a 
conclusion without appealing to authority. Banich (2009) suggests that the only area of 
agreement is that damage to the prefrontal cortex impairs executive function. However 
the support of this proposition is somewhat reminiscent of circular reasoning as Banich 
states that executive function tasks show prefrontal cortex activity during imaging 
studies.
An additional classification for an executive process appears to require certain 
characteristics of the cognitive construct to determine if it can be called “executive”.
The problem with this approach is that the characteristics are hard to define (Stuss,
2000) or lacking evidence for why that specific definition is “executive”. Two examples 
are that: executive processes are involved in control processes (e.g. Norman & Shallice, 
1986) or executive processes are “higher” cognitive processes (e.g. Stuss, 1992). While 
the division of cognitive processes into distinct levels of a hierarchical model has been 
suggested to be based on separate prefrontal regions (Banich, 2009; Koechlin & 
Summerfield, 2007) this does not help define why different levels of these models are 
more or less “executive”. Unlike the term “higher” cognitive functioning; the term 
“control” processes is easier to operationalise and may be a more testable candidate for 
describing executive function (Miller & Cohen, 2001). This would mean that any
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cognitive process which can be described as having a controlling influence on other 
processes would be a candidate for being “executive”.
Another approach to classifying executive function is that it is an emergent function 
which explains the correlations between “executive” tasks much in the same way that g 
does (Banich, 2009). This approach has the benefit of being clearly testable by factor 
analysis methods. Studies have found that performance on “executive” tasks are related 
to each other even if they are fractionable (Miyake et al., 2001) and these associations 
exist after controlling for g (Friedman et al., 2006; Roca et al., 2013: 2014). In this 
scenario, any putative executive function could be tested by determining if it is related 
to other existing executive functions beyond the effects of g.
While there may not be a clear definition, the theoretical approaches to executive 
function suggest that any cognitive process could be tentatively called “executive” if it 
recruits prefrontal cortex activity, is involved in higher/control processes, and is related 
to other executive processes.
1.2.2. Executive Function Components
There have been a vast number of suggestions concerning which cognitive processes are 
executive in nature, below is a figure summarising some of the perspectives.
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The figure above presents theoretically and experimentally focussed papers describing a 
large number of executive components. As many of these suggested processes are 
similar or identical in nature (i.e. attention switching and set switching refer to 
overlapping concepts) they were grouped into seven separate components which will be 
discussed here. These components of executive function are inhibition, set switching, 
working memory, strategic planning, initiation, decision making, and finally, abstract 
and conceptual reasoning. Although there are potentially more suggested components of 
executive function than the limited selection presented here, some of the other processes 
are grouped into these seven categories. For example, a commonly suggested 
component of executive function is attention, attentional control or regulation of 
attention (Stuss & Alexander, 2000; Anderson, 2001; Powell et al., 2004) however these 
were not included as they could be included in either the inhibition category (the 
suppression of attention) or set switching category (the shifting of attention).
In order to determine the neural substrates which subserve these processes the use of 
functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography 
(PET) will be discussed. These two methods both indirectly assess brain activity by 
measuring the 'fuel' use and by-products of active neurons within the brain. The early 
device, PET, typically monitors the physiological activity of glucose, oxygen or 
neurotransmitters, while fMRI typically measures blood oxygenation or blood flow 
(Banich, 2004). The spatial and temporal resolution is much more precise in fMRI and 
has thus become more frequently used since its later inception.
7.2.2.7. Inhibition
The first component to be considered is inhibition, one of the most commonly examined 
executive function components (Miyake et al., 2000), however it is described in a 
number of different ways. Nigg (2000) suggested eight separate forms of inhibition, two 
of which are automatic, two of which are motivational and four which are effortful and 
relate to executive processes. These last four classes of executive inhibition are 
interference control, cognitive inhibition, response inhibition and occulomotor 
inhibition. Confirmatory factor analysis suggests that interference control, behavioural 
inhibition and occulomotor inhibition are all closely related (Miyake et al., 2000; 
Friedman & Miyake, 2004). The focus of this section will be on the two most frequently 
described and well understood types, interference control and behavioural inhibition. A 
further suggested form of inhibition is task set inhibition (Aron, Robbins & Poldrack,
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2004) which refers to the inhibition of one task set response during a set switching 
paradigm. In a switching task in which two tasks are alternated every trial (ABA 
format) the B response is only initiated once after inhibition of the A response, 
comparable to the dictum “an object in motion continues in motion until a force acts 
upon it”. This will be discussed further in the set switching section (see section 
1.2.2.2.).
From the three methods of classification described in Section 1.2.1.7, inhibition is 
arguably one of the key constructs of executive function. Neuroimaging methods 
highlight a clear role of the prefrontal cortex in inhibitory processes, in particular the 
Inferior Frontal Cortex (IFC) during tasks and behaviours which require the “braking" 
of an action (Aron, Robbins & Poldrack, 2004; Aron, Robbins & Poldrack, 2014). 
Behaviourally, inhibition exhibits a controlling influence on other cognitive processes 
by means of slowing them down or stopping them completely (Nigg, 2000). 
Furthermore, there are clear associations between tasks which reportedly measure 
inhibitory processes and other putatively executive function tasks (Miyake et al., 2000; 
Friedman et al. 2006).
7.2.2.2. Set Switching
Set switching, also known as 'attention switching' or 'set shifting', refers to the control 
and configuration of multiple task sets, operations or schemas. The main phenomenon 
and behavioural measure of set switching studies is the concept of a switch cost. This 
concept is measurable when a switch from one task to another results in a greater cost 
than a repeat trial. This cost is observable by greater reaction times and a greater 
number of errors. These switch costs have been observed in both of the two main 
subtypes of switching tasks: alternating runs paradigms (ARPs) and task cueing 
paradigms (TCPs; see Figure 1.7; Altman, 2007). A third paradigm within switching 
tasks is the prespecified task sequence, which involves a switch every trial. Although 
the prespecified task sequence (PTS) paradigm does not allow a direct evaluation of 
switch costs, as every trial is a switch trial, pure repetition trials administered alongside 
it allow a comparison of switch trials with repeat trials and this analysis also yields 
evidence of a switch cost (Arbuthnott & Frank, 2000). This switch cost typically 
encapsulates every additional cognitive process which might aid the task-set 
reconfiguration from response A to response B. Task-set reconfiguration, referred to as
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a sort o f mental 'gear changing' - " (Monsell, 2003; p. 135), will largely depend on 
the task, the paradigm and the switch type.
ARP A A A Break B B B
TCP A A A ‘B ’ Cue B B ‘A ’ Cue A
PTS A B A B A B A B
Figure 1.7: An illustration of the three major switching paradigms using a double task 
(A & B) example. ARP=Altemating Runs Paradigm; TCP= Task Cueing Procedure; 
PTS= Prespecified Task Sequence.
One factor influencing the scale of the switch cost is advance reconfiguration, in which 
knowledge of an upcoming switch allows for preparation -  to start the ‘gear change 
and thus reducing the switch cost. Supporting evidence for advance reconfiguration 
comes from ARP tasks in which the time between the response in the previous trial and 
the presentation of the next task stimulus is manipulated (Rogers & Monsell, 1995) and 
from TCP tasks in which the time between the cue and the stimulus is manipulated 
(Meiran, 1996). In both cases, larger intervals of time were associated with reductions in 
switch costs, supporting the advance reconfiguration hypothesis.
Task set inhibition, usually described as contributing towards switch costs, is a vague 
phenomenon as different switch costs are dependent on the type of switching task 
(Koch, Gade, Schuch & Philipp, 2010). Therefore Nigg's (2000) theories on inhibitory 
components cannot be directly applied as the nature of the inhibition varies along with 
task and paradigm. In tasks which follow a task-cueing paradigm, where the switch is 
unpredictable, there can be expected to be greater demands on behavioural inhibition. 
For tasks in which all the stimuli are visually presented on one page (e.g. The Trail 
Making Test; TMT), and the individual must select the correct response, the authors
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suggest that interference control is involved (Delis et al., 2001), however when stimuli 
appear sequentially on a screen and no distracters are present there is likely to be a 
greater behavioural inhibition effect (Mayr & Keele, 2000). The evidence for an 
inhibitory effect in set switching studies comes from two primary sources. Correlational 
studies show that relationships exist between performance on inhibition tasks and set 
switching tasks (Langenecker, Zubieta, Young, Akil & Nielson, 2007; Sanchez-Cubillo 
et al., 2009), yet the strongest evidence for an inhibitory effect comes from n-2 
repetition paradigms. Tests which require the switching between three task sets results 
in higher switch costs when there is a n-2 repetition (ABA) than when there is a n-2 
switch (ABC; Mayr & Keele, 2000). If task set reconfiguration was the only contributor 
to switch costs then it would be expected that the 'ABC' would lead to greater switch 
costs as there are three separate reconfiguration processes. This higher switch cost for 
'ABA' tests has been referred to as backward inhibition, the notion that residual 
inhibitory effects from previous sets carries over when the reconfiguration process is 
required to reinitiate.
Arguments for set switching to be an executive process are largely supported by meta­
analyses of neuroimaging research (Wager et al., 2004). Although there are 
inconsistencies between studies which appear to be at least partially mediated by the 
switching paradigm (e.g. PTS vs TCP) and the switch type (e.g. rule switch vs task 
switch), there still appears to be a role of prefrontal cortex. These regions include the 
DorsoLateral PreFrontal Cortex (DLPFC) and the medial PFC, in addition to parietal 
sulci regions (Wager et al., 2004; Wager et al., 2005; Hyafil, Summerfield & Koechlin,
2009). If set switching, or its constituent processes, can be conceptualised as a gear 
changing process (Monsell, 2003) then it can be said to influence and control other 
processes, providing evidence that it could be an executive process. Finally, there is also 
a clear role for set switching to be related to other “executive tasks” as determined by 
factor analysis methods (Miyake et al., 2000; Friedman et al., 2006).
1.2.2.3. Working Memory
As discussed in section 1.2.1., one of the early models of working memory (Baddeley, 
1998) incorporated executive function components into the theory. Since these original 
suggestions of executive function being part of the working memory model, there have 
been suggestions that working memory is a component of executive function (e.g. 
Brandt et al., 2009). A third perspective suggests that working memory in its
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maintenance capacity is not an executive process, yet that constant updating and 
manipulation of information in working memory requires executive control (Miyake et 
al., 2000). Despite these varying positions there is an established link between the two 
phenomena from psychometric studies (McCabe, Roediger III, McDaniel, Balota & 
Hambrick, 2010) and neuroimaging data (Osaka et al., 2004). It is clear that working 
memory resources play a key role in the completion of executive function tasks and for 
this reason is becomes essential to describe it within this section. The current 
description will differentiate between updating and maintenance, as well as verbal- and 
visuo-spatial working memory.
Maintenance of working memory representations is the process which limits the decay 
of information held within working memory. Evidence suggests that maintenance of 
verbal information is accomplished primarily through articulatory rehearsal, the process 
of rehearsing verbal information, and attentional refreshing, the process of refreshing 
memory traces through the focussing of attention (Camos, Lagner & Barrouillet, 2009). 
With regards to maintenance of working memory representations within the spatial 
domain, the most commonly suggested mechanism is the attention-based rehearsal 
hypothesis (Awh, Vogel & Oh, 2006) which suggests that such representations are 
maintained through a sustained shift in attention to a memorised location. These 
assumptions have since been refuted by a set of experiments suggesting that a break in 
spatial attention does not impact spatial working memory and instead the authors 
suggest a role of the occulomotor system in the coding of spatial information 
(Belopolsky & Theeuwes, 2009).
Updating involves determining which new items of information are of importance and 
then revising the list of items held in working memory, by replacing the old with the 
new, more relevant, pieces of information (Morris & Jones, 1990). Depending on the 
task situations, whether it be experimental or in a real-world situation, the updating of 
working memory representations may or may not be dependent on three components: 
retrieval, transformation and substitution (Ecker, Lewandowsky, Oberauer & Chee,
2010). The specific components which are evoked are dependent on the nature of the 
task itself. Retrieval of previous information is not always necessary during the 
updating process if the information is merely substituted with new information, 
however if information is to be transformed, the existing information must be retrieved 
and then manipulated into a new piece of information. Ecker et al (2010; p. 171)
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describe a restaurant scene which elucidates how the three components contribute to the 
updating of working memory.
While a role of the prefrontal cortex in working memory has been identified there is 
largely mixed findings when considering working memory as a solitary process. 
However, when considering the maintenance and updating of working memory as two 
separate processes there appears to be more consistency (D’Esposito, Postle & Rympa, 
2000; Veltman, Rombouts & Dolan, 2003). There also appears to be a modality effect, 
with the left PFC involved in verbal and the right PFC involved in spatial working 
memory (D'Esposito, Aguirre, Zarahn, Ballard, Shin & Lease, 1998; Reuter-Lorenz et 
al., 2000). Based solely on the neuroimaging data, there is a case for updating and 
maintenance of working memory to be executive processes, even though they recruit 
different regions of the PFC. When considering the role these processes play, it is not 
clear that the maintenance of information has any role in the control of other processes, 
in contrast to updating which is described as having an active role in influencing 
representations of information maintained in working memory (Baddeley, 1986). 
Although there is considerably less focus in factor analysis studies on working memory 
maintenance, one study that used a single measure of this construct found that it was 
highly related to a latent variable within multiple models of executive function 
(Adrover-Roig et al., 2012). The role of updating has repeatedly been shown to form a 
key part of such models (Adrover-Roig et al., 2012; Friedman et al., 2006; Miyake et 
al., 2000).
1.2.2.4. Strategic Planning
Strategic planning is the ability to make predictions about the future and organise 
behaviour to achieve a goal. This is an increasingly complex and multidimensional 
process that requires a broad range of cognitive skills (Hayes-Roth & Hayes-Roth,
1979; Anderson, Dewhurst & Nash, 2012).
One of the earliest perspectives on planning was discussed by Miller et al (1960) who
described planning as "any hierarchical process in the organism that can control the
order in which a sequence of operations can be performed" (p. 16). It was argued that all
plans involve one, or multiple paths named TOTE (test-operate-test-exit). Firstly it is
tested whether a goal has been completed, if not an operation is carried out to complete
that goal, the operation is then tested to determine success and if the goal is then met,
the plan exits. This occurs in a feedback loop where if an operation is unsuccessful a
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new operation is selected and tested, until the goal is ultimately reached. A second key 
aspect of Miller et al’s work is the contribution of a temporary working memory store 
for the maintenance and manipulation of plan representations. Working memory 
allowed a conscious organisation of the TOTE status, regarding the maintenance of the 
end goal state, the operations chosen to reach that goal and the replacement of a new 
operator when a previous one was judged to be unsuccessful. This TOTE perspective 
has even been employed as a theoretical explanation for a holistic executive function, 
rather than the fractionated account which is presented in this thesis (Kopp, 2012).
When attempting to determine the cognitive processes involved in planning, Burgess, 
Simons, Coates and Channon (2005) pondered several possible processes. One example 
which was suggested was the ability to look forward in time. A key development in the 
field of planning was that future thinking or this ability to look ahead in time shares a 
neural network with episodic memory; primarily temporal, prefrontal, hippocampal, 
cingulate, and parietal regions (Addis, Wong & Schacter, 2007). The future events were 
specifically those which were novel and therefore this overlap was not due to the 
participant just remembering a previous event, and thinking about doing it again. 
Although there was a large overlap between these two putatively separate processes 
there were also several regions unique to each one. These findings build on previous 
work with brain injured patients, such as N.N (Tulving, 1985) who cannot remember 
episodic events or imagine future events suggesting that the processes are intimately 
related. Furthermore, other neuroimaging (Szpunar, Watson, & McDermott, 2007) and 
cognitive experiments (Anderson et al., 2012) have supported these findings. However, 
as these future thinking tasks involve imagining a specific event it is not clear if this 
episodic overlap will extend to all forms of future planning and imagination.
Using a neuropsychological approach to planning, the Tower of Hanoi 
(TOH)/London(TOL) tests, it has been demonstrated that working memory and 
inhibition are correlated with planning abilities although these variables were less 
related to the TOL than the TOH (Welsh, Satterlee-Cartmell & Stine, 1999). While this 
suggests working memory and inhibition contribute to planning, the correlational 
approach cannot prove this as the correlation might represent another shared cognitive 
construct such as processing speed. These findings were extended by Zook, Davalos, 
DeLosh and Davis (2004) who found that working memory and inhibition were 
predictors of the TOH after controlling for fluid intelligence, although this same model 
did not significantly explain performance on the TOL. While both studies suggest that
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the TOL and TOH differ, the results suggest a role of working memory and inhibition in 
planning abilities as determined by the TOH. Specifically it appears that spatial working 
memory and not verbal working memory is involved in the TOH (Handley, Capon,
Copp & Harper, 2002). This suggests that planning several moves ahead on the TOH 
takes up spatial working memory resources and the role of inhibition could be to 
suppress distractions during the task performance. These findings are limited to 
planning within the TOH and may not be applicable to planning in real world situations 
however they do provide some support for the recruitment of a short term memory store 
during planning as described by Miller et al (1960).
A bilateral prefrontal-parietal network has been frequently found to be recruited during 
strategic planning tasks such as the TOH (Newman, Carpenter, Varma & Just, 2003; 
Anderson, Albert & Finch, 2005; Boghi et al., 2006; Newman, Grecco & Lee, 2009) 
which makes this construct a viable candidate for “executive” status. Strategic planning 
is at the core of executive function definitions, as both concepts have been described as 
the organisation of behaviour in order to reach a goal (e.g. Miyake et al., 2000; Banich, 
2009; Koechlin, 2014). Strategic planning is so central to accounts of executive function 
that Kopp (2012) proposed a TOTE conceptualisation of executive function. 
Furthermore, factor analysis methods have found that strategy generation and planning 
are key parts of executive function (Testa et al., 2012) although this model suggested 
they contributed to three separate but related parts of executive function.
1.2.2.5. Decision Making
Decision making is the ability to assess different options, predict the outcomes, and 
select the option which is most beneficial, a process which is undertaken countless 
times in everyday life. The processes by which individuals make decisions are largely 
influenced by a myriad of factors which potentially lead to biases, poor judgement, and 
costly outcomes. One of the major theoretical distinctions in decision making is the 
two-system view (Kahneman & Klein, 2009). This theory suggests that intuitive 
decision making (otherwise known as system one; Stanovich & West, 2000) is fast, 
effortless, emotionally charged, and often influenced greatly by habit (Kahneman & 
Klein, 2009). In contrast, reasoned decision making (system two) is slow, effortful and 
thought out. While system one is often implicit, in which motivations are not always 
clear, system two processing is often clearly explicit. The paradigmatic example which 
defines the two systems is the individual walking across the road with a car speeding
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towards him. The use of the intuitive system would see him jump to safety while a 
reasoned decision making processes would most likely not end well.
Even during system two there is a clear role of emotions which can influence the 
supposedly rational decision making processes. Evidence for this is apparent within the 
framing bias. This cognitive bias is commonly observed when a participant is given £50 
in fake money. They then are given the option as to whether they would like to keep 
£20 or lose £30, both responses resulting in the same outcome. Typically individuals are 
loss aversive with a larger percentage choosing the 'keep £20' option (e.g. De Martino, 
Kumaran, Seymour & Dolan, 2006). Just by framing the question in a different manner 
can have a large effect on the decisions people make, potentially to their detriment.
A development of the role of emotions in decision making was the somatic marker 
hypothesis (Damasio, 1996; Bechara, Damasio & Damasio, 1999; Bechara, Damsio, 
Tramel & Damsio, 2005). Somatic makers refer to bio-regulatory states of the body 
elicited by emotions and can influence decision making consciously or non-consciously. 
Evidence in support of this has come from observing Skin Conductance Responses 
(SCRs) in patients with amygdala damage, VMPFC damage, and normal controls 
(Bechara et al., 1999). Both brain damaged groups displayed significantly reduced 
anticipatory SCRs which was associated with the more disadvantageous card selection. 
In addition amygdala patients failed to develop SCRs in response to reward and 
punishment following card selection. This suggests that in healthy controls the repeated 
exposure to reward and punishment after choosing cards leads to a conditioned SCR 
response which influences subsequent decision making however in individuals with 
amygdala damage this process does not occur. While these findings support the somatic 
marker hypothesis, this type of methodology cannot prove a causal association as the 
SCRs -  or lack thereof - which precede deck selection may not be influencing 
performance and may just be an unrelated artifact of the brain damage.
Neuroimaging data supports the lesions studies with the VMPFC and also the OPFC, 
DLPFC, and amygdala being recruited during decision making processes (De Martino 
et al., 2006; Li, Lu, D'Argembeau, Ng & Bechara, 2010 ). Conceptually, decision 
making processes are not described as controlling other cognitive processes of 
behaviours (Kahneman & Klein, 2009) although other cognitive processes are recruited 
to aid decision making such as information held in working memory (Li et al., 2010).
As system two is a top-down, controlled and willed process, there is a line of reasoning
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which suggests it could be classed as executive (e.g. Miller & Cohen, 2001). Factor 
analysis studies have not included tests of decision making to determine if it would 
form part of a latent variable within an executive function model. These findings 
suggest that system two -  the reasoned decision making system - could be classed as 
executive.
1.2.2.6. Initiation
Initiation is the commencement of a volitional cognitive action usually facilitated 
behaviourally through a motor or verbal response. Dysfunction of initiation was first 
described as psychological inertia which is the body’s propensity to remain in a constant 
state, an aversion to change (Luria, 1976). Although the severest form of inertia tends to 
occur in extreme scenarios such as a symptom of Huntington's disease in which 
initiating movements becomes an increasingly difficult task (akinesia; Wahlin & Byrne, 
2012), much more mild forms of inertia can be very common. The cognitive analogue 
to akinesia has been described in patients with Parkinson's disease and schizophrenia, a 
term referred to as cognitive-akinesia in which a cognitive process cannot be initiated or 
bradyphrenia in which cognitive processes are markedly slowed (Higginson et al.,
2003; Pantellis et al., 1999). Duffy and Campbell's (2001) tripartite theory of executive 
function links initiation with apathy. Their apathetic syndrome includes behavioural and 
cognitive impairments such as diminished spontaneity, diminished verbal output, 
diminished motor behaviour, diminished spontaneous prosody and delayed response 
latency. This is apparent in Powell & Voeller's (2004) review of executive function in 
children, in which initiation is described in terms of procrastination. The suggestion of 
emotion being tied to initiation is supported by a study demonstrating that positive 
mood boosted performance on a verbal fluency test, a class of tests suggested to involve 
initiation (Phillips, Bull, Adams & Fraser, 2002). No such research has been conducted 
observing the effects of motivation of initiation tasks.
While patients with severe cases of neurodegenerative conditions (e.g. Wahlin & Byrne, 
2012) may have trouble initiating cognitive acts (e.g. plans), motor acts (e.g. hand 
movements), or verbal acts (e.g. speech), individual differences in healthy individuals 
cannot be measured in such ways due to the ceiling effects that would arise from testing 
whether an individual (for example) can move their hand . Due to this problem, many 
tests of initiation examine the extent to which an individual can repeatedly initiate acts 
at a fast rate (e.g. verbal fluency tests).
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The definition of initiation is quite vague and has not received the same level of 
theoretical or empirical attention as some of the other executive function components 
(e.g. Anderson, 2002; Powell & Voeller, 2004) and thus it becomes difficult to 
determine which initiated behavioural actions can be classed as "executive". A 
differentiation in neural correlates for volition vs. reflexive responses has been 
discovered using a saccade task and an eye-tracking methodology (Mort et al., 2003). 
These top-down, willed initiated acts could be classified as executive while automatic 
initiated acts (i.e. reflexes) which can be differentiated are not executive. Tests of 
fluency also recruit PFC regions included the left IFC (Costafreda et al., 2006) and 
these tests also form central parts of factor analysis-derived executive function models 
(Testa et al., 2012).
1.2.2.7. Abstract Reasoning and Conceptual Thought
Abstract reasoning and conceptual thought are regularly cited as executive functions 
although are often just described as a process which contributes towards performance on 
the Wisconsin Card Sorting Task (WCST; Lysaker, Bell, Bryson & Kaplan, 1998; 
Powell & Voeller, 2004). The nature of concept formation and abstract reasoning is 
generally applicable to the ability to form concepts about objects and being able to 
group them into categories based on visual, tactile, semantic or abstract rules. The 
Dysexecutive Questionnaire (DEX; Wilson, Alderman, Burgess, Emslie & Evans, 1996) 
contains a single item which measures abstract reasoning: "S/he has problems 
understanding what other people mean unless they keep things simple and 
straightforward". This highlights the real-world applications of abstract reasoning, the 
requirement for an individual to infer meaning where limited concrete information is 
provided.
Two categories of tasks involve a particular type of abstract reasoning - inductive 
reasoning- and these are the WCST and matrix reasoning tests (Primi, 2001; Specht,
Lie, Shah & Fink, 2009). Primi (2001) describes the three stages of the reasoning 
process; 1) perceptual and conceptual analysis of the available stimuli in order to infer 
the rules; 2) the recognition of the parallels between these rules and a new analogous 
situation; 3) inferring the correct sorting structure (i.e. WCST) or pattern (i.e. Matrix 
Reasoning) based on these rules. The author also concluded that abstraction complexity 
is highly related to the central executive (Baddeley & Hitch, 1974).
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Looking at a complex task such as the WCST during fMRI poses a number of problems 
when trying to dissociate the different process involved and determine which neural 
activity which underpins abstraction and concept formation. Lie, Specht, Marshall and 
Fink (2006) used three different versions of the WCST varying in task complexity and a 
baseline condition with multiple contrast measures available, providing the basis to 
partial out different processes recruited during the tasks. These authors suggest that the 
number of sorting dimensions completed on task 'A', the most difficult of the tasks and 
comparable with the traditional WCST, provides a measure of concept formation and 
goal-directed behaviour. This measure was correlated with activity within the right 
DLPFC, the left inferior temporal gyrus and the left superior parietal cortex. A meta­
analysis of WCST performance in general, without the decomposition of individual 
cognitive components shows a wide pattern of brain activation, with key areas being 
identified as the inferior parietal lobule (IPL), the ACC, the bilateral IFG and the 
cerebellum (Buchsbaum, Greer, Chang & Berman, 2005). This suggests that the PFC 
has a role in abstract reasoning and concept formation, indicative of executive 
functioning. While this process does is not directly involved in the control of other 
processes, the reasoning process is a willed and top-down process (Primi, 2001), also 
indicative of executive functioning. Factor analysis studies using the WCST found that 
task analysis, which is similar to Primi’s (2001) first reasoning stage: perceptual and 
conceptual analysis of the available stimuli in order to infer the rules, was one of the 
latent variables within a six factor model of executive function (Testa et al., 2012). It is 
not clear if the other stages of Primi’s account of reasoning are central to executive 
function based on factor analysis, however it does appear that abstract reasoning and 
conceptual thought processes are executive in nature.
1.2.3. Summary
Although defining executive function is a controversial task there are several areas of
agreement. A large body of evidence now suggests that executive function is
fractionable and made up of multiple components. This section has identified a series of
seven dissociable, albeit highly interlinked, executive function components. These
executive function processes appear to recruit prefrontal and cingulate cortical areas, in
addition to supplementary regions like the basal ganglia and amygdala. These brain
regions contain moderate-to-high levels of CBi receptors (see Figures 1.3 and 1.4),
which present the potential for the influence of cannabis on executive function
(Herkenham et al., 1990). These findings highlight that prefrontal regions and networks
40
involved in executive function could be more at risk to the effects of cannabis than other 
processes and behaviours, given that cannabis primarily interacts with the brain through 
CBi receptors (Grotenhermen, 2003).
1.3. The Age of Onset of Cannabis Use
At birth the brain weighs approximately one-third of its adult weight and continues to 
grow and mature through childhood and adolescence, synaptic connections are created 
and pruned, axons are myelinated, neurotransmitter levels and their receptors undergo 
large changes (see Figure 1.8; Rice & Barone, 2000). All of these changes create a 
potential for vulnerability to exogenous factors such as drugs, "Much of the potential 
and many of the vulnerabilities of the brain might, in part, depend on the first two 
decades of life" (Toga, Thompson & Sowell, 2006; p. 148). The following sections will 
discuss the development of the brain in terms of structural, functional and cognitive 
changes, and will then address how environmental factors, such as exposure to 
cannabis, can alter the developmental trajectory depending on the age at which the 
individual is exposed.
Age (yr) B 8 12 18 24 32
Brain Development
Neurogenesis*
Synaptogenesis
Synapse Pruning 
Myelination
Figure 1.8. A timeline of brain development reproduced from Kolb, Mychasiuk & Gibb 
(2013; p.2)."* Neurogenesis is largely complete by 6 months gestation but continues in 
the cerebellum up to the eighth postnatal month and in the hippocampus and 
subventricular zone throughout life."
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I.3.1. Structural Development
Postnatal neuromaturation studies of grey and white matter have found a developmental 
trajectory which continues throughout childhood and well into the third decade of life.
A number of studies show that white matter, which serves as a communication platform 
between brain structures, continues to increase in volume into the second and third 
decade (Reiss et al., 1996; Giedd et al., 1999; Paus et al., 1999). The exact nature of 
these changes is clarified due to studies examining fractional anisotropy (FA). FA 
describes the extent to which a substance (typically water) diffuses equally in all 
directions (isotropic diffusion) or just along one axis (anisotropic diffusion). The 
interactions between the protons within the water and white matter within a singular 
image voxel can describe fibre density, fibre diameter and myelin sheath diameter 
(Pierpaoli & Basser, 1996; Barnea-Goraly et al., 2005). Studies show age-related 
increases in FA in a diverse number of brain areas including prefrontal, temporal, basal 
ganglia and thalamic pathways (Barnea-Goraly et al., 2005; Ashtari et al., 2007).
Ashtari et al (2007) describe their findings of age-related increases in FA, along with 
increased axial diffusivity and no changes in radial diffusivity, as improved white 
matter organisation due to a reduction in tortuosity, which is a product of adolescent 
development. One study which increased the maximum age beyond the 20s to 76 years 
found that white matter changes within the frontal and temporal lobes peak around the 
middle of the fifth decade, suggesting that development does not stop at adolescence 
(Bartzokis et al., 2001).
Unlike white matter, grey matter structures do not develop linearly throughout 
adolescence (Giedd et al., 1999). Giedd et al (1999) report that grey matter across three 
of the four lobes reaches peak volume in the second decade and then begins to decline. 
Frontal, parietal and temporal lobes reach their respective peak volumes between ages
II.0-12.1 years, 10.2-12.1 years and 16.5-16.7 years, which then all decline in volume 
until the maximum age tested at 22 years. Conversely, the occipital lobe's volume 
increased linearly between the tested ages of 4 and 22 years. Many grey matter 
structures follow the three most anterior of the lobes in this typical developmental 
pattern, with dendritic arborisation and subsequent synaptogenesis leading to peak 
volumes at an early age. Dendritic and synaptic pruning then takes over to enhance the 
efficiency of the surviving neural connections. Post mortem examination of a section of 
the prefrontal cortex, the left middle frontal gyrus (1MFG), and a section of the auditory 
cortex, the left Heschl's gyrus, was conducted to examine the time course of
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development from conceptual age 192 - 22300 days (Huttenlocher & Dabholkar, 1997). 
These two different grey matter structures show different rates of development, yet both 
following the same pattern. The auditory cortex reached peak synaptic density at age 3, 
while the MFG reached peak synaptic density at age 3.5. Synaptic elimination was over 
by age 12 for the auditory cortex but the MFG displayed a much more protracted 
development, with synaptic elimination appearing to continue into mid-adolescence. 
This relatively protracted development of the frontal lobes compared with other lobes is 
well supported (Gogtay et al., 2004; Sowell, Thompson, Holmes, Jernigan & Toga, 
1999; Sowell, Trauner, Gamst & Jernigan, 2002). Within the frontal lobes there is 
evidence for different prefrontal cortical gyri to mature at different rates (Gogtay et al., 
2004). This study examined the developmental trajectories of the DLPFC, the VMPFC 
and the OFC. The authors found that the DLPFC matures last in terms of grey matter 
volume reductions, preceded by the VMPFC, while the OFC matures earlier. This 
heterogeneous pattern of development was reflected throughout the cortex, with other 
gyri following separate developmental paths.
1.3.2. Functional Development
Positron emission tomography (PET) is a method of determining functional brain 
activity via glucose metabolism using radioactive isotopes (Banich, 2004). A review of 
the PET studies shows a vast amount of evidence for the development of functional 
brain activity throughout the first two decades of life (Chugani, 1998). This review 
found that functional activity was similar to that of structural brain development and 
cognitive development. Glucose metabolism within the first few years is highest in 
areas which are necessary for survival (i.e. heart rate, breathing, & homeostasis) and 
experience (i.e. movement & sensory input); the brain stem, the thalamus, the primary 
motor cortex and primary sensory cortex. Conversely, within this time period, other 
cerebral activity is relatively low. Cerebral activity follows a sharp incline in baseline 
activity levels throughout the first decade in life and reaches its peak between ages four 
and nine, and similar to the structural findings - the frontal lobes mature latest (Gogtay 
et al., 2004). This peak in functional activity is followed by a slow decline throughout 
the second decade of life to around ages 16-18 when glucose metabolism reaches an 
adult level.
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1.3.3. Cognitive development
Developmental methods such as longitudinal and cross-sectional designs have been 
applied to cognitive development and produced varying degrees of clarity dependent on 
the specific function being measured. A meta-analysis by Romine & Reynolds (2006) 
grouped tasks into planning, verbal fluency, design fluency, inhibition of perseveration, 
and set maintenance. The findings displayed large increases in ability between ages five 
and 11, medium increases between 11 and 14 years, and mixed changes between 14 and 
years and adulthood dependent on the specific functions (see Figure 1.9).
Additional work on other areas of inhibition such as behavioural and interference 
control has shown that maturation occurs in the late teens to early twenties (Brocki & 
Bohlin, 2004; Hooper et al., 2004; Huizinga, Dolan & van der Molan, 2006; Taylor, 
Barker, Reidy & McHale, 2012). It appears that development of the set switching 
construct continues to develop throughout the second decade of life yet the rate of this 
maturation process is too slow to detect differences over small periods of time 
(Huizinga et al., 2006; Anderson, Anderson, Northam, Jacobs & Catroppa, 2001). 
Working memory appears to mature a little earlier, around age 15, for both spatial and 
verbal working memory tasks (Anderson et al., 2001; Huizinga et al., 2006). The 
development of planning abilities differed across different outcome measures from the 
same task with some suggesting a late teen maturation point, and other finding that 
performance increased to the eldest age tested, at 22 (Anderson et al., 2001; Huizinga et 
al., 2006; Taylor et al., 2012; Romine & Reynolds, 2005). Like planning, decision 
making and abstract reasoning also increased in performance to the eldest age group 
tested, suggesting that these processes also continue to mature into the twenties 
(Hooper, Luciana, Conklin & Yarger, 2004; Huizinga et al., 2006; Taylor et al., 2012). 
Verbal fluency gives the most inconsistent results out of all of these processes with no 
age differences being detected between 11-17 (Anderson et al., 2006) and performance 
decreasing between 17 and 18 (Taylor et al., 2012). As the tasks used to measure these 
processes are not process pure (e.g. Sanchez-Cubillo et al., 2009) it is difficult to 
determine development especially if two different cognitive processes which are 
recruited by one task mature at different rates. This needs to be considered when 
inferring a developmental path.
Although there are non-parallel developmental trajectories between executive function 
components, there exists a clear trend for these abilities to improve from childhood
44
throughout adolescents towards adulthood. This trend may not be linear over short 
periods of time, and some temporal fluctuations may appear around age 18 in particular 
(Taylor et al, 2012), yet it is clear that overall, executive function continues to mature 
late into the second decade of life, and even into the third (Hooper et al., 2004; 
Anderson et al., 2006; Huizinga et al., 2006).
In the table and figure below there is a summary of the developmental data discussed in 
this section. It is worth highlighting that the state of the research has not progressed to a 
point where the stages of development are clear and uncontroversial. The information 
below should represent an estimate rather than a final conclusion. Furthermore, the 
years at which development reaches a maturation point is taken from the average age 
across samples and it should also be noted that individual differences, such as sex, will 
influence when a specific individual reaches their own maturation point.
Table 1.1.
A summary o f the estimated age at which each component o f executive function reaches 
maturation.
EF Components Age of Maturation
Inhibition
Behavioural Inhibition 14-17
Interference Control 15-21
Perseveration 14
Set Switching 16-17
Working Memory 15
Strategic Planning 17-22*
Verbal Fluency NC
Decision Making 14-17*
Abstract and Conceptual Thought 15-21*
Note. NC = Not clear based on the available data; * = performance improved up to the eldest group 
in respective study, therefore it is unclear whether performance would continue to improve beyond 
this point.
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Figure 1.9. A graph reproduced from Romine & Reynolds (2005) showing the 
developmental trajectory of various executive function components.
1.3.4. A Vulnerable Period?
This section looks at some of the evidence for the claim presented by Toga et al seen in 
at the beginning of section 1.3. "Much of the potential and many of the vulnerabilities of 
the brain might, in part, depend on the first two decades of life" (Toga, Thompson & 
Sowell, 2006; p. 148). While evidence for earlier onset brain damage conferring greater 
cognitive consequences has been discovered in patients with brain trauma (Barker, 
Andrade, Morton, Romanowski & Bowles, 2010), the claim will be examined in 
relation to whether this period of development is vulnerable to drug use.
1.3.4.1. Structural evidence
Given that the endocannabinoid system has a role in brain development (Lubman, 
Cheetham & Yucel, 2014) it has been suggested that exposure to exogenous 
cannabinoids could interfere with normal development via a CBi receptor mechanism. 
The changing regional dependent availability of CBi receptors throughout development 
may mediate the level of interference by such cannabinoids (Romero et al., 1997).
Studies examining rats have provided some of the most in depth findings regarding the
impact of cannabis on the structural integrity of the brain. Rubino et al (2009)
administered THC to adolescent rats and then examined them again at adulthood.
Results showed lower synaptic density, dendritic length and number within the
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hippocampus, in addition to decreases in pre and post synaptic proteins (VAMP2; 
PSD95) crucial for intra-neuronal communications such as synaptic vesicle 
transportation and fusion with the cell membrane. The authors concluded that these 
abnormalities will reduce synaptic numbers and efficiency of synaptic transmissions. 
This study did not include an appropriate non-adolescent THC administered control 
group but instead cited papers which suggest that THC administered later in life has no 
long lasting effects (Schneider & Kock, 2003). Therefore it could be argued that this 
study only provides evidence for the toxicity of cannabis, rather than providing 
evidence that it interferes with development. In comparison to human studies, this study 
of cannabis on rats was truly experimental, and thus causation was easier to infer.
In humans there is also evidence to suggest a vulnerable period to cannabis use (Wilson 
et al., 2000). A group who started using cannabis before the age of 17 was compared to 
those who started using after the age of 17 and under went MRI examination in search 
of morphological differences. The key findings included lower grey matter volume in 
the early users and this reduction was most marked within the frontal lobes. There was 
no relationship between volume and duration of use, suggesting that the early group did 
not present with volume reduction simply due to extended periods of cannabis use, but 
because of a vulnerability to the drug during a developmentally crucial period. Unlike 
the studies previously discussed involving rats (i.e. Rubino et al., 2009) this study was 
cross-sectional and therefore the causal nature of the interaction cannot be determined.
1.3.4.2. Cognitive evidence
There exists several pieces of evidence derived from studies on cognition; however 
these are discussed in section 1.4 under the title of executive function deficits in 
cannabis users.
1.3.5. Age of Onset Summary
The frontal lobes, and in particular, regions of the prefrontal cortex mature late into the 
second and even third decade of life. Although there is not a clear parallel with 
morphological development, executive function development also continues to mature 
throughout the second and occasionally into the third decade of life. Studies on humans 
and rodents have highlighted preliminary evidence for a risk of damage within this 
developmental period, with early onset exposure to cannabis leading to greater 
structural, functional, and cognitive abnormalities than later onset exposure.
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1.4. Executive Function Deficits in Cannabis Users
The aim of this section is to provide an update on the current state of the research on 
chronic cannabis use and cognition, and present a case for the investigation into the 
effects of the age of onset of cannabis use and executive function. Furthermore, as there 
is a lack of process-pure tasks it is acknowledged that performance deficits discovered 
in previous research may not be due to the specific theoretical cognitive constructs 
suggested here, however based on task reviews and individual author interpretations it is 
aimed to best attribute task deficits into an appropriate cognitive domain. Within each 
cognitive domain several areas will be discussed: the differences between cannabis 
users and controls, the quantity and duration of cannabis use, the effect of the age of 
onset, and neuroimaging findings.
The papers discussed in the following section were chosen based on criteria set out by 
Gonzalez et al (2003). Each study must include 1) a group with a history of "primarily" 
cannabis use; 2) includes an appropriate control group (this is not always the case for 
studies looking at dose-related responses); 3) outcome measures using valid 
neuropsychological tests (un-validated tests are common with neuroimaging devices 
and therefore this does not apply to the neuroimaging discussions); 4) cannabis group is 
drug free on day of testing; 5) study addresses other potential substance use; 6) study 
addresses potential history of neurological or psychiatric problems.
1.4.1. Inhibition
The impact of cannabis has been primarily explored on two inhibitory processes: 
interference control (e.g. the Stroop test) and behavioural inhibition (e.g. Go-No/Go 
tests).
1.4.1.1. Cannabis users vs. controls
Pope, Gruber, Hudson, Huestis and Yurgelun-Todd (2001) along with Gruber et al 
(2011) tested abstinent cannabis users' performance on the same version the Stroop task 
and compared the results with control groups, yet found no marked differences in errors 
made or time taken between the groups. A comparable study with a different version of 
the Stroop task also failed to uncover performance differences between the two groups 
(Solowij et al., 2002). Thames, Arbid and Sayegh (2014) found that recent cannabis 
users (use in the past month) and past cannabis users (no use in the past month) both 
presented with deficits in “executive function”. This variable was a composite score of
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two tests, the Trail Making Test (B-A) and the Stroop test (interference condition). 
Although attributing the deficits to one task or the other becomes problematic, it is 
possible that the impairments detected could be at least part due to interference control, 
as measured by the Stroop test.
1.4.1.2. Quantity o f cannabis use
Although no differences in performance were found between controls and cannabis 
users on the Stroop task (Solowij et al., 2002) there did appear to be a negative 
relationship between years spent smoking cannabis and performance on two outcome 
measures of the task. Bolla et al (2002) also found that the number of spliffs consumed 
per week predicted worse Stroop performance. Contrary results were obtained by Pope 
and Yurgelun-Todd (1996) who administered a version of the Stroop task to heavy 
cannabis users and light cannabis users. This comparison failed to find a direct dose- 
related response between heavy and light using cannabis groups. When the two groups 
were divided into same sex groups, the authors found that the male heavy users took 
significantly longer to complete the task than male light users while no differences were 
present for the females. The authors pointed out that males did not differ greatly from 
females in terms of recent or lifetime cannabis use, but suggest that males may consume 
more cannabis on an individual session than females, thus explaining the discrepancy. 
This suggestion was untested however, and remains speculative.
1.4.1.3. The age o f onset o f cannabis use
There have been two studies which have examined the effect of the age of onset of 
cannabis use on inhibition. Pope et al (2003) recruited a number of cannabis users into 
their study and divided them into early and late onset cannabis users (<17 & >17 years 
old, respectively) while Gruber et al (2011) chose a slightly different age criterion for 
their early and late onset groups (<16 & >16 years, respectively). Both studies 
administered the Stroop task however only Gruber et al found an effect of the age of 
onset. The findings showed that controls outperformed the early group but no 
differences were detected between controls and the late onset cannabis users. A further 
approach using a correlational analysis found that the age of onset was correlated with 
performance on three separate outcome measures from the interference condition of the 
Stroop task: omission errors, commission errors and performance accuracy.
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1.4.1.4. Neuroimaging data
Battisti et al (2010) used a computerised version of the Stroop task paradigm with 
cannabis users and controls while EEG examination was conducted. Contrary to earlier 
findings, the cannabis users presented with behavioural deficits, making a greater 
number of errors on the incongruent condition and showing normal performance on the 
congruent tasks. Furthermore, the users presented with altered electrophysiological 
readings as determined by ERP analysis, in which levels of activation for a conflict 
resolution marker, varied between conditions. Similar findings have been discovered 
under PET and fMRI examination. Eldreth et al (2004) used a Stroop paradigm during 
PET and found that cannabis users showed no behavioural deficits, yet presented with 
underlying metabolic abnormalities. During the incongruent task the cannabis users 
presented with hypoactivity within the ACC and hyperactivity within the left lateral 
PFC relative to controls. Gruber and Yurgellun-Todd (2005) used fMRI during a Stroop 
task and found that overall there were no differences in task performance between users 
and controls. Imaging data also supported the findings of Eldreth et al (2004), as 
cannabis users presented with lower ACC activity and increased bilateral dorsolateral 
PFC activity compared to controls during the incongruent condition. These findings 
suggest that although behavioural deficits may not always be present on interference 
tasks such as the Stroop, there are underlying functional abnormalities that can be 
detected using EEG, PET and fMRI techniques.
Hester, Nestor and Garavan (2009) found no performance differences on a go/no-go 
task between abstinent cannabis users and controls, however cannabis users presented 
with increased activity during the inhibition part of the task within the right putamen, 
IPL and middle cingulate gyrus. Tapert et al (2007) also found no differences in 
performance on the go/no-go task between users and controls. Imaging data also 
showed increased activity in the cannabis users during the inhibition section of the task, 
specific to the right dorsolateral PFC and occipital gyri, and bilaterally in the medial 
frontal cortex, IPL and SPL. These findings suggest that cannabis affects behavioural 
inhibition as measured by the Go/No-Go tasks in the same manner as interference 
control as measured by the Stroop task. Specifically, it means that even though group 
differences are not always found on the behavioural data there tends to be different 
levels of regional brain activity during these tasks between cannabis users and controls.
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1.4.1.5. Summary
The studies which are reviewed here regarding the effects of chronic cannabis use on 
inhibitory processes suggest the impairments are mild, very rarely reaching the 
behavioural level and are unlikely to be picked up by current cognitive assessment 
tools. Despite differences between controls and cannabis users not being detectable 
there is now evidence for an effect of quantity of cannabis use effecting inhibitory 
processes with several studies reporting similar results (Pope & Yurgellun-Todd, 1996; 
Bolla et al., 2002; Solowij et al., 2002). It is not clear whether recruiting a sample of 
more heavy cannabis users would result in differences between cannabis users and 
controls becoming visible as Solowij et al (2002) recruited a cannabis using group 
which had a greater frequency of use (days per month) than Pope and Yurgellun-Todd's 
(1996) 'heavy' cannabis users, and found no such between group differences. 
Furthermore, Solowij et al’s (2002) cannabis sample reported a very long duration of 
use (23.9 years). It is therefore possible that cannabis use does affect inhibitory 
processes at a minor level, with behavioural tasks struggling to detect differences 
between cannabis users and controls. This is supported by neuroimaging studies which 
consistently find abnormalities at electrophysiological and metabolic levels, with 
neuroimaging tools such as EEG, PET and fMRI picking up abnormal activity during 
the task processes, while the less sensitive behavioural data rarely picks up on 
abnormalities present in cannabis users. This highlights the need for more sensitive 
behavioural measures for detecting mild impairments in cognitive and neural 
functioning.
A further explanation for the mixed findings between controls and cannabis users is 
highlighted by Gruber et al (2011) who found no differences in the Stroop task between 
controls and cannabis users, however when dividing the group into early and late onset 
users, differences in performance emerged between controls and early users. It is 
possible that if other studies had also made such a distinction they would have detected 
similar deficits.
A third explanation for the findings is that cannabis use is not a causal factor in the mild 
impairments in inhibitory processing, but rather individual differences in inhibitory 
processes are a causal factor which led to the onset of cannabis use. It has been argued 
that one of the key explanatory factors behind drug use and abuse is a maladapted 
impulse system which has failed to be controlled by higher order cognitive processes
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(Bechara, 2005). It appears that there is support for cannabis use leading to impaired 
inhibition, inhibition deficits leading to cannabis use and also support for a third 
variable explaining both occurrences (Perry & Carroll, 2008). Although it is not clear at 
this stage, it could be that the impairments in neural functioning relating to behavioural 
inhibition found in cannabis users (e.g. Hester et al., 2009) could reflect the cause of 
their cannabis use rather than a product of it, while a dual causation explanation is also 
viable.
1.4.2. Set Switching
Set switching is the ability to switch between multiple cognitive tasks or 'sets'. Tasks 
which fall under the prespecified task sequence structure, in which the switch occurs 
consistently and predictably, include the TMT/Trails B (e.g. Delis et al., 2001). The 
second group are tasks which use a task-cueing (or cognitive flexibility) paradigm, in 
which the switch cue occurs on the task itself and the participant must respond to the 
new information by making a switch to an alternative response. A classic example of 
this paradigm is the WCST (e.g. Berg, 1948).
1.4.2.1. Cannabis users vs. controls
The effects of cannabis on TMT performance are inconclusive as one study examining 
performance between cannabis users and controls showed that users took longer and 
committed more errors on the switching component of the TMT (Medina et al., 2007). 
One study found no significant differences between cannabis users and controls on the 
TMT B (switching component) however the authors do report a trend towards cannabis 
users taking longer to complete the task (Gruber et al., 2011).
This contradicts an earlier, comparable study by Pope et al (2001) which did not find 
this trend. As discussed in the section on inhibition (1.4.1.1), Thames et al (2014) found 
that current and past cannabis users were impaired on a measure o f “executive function” 
which combined the TMT (B-A) and the Stroop test. It is possible that the deficits were 
at least partly due to impairments in set switching, as measured by the TMT (B-A). It is 
possible that methodological differences influence these mixed results as Medina et al 
(2007) used the Delis Kaplan Executive Function System (D-KEFS; Delis et al., 2001) 
version whereas the remaining studies used the Trails A and B version (e.g. Lezak et 
al., 2004). These two tests have the same rules and requirements but the stimuli are set 
out in different ways perhaps yielding varying degrees of sensitivity.
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A study by Solowij et al (2002) did find deficits on the WCST, confined to the measure 
'maintaining the set' which is interpreted as attentional dysfunction, while perseverative 
errors are more indicative of cognitive flexibility. These findings were replicated by 
Gruber et al (2011) who also found deficits on the WCST which could be explained by 
cognitive inflexibility.
1.4.2.2. Quantity/duration o f cannabis use
Pope and Yurgelun-Todd (1996) found that heavy cannabis users produced more 
perseverative errors in the WCST and completed fewer categories on the WCST than 
light users. These two differences could potentially be attributed to impaired set 
switching processes. These findings were replicated by Bolla, Brown, Eldreth, Tate and 
Cadet (2002) who also examined the dose-related effects of cannabis and found the 
heavy users completed fewer categories than light users. This was the only outcome 
measure from the WCST discussed, and it is possible that although perseverations 
influenced the number of categories completed in the study by Pope and Yurgellun- 
Todd, this may not be the case with Bolla et al as another cognitive process such as 
concept formation could contribute to the underlying deficit. Furthermore, Bolla et al., 
(2002) examined the dose related effects of cannabis and did not find a significant effect 
on TMT performance.
1.4.2.3. The age o f onset o f cannabis use
There is further evidence of dissociation between the two separate forms of switching 
tasks. Cognitive flexibility as determined by total perseverations was impaired in early 
cannabis users compared to controls and interestingly, also compared to late cannabis 
users (Gruber et al., 2011). Across other cognitive domains, early onset users’ 
performance were frequently impaired to controls, but this occurrence of early onset 
users being impaired relative to late users highlights quite a substantial effect of the age 
of onset of cannabis use. Performance as measured by ’total categories' was also 
impaired in early cannabis users compared to controls, while there was no difference 
between late cannabis users and controls. This measure (total categories) is less related 
to cognitive flexibility and could be more easily attributed to concept formation. The 
same study reported no differences between controls, early cannabis users and late 
cannabis users on any of the measures of the TMT (Gruber et al., 2011) suggesting that 
cognitive flexibility may be more vulnerable to long term cannabis use than predictable
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task switching. It is also possible that the difference reflects other contributory 
processes which contribute towards task performance as both tasks are not process pure.
Pope et al (2003) found evidence on impaired performance on the WCST, however 
these effects disappeared when controlling for verbal IQ. As verbal IQ was impaired in 
the cannabis using group it is possible that cannabis also had a causal impact of verbal 
IQ rather than just representing a bias in the recruitment method leading to group 
differences. If the problem of causation is disregarded the use of the covariate still 
suggests that the deficits on the WCST were not due to cognitive flexibility but could be 
explained by a common cognitive process between the WCST and verbal IQ although 
it is not clear what this could have been.
1.4.2.4. Neuroimaging data
There are many studies which have adapted standard set switching measures into 
versions which are complementary with the methods employed during various 
neuroimaging devices (e.g. Dove, Pollmann, Schubert, Wiggins & Cramon, 2000; 
Swainson et al., 2003) however a study looking at performance on these tasks combined 
with PET or fMRI data on a sample of cannabis users has not been discovered (last 
searched on 13/03/15). This is an area worthy of further investigation.
1.4.2.5. Summary
When observing the two forms of set switching (prespecified & task-cueing) it is clear 
the latter is impaired in cannabis users, an effect which appears to be related to both the 
quantity of cannabis used and the age of onset of cannabis use. The evidence suggesting 
prespecified task sequence impairment, as measured by performance on the TMT, is 
much more equivocal and needs further research to clarify the inconsistencies. Unlike 
inhibition research, the effects of cannabis on the neural underpinnings of set switching 
have not been examined and thus it cannot be concluded if abnormal activation in a 
manner similar to that with the Stroop task, mediate the performance on the TMT or 
WCST.
1.4.3. Working Memory
The focus of working memory performance in chronic cannabis users will be discussed 
in both verbal (VWM) and visuospatial (VSWM) modalities, and with regards to the 
maintenance or updating of this information. For the purposes of this section only 'pure'
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tasks will be discussed, this refers to tasks which have a primary outcome measure that 
can be attributed to working memory over other processes. Tasks such as the verbal 
fluency test, which partially rely on verbal working memory, will be discussed in a 
different section.
1.4.3.1. Cannabis users vs. controls
From the three studies employing working memory tasks which did not include a 
neuroimaging component, the Cambridge Neuropsychological Test Automated Battery 
(CANTAB; Fray, Robbins & Sahakian, 1996) was used in all instances. The first study 
reported that chronic cannabis use impairs spatial working memory as determined by 
two outcome measures, number of errors made and spatial working memory strategy 
(Harvey, Sellman, Porter & Frampton, 2007). A second study, also employing the 
CANTAB, found that spatial working memory was intact (Grant, Chamberlain, 
Schreiber & Odlaug, 2012). Becker, Collins and Luciana (2014) administered four 
separate assessments of spatial working memory. The two spatial working memory 
subtests from the CANTAB were used (Self-Ordered Search and Spatial Recognition) 
in addition to a computerised version of the Corsi-Blocks task and the Spatial Delayed 
Response Task (DRT). Three of the four tasks did not uncover performance differences 
between cannabis users and controls however the DRT did show that cannabis users 
spatial working memory was impaired after varying levels of time delays. It is not clear 
why only one task was impaired as the DRT shares many similar features with the other 
tasks administered. The authors did not comment on this discordance.
A common assessment of verbal working memory, the digit span task, has not 
uncovered any deficits in cannabis users on either of the forward or backward 
conditions across multiple studies (Gruber et al., 2011; Becker et al., 2014). A different 
assessment of verbal working memory, the letter-number sequencing test from the 
WAIS-III, did uncover performance deficits in cannabis users at two out of three 
occasions after abstinence was initiated (Hanson et al., 2010). The first testing occurred 
at 3.3 days since last use, the second testing at 13.3 days since last use and the final 
testing at 21.0 days (mean-average times). This longitudinal approach not only provides 
evidence of impairment in verbal working memory but also shows that performance 
reaches levels comparable with controls after three weeks. This perhaps suggests the 
impairments are only the residual effects of the cannabinoids in the body rather than 
evidence for the neurotoxicity of cannabis.
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1.4.3.2. Quantity/Duration o f cannabis use
The previous studies discussed which have looked at cannabis users and controls on 
various measures of verbal and spatial working memory did not conduct analyses 
observing the quantity or duration of cannabis use. Solowij et al (2002) did use the 
Omitted Numbers working memory test, however they found no performance 
differences between groups when testing controls, short-term cannabis users (10 years 
of use) and long term cannabis users (23 years of use).
1.4.3.3. The age o f onset o f cannabis use
As with a number of other cognitive domains, Gruber et al (2011) looked at the effect of 
the age of onset of cannabis use on verbal working memory. As with their prior analysis 
on cannabis users and controls, their age of onset analysis failed to show any 
performance differences on either the forward or backwards conditions of the digit span 
task. This suggests that the age that one commences cannabis use does not have an 
effect on verbal working memory, however due to the lack of research on verbal 
working memory and the complete absence of evidence regarding spatial working 
memory it is too soon to come to a conclusion.
1.4.3.4. Neuroimaging data
Evidence suggests that cannabis users are not impaired on tasks which require the 
maintenance of spatial working memory representations (Kanayama, Rogowska, Pope, 
Gruber & Yurgelun-Todd, 2004) however fMRI data from the same study showed that 
the cannabis users had increased activation in regions commonly associated with spatial 
working memory including the DLPFC, in addition to more widespread activation when 
compared to controls. These findings were supported by a study using a spatial n-back 
paradigm (Schweinsburg et al., 2008), however due to the participants being required to 
simply determine whether any space had been occupied before in a block of 10 
randomly appearing shapes, as opposed to a given number of preceding stimuli (e.g. 
three shapes before) this task does not tap into the same executive processes of spatial 
working memory manipulation that the normal n-back task does. The findings showed 
no behavioural differences between groups on the tasks however fMRI data indicated 
that cannabis users had abnormal activation patterns during the task located to the right 
DLPFC and right posterior parietal cortex in addition to the inferior and superior medial 
occipital cortex.
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The maintenance of verbal working memory representations as measured by the 
Sternberg task also appears to be unaffected by chronic cannabis use (Jager, Kahn, 
Brink, Ree & Ramsey, 2006). The task resulted in expected activation in both groups in 
common regions associated with verbal working memory including the DLPFC and 
superior parietal cortex, however the latter of these two regions displayed different 
activation levels in cannabis users relative to controls, within activity failing to decrease 
as working memory load was reduced. In contrast, controls displayed activation levels 
which were commensurate with task complexity.
1.43.5. Summary
The non-neuroimaging studies and the neuroimaging studies' behavioural data suggest 
that both verbal and spatial working memory are largely unaffected in cannabis users. A 
wide range of tasks were administered in the spatial domain and only limited evidence 
supported the proposition that cannabis users are impaired in these cognitive domains. 
Although fewer studies have ventured into the study of verbal working memory a 
similar pattern emerges, that performance is unaffected in cannabis users. Despite these 
behavioural findings, there is consistent evidence that functional activity within the 
DLPFC is different in chronic cannabis users across both domains of working memory. 
As with the inhibition component, it appears that altered working memory functioning 
at the neuronal level is yet to manifest itself at a behavioural level which therefore is 
undetectable by cognitive test performance. This could be due to a compensatory 
mechanism highlighted by the regional hyperactivity and more widespread network 
activation.
Regarding the contribution of quantity and the age of onset of cannabis use, there is too 
little research to ascertain whether or not these factors play a role in the cognitive or 
functional differences between cannabis users and controls.
1.4.4. Planning
Planning and strategy formation are commonly measured by a series of similar tasks 
known as 'towers'. Common examples include the Tower of London (Shallice, 1982), 
Stockings of Cambridge (Fray et al., 1996), the Tower of Hanoi (e.g. Goel & Grafman,
1995) and the D-KEFS' Towers test (Delis et al., 2001). In fact, as Goel & Grafman 
(1995) point out, many authors mistakenly cite the wrong towers test when reporting 
their own data. Although the tests are similar, there are some clear differences. An
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additional test is the Jansari-Agnew-Akesson-Murphy (JAAM; Janasari, Agnew, 
Akesson & Murphy, 2004) test which is an ecologically valid virtual reality test which 
involves organising a diary and other office based tasks which involve planning.
1.4.4.1. Cannabis users vs. controls
Cannabis related deficits have been found on the planning subscale of the JAAM 
(Montgomery et al., 2012) and on the strategic working memory component (also 
known as the Self-Ordered Search test) of the CANTAB (Harvey et al., 2007). All of 
these studies using measures of planning and strategy formation have discovered 
evidence of cannabis induced impairments. Becker et al (2014) administered the Towers 
of London test to cannabis users and controls (see Figure 1.10).
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Figure 1.10. A figure displaying two possible difficulties of the Tower of London Test.
The study showed that for one of the difficulties (three disks) cannabis users took 
significantly more moves to complete the task while no other performance differences 
emerged on the other three difficulties. Furthermore, on the most difficult task (five 
disks) cannabis users displayed significantly faster initiation times, perhaps suggestive 
of impulsivity, however as there were no performance differences on this difficulty it 
appears this faster initiation was not detrimental to performance.
1.4.4.2. Quantity/duration o f cannabis use
Medina et al (2007) found that although performance on the Towers Test (D-KEFS) did 
not predict group allocation with a cannabis using and control group, quantity of 
cannabis use was significantly negatively correlated with the Towers total score, final 
item score and accuracy score. This suggests that if Medina et al (2007) recruited a 
heavier cannabis using sample then between group differences may have appeared.
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Alternatively, the correlation between quantity of cannabis use and the dependent 
variables could be explained by an untested confound.
1.4.4.3. The age o f onset o f cannabis use
Studies describing the effect of the age of onset of cannabis use on measures of strategic 
planning have not been found (last search on 13/03/15).
1.4.4.4. Neuroimaging data
To date the use of neuroimaging devices to examine the neural underpinnings of 
performance on strategic planning tasks has not been conducted on cannabis users 
despite fMRI compatible versions of Towers tests being made available, such as the 
Tower of London (Newman, Greco & Lee, 2009). As with the age of onset this area 
should be explored in more detail (last search on 13/03/15).
1.4.4.5. Summary
Despite often being described as a key component of executive function (e.g. Lezak et 
al., 2004; Delis et al., 2001) the impact of cannabis on planning and strategy formation 
is rarely examined. Several pieces of evidence shows that these processes are vulnerable 
to the effects of chronic cannabis use (Harvey et al., 2007; Montgomery et al., 2012; 
Becker et al., 2014) and therefore the effects of the duration and quantity of cannabis 
use, the age of onset of cannabis use and the functional brain activity which mediates 
performance should all be examined in further detail.
1.4.5. Verbal fluency
In section 1.2.2.7. it was discussed that verbal fluency should be described by the 
underlying processes (i.e. working memory, strategy formation, initiation, inhibition) 
however determining which process is impaired is not easily done. Therefore cognitive 
deficits on verbal fluency tasks will just be described as verbal fluency deficits within 
this section. If deficits are detected on the verbal fluency tasks (VFTs) it is not clear 
where the deficits occurred and therefore deficits on the VFT will be discussed as verbal 
fluency deficits and if further interpretations are possible it will be elaborated on where 
appropriate.
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1.4.5.1. Cannabis users vs. controls
Only one study using a VFT found that cannabis users produced significantly fewer 
words in a given time frame than controls (McHale & Hunt, 2008) while the remaining 
studies found no differences between cannabis users and controls (Pope et al., 2001; 
Medina et al., 2007; Gruber et al., 2011). A key difference between these studies is that 
McHale and Hunt used only one trial, whereas the remaining three studies which found 
no deficits employed variations of the 'FAS' test, in which the average scores across all 
three trials was taken as an indicator of performance. A second difference is that 
McHale and Hunt (2008) instructed participants to write down their responses, while the 
remaining three studies produced words orally. It is possible that these differences 
contributed towards McHale and Hunt detecting impairments on the VFT by cannabis 
users. More recently, a contrary finding has been reported which is that cannabis users 
actually performed significantly better than controls on the COW AT (Becker et al., 
2014). Although number of correct words produced was up, so was the number of 
words produced which were incorrect (i.e. set loss errors) and so this potentially could 
highlight a more impulsive speed-error trade off strategy. Due to the majority of all 
other studies finding conflicting results it is likely that this finding does not represent a 
cannabis induced cognitive improvement but rather a different strategy or a type I error. 
The finding would need replicating and a mechanism explaining this occurrence would 
have to be identified before concluding that cannabis may have a role in cognitive 
improvement.
1.4.5.2. Quantity/duration o f cannabis use
Studies have found no cannabis related deficits between heavy users and light users 
(Pope & Yurgellun-Todd, 1996) and no dose-related effects on verbal fluency 
performance (Bolla et al., 2002). The study by Pope and Yurgellun-Todd (1996) did 
find verbal fluency deficits but only in the heavy cannabis users with low IQ scores.
The authors suggest that those individuals with low IQ are more vulnerable to the 
attentional impairment of chronic cannabis use. Therefore a further possible explanation 
for McHale and Hunt's (2008) findings is that their participants had a lower than 
average IQ, however this was not measured in their study.
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1.4.53. The age o f onset o f cannabis use
It is possible that previous studies examining cognition and cannabis use (without an 
age of onset analysis) could have detected greater impairments in performance if they 
had recruited earlier onset users. This is highlighted by one study finding no 
performance differences while analysing the whole cannabis group yet some differences 
emerged after dividing the group in early and late onset users. Gruber et al (2011) did 
not detect impairments between cannabis users and controls, however when they 
subsequently split the group they discovered that early cannabis users produced 
significantly fewer words than the late cannabis users. The cannabis users with a later 
age of onset appeared to be masking the deficits displayed by the earlier onset users 
when the cannabis groups were combined. Further ANCOVA analyses suggested these 
early onset deficits were not due to greater use of cannabis.
1.4.5.4. Neuroimaging data
There are no studies known to have used a neuroimaging device while employing a 
VFT in cannabis users (last search on 13/03/15). Given the wealth of neuroimaging data 
while using phonemic and semantic VFTs, it is unclear why this approach has not been 
examined with a sample of cannabis users (see Costafreda et al., 2006).
1.4.5.5. Summary
Although the majority of studies show that the verbal fluency remains unaffected by 
cannabis use, Gruber et al (2011) discovered decreased word production in early onset 
users (age of onset <17). However, a more recent study recruited a cannabis using group 
using the same age of onset criteria and found increased word production on the same 
VFT version, the COW AT (Becker et al., 2014). By observing the descriptive statistics 
across the two studies, these two samples of early onset cannabis users were comparable 
in terms of age and IQ, however the sample recruited by Gruber et al used cannabis 
over a year earlier on average despite the same criteria (<17) and used cannabis more 
frequently. This could explain why Gruber found deficits in performance yet is does not 
explain by Becker et al (2014) reported improvements.
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1.4.6. Decision Making
1.4.6.1. Cannabis users vs. controls
A number of studies have examined decision making in cannabis users, the most 
commonly used tool being the Iowa Gambling Test (IGT). Bolla, Eldreth, Matochik and 
Cadet (2005) administered the IGT to cannabis users and controls and found that the 
users showed significant impairments in performance and that there was a significant 
relationship between weekly spliffs smoked and overall performance. Bolla et al (2005) 
administered the IGT twice and on trial two, only the controls and the moderate-use 
subset of the cannabis users showed significant improvement while the heavy-use 
subset failed to show improvements over the two trials of the task. These findings 
initially suggest that cannabis users do not utilise the necessary information to aid their 
decision making processes as time goes on. Whitlow et al (2004) found similar results 
with cannabis users selecting more cards from disadvantageous decks than controls. 
While both groups started by choosing disadvantageous cards the controls showed an 
improvement over time while the cannabis users did not appear to improve as the task 
went on. These findings have been replicated more recently with the performance 
differences only becoming apparent over the last 40 cards (out of 100; Becker et al., 
2014). Despite these results, Becker et al (2014) found that overall performance on the 
IGT only displayed a trend for cannabis users to choose disadvantageous cards.
In order to identify the cognitive mechanisms which explain cannabis users' 
performance on the IGT, Fridberg et al (2010) administered the IGT to cannabis users 
and controls and ran two computational models of performance to assess the factors 
which contribute towards performance: the Expectancy-Valence Learning model (EVL) 
and the Prospect-Valence Learning model (PVL). The PVL is an updated version of the 
EVL and both assess motivation, memory and response processes in the participants 
during the task. The results from the experiment firstly supported previous findings in 
that the cannabis users displayed impaired performance on the task compared to 
controls through blocks 2-5 (21-100). Secondly, the findings suggest that the PVL 
model predicted group membership in 96.9% of participants which was higher than 
using IQ and IGT performance to predict group membership (84.4%). Thirdly, the 
authors suggest that psychological processes crucial for decision-making could be 
disrupted in chronic cannabis users. The disruptions are due to a relative insensitivity to 
losses and more sensitivity to gains in chronic cannabis users. Users also displayed a
62
recency effect, with decisions being weighted more on recent outcomes when compared 
to controls. Cannabis users also displayed less consistency, with selections being less 
consistent with their expectances of the outcomes from each deck. The authors suggest 
this finding is explained by impulsivity and a propensity for risk-seeking. These results 
highlight the cognitive mechanisms which may explain poor decision making abilities 
by chronic cannabis users on the IGT. These interpretations are backed up by non­
cannabis using samples in which individual differences in impulsivity and risk taking 
are related to disadvantageous IGT performance (Upton, Bishara, Ahn & Stout, 2011; 
Burdick, Roy & Raver, 2013).
The Information Sampling Test (1ST) is a measure of reflective impulsivity and 
therefore measures the ability to collect information necessary for a decision but before 
the decision has actually been made (Solowij et al., 2012). Solowij et al., (2012) study 
administered the 1ST to cannabis users, alcohol users and controls and found clear 
impairments on the task which were most likely associated with cannabis use, rather 
than alcohol use, other drug use or other confounding variables. These results support 
the data from studies using the IGT, by suggesting that cannabis use is associated with 
increased levels of impulsivity.
1.4.6.2. Quantity/duration o f cannabis use
One study found that although cannabis users did not present with overall impairments 
compared to controls, there was also a dose-related response, with number of 'spliffs 
smoked' being negatively correlated with advantageous card selections on the IGT 
(Verdejo-Garcia et al., 2007). The authors also reported that controls and a cocaine 
using group showed improved performance over the five blocks while the cannabis 
users maintained a constant level throughout. These findings suggest that cannabis users 
have impairments in decision making and also a diminished capacity to learn from 
mistakes. This inability to learn could be due to the recency effect discussed earlier in 
which cannabis users have a tendency to make decisions based on more recent card 
selection than performance as a whole (Fridberg et al., 2010). Alternatively the lack of 
improvement over the whole test could be due to an attentional bias towards immediate 
gains; Fridberg et al (2010) noted that cannabis users display a hypersensitity to gains 
and a relative insensitivity to losses. As the disadvantageous cards are those which pay 
out greater amounts in the short term, this could explain why cannabis users persevered 
rather switching strategies. Alternatively, the cannabis users may be learning about the
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consequences of their actions from repeated trial and error on the IGT, they just may not 
be acting advantageously on this information in a pattern previously discovered in those 
with VMPFC damage or sociopathology (Sobhani & Bechara, 2012).
1.4.6.3. The age o f onset o f cannabis
One study used a delay discounting paradigm and found that the age of onset of 
cannabis use was highly related to the probability of choosing initial short term gains 
over more beneficial long term gains (Kollins, 2003). Furthermore, multiple measures 
of performance on the 1ST have been found to be correlated with the age of onset of 
cannabis use (Solowij et al., 2012), suggesting that impaired assessments of information 
prior to decision making also gains severity with a decreasing age of onset. This 
analysis was correlational rather than quasi-experimental and thus there could be 
multiple salient confounding variables explaining this association.
1.4.6.4. Neuroimaging data
In addition to the behavioural abnormalities of decision making there has been some 
examination into the neurological underpinnings of these effects. During the IGT there 
is evidence of reduced activation specific to the right lateral OFC and DLPFC in 
cannabis users relative to controls, and increased activation in the left cerebellum (Bolla 
et al., 2005). When the same study divided the cannabis group into heavy and moderate 
users, the heavy users showed reductions in activation in the left medial OFC and 
DLPFC and increases in activity in the left cerebellum and parietal lobe when compared 
to the moderate group. The authors suggested that this abnormal pattern of activation 
within frontal reward networks highlights that long term drug use is associated with 
neuroplastic changes in brain function. The heavy users also showed diminished 
behavioural performance on the IGT during this study.
1.4.6.5. Summary
These studies provide evidence that chronic cannabis use results in altered functional 
activity within the prefrontal cortex and cerebellum during decision making processes 
and in addition to these functional changes, these impairments are detectable at the 
behavioural level, leading to impaired decision making on the IGT. Furthermore it is 
proposed that these faulty decision making processes are explained by a hypersensitivity 
to gains, a hyposensitivity to losses and the recency effect. There is limited research on
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the age of onset of cannabis use and decision making, and none with regards to the IGT.
Further research should explore this area.
As with the discussion on impulsivity leading to cannabis use found in section 1.4.1.3., 
it could be that there is a dynamic, transactional interplay between cannabis use and 
decision making. As suggested with delay discounting, the use of the IGT in an 
longitudinal study would address whether the consistently found impairments on this 
task are a product of the pharmacological effects of cannabis on the brain, or rather a 
factor involved in the initiation of cannabis itself.
1.4.7. Abstract and Conceptual Reasoning
Commonly used measures of abstract and conceptual reasoning include sorting tests 
such as the D-KEFS sorting test (Delis et al., 2001) and the Goldstein-Scheerer task 
(Goldstein & Scheerer, 1941), however the most prevalent is the WCST. Although the 
perseverative errors measured from the WCST has already been discussed as a measure 
of cognitive flexibility this section will focus on the measure 'total categories sorted' as
an indicator of abstract and conceptual reasoning.
1.4.7.1. Cannabis users vs. controls
All of the studies examining this outcome measure of the WCST did not find any 
differences between cannabis users and controls (Gruber et al., 2011; Pope et al., 2001; 
Solowij et al., 2002). This suggests that abstract and conceptual reasoning is not 
affected by long term cannabis use.
1.4.7.2. Quantity/duration o f cannabis use
An inspection of the effects of the quantity of cannabis use on this outcome measure 
showed initially that light users completed more categories than heavy users on the 
WCST (Pope & Yurgellun-Todd, 1996), however the authors explain this finding to 
increased errors on the task, so it is unclear if the deficits could be attributed to 
cognitive flexibility, abstract reasoning or another contributory cognitive process. Bolla 
et al (2002) found an inverse relationship between weekly spliffs smoked and number of 
categories completed, providing evidence that greater cannabis use leads to impaired 
performance on the WCST. Despite these two studies in support of a dose related effect, 
a comparison of short-term and long term users by Solowij et al (2002) only found 
evidence of long term use impairment on one outcome measure of the WCST, failure to
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maintain the set, which as previously discussed is more likely to reflect attentional 
failings rather than a conceptual deficit.
1.4.7.3. The age o f onset o f cannabis use
The strongest evidence for the impact of cannabis on this measure of the WCST comes 
from studies looking into the effect of the age of onset. Gruber et al (2011) that early 
onset users displayed many deficits on the WCST compared to controls while the late 
onset users only displayed mild deficits. Similar findings were reported by Fontes et al 
(201 lb) who found early cannabis users completed fewer categories than controls, while 
late users did not significantly differ from either group. In contrast to Gruber et al 
(2011), Fontes et al (201 lb) did not control for lifetime use when examining the effect 
of the age of onset. Therefore the greater deficits could be due to the longer use and 
greater history of spliffs consumed by the early onset users.
1.4.7.4. Neuroimaging data
No known studies have administered a measure of abstract reasoning on cannabis users 
during a functional assessment of brain activity (last searched on 13/03/15). This could 
be accomplished by the use of a computerised version of the WCST, as done by 
Riehemann et al (2001).
1.4.7.5. Summary
While there appears to be no differences in abstract and conceptual reasoning between 
cannabis users and controls, there is tentative evidence suggesting that the quantity of 
cannabis use affects these processes in cannabis users and there is stronger evidence that 
the age of onset affects these processes in cannabis users. The majority of these studies 
employ the WCST however it is unknown if a study has used another measure of 
abstract or conceptual reasoning with cannabis users. Using a measure such as the D- 
KEFS sorting test, a measure which is more process pure than the WCST, would be a 
beneficial way of determining if deficits previously found are detectable by other 
measures of abstract and conceptual reasoning.
1.4.8. The Importance of Abstinence
This section will address whether the impairments found in previous studies are 1) due 
to the 'hangover' effects of cannabis, 2) due to the withdrawal effects or 3) are
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symptomatic of cannabis induced neuropathology. It is unlikely that the findings 
discussed throughout section 1.4. are due to the acute intoxication of cannabis as the 
studies typically ensure a minimum abstinence period of 12 hours in which the acute 
effects are likely to be over. Some studies were deliberately not discussed as they 
included a mix of individuals who were abstinent and intoxicated (e.g. Ehrenriech et al., 
1999) which therefore leads to interpretation problems.
The importance of abstinence is clear when considering the central tenet of the current 
thesis: the age of onset. Early onset cannabis use conferring greater vulnerability to the 
severity and prevalence of executive function deficits is one possible interpretation. 
Alternatively, it is possible that early onset users are more prone to physical dependence 
on cannabis and therefore are more likely to experience withdrawal effects than late 
onset users (Hall, 2014).
1.4.8.1. The Stages o f Abstinence
Similar to alcohol, the use of cannabis leads to a hangover period, yet the nature of the 
'hangover' is vastly different between the two substances. In a review by Crean, Crane 
and Mason (2012) the 'residual' period was described as occurring between seven hours 
and 20 days of abstinence. This is a problematic definition as it fails to discriminate 
between the 'hangover' period and the withdrawal effects of abstinence among those 
dependent on cannabis. Cognitive deficits have been observed in non-users of the drug 
following administration in the period 12-24 hours after receiving a dose of cannabis, 
suggestive of a "hangover" like experience (Pope, Gruber & Yurgellun-Todd, 1995).
The withdrawal effects of cannabis are well documented, with approximately 42% of 
cannabis users having experienced withdrawal symptoms (Levin et al., 2010) and such 
symptoms becoming apparent after one day and lasting for around 20 days (Budney, 
Moore, Vandrey & Hughes, 2003). These withdrawal effects typically consisted of 
subjective, affective and behavioural states. Cognitive performance in this study was not 
measured however it is possible that these withdrawal effects are mediating the 
impairments found in cannabis users who have been abstinent for 1-20 days.
The ambiguities inherent in the term 'residual' reflect the relative difficulties 
surrounding the attribution of cognitive deficits to the stages of abstinence. The 
commonly used abstinence criteria for inclusion is 12 hours (e.g., Solowij et al., 2002; 
Pope et al., 2003; Gruber et al., 2011) and this means that attributing any discovered 
cognitive deficits to withdrawal effects, hangover effects or cannabis induced
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neuropathology is not simple. In order to minimise the likelihood of such cognitive 
impairments being the result of withdrawal or hangover effects, studies which enforced 
a longer abstinence period will be discussed. For the purposes of this discussion, the 
definition of 'long term effects' by Crean et al (2012) is suitable (three weeks or more of 
abstinence) as this passes the withdrawal phase proposed by Budney et al (2003).
1.4.8.2. The Long Term Effects o f Cannabis
While section 1.4 on executive function deficits in cannabis users included a number of 
studies examining cognitive deficits in cannabis users this section focusses on those 
which used a three week abstinence criteria. Thus, several studies will be re-examined, 
and others that were not included but which include cognitive measures not under the 
bracket of executive function will be included.
Perhaps the strongest piece of evidence within this debate was the meta-analysis 
conducted by Schreiner and Dunn (2012) which separated studies into two categories. 
Firstly, a meta-analysis of the effects of cannabis on cognition in which only acutely 
intoxicated cannabis users were excluded and a second meta-analysis on a subset of 
those studies which used a minimum 25 day abstinence criteria. The first meta-analysis 
which the authors conducted found cannabis-related impairments across many cognitive 
domains. The second meta-analysis found no effects of cannabis on cognition. This 
study provided convincing evidence that any of the deficits in cognitive performance 
discovered in cannabis users represents a temporary impairment which recovers over a 
period of weeks. Despite the conclusions drawn from this research there are three main 
limitations which suggest that cannabis may still be having a lasting effect on cognition. 
Firstly, the authors had to group test performance into domains (i.e. attention; motor; 
executive; etc.) due to the lack of neuropsychological test conformity across studies. 
This means that if performance on one test consistently detected cognitive impairments 
in cannabis users (i.e. the IGT) and it is combined with a test which does not (i.e. Digit 
Span) then the combined score may misleadingly suggest there is no impairment in the 
underlying cognitive construct (i.e. attention). Secondly, the follow up meta-analysis 
included 13 studies and thus a large number of participants, however when divided up 
into cognitive domains several of the analyses were lacking data. To illustrate this point 
the motor construct analysis only consisted of data from two studies. Thirdly, the meta­
analysis did not consider variables such as the age of onset. As discovered by Gruber et 
al (2011) - a study not included in the meta-analysis - when considering cannabis users
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as a whole group impairments in cognition may not be detected, however after splitting 
the users into early and late onset groups, impairments appear in the early onset group. 
Furthermore, the meta-analysis which consisted of long term cannabis use (>25 day 
abstinence criteria) found that the attention construct, which consisted of the Digit Span 
test, the TMT-A, the Continuous Performance Task and the IGT showed a trend 
towards group differences (/?=.06). While the findings of this study should be 
considered as evidence that cannabis does not cause long lasting cognitive damage, the 
results should not be considered conclusive but rather an important milestone 
highlighting the need for more research.
A number of the individual studies discussed here were included in Schreiner and 
Dunn's (2012) meta-analysis. Those which were not included will be highlighted as 
such.
Pope et al (2001; 2002; 2003) conducted several pieces of research in which 
performance was tested at 0, 1,7 and 28 days since last cannabis use. The use of daily 
or every other day urine tests ensured abstinence from cannabis during this time. 
Collectively these three studies found that deficits were present on multiple tasks 
throughout all stages before controlling for verbal IQ however these effects disappeared 
after controlling for verbal IQ. The problems with this methodology are discussed above 
(section 1.4.2.3) however the concluding remarks by the authors suggest that long term 
cannabis use is not associated with impaired cognition.
Hanson et al (2010) tested cannabis users' performance at three days, two weeks and 
three weeks following their last use of cannabis. Abstinence was measured by urine and 
breath tests every three to four days. This study was not included in the meta-analysis 
discussed above. While many cognitive measures highlighted impaired performance at 
three days, cannabis users were only impaired relative to controls on one test at three 
weeks. This was the Ruff 2 & 7 test of sustained visual attention using serial and 
parallel search components (Ruff & Allen, 1996).
After 23 days of abstinence another study discovered group status (cannabis vs. 
controls) was related to cognitive performance across multiple domains including set 
switching, complex attention, psychomotor speed and verbal store memory using 
composite scores from multiple assessments (Medina et al., 2007). Abstinence was 
measured by urine and breath tests every three to four days. Such widespread deficits 
were also discovered by Bolla et al (2002) after 28 days of abstinence, however this
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study was looking specifically at the frequency of cannabis use. Frequency of cannabis 
use was inversely related to performance on the Grooved Pegboard, the WCST, and the 
Stroop test, in addition to several non-executive tests of cognition. Abstinence was 
measured by random drug tests and by admitting participants for 30 days into their 
research facility. This study by Bolla et al (2002) was not included in the meta-analysis.
While many of the previous studies discussed in section 1.4 found executive function 
impairments in cannabis users (e.g. Gruber et al., 2011; Fontes et al., 201 lb) it is not 
clear if these are attributable to cannabis related withdrawal, hangover effects or 
neuropathology. However the studies discussed in this section clearly show that some 
deficits are still detectable after three weeks or more of abstinence providing evidence 
for longer lasting damage caused by chronic cannabis use.
1.5. Putatively Confounding Variables
The majority of studies addressing cognitive performance in cannabis users have used 
measures to control for the effects of confounding variables. This is necessary as the 
quasi-experimental design dictates that other factors could be mediating the between- 
group effects. These confounding variables which could potentially have an influence 
on this association are intelligence quotients (e.g. Mahone et al., 2002), education (e.g. 
Grimley & Banner, 2008), sex (e.g. Duff & Hampson, 2001), depression (e.g. Watkins 
& Brown, 2002), anxiety (e.g. Eysenck, Santos, Derakshan and Calvo, 2007), obsessive 
compulsive disorder (e.g. Gu et al., 2008), motivation (e.g. Macher & Earlywine, 2012), 
tobacco use (e.g. Jacobsen et al., 2005), brain trauma/disease (e.g. Alvarez & Emory, 
2006), learning disorders (e.g. White, Burgess & Hill, 2009), chronic alcohol use (e.g. 
Yonker, Nilsson, Hernitz & Anthenelli, 2005), recent alcohol use (e.g. Howlan et al., 
2010), other recreational drug use (e.g. Morgan & Curran, 2006), and recent drug use 
(e.g. Curran & Travill, 1997). The confounding variables are not mutually exclusive and 
potentially all could contribute to the associations discovered between cannabis use and 
impaired cognition. This is not an exhaustive list as practical considerations dictate that 
not every potential confounding variable can be assessed. These variables were selected 
based on reviews of previous research on cannabis and cognition (e.g. Gruber et al., 
2012 ).
In order for a confounding variable to be considered it firstly must be related to the 
dependent variable (i.e., executive function; Dancey & Reidy, 2004). If a specific 
variable does not impact executive function in a beneficial or detrimental way then it
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could not be an explanatory factor for the cognitive decline associated with cannabis 
use. Secondly, of the numerous factors which do impact cognition, those which are 
highly associated with cannabis use will be the most salient.
Many variables could be explaining the previously detected cognitive impairments 
detected in cannabis users as opposed to a causal explanation (e.g. neurotoxicity). 
Therefore relevant exclusion criteria, group matching, or statistical covariates need to be 
enacted where appropriate to deal with the effects of these potentially confounding 
variables.
1.6. Literature Review Summary 
1.6.1. Synopsis
The chapter has demonstrated a clear link between chronic cannabis use and impaired 
executive functioning. The explanation for these deficits could be causal, a cannabis 
related neural toxicity which alters the developmental trajectory of cognition and its 
associated neural networks. There are many alternatives to the causal hypothesis and 
these other factors (e.g. education) may explain some of the group differences which 
have previously been discovered in cognitive performance (e.g. Pope et al., 2003), 
however based on the evidence reviewed it is likely that chronic cannabis use does have 
an impact on cognition.
1.6.2. Gap in the Literature
The associations between chronic cannabis use and executive function are quite strong 
in some cognitive domains, yet mixed in others. One series of explanations for these 
mixed findings are the patterns of behaviours relating to cannabis consumption. The 
earliest cannabis use behaviour to be explored in great detail was the quantity of 
cannabis use. Several studies (e.g. Pope & Yurgellun-Todd, 1996; Bolla et al., 2002) 
addressed the nature of quantity of use and their conclusions have been incorporated 
into a large number of subsequent studies. It is now common practice to include clear 
information regarding the quantity of cannabis used by each study's cannabis group or 
to include specific analyses addressing the impact of this variable.
A newer cannabis behavioural variable to be examined is the issue of the age of onset of 
cannabis use. Only a few studies have explicitly looked at early and late onset groups 
and the performance on cognitive tasks (Pope et al., 2003; Fontes et al., 201 lb; Gruber
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et al., 2011). The first study to explore this included individuals who were acutely 
intoxicated and therefore this was not considered (Ehrenreich et al., 1999). These three 
studies have addressed several of the components of executive function, yet not all (e.g. 
decision making, non-verbal fluency/initiation, and verbal set switching). Furthermore, 
there appears to be mixed findings among these three studies regarding which cognitive 
processes are affected by the age of onset of cannabis use.
1.6.3. Research Aims
The current research programme aims to build upon several studies (Pope et al., 2003; 
Fontes et al., 201 lb; Gruber et al., 2011) by exploring if early onset cannabis use is 
associated with greater cognitive impairments than later onset users, with the following 
aims: 1) determine if early onset cannabis use is associated with more numerous and 
more severe deficits than late onset cannabis use; 2) if an association exists, to attempt 
to explore whether the relationship is causal; 3) to identify if specific cognitive domains 
are more vulnerable to cannabis than others; 4) to develop a new instrument for 
assessing cannabis use history among participants.
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Chapter Two. Methodology
This chapter outlines the methodology used over the course of this research programme, 
covering two quasi-experimental studies and one survey study. The aim of the thesis is 
to study executive function abilities in cannabis users relative to control groups with a 
focus on the age of onset of cannabis use. This chapter will firstly discuss the research 
designs and statistical methods used in the research programme, and then will highlight 
the various methods for assessing executive function, drug use and relevant covariates.
Table 2.1.
A table describing the three studies o f this thesis, the designs, and the primary outcome 
measures
Study Method Outcome Measures
Neuropsychological Quasi-experimental, Cognition (e.g. executive function)
Study neuropsychological IQ
(Chapter Three) tasks, questionnaires Mental health
Lifestyles & drug use
Eye Tracking Quasi-experimental, Cognition (e.g. executive function)
Study eye-tracker, IQ
(Chapter Four) computerised tasks, Mental health
questionnaires Lifestyles & drug use
Survey Study Correlational, Lifestyles & drug use
(Chapter Five) questionnaire
Note. lQ=Intelligence Quotient.
2.1. Research Designs and Data Collection
This section will evaluate the methods in their capacity of addressing the research of 
cannabis use and cognition.
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2.1.1. Quasi-Experiments
2.1.1.1. Overview
The quasi-experimental method involves the allocation of individuals to groups based 
on pre-existing criteria which cannot be randomised (e.g. cannabis use; Fife-Schaw, 
2006). As the experimenter must allocate participants to groups based on pre-existing 
criteria, the cannabis using participants are automatically allocated to the cannabis 
group and the non-cannabis using participants are allocated to the control group.
As participants cannot be randomly allocated to the different levels of the independent 
variable - i.e. cannabis use (or equivalent) - studies using this method cannot infer 
causation without additional methods. Several criteria have been proposed for 
establishing causation (Hill, 1965) and although they individually differ in terms of 
relevance and validity across studies they are still used regularly to determine causal 
effects (Hofler, 2005). These criteria are: (1) strength of the association; (2) consistently 
finding an association; (3) associated a specific cause (e.g. cannabis use) with a specific 
effect (e.g. memory deficits); (4) temporality; (5) biological gradient/dose-response 
effect; (6) a plausible biological mechanism which explains a causal effect; (7) 
coherence with research in related fields; (8) the association is tested by experiment in 
randomised controlled trails; and (9) an analogous cause (e.g. another drug) has a 
similar effect (e.g. impaired cognition).
Some of these criteria provide less support than others and just because all criteria are 
met it does not necessarily prove a causal relationship, and in contrast, if a criterion is 
violated this does not necessarily preclude a causal relationship (Hofler, 2005). Single 
studies do not attempt to meet all of these criteria simultaneously however converging 
multidisciplinary research can help determine if the relationship between cannabis use 
and cognition is causal.
2.1.1.2. Limitations
Due to ethical and practical reasons a true experimental study cannot be utilised to 
investigate the harmful effects of chronic cannabis use and so a quasi-experimental 
approach is adopted within this thesis. This approach means that criterion eight of Hill’s 
criteria (Hill, 1965), the use of experiments, cannot be used thus making it more 
difficult to infer a causal relationship. Therefore even if groups of “cannabis users” and
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“controls” are compared it is not clear that the differences in cognition are due to the 
effect of cannabis or a confounding variable (Fife-Schaw 2006; Hill 1965; Hofler,
2005). The conclusions from the quasi-experimental studies in the current thesis must 
take this limitation into consideration, such that no causal link between cannabis and 
cognition can be made. In order to infer causation however, a link between cannabis and 
cognition in the current quasi-experimental studies would be a necessary, albeit 
insufficient criterion, namely Hill’s criterion two.
Some have taken this critique further and suggested that in the presence of error, in this 
case referring to confounding variables, a conclusion cannot be supported (Mayo,
1996). Specifically, if an alternative explanation explains the pattern of data equally 
well then the experimental hypotheses cannot be supported by the experiment.
Chalmers (1999) elaborates on this point by highlighting that even pure experimental 
tests are fallible when considering that any advance in technology or understanding can 
easily make an experimental result void. Thus, experimental, and to a greater extent, 
quasi-experimental research, is only reliable if the knowledge guiding the research is 
accurate.
2.1.1.3. Strengths
The true experimental approach has many strengths however there is one area in which 
quasi-experiments are considered superior. This is the area of external validity (Fife- 
Schaw, 2006). Recruiting cannabis users who have been using the drug for many years 
allows the findings of quasi-experiments to be representative of typical cannabis users. 
The patterns of cannabis use, methods of administration and strains of cannabis will 
more similar to those used by recreational users. Therefore, if an experimental approach 
was undertaken, causation would be easier to infer, yet less able to generalise to other 
cannabis users.
A strength of both categories of experiment is that of falsification (Popper, 2002). While 
Mayo (1996) argues that a true conclusion cannot be made from an experiment in 
situations where other explanations are also valid, an experimental approach can rule 
out other conclusions. The ability to falsify a proposition is essential to furthering 
understanding (Chalmers, 1999; Popper, 2002). While this means that if an association 
between cannabis use and cognition exists it cannot be proved; it also implies that if
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such an association does not exist, then subjecting the proposition to experiment could 
falsify the claim. Furthermore, if such an association does exist between cannabis use 
and cognition then (quasi-) experiments can help rule out confounding variables (e.g. 
age), by ensuring that groups are matched for this variable.
2.1.2. Surveys, Questionnaires and Interviews
2.7.2.7. Overview
The Cannabis Use and Lifestyles Form (CannaForm; see section 2.3; Appendix A.2.1) 
was used in the current research programme to determine exclusion and inclusion 
criteria for several quasi-experimental studies (see Chapters Three and Four) in addition 
to collecting data to determine factors which may mediate the relationship between the 
age of onset of cannabis use and executive function (see Chapter Five). This 
questionnaire was developed within the research programme.
The CannaForm was developed to meet multiple needs and therefore could be described 
as a structured survey, a questionnaire, or a structured interview. The distinction made 
here between these three formats is that of: (1) the method of administration and (2) the 
intended use of the data, yet all the information gathered was in response to the same 
questions from the CannaForm. There were a number of participants who were 
interviewed and some who filled in the questionnaire themselves. For the interviews the 
experimenter read out the questions within the questionnaire; this was the favoured 
method as it maximised the possibility that every question was answered to a desired 
level of detail. With regards to purpose; some of the data was used for exclusion 
criteria, inclusion criteria, and descriptive demographic and lifestyle information for use 
within the quasi-experiments. However, the questionnaire data was also analysed to 
make statistical sample to population inferences about certain behaviours surrounding 
drug use, characteristic of a survey.
2.7.2.2. Survey Limitations
In order for sample to population inferences to be made there are several criteria which 
must be met, these are random sampling, sampling distributions and sample size 
(Sturgis, 2006). In order for a sample to represent the population it must be a random 
selection from the population, it must be representative of the various statistics taken
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from other samples within the population (e.g. age) and it must be of sufficient size to 
generalise. If these criteria are not met then interferences made from the findings carry 
clear limitations. The participants used in Chapter Five were recruited using opportunity 
methods and thus the sample is biased towards certain sub-populations (e.g. students 
and females). This means that the results from the survey study cannot be considered 
representative of the general population.
2.1.2.3. Survey Strengths
The use of surveys is so prevalent among the social sciences for pragmatic reasons.
They are cheap, easy and fast to both create and fill in (Sturgis, 2006). This allows a 
relatively easy way of gathering large amounts of data on a myriad of topics. With 
regards to the research discussed in the current thesis, the structured questions allows 
the examination of certain lifestyle and drug use behaviours across the sample, while 
several open questions allow the participants to list any additional behaviours or go into 
more detail, see example below:
15. How have you smoked cannabis in the past?
I I Joints d |  Bongs Q  Pipel I Other (please 
specify).........................
The three examples listed above are the most commonly reported methods, however 
specialist cannabis paraphernalia websites and shops host a variety of novel and 
technologically advanced methods of consuming cannabis (e.g. vaporisers) which the 
participant can include in the 'Other' section if they so choose.
2.1.2.4. Questionnaire and Interview Limitations
Obtaining information for exclusion criteria, inclusion criteria and descriptive 
demographic and lifestyle information for use within the quasi-experiments was done 
either via self-report questionnaire, or structured interview, with the experimenter 
reading out the questions from the questionnaire.
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Using this method for assessing lifestyle factors has several limitations which are not 
unique to this section, but which can also be applied to the survey discussion in the 
previous section. Firstly, the use of a questionnaire assumes the participant has perfect 
memory about behaviour and events in an individual's lifetime which is not the reality 
(Fife-Schaw, 2006). For example, the CannaForm includes a question about an 
individual's GCSE grades, this could be misremembered by the participant. A more 
accurate, yet time consuming, method would be accessing the grades by contacting the 
appropriate school or asking to see certificates. This was not done as it would not be 
possible under the current anonymity procedure. Secondly, sensitive information may 
be misreported or not reported at all. For example, the CannaForm asks the participant 
to list the illegal drugs they have tried at least once and to give information about their 
last use and amount of use. The participant may be motivated to not reveal their 
previous drug use and a more accurate way of assessing this could be through the 
biological analysis of hair, urine, blood or saliva samples. Despite concerns of the 
reliability of self-report drug questionnaires, a review of studies suggests that reliability 
is high for test-retest and inter-rater reliability (80+%; Darke, 1998). This could mean 
that the drug users are just very consistent with their lies however, repeatedly reporting 
the same misinformation. When validity is examined, in particular comparing self- 
reported drug use to urine or hair tests, there is also high levels of concordance (80+%; 
Darke, 1998). This suggests that while there may be individual fluctuations in levels of 
accuracy about drug use, on average participants are good -  albeit not excellent -  at 
reporting their drug use histories.
2.1.2.5. Questionnaire and Interview Strengths
As with the survey section, the strengths for assessing drug use behaviours and 
lifestyles are primarily for pragmatic reasons regarding cost, ease and speed. Costly and 
labour intensive methods may provide more accurate results for certain questions asked 
yet are unpractical for gaining large amounts of information from a large amount of 
participants.
2.1.3. Recruitment Methods
This section will discuss the various recruitment methods which were employed over 
the survey and quasi-experimental stages of the research programme.
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2.1.3.1. Survey Recruitment
The first stage of the research involved administering the CannaForm to a large number 
of individuals. The first recruitment strategy employed was opportunity sampling in 
which individuals were approached on several locations of an English university’s 
grounds, at student accommodations, and during psychology seminars. Psychology 
seminars were specifically targeted due to the need for psychology first years to obtain 
credits for taking part in psychology research projects. This method yielded the largest 
percentage of the total participants recruited. Participants from all groups (controls, 
tobacco users and cannabis users) were recruited using this method.
The second strategy was purposive sampling in which cannabis users were specifically 
targeted for recruitment via a local cannabis society. This online based group are 
involved in the dissemination of news stories and research about cannabis use. After 
receiving permission from the administrators of the group, information on the current 
research was put online with a contact e-mail address. The information instructed 
people who were either cannabis users, or non-smoking individuals (for the control 
group) to contact the primary researcher without declaring any sensitive or 
incriminating information. Upon contact, the full electronic version of the information 
sheet (see Appendix A.3.1) was sent to the potential participants with the instructions to 
read it and reply if they are still interested in taking part. If the individual agreed to take 
part then the CannaForm would be administered over the phone.
The final strategy was the snow-ball technique, in which recruited participants would 
inform suitable friends or acquaintances to contact the primary researcher and express 
an interest in taking part. This last strategy was primarily used for the further 
recruitment of cannabis users.
The primary purpose of typical quantitative studies is to generalise findings to the
general population. In order to do this, random sampling methods need to be used
(Sturgis, 2006). The present study did not use random sampling methods and therefore
certain limitations need to be considered. Firstly, the opportunity sampling methods
resulted in a narrow sample; predominately students, predominately adolescents and
young adults, and predominately those currently residing in the north of England (see
Chapter Three for more information). These demographic characteristics are not
representative of the general English population. Secondly, purposive sampling methods
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resulted in the recruitment of cannabis users who visited the cannabis society's web 
page. Finally, the snow-ball technique methods resulted in the recruitment of people 
who were friends or acquaintances of those who had already taken part. These two 
subsets of cannabis users may not be typical of the general cannabis using population 
and thus may lead to a biased sample.
2.1.3.2. Quasi-Experimental Recruitment
The recruitment procedure for the quasi-experiments directly followed from the survey 
recruitment. Of the individuals whom were both suitable and willing to take part in the 
quasi-experiments, the participants were contacted via e-mail to arrange a convenient 
time. The suitability for the study was assessed by determining if the responses in the 
CannaForm met or violated the many inclusion and exclusion criteria (see the Methods 
sections of Chapter Three and Four). The willingness was assessed on the consent form 
preceding the CannaForm, in which the participants could state whether or not they 
wished to be contacted for later stages of the research.
2.1.4. Ethical Considerations
Due to the sensitive nature of the information collected, the present research programme 
had greater than minimal risk of psychological harm or stress to the participants (British 
Psychological Society research ethics, 2010). The British Psychological Society (BPS) 
suggests a number of criteria which, if met, could lead to an increased risk of the harms 
mentioned above. The first criterion which was met by the current research programme 
was related to the information collected on the participants' illegal drug use, health and 
education. Secondly, this research also involves the collection of biological samples.
The sample collected was hair strands and thus are exempt from human tissue laws.
Ethical approval for all phases and elements of the research were jointly provided by 
Sheffield Hallam University’s Biosciences Ethics Review Group and the Faculty of 
Development and Society’s ethics committee. The Biosciences Ethics Review Group 
was primarily contacted due to the collection of hair samples from the participants.
2.1.4.1. Sensitive Information
The first BPS criterion for risk which was met consisted of the collection of personal 
and sensitive information relating to illegal drug use. In order to minimise the risk of
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psychological harm or stress associated with revealing such information several 
methods were employed. The first method involved providing information about the 
sort of questions to be asked and the rights of the participant. The information sheet 
provided a clear account of the sort of questions which were to be asked so the 
individual could make an informed choice about whether or not to take part, and also 
included a statement which clearly stated that the participant did not have to answer any 
questions which they did not want to.
The second method ensured the participant that any information they provided would be 
anonymous and therefore such sensitive information could not be linked with their 
name. This was accomplished by coding every piece of data collected (The CannaForm, 
cognitive tests, questionnaires, hair samples) with a unique code instead of their name. 
The participant's name was only recorded on the consent form and therefore it is on 
record that an individual took part in the study, yet no sensitive information or data can 
be linked with any name.
2.1.4.2. Biological Samples
The collection of any biological data carries the potential to distress the individual 
depending on the specific sample selected (hair, blood, saliva, etc.) The selected sample 
- hair - was thought to be one of the least distressing, perhaps comparable with saliva. 
Urine and blood samples have the potential for the participant to feel embarrassed, 
stressed or experience actual physical pain, and were avoided for these reasons (see 
section 2.5). In order to minimise the potential stress caused by taking a hair sample, the 
participants were informed that individual hairs would be cut with scissors one at a time 
from separate location on the head to alleviate the worry of a patch of hair going 
missing. Furthermore, the participants were given the opportunity to opt out of the 
procedure on two separate occasions, on the consent form and also during the 
experiment when the experimenter asked the participant if they were still happy to 
provide a hair sample.
2.1.4.3. Informed Consent
All participants read the information sheet and consent form which included the option 
to (1) complete the questionnaire, (2) participate in the cognitive testing phase, (3) 
provide a hair sample, or all of the above (see Appendix A.3.2). The participant was
81
only contacted for the cognitive phase of the study if they consented to do so, if they 
provided an appropriate means of contact, and if they were suitable based on the 
inclusion and exclusion criteria.
2.2. Data and Statistical Methods
This section will outline the type of data collected and the statistical methods and 
analyses used over the three quasi-experiments (Chapters Three and Four) and the 
survey and questionnaire based study (Chapter Five).
2.2.1. Data
2.2.7.7. Cognitive Tasks
The cognitive testing involved the administration of a number of paper, computer, and 
orally based tasks over multiple studies and was recorded in terms of reaction times, 
completion times, total correct responses, errors, and percentage of advantageous 
responses. All of these data which were collected and analysed were continuous and 
ratio in nature.
The administration of the three Delis Kaplan Executive Function System (D-KEFS) 
tests (see Section 2.5) were divided into two categories. The Trail Making Test was 
scored on the length of time taken to complete each component while the Verbal 
Fluency Test and the Design Fluency Test were scored on the amount of correct 
responses within a given time limit. For all of these three tests the raw performance 
scores were converted into age scaled scores. Age is one of the biggest predictors of 
variance in task performance (Delis et al., 2001) and the use of age-scaled scores 
minimised the influence of age on test performance. In addition to the D-KEFS tasks, 
only the IQ subtests were provided with age scaled conversion scores and therefore only 
the Symbol Search Task from the WAIS-iii (see Section 2.9.1) and the numerous 
components of the Wechsler Abbreviated Scale of Intelligence (see Section 2.10) were 
converted into age-scaled scores. For the remaining cognitive tasks: the Grooved 
Pegboard and the Iowa Gambling Task; raw scores were used.
The majority of data collected from these cognitive tasks were parametric, however in 
order to meet the assumptions for parametric analyses several of these scores were 
transformed or trimmed in order to increase statistical power (Ratcliff, 1993). The
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precise details regarding the transformation selected and the specific outcome variable 
which needed transforming are discussed in the methods sections of the chapters 
describing the relevant studies (Chapters Three, Four, and Five).
2.2.7.2. Mental Health Questionnaires
The three mental health questionnaires used throughout the research programme all 
required the response to statements on a Likert, or Likert-style, response format and 
therefore are ordinal in nature. These three questionnaires on depressions and anxiety 
(see Section 2.11), obsessions and compulsions (see Section 2.12), and motivation (see 
Section 2.13) were included along with the IQ tests and various other variables to act as 
potential covariates. For each of the five dimensions from these three questionnaires, the 
sum of the responses was used to estimate each mental health or emotional state.
These confounding variables also needed to be checked for parametric assumptions and 
therefore appropriate transformations and data trimming were employed. The precise 
details regarding the methods selected and the specific outcome variable which needed 
transforming are discussed in the methods sections of the chapters describing the 
relevant studies (Chapters Three and Four).
2.2.1.3. Reaction Times
The Tobii Visual Search Task and the Tobii Set Switching Task (Section 2.17) are both 
computer based tasks which yield behavioural reaction times and gaze data. Such data 
are normally not parametric (Whelan, 2008) and require specific transformation 
methods.
In order to meet the assumptions for parametric analyses several of these scores were 
transformed or trimmed in order to increase statistical power (Ratcliff, 1993). The 
precise details regarding the transformation selected and the specific outcome variable 
which needed transforming are discussed in the method section of the chapter 
describing the relevant study (Chapter Four).
2.2.1.4. CannaForm Data
The CannaForm contains numerous questions on demographics, education, health, 
alcohol use, tobacco use and illegal drug use. The variety of questions yields nominal 
data such as:
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What is your primary method of smoking cannabis?
Q  Joints d ]  Bongs I I Pipes I I Other (please specify)
The CannaForm also yields ratio data such as:
On how many days would you drink alcohol in a typical week?
The presence of nominal data and of numerous outliers dictated that the majority of data 
was non-parametric. The use of these data was not always for inferential analyses, but 
rather for descriptive statistics, inclusion criteria and exclusions criteria into subsequent 
stages of the studies. Therefore transformations were not always necessary.
For the occasions when transformations or data trimming was required, the details 
regarding these transformations and the specific outcome variable which needed 
transforming are discussed in the methods sections of the chapters describing the 
relevant studies (Chapters Three, Four, and Five).
2.2.2. Statistical Analyses
A variety of statistical tests were used within the current thesis including AN(C)OVAs, 
post hoc testing, correlations, logistic regression, and non-parametric equivalents of 
these tests. The selected tests were chosen based on guidelines put forth by various 
manuals (e.g. Hosmer & Lemeshow, 2000; Meyers et al, 2013, Tabanick & Fidell,
2010). Relevant parametric and test specific assumptions of the data were checked prior 
to implementing such analyses based on guidelines by these manuals and supplemented 
with statistical articles (e.g. Owen & Froman, 1998; Ratcliff, 1993). For further 
information see the method sections of Chapters Three, Four, and Five.
2.3. The Cannabis Use and Lifestyles Form (CannaForm)
The CannaForm was designed during this research programme to fulfil three purposes. 
Firstly, the CannaForm acted as a screening tool; collecting information about the 
participant which could influence performance on the neuropsychological battery of 
tasks, leading to the subsequent exclusion or inclusion into the experimental studies. 
Secondly, after the participant had been deemed acceptable to take part in the
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experiments (if they were), the information provided in the CannaForm determined the 
group to which they were allocated (i.e. cannabis, early onset cannabis, late onset 
cannabis, tobacco or control). Finally, the CannaForm was also completed by a large 
number of participants who did not take part in the experimental studies, with the aim of 
determining if any lifestyle variables could be mediating the relationship between the 
age of onset of cannabis use and executive function. This was done by looking at 
variables previously found to be linked with executive function (e.g. educational 
achievement; Grimley & Banner, 2008) and investigating if these variables are related 
to the age of onset of cannabis use.
2.3.1. The Creation of the CannaForm
Previous measures of assessing drug use and lifestyles typically within the cannabis- 
cognition field have involved screening questions in the form of an interview conducted 
in person or via telephone (e.g. Pope et al., 2001; Medina et al., 2007; Fontes et al.,
2011). As no widely available screening questionnaire with a cannabis focus has been 
developed, the first goal was to create such a device to be used throughout the current 
research programme. One exception to this is a drug use questionnaire developed by 
Solowij (1998) however this lacked the depth of questions which was desired for the 
current experiments. The first version of the CannaForm, version 1.0 (vl.0), was used 
and adapted throughout the research programme, leading to v2.0. Figure 2.1 describes 
the basic stages of the CannaForm’s development however more information can be 
found in Chapter Five.
2.3.2. Exclusion Criteria
One of the primary purposes of the CannaForm was collect information on 
demographics, lifestyles and drug use to determine whether or not an individual needed 
to be excluded from subsequent cognitive testing. Based on suggestions from Gonzalez 
et al., (2002), previous comparable studies (e.g. Pope et al., 2001; 2003; Medina et al., 
2007; Gruber et al., 2011) and further research from the primary researcher, a list of 
seven categories of exclusion criteria was created: 1) brain trauma, 2) learning 
disorders, 3) non-native English speakers, 4) chronic alcohol use, 5) recent alcohol use, 
6) other drug use, 7) mental health problems and 8) recent drug use. The rationale for 
selecting these criteria was that each variable covaried with cannabis use and cognition 
(see Section 1.5. for a full discussion).
85
2.3.3. Inclusion Criteria
The criteria necessary to allocate individuals to groups will now be discussed. The 
current thesis included several quasi-experiments with a number of different groups. 
These groups included a cannabis using group, an early onset cannabis using group, a 
late onset cannabis using group, a tobacco using group and a control group, each with 
specific criteria for inclusion.
2.3.3.1. The Cannabis Group
The cannabis group criteria needed to ensure that the primary substance of use was 
cannabis (Gonzalez et al., 2002) in addition to the general exclusion criteria discussed 
above. Previous studies have taken different approaches relating to cannabis inclusion 
criteria, ranging from recruiting those diagnosed with cannabis dependence to those 
who use recreationally. The focus of the current thesis was decided to be focussed on 
the more recreational user, a non-treatment seeking individual who uses primarily for 
recreational purposes. The next aim was to differentiate from those who have ‘tried’ 
cannabis to those who have used for a prolonged period of time. As there are no set 
criteria on this, the current thesis used the criteria: 1) the individual must have been 
using cannabis regularly for a period of at least six months OR 2) the individual must 
have accumulated at least 50 separate lifetime uses of cannabis.
2.3.3.2. The Early and Late Onset Cannabis Groups
There were two criteria for the age at which the group was split was based. Before the 
divide could occur it needed to be identified what was considered an 'early' onset group. 
Examining previous similar studies shows a small range of different definitions with 
some studies splitting at the age of onset of <15 years (Fontes et al., 2011), <16 years 
(Gruber et al., 2011) and <17 years old (Wilson et al., 2000; Pope et al., 2003).
The aim was to define an early group as a period in which maturational processes for 
executive function had not reached adult levels, and thus are susceptible to interference 
from cannabis. By observing neurological data and cognitive data (Section 1.3), this 
could be anywhere between ages 15-30. Due to this vague guideline, it was decided 
that the divide would be data-led and that a median split would be used. This was done 
to ensure that similar numbers of cannabis users were allocated to each of the two
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groups. For all studies, the divide was chosen as <15 years for early onset users and >16 
years for late onset users.
2.33.3. The Tobacco Group
The use of a tobacco ‘control’ group in addition to a ‘non-smoking’ control group for 
comparison with cannabis groups is relatively novel, with only one known study 
previously employing this method (McHale & Hunt, 2008). It was aimed to have a 
group of tobacco users who matched the cannabis group for tobacco use as a method of 
dissociating any effects of tobacco on cognition from the effects of cannabis on 
cognition. The inclusion criterion into the tobacco group was regular use for a period of 
no less than six months.
2.3.3.4. The Control Group
A non-smoking control group is commonly used in comparable studies unlike the 
previous tobacco smoking control group described above. The only additional criterion 
to be included in the non-smoking control group, the individual must have used other 
drugs (including cannabis and tobacco) less than 15 times in total.
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VPrevious papers on cannabis use and cognition were read to 
determine (1) factors which may mediate the relationship 
between cannabis use and cognition (2) salient demographic 
information and (3) salient drug use information. These 
pieces of information were to be incorporated into the new 
questionnaire -  the CannaForm.
A drug and lifestyle questionnaire from Solowij (1998) was 
used as a basic template. Modifications to existing questions 
were made and additional questions were added by the 
primary researcher in order to meet the requirements 
determined in step 1.
Further changes were made by the primary researcher and 
his three supervisors.
>r
A small pilot study was conducted in which two self- 
reported cannabis users completed the CannaForm and gave 
verbal feedback on any questions they felt needed altering or 
adding. Any necessary changes were then made by the 
primary researcher.
The CannaForm vl.O was then used for data collection for 
the first study and for demographic data collection. 
Throughout the process the primary researcher made notes 
on which questions the participants struggled to answer or 
needed changing for various reasons.
Several small changes were made for the second study 
which included formatting and the addition of several new 
questions (the CannaForm v2.0). No existing questions were 
changed in order for the new sample to be added to the 
existing demographic sample.
r  - - - - - - - - - - - - - - - - - - - - - - - - - --------- ----------------------------- --
I See Chapter Five for future developments of the '
I CannaForm. *
.____________________________________________________ I
Figure 2.1. The steps taken to create the CannaForm in its current form along with a 
proposed next step to be taken after the completion of the research programme.
2.4. The Recent Use Questionnaire
The method of recruiting participants into the two quasi-experimental studies began 
with the completion of the CannaForm; the subsequent procedure however was split 
into two options. Some participants were immediately accepted based on a review of the 
CannaForm and the neuropsychological testing phase began immediately. The majority 
of participants were contacted at a later date and a time was agreed via e-mail or phone 
correspondence to arrange the testing phase. The criterion for these two separate 
methods was based on the participant's availability. For those who were contacted later, 
an additional questionnaire was created which solely included questions on the 
participant’s recent drug and alcohol use taken from the CannaForm (see Appendix 
A.2.1.4). Before the cognitive testing, all participants were informed at least once that 
they must abstain from alcohol use for 24 hours (although exceptions to this rule can be 
found in Section 2.3.2.5.), from cannabis use for 24 hours and other recreational drug 
use for seven days.
2.5. Biological Analysis of Hair Samples
Due the limited reliability of self-report drug use (Tourangeau & Yan, 2007) a second 
method was considered to measure drug use. Urine testing is the most frequent choice 
for drug testing within comparable cognition-cannabis use studies (Pope & Yurgelun- 
Todd, 1996; Pope et al, 2001). In addition some studies have tested hair for 
cannabinoids (Hermann et al., 2009), while others have tested saliva and blood samples 
(Kauert, Ramaekers, Schneider, Moeller, & Toennes, 2007). While saliva, urine, and 
blood are good for testing recent drug use, the reliability of these methods is still 
relatively poor (Musshof & Madea, 2006). For example a positive urine test may 
indicate that an individual has used cannabis within 24 hours or seven days, the former 
would violate an exclusion criterion of the current studies while the latter would not and 
it would not be possible to determine which. This reliability it partially influenced by 
the tool used to analyse the samples (e.g. gas chromatography; Musshof & Madea, 
2006).
The decision of which medium to collect was based upon the desired type of 
information collected, the discomfort caused to the participant, practical issues relating 
to funding, storage and ethics. It is for these reasons that hair was chosen to be tested. 
The negative corollary of this decision is that recent use information cannot be
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ascertained. Advantages include that it is the most sensitive method, a method which 
causes minimal discomfort to the participant and is the cheapest method in terms of 
storage costs as it does not need to be refrigerated or frozen (Musshof & Madea, 2006).
2.6. The Delis-Kaplan Executive Function System™ Battery (D-KEFS)
The D-KEFS consists of nine separate tasks designed to measure different components 
of executive function (Delis et al., 2001). Within the present research program, three of 
these tasks were selected as part of a neuropsychological battery for measuring 
executive function. These tasks are the Trail Making Test, the Verbal Fluency Test and 
the Design Fluency Test. In addition to the materials for the individual tasks, several 
supporting materials were used. The Manual provided the information necessary for 
administering each of the tasks correctly, the Standard Record Form was used to 
score and keep a record of the participant’s performances and the Stimulus Booklet 
was used in conjunction with each of the individual task materials, providing visual 
reminder of the rules and instructions for each task, in addition to containing all the 
information to convert the raw scores into age-scaled scores.
The D-KEFS was chosen as a primary source of neuropsychological tests as it is widely 
used in clinical and healthy populations (e.g. Delis et al., 2001; Huey et al., 2009; 
Mahurin et al., 2006), it has extensive normative data (Delis et al., 2001), it has been 
extensively tested for reliability and validity (Delis et al, 2001), and it has been shown 
to be sensitive to prefrontal cortex damage (e.g. Yochin, Baldo, Nelson, & Delis, 2007; 
Yochin, Baldo, Kane, & Delis, 2009). The D-KEFS also provides the option to create 
age-scaled scores for the majority of the outcome measures and utilises multiple 
methods of contrasting different scores which aids in maximising process purity.
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Table 2.2
A list o f the selected D-KEFS tests and the primary processes measured as reported by 
the authors.
Primary Processes Measured
Trial Making test Visual scanning, numerical sequencing, alphabetical 
sequencing, cognitive flexibility, working memory, 
motor speed
Verbal Fluency test Initiation, strategic retrieval of lexical items, attention, 
verbal knowledge, working memory, cognitive 
flexibility
Design Fluency test Visual attention, non-verbal creativity, motor speed, 
initiation, cognitive flexibility, working memory
Note. There are six more D-KEFS tests which were not used in the current research 
programme.
2.6.1. The Trail Making test
The Trail Making Test (TMT) was incorporated into the Halstead-Reitan battery in its 
original form o f ‘Trails A ’ and ‘Trails B’ (Reitan & Wolfson, 1985). The total D-KEFS 
version (Delis et al., 2001) contains five components: Visual Scanning, Number 
Sequencing (i.e. Trials A), Letter Sequencing, Number-Letter Switching (i.e. Trails B), 
and Motor Speed.
All subtests within the TMT include an array of numbers and letters, each enclosed by a 
circle, which are spread sparsely over sheet of A3 paper. Each subtest requires the 
participant accomplish a different goal with each array of alphanumerical stimuli. For 
all subtests the rules were verbally administered to the participant, the un-timed practice 
section is completed and the experimenter corrects any mistakes made. Once the 
practice is over the participant is instructed that they can begin the main section and that 
they will be timed.
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2.6.1.1. Rationale
The rationale for choosing the TMT for the first study was that previous experiments 
have identified that this task recruits executive processes (Arthbunutt & Frank, 2000; 
Sanchez-Cubillo et al., 2006) including set switching, working memory, and inhibition. 
While TMT variants have been used before to identify cognitive impairments in 
cannabis users (Medina et al., 2007) and to examine the age of onset of cannabis use 
hypothesis (Gruber et al., 2011), the results are still inconclusive as discussed in section
1.4.2. This test was included to help elucidate the relationship between cannabis use 
variables and the cognitive processes which contribute towards performance on the 
TMT.
2.6.1.2. Visual Scanning
The goal of the Visual Scanning is to draw a line through each circle which contains the 
number ‘3’. This component primarily measures visual scanning and selective attention 
(Delis et al, 2001). It also measures several more fundamental processes such as 
recognition of numbers and thus acts as a control condition, in order to detect any 
fundamental deficits which could masquerade as executive dysfunction in the switching 
component (section 2.7.1.5). The indicator of performance used in the first study is the 
age-scaled score of the total time taken to complete this task.
2.6.1.3. Number Sequencing
This subtest requires that the participant connects the numbers, while ignoring the 
letters, by drawing a line in ascending order from ‘1’ to ‘16’ across a new array of 
numbers and letters. This component primarily tests fundamental numerical processing, 
visual scanning, selective attention, and motor speed (Delis et al, 2001). It is primarily 
used as a control condition for the switching component and the indicator of 
performance for this subtest used in the first study is the age-scaled score of the total 
time taken to complete this task.
2.6.1.4. Letter Sequencing
This subtest requires that the participant connect the letters, while ignoring the numbers, 
in order from ‘a’ to ‘p \  This also acts as a control condition for the switching 
component, testing verbal skills, visual scanning, selective attention, and motor speed
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(Delis et al, 2001). The indicator of performance for this subtest used in the first study is 
the age scaled score of the total time taken to complete this task.
By combining the scaled score from this, and the previous subtest, a combined Number 
Sequencing and Letter Sequencing score can be produced, referred to as the composite 
scaled score. The use of this composite score is discussed below in section 2.7.1.5.
2.6.1.5. Number-Letter Switching
The fourth component, also known as ‘trails B’, is the primary measure of executive 
function within the TMT. The participant is required to draw a line, in ascending order, 
while switching between numbers and letters, so that they must draw a line from ‘ 1’ to 
‘a’ to ‘2’ and continuing in such a pattern until the task culminates at the letter ‘p ’. The 
primary function tested in this subtest is set switching in the form of a prespecified task 
sequence paradigm (Delis et al, 2001). The task also recruits the processes measured in 
previous components: visual scanning, selective attention, motor speed, 
numerical/alphabetical processing.
There were three indicators of performance derived from this task and reported in first 
study. These were the (1) age-scale score of the total time taken to complete the task, (2) 
the number of errors made during this task, and (3) the contrast score. This contrast 
score involves subtracting the age scaled composite score discussed in the previous 
section from “(1)”, reported in this section. This score is then converted into a 
secondary age-scaled score. This contrast process aims to minimise the other 
contributory processes involved in the task (e.g. visual scanning) and be a purer 
measure of executive function. Construct validity testing suggests this process yields a 
better estimate of executive function than the basic time taken to complete the task 
(Sanchez-Cubillo et al., 2009).
2.6.1.6. Motor Speed
This subtest involves connecting the circles by drawing a line along a designated path in 
the quickest possible time. The task was introduced to ascertain whether any pre­
existing fundamental motor related deficit existed which could impair performance on 
the Number-Letter Switching subtest. The participant is required to connect the dots 
which are marked with a dotted line, requiring only basic motor skills to complete the
task (Delis et al, 2001). As with the other control conditions, one indicator of
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performance is used here, the age-scaled score of the total time taken to complete this 
test.
2.7.2. The Verbal Fluency Test
Numerous versions of verbal fluency tests exist including one by Bechtoldt, Benton and 
Fogel (1962) featuring the letters F, A, and S. While many letters can be used for this 
test, FAS are the most common, leading to many calling the task the “FAS task”. Delis 
et al., (2001) incorporated the original FAS test into a larger verbal fluency measure, 
including three subtests: letter fluency, category fluency, and category switching. Each 
one of these three tasks involves verbally explaining the rules to the participant 
followed by their attempts. Responses are written down by the experimenter and coded 
for errors.
2.7.2.1. Rationale
The rationale for selecting the verbal fluency test was that a set of experiments has 
shown that retrieval ability on this test was influenced by constraints and individual 
differences in working memory capacity and focussed attention (Rosen & Engle, 1997). 
These findings suggest that this test measures some key processes associated with 
executive function. This test has also been shown to be sensitive to detecting deficits in 
individuals with frontal lobe trauma compared to healthy controls and non-frontal 
trauma patients (Ferstyl, Guthke & von Cramon, 2002). The majority of research on the 
fluency tests has suggested that cannabis use is not related to performance (see Section 
1.4.5) however there is evidence that early onset users are vulnerable to performance on 
the letter fluency test but not the category fluency test (Gruber et al., 2011) while Pope 
et al (2003) found the opposite, with evidence of early onset related impairments on the 
category fluency test but not the letter fluency test. The inclusion of both of these tests 
will help resolve these contradictory findings.
The D-KEFS version of the verbal fluency test also includes the set switching condition 
which has never been administered to cannabis users before and therefore provides an 
opportunity to further extend the cannabis-cognition literature.
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2.7.2.2. Letter Fluency
Within the Letter Fluency task the participant is given one minute to name as many 
words as they can think of whilst adhering to certain rules. The participant may not 
provide any variation of a word they have already provided (e.g. hard and harder) and 
may not provide the names of places, people, or numbers. The task was repeated three 
times, with three different letters, F, A, and S. This component measures initiation, 
working memory, strategy formation, attention, and speed of verbal processing (Delis et 
al, 2001). The number of correct responses over the three conditions are summed and 
then converted into an age-scaled score to indicate the level of performance on this task.
2.7.2.3. Category Fluency
For Category Fluency the participant is given one minute to name as many words that 
they can think of which belong to a certain semantic category. This component contains 
two trials with different categorical specifications (i.e. names of animals and boys 
names). This task involves mostly the same processes as letter fluency, however this 
component tends to be less sensitive to damage, as lexical items are more readily 
organised semantically and thus easier to retrieve (Delis et al, 2001). The total correct 
responses across these two categories are summed and converted into an age-scaled 
score to indicate the level of performance on this task.
2.7.2.4. Category Switching
Category Switching, similar to the previous component, requires the naming of items 
which belong to a given category, however the participant must alternate between 
naming items from two sets of categories (i.e. items of fruit and items of furniture). This 
component involves the same processes as the category fluency task, however there is 
also a set switching factor built into this component, furthermore the demands placed on 
working memory are greater, as the participant must maintain and update two lists of 
semantic lexical items as opposed to one (Delis et al., 2001). This task contains two 
indicators of performance: the age-scaled score of the total number of correct responses 
on this task and the age-scaled contrast score. The contrast score, like the TMT, 
involves controlling for more fundamental processes by subtracting the score from the 
Category Fluency subtest from the Category Switching subtest. The score is then age- 
scaled again to provide the Switching Contrast score. This is to increase the process
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purity of the set switching involvement however, unlike the TMT, validity testing by an 
unaffiliated research group is yet to confirm this suggestion.
Furthermore, two error scores were derived from this test. The total number of 
repetition errors and set loss errors (rule violations) were calculated and then converted 
into a percentage of the total responses.
2.7.3. The Design Fluency Test
In the 1980’s the five-point test was designed in order to be a nonverbal counterpart to 
the verbal fluency tests (Regard, Strauss & Knapp, 1982). A design fluency task did 
already exist in which participants must draw novel and nonsense images, but a lack of 
standardised scoring data and inter-experimenter scoring variances resulted in a lack of 
usage by the academic community. The new five-point test involved the creation of as 
many novel designs as the participant could create based on the premise of drawing 
straight lines between a series of proximate dots on a piece of paper. This task provided 
the standardised scoring system and data which the previous design fluency task lacked.
The D-KEFS version of this task (Delis et al., 2001) contains three components: filled 
dots, empty dots, and filled-empty switching. For each task the participant is verbally 
given instructions, and then allowed a short practice attempt, before being required to 
create as many designs as they can within the time limit whilst adhering to the rules.
2.7.3.7. Rationale
This measure is a D-KEFS standardised task with age scaled scores and shown to be 
sensitive in detecting impairments among certain populations including frontal lobe 
lesions and epileptic patients (Baldo, Shimanmura, Delis, Kramer & Kaplan, 2001; 
McDonald, Delis, Norman, Tecoma & Iragui, 2005). While the verbal fluency test is 
particularly sensitive to left frontal lobe lesions (Paulesu et al., 1997; Phelps, Hyder, 
Blamire & Shulman, 1997) the design fluency test is particular sensitive to lesions in the 
right frontal lobe (Ruff et al., 1994; Lee et al., 1997).
The selection of this test was partly influenced by the fact that it has not been previously 
used to test for impairments associated with chronic cannabis use. This test therefore 
provided a unique and novel approach to assessing cognitive integrity in cannabis users.
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2.73.2. Filled Dots
The first component of the Design Fluency Task consists of a page containing 80 
identical boxes, each containing five filled black circles, or ‘filled dots’. The test 
involves the creation of a unique design within each box by connecting the filled dots 
with four straight lines and to complete as many of these designs as possible within one 
minute. This subtest is a measure of visual attention, non-verbal creativity, and motor 
planning (Delis et al., 2001; Suchy et al., 2010). The total number of correct and unique 
designs is converted into an age scaled score and used as the main indicator of 
performance for this subtest.
2.73.3. Empty Dots
This component differs from the first in that each one of the identical boxes now 
contains a number of filled black circles and hollow black circles, or ‘empty dots’. The 
task involves the creation of a unique design within each box by connecting the empty 
dots with four straight lines. This subtest is a measure of visual attention, inhibition, 
non-verbal creativity and motor planning (Delis et al., 2001; Suchy et al., 2010). The 
total number of correct and unique designs is converted into an age scaled score and 
used as the main indicator of performance for this subtest.
The two scores from the filled and empty dot tests are combined into a composite score 
which is then used to control for non-switching related processes after completion of the 
third subtest.
2.73.4. Switching
This subtest contains a series of boxes containing both filled and empty dots, yet here 
the participant is required to alternate between connecting the two varieties of dot. Such 
that if a line begins at a filled dot it must terminate at an empty dot. This subtest 
measures all the same processes described in the earlier subtests however it also 
measures set switching (Delis et al., 2001). In contrast, Suchy et al (2010) found that 
this measure was related to visual search and attentional resources yet surprisingly was 
unrelated to cognitive flexibility. The total number of correct and unique designs is 
converted into an age scaled score and used as the main indicator of performance for 
this subtest.
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By contrasting the age scaled score for this subtest with the composite score from the 
first two subtests, a new score is created which aims to be a purer measure of set 
switching (Delis et al., 2001). Unlike the TMT, validity testing by an unaffiliated 
research group is yet to confirm this suggestion.
Furthermore, two error scores were derived from this test. The total number of 
repetition errors and set loss errors (rule violations) were calculated and then converted 
into a percentage of the total responses.
2.7. The Grooved Pegboard
The Grooved Pegboard Test (GPT) has been found to be a sensitive measure of motor 
performance used in a number of test batteries (Mathews & Klove, 1964). There are 25 
pegs which are used in the task which resemble two long metal cylinders of different 
diameters which have been fused together. Traditionally the task involves the placing of 
these identical pegs into holes, however the pegs must be rotated a certain amount in 
order to fit the peg in. This is first completed by the dominant hand and subsequently by 
the non-dominant hand. The participant’s performance on this task is measured by the 
time taken to complete it with each hand.
2.7.1. Rationale
This test was chosen as it has been found to be sensitive to nigrostriatal damage 
(Bohnen et al., 2007) in addition to providing a more complex assessment of manual 
dexterity beyond the basic level of motor speed measured by completing the motor 
speed subtest of the TMT. The relationship between GPT and cannabis use is not clear 
however one study exploring the relationship found a dose-response effect with more 
frequent cannabis users displaying slower completion times on the task (Bolla et al., 
2002). The effect of the age of onset of cannabis use on the GPT has not been explored 
and therefore this represents an opportunity to extend the literature on how chronic 
cannabis use affects manual dexterity.
2.7.2. The Place Task
The primary use of the grooved pegboard is the placing of the 25 pegs from the tray into 
the holes contained within the board, completed first with the dominant hand and then 
the non-dominant hand. This component has been suggested to measure visuomotor
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control, complex motor speed (Bryden & Roy, 2005) and motor planning (Baser &
Ruff, 1987) while recent validity research suggests that the role of basic motor speed is 
smaller than a cognitive role in GPT completion (Bezdicek et al., 2014; Strenge, 
Niederberger & Seelhorst, 2002). These studies suggest that attention, visual speed, and 
a continuous monitoring of performance are involved in task completion. The main 
performance indicator is the total time taken to place all 25 pegs into the holes and this 
is assessed with both hands yielding two scores.
2.7.3. The Remove Task
This requires the participant to remove the pegs from the holes and place them back into 
the tray from which they came. This has been suggested to be a purer measure of motor 
speed as it reduces the use of such processes as motor planning and attention (Bryden & 
Roy, 2005). Up until this time there had been no validity testing to confirm this 
hypothesis and therefore the current thesis included an analysis for confirmation. The 
results are discussed in Chapter Three, and they support Bryden & Roy’s (2005) 
hypothesis for a larger role of motor speed in this subtest. The main performance 
indicator is the total time taken to remove all 25 pegs out of the holes and this is 
assessed with both hands yielding two scores.
2.7.4. The Contrast Measure
The current research programme introduces a new method of analysing performance on 
the grooved pegboard task. This is analysed by contrasting the two previous measures 
(place task time taken - remove task time taken) for both the dominant and non­
dominant hand. This contrast aimed to minimise the effects of motor speed and results 
in a purer measure of the cognitive abilities, such as attention, motor planning, and 
visuo-motor coordination. Validity testing is also conducted on this measure and 
reported in Chapter Three. While the tests could not identify what is influencing 
performance on this measure, they do highlight that the motor speed is not involved in 
this measure as opposed to the place task or the remove task.
2.8. The Iowa Gambling Task
This computer based task was originally developed to detect damage to the 
ventromedial prefrontal cortex within a gambling paradigm (Bechara et al, 1994). It 
involves four decks of cards which can either result in the participant gaining or loosing
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virtual money. Decks ‘A ’ and ‘B’ are set to provide large short term gains of £1000 per 
10 cards, but long term losses of £1250 per 10 cards, generating a net loss of £250. 
Cards ‘C’ and ‘D’ are set to provide smaller short term gains of £500 per 10 cards and 
long-term losses of £250 per 10 cards which generates a net profit of £250 (see Figure 
2.9). The task is completed when the participant has selected 100 cards. Performance on 
this task is measured by the number of advantageous cards chosen, with the 
presumption that those who identify the long term gains sooner will switch to choosing 
the advantageous cards.
The authors of the task suggest that intuitive or emotional guided decision making 
processes are the primary cognitive resources recorded by the task (e.g. Bechara et al., 
1994) and validity studies seem to confirm this suggestion (Buelow & Suhr, 2009). It 
appears that “hot” decision making processes i.e. emotional more than cognitive, are 
explaining performance which explains mixed findings when correlating performance 
with measures of executive function. There also seems to be a link between IGT 
performance and risk taking behaviour as assessed by real-world risk taking behaviours 
such as drug use and gambling (Buelow & Suhr, 2009).
Bechara et al., (1994; 1999; 2005) have suggested that non-conscious emotions 
influence decision making, to an extent, before conscious realisation of the correct 
decision becomes apparent. According to the authors, these ‘hunches’ are manifested 
physically in the form of an autonomic response, such as increased skin conductance 
which is mediated by activation of the ventromedial prefrontal cortex and amygdala. 
Physiological testing showed that the healthy controls had this physiological response 
after a certain amount of cards had been chosen, the stage the authors named ‘pre­
hunch’. The test subjects, those with ventromedial prefrontal lesions, did not display 
this skin conductance response (SCR) whilst pondering the selection of a 
disadvantageous card. Further research has recruited those with amygdala lesions, in 
addition to VMPFC and controls, to take part in the IGT while measuring SCRs 
(Bechara et al., 1999). Both lesions groups not only performed worse on the task, but 
both showed significantly diminished SCRs whilst pondering the disadvantageous 
cards. This research now suggests that the autonomic responses, which are influenced 
by the VMPFC and the amygdala, influence the ability to make good decisions on this 
task.
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Figure 2.8. A screenshot of the IGT, displaying the four decks, the total amount won, 
the total amount borrowed and the amount won on the previous selection of deck A.
2.8.1. Rationale
As discussed this task has shown to be sensitive in detecting impairments by those 
afflicted with VMPFC and amygdala trauma. While this task has been largely 
successful in detecting impairments in chronic cannabis users (Whitlow et al., 2004; 
Bolla et al., 2005; Fridberg et al., 2006; Verdejo-Garcia et al., 2007) there is no data on 
whether the age of onset mediates deficits on this task. Therefore the current research 
programme will make an original contribution to this area by determining how the age 
of onset of cannabis use influences decision making.
Furthermore, this task is a relatively ecologically valid measure of decision making 
(Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia, 2006). Whereas some tasks isolate 
deficits within an experimental paradigm which then must be extrapolated to real life 
behaviours, this task creates a situation which is more applicable to behaviours that 
occur outside of the laboratory.
2.9. The Affectiva™ Qsensor
Within the current research program the Qsensor was used in conjunction with the Iowa 
gambling task and measures SCR, a form of autonomic nervous system arousal. The 
Qsensor is a portable, wrist worn device, containing two electrodes which measure SCR 
(Poh, Swenson & Picard, 2010).
SCR changes occur to situations which have subjective salience, including winning and 
losing, potential threats, emotions, anticipation of a salient outcome and cognitively 
demanding tasks (Critchley, 2000). SCR is influenced by the sympathetic
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subcomponent of the autonomic nervous system. There is evidence that such activity is 
mediated by the hypothalamus and the brainstem, with additional regions including the 
VMPFC, DLPFC, amygdala, anterior cingulate, insula, and parietal lobe. The region of 
influence is dependent on the situation, with the VMPFC and amygdala being 
associated with motivational behaviour, while the anterior cingulate cortex influences 
SCR during risk assessment (Frederikson et al., 1998; Critchley et al., 2001) and the 
right parietal lobule influences SCR during visual attention (Critchley et al., 2000).
The Qsensor was chosen to be administered in tandem with the IGT to determine if 
decision making processes in cannabis users were influenced by anticipatory SCRs 
comparable with VMPFC/amygdala trauma patients (Bechara et al., 2004). Although 
data collection was conducted with this device the analysis was not completed as the 
company supplying the hardware and analytical software discontinued the product 
during the data collection process.
2.10. The Wechsler Adult Intelligence Scale® Third Edition (WAIS-iii)
The WAIS-iii (Wechsler, 1997) contains a 14 individual sub components which 
measure various intellectual properties, however in the current research programme 
only the symbol search task was used. Additionally the record form was used to record 
the scores of the participants and the administration and scoring manual was used for 
the conversion of raw scores into age-scaled scores.
2.10.1. The Symbol Search Task
This task requires the participant to determine whether one of two target symbols appear 
in a row of a further five random symbols (see Figure 2.11). The participant makes their 
choice by marking either the ‘yes’ or ‘no’ boxes. After the allotted two minutes has 
expired, or the participant has completed the 60 trials, the task is stopped and the score 
calculated. The total correct responses score is converted into an age-scaled score using 
the administration and scoring manual. This task measures visual processing speed and 
motor speed (Wechsler, 1997).
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Figure 2.11. An example of one item of the Symbol Search Task in which one of the 
targets is present in the stimuli.
2.10.1.1. Rationale
This task was chosen as a measure an additional measure of visual processing 
(Wechsler, 1997). Although not considered an executive function, a number of other 
visual tasks were included which recruit visual processing speed as a contributory 
process (e.g. TMT; DFT) and therefore the inclusion of a more process pure assessment 
of this cognitive construct would allow an in-depth analysis of which processes are 
affected (if any) by chronic cannabis use.
2.11. The Wechsler Abbreviated Scale of Intelligence (WASI)
To create this IQ score the WASI was employed which includes four tasks: vocabulary 
and similarities, block design, and matrix reasoning (Wechsler, 1999). All four 
components create a full scale IQ score, which was the statistic used as a covariate in 
the first and second studies (see Chapters Three and Four). All responses from each 
subcomponent are recorded within the record form, while scoring and administration 
was aided by the manual. During the administration of certain sections of the test the 
stimulus booklet was used to provide the participant with necessary visual information.
2.11.1. Rationale
The present study included the WASI estimated full scale IQ (FSIQ) scores as a 
predictor of premorbid intelligence. Lezak et al., (2004) advised against using a single 
measure for premorbid estimates and suggested that as much information as possible 
should be utilised where possible. This is partly due to the fact that individuals can vary 
largely in their abilities across different cognitive domains (Taylor & Heaton, 2001) and 
the use of a single task thought to be resistant to the effects of insult may be inaccurate. 
It is for these reasons that the FSIQ, comprised of two verbal and two performance IQ 
subtests, was used to estimate premorbid intelligence.
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The rationale for choosing the WASI as opposed to the full WAIS-IV was partly for 
practical reasons, being that including the full scale version would increase the testing 
time of a cognitive battery which already includes a large number of questionnaires and 
neuropsychological tests and this would therefore increase potential fatigue effects. 
Furthermore, WASI scores have been shown to be strongly correlated with WAIS-iii 
scores in a normal sample (.84 to .92) although slightly less in a mixed clinical sample 
(.71 to .82; Axelrod, 2002).
All four subtests of the WASI are administered to the participant and the raw scores are 
then converted into age-scaled t-scores which are then converted into verbal, 
performance, and FSIQ scores. See Table 2.8 below for the authors’ account of which 
areas of intelligence are tested.
Table 2.3
An account o f the four WASI subtests and the primary areas o f intelligence measured.
WASI Subtest Primary cognitive processes measured
Vocabulary memory, crystallized intelligence
Block design spatial visualisation, general intelligence
Similarities abstract verbal reasoning, general intelligence
Matrix reasoning non-verbal fluid reasoning, general intelligence
2.12. The Hospital Anxiety and Depressions Scale (HADS)
The HADS was developed by Zigmond and Snaith (1983) with the aim of a quick and 
reliable measure of depression and anxiety. The questionnaire combines seven 
depression orientated statements and seven statements aimed to measure anxiety with a 
four point Likert-style response section ranging from 0-3.
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The participant’s results can suggest that they fall within the normal range (0-7), 
borderline abnormal (8-10) or abnormal range (11+) for depression or anxiety (Zigmond 
& Snaith, 1994). A typical statement is presented in the following format:
1) I feel tense or wound up:
3. M ost of the time
2. A lot o f the time
1. From time to time/occasionally
0. Not at all
2.12.1. Rationale
The rationale for choosing a measure of anxiety and depression is that these two 
conditions are both prevalent among cannabis users and can have a negative impact on 
cognition (see Section 1.5.5). The inclusion of such a measure would help determine 
whether cannabis-related impairments in executive function are mediated through 
anxiety and depression, or whether such deficits are independent of these mental health 
problems.
The rationale for choosing the HADS was based on the desire for a quick and simple 
method of assessing mental health symptoms in those who have not received a 
psychiatric diagnosis. A review of a large number of studies examining the reliability 
and validity of the HADS was conducted by Bjelland, Dahl, Haug & Neckelmann 
(2002). The findings highlight a satisfactory to excellent internal reliability (Cronbach's 
a=.68-.93) and this remains fairly consistent across males, females, a wide range of ages 
and many clinical samples. The HADS anxiety sub-score also shows satisfactory to 
good concurrent reliability with the State -Trait Anxiety Inventory (.64 - .81) and the 
depression sub-score shows good concurrent reliability with the Beck Depression 
Inventory (.61 - .83). The main critique of the HADS is that nearly half (9 out of 20) of 
the reviewed papers conducting factor analysis found greater than a two factor model, 
suggesting the measure does not just measure anxiety and depression, but also a third 
latent variable (occasionally called restlessness). Despite this critique, the authors 
(Bjelland et al., 2002) suggest that the data still best fits a two-factor model with a 
certain degree of overlap to be expected due to the co-morbidity of anxiety and 
depression.
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2.13. The Clark-Beck Obsessive-Compulsive Inventory (CBOCI)
The CBOCI was produced to detect the severity of obsessive and compulsive symptoms 
(Clark, Beck, Antony, Swinson & Steer, 2005). The CBOCI can provide information 
regarding obsessions, assessed over fourteen items; compulsions, assessed over eleven 
items and a combination of the two subcomponents, assessed using the full twenty-five 
items, all using a four-point graded-response format. A typical section followed the 
following format:
0. I never or rarely have obsessional intrusive thoughts, images, or impulses of dirt or 
contamination
1. I occasionally (less than weekly) have obsessional intrusions of dirt or contamination
2. I frequently (several times a week) have obsessional intrusions of dirt or contamination
3. I very frequently (daily) have obsessional intrusions of dirt or contamination 
The participant was instructed to read the passage on the front sheet of the CBOCI 
which explains the process of completing the questionnaire. The participant must 
respond by circling the number of the statement which best describes their thoughts, 
feelings or behaviours during the day of testing and the previous two weeks.
2.13.1. Rationale
The rationale for choosing a measure of OCD within the current research programme is 
based on the effects that obsessions and compulsions can have on executive function 
and the prevalence of OCD symptoms present in drug users (see Section 1.5). The 
inclusion of this measure may help determine whether cannabis-related impairments in 
executive function are mediated through obsessions and compulsions, or whether such 
deficits are independent of these mental health issues.
The CBOCI was chosen to provide an easy assessment of obsessive and compulsive 
symptoms without the need of a trained clinician. The measure boasts good internal 
reliability for healthy, OCD and mixed clinical samples across the two sub-scores and 
the combined total (Cronbach's a=.79-.95; Clark et al., 2005). Additionally the model 
shows good concurrent validity as determined by high correlations (.74) with an 
established 'gold standard' of OCD measures, the Yale-Brown Obsessive Compulsive 
Scale (Y-BOCS), which is administered by trained clinicians (Steketee, 1994). Factorial 
validity was also high, with a principal component analysis supporting a two-factor
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model with only a single item from the CBOCI not loading on its theorised factor (Clark 
et al., 2005).
2.14. The Apathy Evaluation Scale (AES)
The AES was developed to measure diminished motivational states which are not 
attributable to cognitive impairment, emotional distress, or diminished consciousness 
(Marin, Biedrzycki & Firinciogullari, 1991). The self-report version was used in the 
current research programme which required the participant to respond to statements on a 
four-point Likert style response section. A typical section followed the following 
format:
2 .1 get things done during the day 
Not at all Slightly Somewhat A Lot
The participant is required to circle the answer that best describes their thoughts, 
feelings and activities during the past four weeks.
2.14.1. Rationale
As with the two other mental health questionnaires, the AES is an easy to use and fast 
measure of a particular state - in this case - apathy/motivation. This was included due to 
reports of diminished motivation in cannabis users and due to motivation's role in 
executive function (see Section 1.5).
The AES was chosen as the measure of motivation for several reasons. The primary 
reason was that this specific measure has uncovered differences before between 
cannabis users and alcohol using controls (Solowij et al., 2011), suggesting that it is a 
sensitive measure for detecting diminished motivation in cannabis users, if any is 
present. Furthermore, the measure has shown good internal reliability (Cronbach's 
a=.86), yet predicative validity was weaker in the self-report measure than the clinician 
or informant measure (Marin et al., 1991). The study found that three of five 
behavioural measures of motivation were significantly associated with AES self report 
scores compared to five out of five for the clinician and informant version of the AES.
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Whether or not these behavioural measures actually predict motivation themselves 
however is questionable, as performance on the computer game PACman was used as 
one of the measures. While several of the measures including 'PACman latency' (how 
long it took for the participant to decide to play another game) may indicate 
motivational levels, performance itself may be reflective of previous computer game 
experience or other factors unrelated to motivation.
2.15. Mental Health Summary
The original plan was to use the questionnaires (HADS and OBOCI) for exclusion 
criteria purposes however the criteria for an abnormal score in HADS ranged vastly 
across different studies (from 3-11 out of a possible 21; Bjelland et al., 2002) and 
therefore it was decided instead to use the data as a potential covariate and to match the 
two groups for scores across the four sub components (anxiety, depression, obsessions, 
and compulsions). The AES was also adopted for this purpose in the eye-tracking study 
(Chapter Four).
2.16. Tobii Visual Search Test
2.16.1. Rationale
The neuropsychological study reported in this thesis (Chapter Three) suggested a 
combination of set switching and visual attention deficits in the cannabis users. In order 
to deconstruct the processes relating to these two areas of cognition, a computerised 
analogue of the Visual Scanning subtest from the D-KEFS TMT was created. The use 
of a computerised version of this task with the Tobii eye tracker allowed a number of 
different outcomes measures to be derived from both behavioural data and eye tracking 
data. These different outcome measures aimed to isolate the area/s which is impaired, in 
a similar fashion to that conducted by Huestegge, Radach, Kunert and Heller (2002).
2.16.2. The Tobii Eye Tracker
The device used to monitor gaze was a Tobii T120 with the eye tracking cameras built 
into a 17" monitor which presented the stimuli used in the task described in Section
2.16.3.
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2.16.3. Task Structure
The computerised adaptation of the visual search test from the TMT, hereinafter called 
Tobii VST, was designed using Tobii Studio. The computerised adaptation of the 
Number-Letter Switching task from the TMT, hereinafter called the Tobii SST was also 
designed using Tobii studio. The task which was designed for use with the Tobii eye 
tracker was aimed to replicate the task demands of the visual scanning and set switching 
subtests from the D-KEFS TMT.
The process of creating the new tasks required the consideration of the following 
aspects: number of trials, target to non-target ratio, the stimulus size, the display size, 
the set size per trial, the target symbol, the non-target symbols, the spatial density, and 
the stimulus arrangement. The criteria for creating each aspect of the new task were 
based on at least one of the four following sources. Firstly, where possible the new task 
would replicate the D-KEFS version of the visual search subtest. Secondly, the new task 
would aim to replicate previous comparable studies (Ehrenreich et al., 1999; Huestegge 
et al., 2002). Thirdly, theoretical considerations would be applied to the construction of 
a given aspect and finally, where necessary, practical considerations would take priority. 
Further information on this process can be found in Appendix A.2.2.
The Tobii VST involved a participant identifying whether or not a target symbol was 
presented amongst an array of distractor stimuli. The Tobii SST, maintained the same 
premise, however the target symbol would switch every trial from a target letter to a 
target number and then back again. An example of a trial can be seen below (Figure 
2.17).
109
©
©
© ©
©
©
© ©
©
© © ©
©
©
©
©^ ©
© ©
©
Figure 2.17. A  sample target trial taken from the Tobii VST
2.16.4. Behavioural Outcome Measures
2.16.4.1. Areas o f Interest
Before eye-tracking analyses could be conducted the areas of interest (AOIs) needed to 
be determined. A stage in the analysis using the Tobii eye tracker, studio and analysis 
package, is to code various areas on the test with AOIs. This allows the software to 
determine whether or not a fixation landed within a given area. Although there are no 
official guidelines on AOI dimensions, Goldberg & Helfman (2010) suggest that 
practical concerns along with empirically led information about foveal focal dimensions 
(Raynor, 1998) should guide AOI sizes. It is for these reasons that all 20 stimuli per trial 
were categorised as AOIs with a 1.2cm "padding" extending beyond the edges of each 
stimulus.
2.16.4.2. Reaction times
The mean reaction time for the target trials was assessed for both the Tobii VST and the
SST. The reaction time for the target trials encapsulates the majority of processes
involved in the task: time taken to employ a search strategy, time taken to shift foveal
110
focus across the array, time taken to process the stimulus and determine if it is a target 
or not, time taken to coordinate the appropriate motor response (button pressing) once 
the target has been located and time taken for the motor response to be initiated and 
completed. This unfiltered measure is likely to be the one which most replicates 
performance on the TMT subtests. Furthermore, this measure can be broken down from 
a total reaction time score into a 'correct' reaction time score, the mean time taken to 
identify a target across all trials in which the participant correctly identified the target.
The mean reaction time for the non-target trials includes additional processing. Once the 
target is found in target trials the search no longer needs to proceed, however for the 
non-target trials the individual must proceed until the participant reaches a threshold 
level of confidence that the target is not present. This is supported by the larger reaction 
times for non-target trials found by Huestegge et al (2002).
2.16.4.3. Errors
Omission errors (not identifying a target) and commissions errors (identifying a target 
which does not exist) were included for the analysis. This was considered alongside the 
reaction time data to determine the nature of the performance on the task. It is worth 
noting that increased errors could also be descriptive of more severe abnormalities such 
as an inability to process and identify symbols, however this has never been identified 
before in tasks which require cannabis users to identify abstract symbols (see Chapter 
Three) or read sentences (Huestegge, Kunert & Radach, 2010).
2.16.5. Eye-Tracking Outcome Measures
2.16.5.1. Unique Fixation Count
One of the primary measures investigated by Huestegge et al (2002) was the total 
fixation count which is the mean number of fixations per trial. The total number of 
revisits was also included by these authors however a different approach was chosen in 
this thesis. As revisits will increase the total number of fixations, the current study 
aimed to just look at the total number of unique fixations which increases the process 
purity of this measure. The number of unique fixations per trial describes search 
efficiency: the number of steps taken before the target is located, and therefore could be 
an indicator of strategic search efficiency (Najemnik & Geisler, 2005). When searching
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a visual scene, attention does not dart around randomly, but rather it follows a 
systematic pattern even when it appears to be random. Najemnik and Geisler (2005) 
describe several characteristics of the theoretical 'ideal' search strategy which include 
searching regions of 'high gravity', in which focus is drawn to clusters of high 
information (or stimuli).
2.16.5.2. Fixation Duration
This is the mean amount of time spent gazing at a particular location before a saccade is 
made. This period of fixation is the primary point at which information can be 
processed as the velocity of saccades leads to a marked reduction in the sensitivity to 
acquire new information, a term dubbed saccadic suppression (Matin, 1974). This 
fixation duration time is dependent on several factors: the extraction and visual 
processing of the stimulus within the foveal focus, the amplitude/distance of the 
previous saccade, peripheral scanning of stimuli outside the foveal focus and the 
planning and initiation of a subsequent occulomotor action (Salthouse & Ellis, 1980; 
Hooge & Erkenlens, 1998; Radach & Heller, 2000). Longer fixation latencies could be 
indicative of needing longer to process the content of the visually available information. 
This has been shown by varying the discriminability of the stimuli across trials (Hooge 
& Erkenlens, 1998) and by varying the stimulus exposure time (Salthouse & Ellis, 
1990). The role of peripheral processing in fixation durations has been identified by the 
discovery that longer fixations tend to follow large saccades. Following a short saccade 
there would have been a certain degree of extra-foveal or peripheral processing and 
therefore subsequent durations would be reduced. The destination after a longer saccade 
would have received minimal prior processing and therefore after this eye movement 
there have been shown to be longer fixation durations (Radach & Heller, 2000; Rayner, 
2009).
2.16.5.3. Fixation revisits
Frequent revisiting to a previously fixated region of the array was a measure used by 
Huestegge et al (2002) which uncovered impairments in their cannabis using sample. 
There have been suggestions that memory is not involved in visual search, most notably 
by Horowtiz & Wolfe (1998) who found that performance did not differ between a 
static search grid (target'T' among distractor ’L's) and a changing search grid in which
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the letters shifted position every 111ms. This study suggested that the use of memory 
regarding previous searched areas in every array did not aid performance in this specific 
task. Further support comes in the form of a dual-task format in which Woodman,
Vogel and Luck (2001) found that manipulating the load placed in visual working 
memory, in the form of the colour of objects, did not impair visual search processes. 
However, subsequent research from the same group (Woodman & Luck, 2004) found 
that by changing the visual working memory task with a spatial working memory task, 
visual search became impaired during a comparable dual-task format. In addition to 
these findings, it has been shown that the number of revisits in a search array is lower 
than would be expected by chance, which suggests a role of a memory system in visual 
search, albeit an imperfect memory system as revisits still occurred (Gilchrist & Harvey, 
2000). Therefore, greater numbers of fixation revisits in the current task could be 
interpreted as spatial working memory impairments. Although this should be interpreted 
with caution as fewer revisits may be due to an organised 'reading-like' search strategy, 
rather than an accurate memory of previously visited areas.
2.17. The Visual Object and Space Perception Battery
2.17.1. Exclusion Criteria
In order for the individual to take part in the Tobii tasks it was essential to ensure that 
any performance variance was not due to impaired vision. To avoid this possibility, 
every individual completed four subtests of the VOSP: Object Detection, Incomplete 
Letters, Position Discrimination, and Number Location (Warrington & James, 1991). 
These tests were chosen as each one recruited a fundamental visual process required to 
complete the Tobii tasks. The pass/fail guidelines suggested by the authors were divided 
into two age categories, those under the age of 50 and those who were 50 and above. 
Table 2.4 displays the information about each of the four subtests of the VOSP which 
were used in the experiment discussed in Chapter Six.
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Table 2.4.
The four subtests o f the VOSP with the pass/fail scores and the aspects o f perception 
measured.
Subtest Possible
Scores
Fail Score 
(age <50)
Fail Score 
(age >50)
Processes measured
Object
Detection
0-20 15 or less 15 or less VOP
Incomplete
Letters
0-20 17 or less 16 or less VOP; alphabetical 
recognition
Position
Discrimination
0-20 18 or less 18 or less VSP
Number
Location
0-10 7 or less 7 or less VSP; numerical 
recognition
Note. VOP = visual object perception; VSP = visual spatial perception.
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Chapter Three. Visuo-motor and Set Switching Deficits in Early Onset, Abstinent
Cannabis Users
3.1. Introduction
Previous studies have identified widespread cognitive deficits in chronic cannabis users 
yet there still remains some controversy as to why these results are not always 
replicated (Pope et al., 2001; Pope et al., 2002; Medina et al., 2007; McHale & Hunt, 
2008). Explanations for these inconsistent results tend to relate to either 1) 
methodological factors such as the tasks which were administered, 2) factors associated 
with cannabis use which act as confounding variables or 3) non-cannabis related 
confounding variables such as sex and IQ. The cannabis use variables include the length 
of abstinence from cannabis (for review see: Crean et al., 2010), the lifetime quantity or 
duration of cannabis use (Bolla et al., 2002; Solowij et al., 2002), the frequency of 
cannabis use (Gruber et al., 2011; Pope & Yurgellun-Todd, 1996) and the age of onset 
of cannabis use (Pope et al., 2003; Fontes et al., 2011; Gruber et al., 2011).
3.1.1. Executive Function and the Age of Onset Hypothesis
The age of onset hypothesis was first suggested after observations of the protracted 
functional and structural development of the brain, particularly the frontal cortex, which 
continues to develop beyond adolescence (Reiss et al., 1996; Giedd et al., 1999; Gogtay 
et al., 2004). The dorsolateral (DLPFC), ventrolateral (VLPFC), and orbitofrontal 
(OFC) have a protracted development and mediate executive functions to varying 
degrees (Alvarez & Emory, 2006). These morphological developments are accompanied 
by changes in executive function which continue to mature into the third decade of life 
(Romine & Reynolds, 2005). Due to the possibility that exposure to A9-THC confers 
greater adverse consequences due to the interruption of normal development through 
CBi receptor activation, a number of studies have tested the hypothesis that early onset 
cannabis use leads to greater and more widespread cognitive deficits than later use 
(Ehrenreich et al., 1999; Pope et al., 2003; Fontes et al., 201 lb; Gruber et al., 2011).
The earliest study to investigate the age of onset hypothesis in cannabis users found that 
the early onset users presented with deficits in visual scanning and divided attention
115
(Ehreneich et al., 1999). However, this study included users whose abstinence periods 
ranged from two hours to one week suggesting that a proportion of the effects 
discovered could be attributed to acute intoxication or 'hangover' effects rather than the 
long lasting damage from chronic cannabis use.
Pope et al (2003) administered a battery of cognitive tasks to early onset cannabis (EoC) 
users (<16 years), late onset cannabis (LoC) users (>17 years), and controls and found 
greater performance deficits in EoC users than LoC users when compared to each other 
and a control group. These deficits were on a verbal fluency task and the Wisconsin 
card sorting task (WCST), however these group differences were removed when verbal 
IQ was used a covariate. The authors used verbal IQ as an estimate of premorbid 
intelligence however they only used one test to estimate this score, the vocabulary 
subtest from the WAIS-III. The problem with using this IQ variable as a covariate is 
that it was found to be significantly reduced in cannabis users. If it was cannabis use 
which caused both the deficits on the executive function tasks and the deficits on the IQ 
test then this analysis would remove some of the variance in the dependent variable 
associated with the independent variable (early onset cannabis use vs. late onset 
cannabis use vs. controls) which leads to a reduction in power (Owen & Froman, 1998). 
This method by Pope et al (2003) could be improved by collecting IQ estimates from a 
range of tests and using a full scale IQ score which could reduce the possibility of it 
being fragile to the effects long term cannabis use. Although Pope et al’s study does not 
show a clear association between the age of onset and executive function, it suggests 
that EoC use could be related to impaired performance on the verbal fluency task and 
the WCST. Pope et al (2003) also included measures of sustained attention (Conners' 
Continuous Performance test) and inhibition (the Stroop test) however no between 
group differences were discovered on these measures before or after controlling for 
VIQ. In comparison with Ehrenreich et al's (1999) abstinence criteria, Pope et al (2003) 
used a 28 day 'monitored' abstinence period. This excludes the possibility that the 
cannabis groups' performance is due to acute intoxication, 'hangover' effects (Pope et 
al., 1995) or withdrawal effects (Budney et al., 2003) as all these phases are likely to 
have passed.
Another study detected impairments across a number of different executive function 
measures in cannabis users compared to controls (Gruber et al., 2011). In the second
116
half of the analysis Gruber et al (2011) divided the cannabis group into an EoC group 
(<15 years) and a LoC group (>16 years old). It became apparent that the early onset 
group were accounting for most of these previous impairments in the whole cannabis 
group. Gruber et al partially replicated the findings from Pope et al (2003) by detecting 
early onset related deficits on the WCST. However, while Pope et al (2003) did not 
discover any deficits on the Stroop task, Gruber et al's (2011) findings did identify such 
deficits in the early onset group. Gruber et al's abstinence period was set at 12 hours, 
this makes acute intoxication unlikely, however leads to issues attributing the effects to 
'hangovers' (Pope et al., 1995), withdrawal (Budney et al., 2003) or long lasting 
damage. While Gruber et al (2011) did use covariate methods to control for the effects 
of cannabis use variables (e.g. frequency of use) they did not apply the same approach 
used by Pope et al (2003) and control for the effects of IQ. Gruber et al (2011) did 
include strict exclusion criteria and matched groups for age and IQ to ensure these 
variables were not explaining group differences in cognition.
A study was conducted by Fontes et al (201 la; 201 lb) who administered the Frontal 
Assessment Battery (FAB) to a group of chronic cannabis users and controls. This 
battery measures conceptualisation, verbal fluency, motor programming, inhibition and 
environmental autonomy, all related to frontal circuitry (Guedj et al., 2008). When 
observing the cannabis group there were clear deficits in performance on the overall 
FAB score and the motor programming subtest (Fontes et al., 201 la). As with Gruber et 
al (2011), the cannabis group was subsequently divided into early (<14 years) and late 
(>15 years) onset cannabis groups (Fontes et al., 201 lb). The EoC group presented with 
deficits on the total FAB score compared to both controls and a LoC group while no 
deficits were apparent between the LoC group and controls on any measures (Fontes et 
al., 201 lb). In addition, Fontes et al (201 lb) examined performance on the WCST and 
the Stroop test which both highlighted impairments in the EoC group yet not the LoC 
group. These studies provide strong evidence that EoC use confers greater cognitive 
consequences related to cognitive flexibility and interference control (Pope et al., 2003; 
Gruber et al., 2011; Fontes et al., 201 lb), furthermore Fontes et al (201 lb) found 
impairments on the combined score of the FAB, perhaps suggesting more general 
frontal abnormalities in functioning. These studies have found preliminary evidence for 
a period of cognitive vulnerability, susceptible to the effects of chronic cannabis use.
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One study tested the age of onset hypothesis on verbal working memory during fMRI 
(Becker, Wagner, Gouzoulis-Mayfrank, Spuentrup & Daumann, 2010). No performance 
differences were found on a verbal working memory task between EoC users (<15 
years) and LoC users (>16 years), however fMRI data suggested greater and more 
widespread cortical activity in the early users suggestive of inefficient processing. This 
increased activity only correlated with age of onset and did not correlate with the period 
of abstinence, total lifetime use or frequency of use. These correlations were with 
activity localised to primarily prefrontal and parietal regions, consistent with previous 
uses of the n-back test (Owen et al., 2005). Similar findings were shown by a 
comparable study investigating inhibitory processes in cannabis users during fMRI 
(Gruber, Dahlgren, Sagar, Gonenc & Killgore, 2012). Although this study also showed 
no differences in behavioural performance, the early (<15 years) and late (>16 years) 
onset groups differed in the levels of activation within an area often implicated in 
inhibitory processing, the anterior cingulate cortex (Bush & Shin, 2006). It appears that 
when no behavioural abnormalities are evident, there are distinct differences in 
functional brain activity between early and late onset cannabis users.
These studies described above (Becker et al., 2010; Fontes et al., 201 lb; Gruber et al.,
2011; Gruber et al., 2012; Pope et al., 2003) have all used a methodology which
compares an EoC group with a LoC group, however earlier initiation of cannabis use
could potentially have the corollary of increased lifetime cannabis use which could
therefore be explaining these deficits. As already discussed, Gruber et al (2012) used
correlations between appropriate confounding variables and regional functional brain
activity to determine this and found a significant correlation with the age of onset but
not total cannabis use. Two of these studies included estimated total lifetime cannabis
use as a covariate and re-ran the analysis which had little effect on the results,
suggesting that this variable did not explain the differences between groups (Pope et al.,
2003; Gruber et al., 2011). Fontes et al (201 lb) did not control for the effects of lifetime
cannabis use, however the two groups (EoC users and LoC users) had similar lifetime
cannabis use, with no significant differences (6790 and 5160 lifetime spliffs,
respectively). It is therefore unlikely that lifetime cannabis used mediated the
performance deficits shown by early onset cannabis users. Becker et al (2010) found a
similar pattern of cannabis use, that there were no difference in lifetime use between
their early and late onset groups, however they did discover that the EoC group used
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cannabis more frequently (uses per month) and therefore used this as a covariate. The 
results remained unchanged after this analysis. With this combination of methods used 
over five studies, it seems unlikely that the age of onset effects discovered were due to 
lifetime cannabis use. Gruber et al (2011) also found that cannabis frequency 
(smokes/week) and magnitude (grams/week) was also related to poorer performance on 
several tasks however after controlling for these two variables in the main analysis there 
was still an age of onset effect. When combined with other studies showing a similar 
effect (Pope & Yurgelun-Todd, 1996; Bolla et al., 2002), this suggests that several 
cannabis use variables (e.g. age of onset; frequency of use) have contributory, adverse 
effects on cognitive performance.
3.1.2. Confounding Variables
Cannabis is typically smoked with a tobacco product to increase the ease at which it can 
burn. A recent study surveying drug users found that 94.6% of people who have smoked 
cannabis, always or occasionally smoke it with tobacco (See Chapter Five). Despite 
this, only one known study has accounted for tobacco use by the inclusion of as tobacco 
using control group (McHale & Hunt, 2008). When considering there is a potential 
dual-causality with altered cognition being both a product of tobacco use (Rezvani & 
Levin, 2001; Jacobsen et al., 2005), in addition to being a risk factor for it (Dinn, 
Aycicegi & Harris, 2004; Perry & Carrol, 2008), it becomes even more important to 
account for the effects of tobacco use when studying the cognitive alterations associated 
with chronic cannabis use. While tobacco is rarely considered as a confounding 
variable, alcohol and other drug abuse are frequently incorporated into exclusion criteria 
while weekly alcohol use is often statistically controlled (e.g. Pope et al., 2001; Solowij 
et al., 2002; Gruber et al., 2011). This is necessary as alcohol and drug use have also 
been associated with impaired cognition during acute intoxication, hangover symptoms 
and in terms of the residual effects of the respective drugs (Morgan & Curran, 2006; 
Stephens et al., 2008; Verdejo-Garcia et al., 2007).
In addition to the effects of tobacco, estimated IQ scores have shown moderate
correlations with tests of executive function (Ardila, Pineda & Rosselli, 2000). It is
necessary to examine any possible group differences in intelligence to ensure that if any
deficits in executive function are found, they are not a product of lower intelligence.
Furthermore, certain mental health problems have a high prevalence rate among
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cannabis users (Patton et al., 2002) and such conditions, e.g. anxiety and depression, can 
impact on executive functioning (Eysenck, Santos, Derakshan & Calvo, 2007; 
McDermott & Ebmeier, 2009). Based on the previous use of exclusion criteria and 
statistical covariates from previous cannabis-cognition research, in addition to further 
empirical data on diminished executive function, this study utilises a broad range of 
measures to account for confounding variables.
The present study aims to follow on from previous research examining executive 
function abilities in cannabis users when compared to a tobacco using group and a non­
smoking control group. This study will include: 1) measures which have been used 
before in the literature which have detected deficits in order to replicate findings; 2 ) 
updated and improved measures of older tasks to replicate previous findings with better 
tools; and 3) several measures which have not been tested on a cannabis sample in order 
to add to the literature by exploring new areas of cognition in long term cannabis users. 
This battery of tasks will test previous findings, provide more rigorous and sensitive 
testing procedures and allow the discovery of new and up-to-date information on 
chronic cannabis use across a broad range of executive function components and 
modalities. The inclusion of a tobacco group will test whether previously detected 
cognitive deficits associated with cannabis use will be found when compared to tobacco 
users. It is predicted that the cannabis users will show impairments on each of the tasks 
when compared to controls and tobacco smokers.
3.1.3. Summary
The present study aimed to extend previous age of onset research, examining whether
EoC use leads to worse executive functioning than LoC users, controls and tobacco
users. It was also predicted that LoC users will present with deficits relative to the
controls and tobacco users, albeit less than the EoC group. In a manner similar to
Gruber et al (2011) and Fontes et al (201 la; 201 lb), the cannabis users were first
analysed as a whole group and then as separate EoC and LoC groups. The present study
assessed decision making, non-verbal fluency, verbal set switching, motor coordination
and visual processing speed, all areas previously unexplored with regards to the age of
onset hypothesis. In addition to these domains, visual scanning, non-verbal set
switching, verbal fluency and motor speed were assessed similar to previous age onset
research (Ehrenreich et al., 1999; Pope et al., 2003; Fontes et al., 2011; Gruber et al.,
1 2 0
2011) in an attempt to replicate previous findings with a more robust measure (the D- 
KEFS; Delis et ah, 2001).
3.2. Method
3.2.1. Participants
The cannabis users in the current study were non-treatment seeking recreational users 
recruited primarily from the student population. Participants were contacted during 
undergraduate seminars, through student accommodation, and using the 'snowball' 
technique. Following completion of the CannaForm participants were excluded from the 
experiment if they met any of the following criteria: serious head injuries, any 
neurological conditions, any learning, developmental or genetic disorders, English not 
being their first language, other drug use (>15 lifetime uses), excessive alcohol use (>37 
units/week) and recent drug (past week) and alcohol use (more than 7.2 [males] or 4.9 
[females] units in past 24 hours; See Section 2.3.2). From the original sample of 378 
participants who completed the CannaForm, and after inclusion criteria inspections and 
subsequent participant contact, a total of 84 individuals participated in the study. 
Participants were firstly assigned to one of three separate groups: a non-smoking control 
group (n=21), a tobacco smoking control group (n=25), and a cannabis using group 
(n=32). The criterion for entry into the cannabis and tobacco groups was a history of 
regular use of the respective drug. Regular use was determined by >1 uses per month, 
for a period of no less than 6  months or total lifetime use exceeding 50 uses. See Table 
3.2 for further demographic information and Table 3.4 for further drug use information.
For the secondary analysis, the cannabis group was divided into early onset cannabis 
users (EoC; age of onset < 15 years; n= 16), late onset cannabis users (LoC; age of onset 
>16 years; n= 16). See Table 3.3 for further demographic information and Table 3.5 for 
further drug use information.
3.2.2. Ethical Considerations
In order to protect the anonymity of the participants a careful procedure was enacted. 
The first two pages of the CannaForm contained an information sheet and a consent 
form (see Appendix A.3.1). The information sheet stated that there were two primary 
data collection phases; the completion of the CannaForm and the administration of a
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battery of neuropsychological tasks. A detailed account of the purpose and nature of 
these two phases, along with the participant's rights were explained in information 
sheet. The consent form provided the opportunity to state if the participant would like to 
take part in the CannaForm phase or both of the phases.
Once the participants had completed the CannaForm the responses were examined to 
determine whether a) they elected to take part in phase two and b) they met the criteria 
to take part in phase two. If both of these conditions were met then the contact details 
were recorded in a separate document which indicated they were suitable for phase two. 
Irrespective of whether these conditions were met or not, the consent form was 
separated from the CannaForm resulting in an anonymous questionnaire identifiable 
only by a unique code which the participant created.
Participants who were suitable for the cognitive testing phase were contacted via the 
means they provided and a testing date was arranged. Upon arrival the participant was 
asked to reproduce their unique code so that all cognitive tasks would be labelled with 
the code which was reported on their completed CannaForm. At the end of the cognitive 
testing the participant was asked to provide a hair sample. The reason for this procedure 
and the consent for providing a sample were contained within the information sheet and 
consent form, however this information was given to the participant again and they 
were given the option to opt out.
Upon completion of both of the CannaForm phase and the cognitive testing phase, the 
participant was provided with a debrief sheet. This was to inform the participant of the 
nature of the study, their rights and the contact information of the experimenter.
3.2.3. Drug Use
The drug use data for the cannabis use analysis can be seen in Table 3.4 and the drug 
use data for the age of onset of cannabis use analysis can be found in Table 3.5. For 
further information on how these values were estimated see Appendix A.2.1.5.
In addition to the self-reported questionnaire responses on drug use approximately 50- 
lOOmg of hair taken from the scalp but not containing the hair root was cut and 
collected by the experimenter. Due to a prolonged endeavour to create a sensitive and 
accurate method for detecting cannabinoids and other drug derivatives in the hair
samples using Matrix-Assisted Laser Desorption/Ionisation (MALDI), the method is not 
finalised at time of writing. Despite not being able to validate the self-report data using 
the hair samples, Gruber et al (2011) report that the act of collecting urine samples and 
informing participants that they were to be tested for drug use improved the honesty of 
drug use reports. The current study used a similar method with the hair samples and in 
support of this claim one participant requested to change their drug use information 
after learning the purpose of collecting the hair sample.
3.2.4. Neuropsychological measures
A battery of neuropsychological tasks was used to measure a comprehensive range of 
cognitive functions. Task order was counterbalanced and testing lasted approximately 
two hours for each participant.
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Table 3.1.
Table o f the neuropsychological tests used and the cognitive processes they measure.
Neuropsychological Outcome Measures Primary cognitive processes
Task measured
D-KEFS - TMT Visual Scanning Visual scanning, visual attention
Number Sequencing Numerical sequencing, motor 
speed
Letter Sequencing Alphabetical sequencing, motor 
speed
Set switching Set switching, motor speed, 
visual scanning
Switching contrast Set switching
Errors Set switching, maintaining the 
set
D-KEFS - VFT Letter Fluency Initiation, inhibition, strategy 
formation, working memory
Category Fluency Initiation, inhibition, strategy 
formation, working memory
Category switching Set switching, inhibition, 
strategy formation, working
Switching contrast memory
% of set loss errors Set switching
% of repetition errors Verbal learning problems 
Perseveration, working memory
D-KEFS - DFT Design fluency Non-verbal creativity, initiation, 
strategy formation
Design switching Non-verbal creativity, initiation, 
strategy formation, set switching
Switching Contrast Set switching
Set Loss Errors Working memory, set switching
Repetition Errors Perseveration, working memory
IGT % of advantageous decks Decision making
SST Scaled Score Visual processing speed
Errors Visual processing
Grooved Pegboard Place task Motor programming, motor 
speed, visuo-motor coordination
Remove task Motor speed
Place/remove contrast Motor programming, visuo- 
motor coordination
Note. D-KEFS = Delis Kaplan Executive Function System; TMT = Trail Making Test; 
VFT = Verbal Fluency Test; DFT = Design Fluency Test; IGT = Iowa Gambling Task; 
SST = Symbol Search Task.
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3.2.5. Questionnaires and Physiological Measures
The CannaForm was used to screen any unsuitable participants and allocated suitable 
participants into the appropriate group. Two standardised mental health/emotional 
questionnaires were also included in the present study: the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983) and the Clark-Beck Obsessive- 
Compulsive Inventory (CBOCI; Clark & Beck, 2002). During the Iowa Gambling Task 
an Affectiva Q™ Sensor (Poh, Swenson & Picard, 2010) was attached to the non­
dominant wrist of the participant to record anticipatory skin conductance responses 
(SCRs). As the company which produced the hardware and the software for the Q™ 
Sensor discontinued the product during data collection the analysis the SCR data could 
not be completed.
3.2.6. Design
The present study employed a quasi-experimental approach, with the participant's 
smoking habits determining which condition they were allocated to. The first 
independent variable was cannabis use, with three levels including: cannabis users, 
tobacco smokers and a non-smoking control group. The dependant variables were the 
28 cognitive task outcome measures. To ensure the groups were matched for IQ, clinical 
and demographic variables, the CannaForm was administered alongside the HADS, the 
CBOCI, and the WASI.
The second independent variable was the age of onset of cannabis use, with four levels 
including: EoC users, LoC users, tobacco users, and a non-smoking control group. The 
dependant variables were unchanged from the first stage.
3.2.7. Procedure
Participants were recruited primarily on University campuses, student accommodations 
and using the snowball technique. Each individual received the CannaForm which was 
either administered by the experimenter or self-completed. The questionnaire was then 
checked to determine if the participant met the inclusion criteria.
Once participants had been accepted and allocated into a group they were either tested 
immediately or subsequently contacted to arrange a time for testing. Immediate or 
delayed testing was solely dependent on participant availability. The testing session
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lasted approximately two hours per individual and the order of the tasks was 
randomised. In addition to demographic data, further information was collected 
including the temperature of the room and the dominant hand (right, left or 
ambidextrous) of the participant. For physiological recordings the Q-sensor was placed 
on the non-dominant wrist of the participant and activated before the IGT was 
administered. The participant wore the Q-sensor for approximately five minutes before 
the IGT was initiated to allow the device to acclimatise to the individual and for a 
baseline measure to be taken.
At the end of the experiment the participant was asked to provide a hair sample of 
approximately 50mg, this was collected using scissors and cut as near to the scalp as 
possible, without removing the root of the hair. The participant was then debriefed.
3.2.8. Statistical Analysis
3.2.8.1. ANOVA and Kruskal-Wallis
The main analysis process consisted of six steps. The assumptions tested for the 
ANOVA included the presence of outliers, normality and homogeneity of variance. 1) 
Univariate outliers were checked by converting raw scores to z-scores and observing 
whether any cases were ±3 z-scores from the group mean (e.g. Whelan, 2008). In order 
to keep the data which were considered outliers the Winsorising method was used by 
converting all outliers to the nearest non-outlier score (Field, 2013). 2) Razali and Wah 
(2 0 1 1 ) recommend that the most effective way to assess normality is through a 
combination of graphical inspection, formal tests and observation of skewness/kurtosis 
statistics and these three methods are hereinafter referred to as the normality protocol. 
This normality protocol was implemented in the current study with the chosen graphical 
method being histograms, the chosen formal test being Shapiro-Wilk's due to its 
suitability for group sizes between three and 50 (Shapiro & Wilk, 1965). Finally, 
skewness and kurtosis statistics were inspected based on Leech, Barrett and Morgan's 
(2005) guidelines, any value ±1 or greater was considered non-normal. This process was 
only aimed to rule out severely non-normal distributions as ANOVAs have been found 
to be robust to non-normal distributions (Schmider, Ziegler, Danay, Beyer & Buhner, 
2010). Meyers, Gamst and Guerino (2009) set out guidelines to deal with severe non­
normal distributions which involved five different transformation methods. Each of
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these methods was applied to each non-normal distribution to determine if normal 
distributions could be achieved. These methods were the square root of X (Vx), base 1 0  
logarithm of X (log 10(x)), inverse of X (x-1 ), square of X (x2) and cube of X (x3). 
Following successful attempts to transform the non-normal distributions, ANOVAs 
were run on the data and following the unsuccessful attempts, a Kruskal-Wallis test was 
used in place of the ANOVA. For these Kruskal-Wallis tests the original data was used 
instead of the Winsorised data. 3) For the remaining variables which were to be 
analysed using the ANOVA method homogeneity of variance was tested. The standard 
Levene's test is overly sensitive to slight variations in variances (Howell, 2011) and thus 
any dependent variable which yielded a significant (a = .01; Meyers et ah, 2012) effect 
from a Levene's test or Brown-Forsythe test (Brown & Forsythe, 1974) was subject to 
further examination of standard deviations and variances. If standard deviations 
between groups differed by a magnitude of four or variances differed by a magnitude of 
10 then these were considered heterogeneous variances (Tabachnick & Fidell, 2010). 
Any dependent variable which violated the assumption of homogeneity of variance was 
assigned to the Kruskal-Wallis method. 4) The ANOVA and Kruskal-Wallis tests were 
then run. 5) Tukey's HSD (for approximately equal sample sizes) and Hochberg's GT2 
(for uneven sample sizes) were run to follow up any significant ANOVA test 6 ) 
Bonferroni corrected Dunn's tests were run to follow up any significant Kruskal-Wallis 
test.
In post hoc situations where prior research informed the directional hypothesis then 
one-tailed hypotheses tests were conducted, however in situations were no such 
directional hypothesis was made then two-tailed hypothesis were used. Each post hoc 
test is labelled appropriately. When one-tailed tests were used the p-value was adjusted 
by dividing the value by two.
3.2.8.2. Categorical analyses
For categorical data 2x3 chi square tests were run. This analysis process consisted of 
three steps. 1) Contingency tables were examined to test the expected frequencies 
assumption. If any expected counts were 0, 1, or more than 20% were greater than 5 
then this assumption was violated. 2) If the assumption was violated the Fisher's exact 
test was used which accounts for this violation (Field, 2013). If the assumption was not
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violated then the likelihood ratio was chosen over the Pearson chi-square test as it is 
more suitable for small sample sizes, such as the sample in the current study.
3.2.8J. ANCOVA
In order to control for the effects of salient covariates an ANCOVA method was 
implemented which consisted of five steps. 1) Any potential analysis using the 
ANCOVA method must meet the assumptions necessary for an ANOVA and therefore 
any previous transformations applied to dependent variables were maintained for the 
ANCOVA. Furthermore, analyses which were assigned to the Kruskal-Wallis method 
were unsuitable for ANCOVA. 2) Independence of the treatment and covariate effect 
was tested. This assumption states that the potential covariate must be un-related to the 
independent variable in the analysis. If this is not the case then including a covariate 
will lose some of the variance associated with the grouping variable and thus lead to an 
underpowered analysis and misleading results (Owen & Froman, 1998; Field, 2013). 3) 
Associations between the covariate and the dependent variable need to be present in 
order for ANCOVA to be justified (Dancey & Reidy, 2011). Furthermore, this 
association needs to be large enough to account for the reduction in power associated 
with running an ANCOVA (Owen & Froman, 1998). Pearson's (for parametric data) 
and Spearman's (for non-parametric data) correlations were run to test this assumption. 
Any significant association (a = .05) was considered as a covariate. 4) The next 
assumption is linearity of regression which assumes that the covariate is linearly 
associated with the dependent variable (Meyers et al., 2012). Visual inspections of 
scatter graphs checked this assumption. The transformation protocol (see Section
3.2.8.1.) was applied following the violations of this assumption and scatter graphs were 
re-examined to check if the violation had been corrected. 5) The final assumption is 
homogeneity of regression (Meyers et al., 2012) which assumes that different levels of 
the independent variable will have similar regression slopes with the dependent 
variable. This was tested by observing the independent variable X covariate interaction 
effect in the ANCOVA output (Meyers et al., 2012).
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3.3. Results
3.3.1. Demographic Data
Data from the CannaForm pertaining to demographic characteristics were collected and 
analysed to determine whether relevant factors differed between the three groups.
There were three variables which could be analysed through the ANOVA method and 
therefore assumptions were tested. These three variables were checked for outliers and 
one case was at ±3 z-scores from the group mean which was subsequently Winsorised. 
The normality protocol of assessing histograms, the Shapiro-Wilk's test, skewness 
statistics and kurtosis statistics suggested that there were deviations from normality for 
the educational achievement variable. The six transformation methods described in 
section 3.2.8 were implemented and the normality protocol suggested that the square 
method was the most effective for the educational achievement variable. The age and 
years of education variables for both analyses proved to be non-normal and the 
transformation protocol followed by a repeated normality protocol suggested that the 
distribution could not be corrected. Therefore years of education and age were analysed 
using the Kruskal-Wallis method.
3.3.1.1. Cannabis Use Analyses
A one-way ANOVA was run to test whether the groups (Controls vs. Tobacco users vs. 
Cannabis users) were matched for educational achievement (see Table 3.2). There was 
no main effect between groups for the educational achievement variable [F(2,80)=2.51, 
p=.087, partial rj2=.059].
Two Kruskal-Wallis tests were run to test whether the groups (Controls vs. Tobacco
users vs. Cannabis users) were matched for two demographic variables. There was no
main effect between groups for the years of education variable \)C(2)=2.36, p=.301]
however there was a significant main effect of age [/2(2)=6.91, p=.032]. Follow-up
Dunn's tests were run on the age variable. This showed that the cannabis group were
significantly older than the controls [7 (57)= 15.97, p=.026, 2-tailed] while there was no
difference between the cannabis users and tobacco users [7(55)=7.85,p=.618, 2-tailed]
and no difference between the controls and tobacco users [f(50>=8 . 12, p=.625, 2-tailed].
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In order to analyse the categorical data three separate 2x3 chi-square tests were run to 
test the hypothesis that sex, nationality, and handedness were matched across groups 
(controls vs. tobacco users vs. cannabis users). Two of the variables, nationality and 
handedness, violated the assumption of expected frequencies and thus were analysed 
using Fisher's exact test. Sex did not violate this assumption and therefore was analysed 
with the Likelihood ratio method. There was no significant main effect of cannabis use 
on sex [/2(2)=4.58 p=A 14 (likelihood ratio)], nationality [ /2=5.53, p=.559 (Fisher's)], or 
handedness [^=0.24,/?= 1.00 (Fisher's)].
3.3.1.2. Age o f Onset Analyses
A one-way ANOVA was run to test whether the groups (Controls vs. Tobacco users vs. 
EoC vs. LoC) were matched for educational achievement (see Table 3.3). There was no 
main effect between groups on for the educational achievement variable [F(3,79)=L84, 
p=.147, partial r/2=.065].
Two Kruskal-Wallis tests were run to test whether the groups (Controls vs. Tobacco 
users vs. EoC vs. LoC) were matched for two demographic variables. There was no 
main effect between groups for the years of education variable f / 2 (3)=2.63, p=.452] or 
the age variable [/2(3)=7.02,p=.071].
In order to analyse the categorical data three separate 2x4 chi-square tests were run to 
test if sex, nationality and handedness were matched across the groups (controls vs. 
tobacco users vs. EoC users vs. LoC users). Two of the variables, nationality and 
handedness, violated the assumption of expected frequencies and thus were analysed 
using Fisher's exact test. Sex did not violate this assumption and therefore was analysed 
with the Likelihood ratio method. There was no significant main effect of cannabis use 
on sex [/2(3)=5.08, p=. 166 (likelihood ratio)], nationality [^=8.50, p=.650 (Fisher's 
exact test)],or handedness [/2=0.79,p=.905 (Fisher's exact test)].
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3.3.2. Drug Use Data
When a testing date and time was arranged the participants were asked to abstain from 
alcohol use and cannabis use for twenty-four hours and other recreational drug use for 
one week prior to the testing time. All participants reported their last alcohol and drug 
use which showed drug use within the accepted timeframe for all participants. The aim 
was to recruit participants with less than 15 uses of cannabis use for the control and 
tobacco users however and although this was met for the controls, five participants from 
the tobacco group violated this criterion [range=0-24 spliffs; x=3.42; SZ)=5.63]. It was 
aimed to have less than 15 users of tobacco for controls, this criterion was violated for 
one participant [range=0-26 cigarettes; x= \A  1; SD=4.99]. It was also aimed to have 
less than 15 episodes of other drug use (total episodes of drug use; not including 
cannabis, alcohol or tobacco) across all three groups. This criterion was met for the 
control group and the tobacco group however was violated for three of the participants 
from the cannabis group (see Table 3.3). As these violations were only small, these 
participants were kept in the study.
The normality protocol of assessing histograms, the Shapiro-Wilk's test, skewness 
statistics and kurtosis statistics suggested that there were deviations from normality for 
the all of the drug use variables seen in Table 3.3, with the exception of the desired 
cannabis intoxication level. The five transformation methods described in section 3.2.8 
were implemented on the non-normally distributed variables and a repeated normality 
protocol suggested that the root method was the most effective for weekly alcohol use 
and age of onset of cannabis use. The remaining variables could not be transformed 
therefore these variables were to be analysed using the Kruskal-Wallis test.
3.3.2. J. Cannabis use analyses
Three one-way ANOVAs were run to test if the groups (Controls vs. Tobacco users vs. 
Cannabis users) were matched for weekly alcohol use, the age of onset of cannabis use 
and the desired intoxication level when using cannabis (see Table 3.4). There was a 
significant main effect between groups for the weekly alcohol use variable [F(2,74)=3 .4 9 , 
p=.036, partial ^2=.086]. In contrast, there were no significant main effects between 
groups for the age of onset of cannabis use [F(2,45)=0 . 95, p=.395, partial rj2=.040] or the 
desired level of intoxication during cannabis use [F(2,37)=0 . 58, p=.567, partial r]2=.031].
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Seven Kruskal-Wallis tests were run to test if the groups (Controls vs. Tobacco users vs. 
Cannabis users) were matched on seven drug use variables (see Table 3.3). There was 
no main effect between groups for the number of amphetamine uses [j2(2)=5 .9 7 , p=.051, 
//2=.072] however there was a significant main effect of lifetime cannabis use 
[^2(2)=65.19,p<.001, >72=.804], length of cannabis use in years [/2(2)=5 9 .2 2 , p<.001, 
^2=.790], lifetime tobacco use [/2(2)=41.62, /?<.001, r/2=.50\], lifetime ecstasy use 
\X2(2)= 12.70, p=.002, rj2- .  153], lifetime cocaine use [/2(2)=7 .3 7 , p=.025, /72=.089], 
lifetime magic mushroom use [ /2(2)=6 .7 4 , p=.034, //2=.081] and lifetime other drug use 
[/2(2)= 19.63, /?<.001, //2=.237].
3.3.2.1.1. Controls vs tobacco users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested that tobacco users consumed significantly more alcohol per 
week than controls [f(50)=2.33, /?=.033, <7=0.81, 1-Tailed GT2] and significantly more 
tobacco than controls [f(50)=40.61,pc.001, /-0 .86, 1-Tailed Dunn's].
In contrast, there were no differences between controls and tobacco users in lifetime 
cannabis use [t(50)= 10.63, p=. 145, /-0 .23, 1-Tailed Dunn's], years of cannabis use 
[?(50)=9.44, p=. 197, r=0.21, 1-Tailed Dunn's], lifetime ecstasy use [7(50)=5.06, p=314, 
r=0.16, 1-Tailed Dunn's], lifetime cocaine use (7(50)=1.74, p=.500, r=0.07, 1-Tailed 
Dunn's], lifetime mushroom use [r(50)=0.00, p=.500, a-0.00, 1-Tailed Dunn's] and 
lifetime total drug use [7(50)=9.36, p=.190, a-0.25, 1-Tailed Dunn's].
3.3.2.1.2. Controls vs cannabis users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested that cannabis users consumed significantly more alcohol 
per week than controls [f(57)=2.26, p=.039, <7=0.60, 1-Tailed GT2], significantly more 
tobacco than controls [7(57)=29.52,/?<.001, r=0.62, 1-Tailed Dunn's], significantly more 
cannabis than controls |7(57)=46.00,pc.OOl, /-1 .00, 1-Tailed Dunn's], significantly 
longer use of cannabis than controls [t(57)=40.89, pc.OOl, /-0.95, 1-Tailed Dunn's], 
significantly more ecstasy than controls [f(57)= 14.42, /7<.0 0 1, /-0.45, 1-Tailed Dunn's], 
significantly more cocaine than controls [7(57)=7.83, p=.0\6, r=0.33, 1-Tailed Dunn's], 
significantly more magic mushrooms than controls [f(57)=5.25, p=.039, r=0.29, 1-Tailed 
Dunn's] and significantly more other drugs than controls [f(57)=21.56,p<.001, r=0.57, 1- 
Tailed Dunn's].
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It is necessary to clarify at this point that the statistically significant differences between 
controls and cannabis users for ecstasy, cocaine, magic mushrooms and other drug use 
does not represent a substantively significant difference (see Table 3.4). However, the 
difference between these two groups weekly alcohol use, lifetime tobacco use, lifetime 
cannabis use and duration of cannabis use does represent a substantively significant 
difference.
3.3.2.1.3. Tobacco Users vs Cannabis Users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested than cannabis users have consumed significantly more 
cannabis than tobacco users [7(55)=35.38, pc.OOl, /-0 .76, 1-Tailed Dunn's], significantly 
longer use of cannabis than tobacco users |7(55)=31.45,p<.001, /-0 .70, 1-Tailed Dunn's], 
significantly more ecstasy than tobacco users [7(55)=9.36, p=.040, /-0 .29, 1-Tailed 
Dunn's], significantly more magic mushrooms than tobacco users [7(55)=5.25, p=.044, 
/-0 .29, 1-Tailed Dunn's] and significantly more other drugs than tobacco users 
[?(55)=1 2 .2 0 , p=.022, r=0.34, 1-Tailed Dunn's]. It is necessary to clarify at this point that 
the statistically significant differences between tobacco users and cannabis users for 
ecstasy, magic mushrooms and other drug use does not represent a substantively 
significant difference (see Table 3.3). However, the difference between these two 
groups in lifetime cannabis use and duration of cannabis use does represent a 
substantively significant difference.
There were no significant differences between cannabis users and tobacco users for 
units of alcohol consumed per week [f(55)=0.16, p=.500, <7=0.07, 1-Tailed GT2], lifetime 
tobacco use [7 (55)= 1 1.09, p=. 120, /-0 .24, 1-Tailed Dunn's], and cocaine use |7(55)=6.09, 
p=.077, /-0.27, 1-Tailed Dunn's].
3.3.2.2. Age o f onset analyses
Three one-way ANOVAs were run to test whether the groups (Controls vs. Tobacco 
users vs. EoC vs. LoC) were matched for estimates of drug use as measured by weekly 
alcohol use, the age of onset of cannabis use and the desired intoxication level when 
using cannabis (see Table 3.2). There was a significant main effect between groups for 
the age of onset of cannabis use [F(3,44)=l 1.6 8 , /?<.001, partial i/2=.443]. In contrast, 
there were no significant main effects discovered between groups for the weekly alcohol 
use variable [F(3,73)=2 .4 3 , p=.072, partial ;/2=.091] or the desired level of intoxication
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during cannabis use [F(3,36)=0.54, p=.651, partial rj2=.043]. Only significant omnibus 
tests are followed up with post hoc tests. Controls were not included in the follow up 
analysis for age of onset as only three participants reported an age of onset of cannabis.
Seven Kruskal-Wallis tests were run to test whether the groups (Controls vs. Tobacco 
users vs. EoC vs. LoC) were matched for estimates of drug use as measured by seven 
variables (see Table 3.5). There was a significant main effect between groups for the all 
tests including lifetime tobacco use I/2 (3)=43.65, p<.001, //2=.526], lifetime cannabis 
use ( /2(3)=65.21, pc.OOl, //2=.805], years of cannabis use [ /2(3)=60.58,/?<.001, ;/2=.808], 
number of amphetamine uses I/ 2 p p  10.45, p=.015, //2=.126], lifetime cocaine use \ x  
(3)=9.17,/?=.027, >72=.l 10], lifetime magic mushroom use [x2 (3)=9 .5 3 , p=.023, rp=.l 15], 
lifetime ecstasy use [ / ^ p  12.86, p=.005, >72=.155] and lifetime other drug use [x2 
(3)=21.77, p<.001, ^2=.262].
3.3.2.2.1. Controls vs EoC users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested that EoC users consumed significantly more tobacco than 
controls [7(42p35.49, p<.001, r=0.72, 1-Tailed Dunn's], significantly more cannabis than 
controls [t(42)=45.40, pc.OOl, /-0 .94, 1-Tailed Dunn's], significantly longer use of 
cannabis than controls [f(42p45.39, p<.001, r=0.84, 1-Tailed Dunn's], significantly more 
amphetamine use than controls [/(42)= 10.69, /?=.006, /-0 .47, 1-Tailed Dunn's], 
significantly more cocaine than controls [7(42pl0.59, p=.0\2, r=0.44, 1-Tailed Dunn's], 
significantly more mushroom use than controls [/t(42)=7.91, /7=.016, /-0 .42, 1-Tailed 
Dunn's], significantly more ecstasy use than controls [^42)= 13.28, p=.024, r=0.41, 1- 
Tailed Dunn's], and significantly more other drug use than controls [f(42)=25.41, pc.OOl, 
r=0.66, 1-Tailed Dunn's].
It is necessary to clarify at this point that the statistically significant differences between 
controls and EoC users for amphetamines, ecstasy, cocaine, magic mushrooms and 
other drug use does not represent a substantively significant difference (see Table 3.5). 
However, the difference between these two groups for lifetime tobacco use, lifetime 
cannabis use and duration of cannabis use does represent a substantively significant 
difference.
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3.3.22.2. Controls vs LoC users (Hochberg's GT2 and Dunn's test]
The post hoc tests suggested that LoC users consumed significantly more tobacco than 
controls [f(42)=23.55, p=.005, /-0 .48, 1-Tailed Dunn's], significantly more cannabis than 
controls |7(42)=46.56, pc.001, /-0.99, 1-Tailed Dunn's], significantly longer use of 
cannabis than controls [f(42)=36.66,pc.OOl, r=0.84, 1-Tailed Dunn's], significantly more 
ecstasy use than controls [f(42)=15.56, p=.006, a-0 .4 8 ,  1-Tailed Dunn's], and 
significantly more other drug use than controls |7(42)= 17.44, p=.009, /-0 .45, 1-Tailed 
Dunn's].
In contrast, there were no differences between LoC users and controls for amphetamine 
use [?(42)=2.53, /?=.500, r=0.11, 1-Tailed Dunn's], cocaine use [f(42)=5.06, p=.500, 
/-0 .21, 1-Tailed Dunn's], or mushroom use [f(42)=2.59, p=.500, a-0.14, 1-Tailed 
Dunn's].
It is necessary to clarify at this point that the statistically significant differences between 
controls and LoC users for ecstasy and other drug use does not represent a substantively 
significant difference (see Table 3.5). However, the difference between these two 
groups lifetime tobacco use, lifetime cannabis use, and duration of cannabis use does 
represent a substantively significant difference.
3.3.2.2.3. Tobacco users vs EoC users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested than EoC users has a significantly higher lifetime cannabis 
use than tobacco users |7(40)=34.78, pc.001, /-0 .72, 1-Tailed Dunn's], significantly 
longer use of cannabis than tobacco users [/(40)=35.96, p<.001, r=0.79, 1-Tailed Dunn's], 
started using cannabis significantly earlier than tobacco users [/L(28)=4.18 , p<.001, 
d= 1.45, 1-Tailed Hochberg's], had significantly more amphetamine use than tobacco 
users [r(40)=9.07, p=.028, a-0.41, 1-Tailed Dunn's], had significantly more magic 
mushroom use [7(40)=7.91, p=.018, r=0.43, 1-Tailed Dunn's], and significantly more 
other drug use than tobacco users [f(40)= 17.55, p=.010, a-0.46, 1-Tailed Dunn's].
There were no significant differences between EoC users and tobacco users for lifetime 
tobacco use |7(40)=5.12,p=.500, r=0.11, 1-Tailed Dunn's], ecstasy use |7(40)=8.22, 
p=.314, /-0 .25, 1-Tailed Dunn's], and cocaine use [f(40)=8.85, p=.054, r=0.37, 1-Tailed 
Dunn's].
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It is necessary to clarify at this point that the statistically significant differences between 
tobacco users and EoC users for amphetamines, magic mushrooms and other drug use 
does not represent a substantively significant difference (see Table 3.5). However, the 
difference between these two groups in lifetime cannabis use, age of onset of cannabis 
use and duration of cannabis use does represent a substantively significant difference.
3.3.22A. Tobacco users vs LoC users (Hochberg's GT2 and Dunn's test)
The post hoc tests suggested that LoC users have a significantly higher lifetime 
cannabis use than tobacco users [?(40)=35.94, pc.001, r=0.76, 1-Tailed Dunn's] and 
significantly longer use of cannabis than tobacco users [7(40)=27.23, pc.001, a-0.61, 1- 
Tailed Dunn's].
There were no significant differences between LoC users and tobacco users for lifetime 
tobacco use [t(40)= 17.06, p=.074, r=0.35, 1-Tailed Dunn's], age of onset of cannabis use 
[f(28)= 1-16 ,p= .812, <r/=0.38, 1-Tailed Hochberg's], amphetamine use |7(40)=0.91, p=.500, 
r=0.04, 1-Tailed Dunn's], magic mushroom use (7(40)=2.59, p=.500, /-0 .14, 1-Tailed 
Dunn's], ecstasy use (7(40)=10.50, p=.\ 15, r=0.32, 1-Tailed Dunn's], cocaine use 
[r(40)=3.32, p=.500, /-0.14, 1-Tailed Dunn's], and other drug use [f(40)=9.58, p=.320, 
a-0.25, 1-Tailed Dunn's].
Unlike previous two-group comparisons in this section, both statistically significant 
results between tobacco users and LoC users do highlight substantively significant 
differences (see Table 3.5).
3.3.2.2.5. EoC Users vs LoC Users (Tukey's HSD and Dunn's test)
The post hoc tests suggested than EoC users started using cannabis significantly earlier 
than LoC users [f(3i)=5.64,/?<.001, <7=2.10, 1-Tailed Tukey's].
There were no significant differences between LoC users and EoC users for lifetime 
cannabis use [f(3i)=1.16, p=.500, /-0.02, 1-Tailed Dunn's], years of cannabis use 
[f(31)=8.73,p=.500, r=0.18, 1-Tailed Dunn's], lifetime tobacco use |7 (3i)=l 1.94, p=.463, 
/-0 .22, 1-Tailed Dunn's], amphetamine use [f(3i)=8.16, p=. 103, a-0.33, 1-Tailed 
Dunn's], magic mushroom use [f(3i)=5.31, p=.285, r=0.26, 1-Tailed Dunn's], ecstasy use 
[f(3i)=2.28, p=.500, r=0.06, 1-Tailed Dunn's], cocaine use |7 (3i)=5 .5 3 , /?=.500, r=0.21, 1- 
Tailed Dunn's], and other drug use [7 (3i)=7 .9 7 , p=.500, r=0.19, 1-Tailed Dunn's].
139
The only statistically significant result here, in the age of onset of cannabis use, is a 
substantively significant result.
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3.3.3. Mental Health Data
Data from the HADS and the CBOCI was collected for each of the four outcome 
variables to determine whether the three groups differed on measures of depression, 
anxiety, obsessions and compulsions. The possible scores on the two HADS tests 
ranged from 0 -2 1  with higher scores indicating higher levels of anxiety or depression. 
The possible scores on the CBOCI ranged from 0-42 for the obsessions scale and from 
0-33 for the compulsions scale with higher scores indicating more severe symptoms of 
OCD.
The four variables were checked for outliers and three cases were at ±3 z-scores from 
the group mean which were subsequently Winsorised. The normality protocol of 
assessing histograms, the Shapiro-Wilk's test, skewness statistics and kurtosis statistics 
suggested that there were mild deviations from normality for the anxiety measure from 
the HADS and the obsessions measure from the CBOCI however due to the robustness 
of the ANOVA method these were not altered. The depression measure from the HADS 
and the compulsions measure from the CBOCI deviated more severely from normality 
and thus were transformed using the root transformation. The six transformation 
methods described in section 3.2.8 were implemented and the normality protocol 
suggested that the root method was the most effective.
Before the ANOVA procedure was completed, homogeneity of variance was checked 
using the Levene test and the Brown-Forsythe test and assumptions were met.
3.3.3.1. Cannabis Use Analyses
Four one-way ANOVAs were run to test if the groups (Controls vs. Tobacco users vs. 
Cannabis users) were matched for mental health symptoms, as measured by four 
variables (see Table 3.6). Between-subject effects showed no significant differences 
between groups on individual measures of mental health: anxiety [F(2,8i)=0.09, /?=.914, 
partial ^2=.002], depression [F(2,8i)=2 .4 9 , p=.089, partial i/2=.058], obsessions 
[F(2,8n=0 .8 8 , p=.418, partial yj2=.021] and compulsions [F(2,8i)=0 .7 9 , p=.456, partial 
rj2=.019]. As there were no significant main effects of cannabis use on mental health 
traits, post hoc comparisons were not run.
143
3.3.3.2. Age of Onset Analyses
Four one-way ANOVAs were run to test whether the groups (Controls vs. Tobacco 
users vs. EoC vs. LoC) were matched for estimated of mental health symptoms, as 
measured by four variables (see Table 3.7). Between-subject effects showed no 
significant differences between groups on individual measures of mental health: anxiety 
[F(3,80)=O.26,p=.851, partial tf=.010], depression [F(3,80)= 1.74,/?=. 167, partial ;/2=.061], 
obsessions [F(3,80)=0.60, /?=.620, partial t/2=.022] and compulsions [F(3,80)=0.90, /?=.447, 
partial t f=.033]. As there were no significant main effects of cannabis use on mental 
health traits, post hoc comparisons were not run.
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3.3.4. IQ Data
The estimates of IQ derived from the WASI were collected and analysed to determine 
whether the three groups differed on measures of FSIQ and each of the four subtests. A 
qualitative interpretation by the authors breaks up performance into extremely low (69 
and below), borderline (70-79), low average (80-89), average (90-109), high average 
(110-119), superior (120-129) and very superior (130 and above) categories (Wechsler 
et ah, 1999). The remaining possible scores (age-scaled) are 20-73 for the Vocabulary 
subtest, 24-73 for the Block Design subtest, 20-71 for the Similarities subtest, and 20-69 
for the Matrix Reasoning subtest. Higher scores on all of the subtests indicate better 
performance.
The five variables were checked for outliers and seven cases were at ±3 z-scores from 
the group mean which were subsequently Winsorised. The normality protocol of 
assessing histograms, the Shapiro-Wilk's test, skewness statistics and kurtosis statistics 
suggested that there were mild deviations from normality for all of the variables but 
none so severe that they warranted transformations and were thus deemed appropriate 
for ANOVA testing. Before the ANOVA procedure was completed, homogeneity of 
variance was checked using the Levene test and the Brown-Forsythe test and there were 
no violations.
3.3.4.1. Cannabis Use Analyses
Five one-way ANOVAs were run to test if the groups (Controls vs. Tobacco users vs. 
Cannabis users) were matched for IQ estimates, as measured by five variables (see 
Table 3.8). There were no significant main effects of cannabis use on full-scale IQ 
[/7(2,8i)=2.36,p=.101, partial /72=.055], vocabulary subtest [F(2,77)=2.58, p=.082, partial 
rf~ .063], block design subtest [F(2,77)=0.04, p=.961, partial ^2=.001], similarities subtest 
[F(2,77)=0 .6 8 , p=.511, partial //2=.017] and the matrix reasoning subtest [F(2,77)=2.80, 
p=.061, partial >72=.068]. As there were no significant main effects of cannabis use on 
IQ post hoc comparisons were not run.
3.3.4.2. Age o f Onset Analyses
Five one-way ANOVAs were run to test whether the groups (Controls vs. Tobacco 
users vs. EoC vs. LoC) were matched for estimated of IQ, as measured by five variables
147
(see table 4.4). There were no significant main effects of cannabis use on full-scale IQ 
fF(3,80)=1 .6 8 ,p = .1 7 7 , partial t]2=.059], vocabulary subtest [F(3,76)=1.70, p=.174, partial 
rj2=.063], block design subtest [F(3,76)=0.08, p=.913, partial ^2=.003], similarities subtest 
[F(3,76)=0.84, p=.478, partial 7/2=.032] and the matrix reasoning subtest [F(3,76)=1.85, 
p=.145, partial 772=.068]. As there were no significant main effects of cannabis use on 
IQ post hoc comparisons were not run.
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3.3.5 Cognitive Data
Data from the battery of neuropsychological tests was collected and analysed to 
determine whether the three groups differed on measures of executive function and 
other domains of cognition. Variables from four of the tests (TMT; VFT; DFT; SST) 
contained normative data which enabled the raw data to be converted in age scaled 
scores. There was one exception to this; the number of errors on the SST remains a raw 
score. This resulted in 20 dependent variables which were transformed into age scaled 
scores. For the primary (i.e. not the errors) age-scaled scores the possible range of 
scores was 1-19 with a score of 10 representing an 'average' score. For the error scores 
on the TMT, VFT and DFT, the possible range of scores was typically 1-13, with a 
score of 10 still representing an 'average' score. From the remaining variables, the IGT 
data was converted into the percentage of beneficial selections with a possible range of 
0-100%. The GPT Place and Remove scores are self-terminating, with lower scores 
indicating faster performance. The GPT Contrast Measure needs to be compared with 
the Place and Remove Tasks for interpretation, with higher or lower scores suggesting 
impaired motor coordination or speed, respectively.
The 28 variables were checked for outliers and fourteen cases were at ±3 z-scores from 
the group mean which were subsequently Winsorised. The normality protocol of 
assessing histograms, the Shapiro-Wilk's test, skewness statistics and kurtosis statistics 
suggested that there were mild deviations from normality the majority of the variables 
however these were within acceptable limits for the ANOVA. The six transformation 
methods described in section 3.2.8 were implemented and the normality protocol 
dictated which transformation method was selected (see Table 3.10 for which variables 
were transformed). All error scores from the TMT, VFT, DFT and SST were non- 
normally distributed and the transformation protocol proved ineffective and therefore 
these variables were subject to the Kruskal-Wallis test. ANCOVAs were run in 
situations where a confounding variable was identified and met the appropriate 
assumptions, whereas ANOVAs were run in the remaining situations.
3.3.5.1. Cannabis Use Analysis
22 one-way AN(C)OVAs were run to test the hypothesis that there would be mean 
differences between cannabis use (Controls vs. Tobacco users vs. Cannabis users) and
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executive function, as measured by 22 variables (see Table 3.10). There was a 
significant main effect between groups on the TMT Visual Scanning test when 
controlling for anxiety, depression and obsessions [F(2,79)=4.59, /?=.013, partial 
rj2=. 104], TMT Switching when controlling for FSIQ [F(2,8o>=5.66, /?=.005, partial 
;/2=.124], DFT Switching when controlling for FSIQ [F(2,80)=8.34, p=.00\, partial 
a/2=.172], DFT Switching Contrast [F(2,8i)=6.62, /?=.002, partial //2=. 141], and GPT 
(DH) Contrast Measure [F(2,8i)=4.65, /?=.012, partial rj2=A03]. Based on Cohen's (1998) 
guidelines of a small (>/2~.01), medium {r]2 -.059) and large (//2~.138) effect sizes, the 
significant ANCOVAs from the current analyses appear to range in effects sizes from 
medium to large. In this context the effect size represents the percentage of variance of 
the dependant variable accounted for by the independent variable. By example, the 
largest effect size produced in this analysis, the DFT Switching variable (partial 
rj2=.\12), suggests that approximately 17% of the variance in DFT switching 
performance can be accounted for the smoking status of the individual.
The remaining measures did not show a significant main effect including TMT Letter 
Sequencing [F (2 ,8 i)= 0 .1 4 , /? = .8 6 8 , partial //2= .0 0 4 ] ,  TMT Number Sequencing when 
controlling for depression [F(2,80)=0.94, /? = .9 7 7 , partial >/2= .0 0 1 ] ,  TMT Motor Speed 
[F (2 ,8 i)= 0 .0 3 ,/? = .9 6 8 , partial //2= .0 0 1 ] ,  TMT Switching Contrast when controlling for 
sex [F (2,80)= 1 .2 1 ,/? = .3 0 5 , partial rj2=.0 2 9 ] ,  VFT Letter Fluency [F (2 ,8 i)= 0 .2 7 ,/? = .7 6 2 , 
partial r/2=.001], VFT Category Fluency when controlling for FSIQ [F(2,80)=0.93, 
/? = .4 0 1 , partial rj2=.0 2 3 ] ,  VFT Switching [F (2 ,8 i)=  1 .3 2 ,/? = .2 7 3 , partial rj2=.032], VFT 
Switching Contrast [F(2,8i)=L51,/?=.227, partial //2= .0 3 6 ] ,  DFT Filled Dots when 
controlling for FSIQ [F(2,80)=0.25, /? = .7 7 7 , partial ^2= .0 0 6 ] ,  DFT Empty Dots when 
controlling for FSIQ [F(2,80)=0.13, /? = .8 7 9 , partial ^2= .0 0 3 ] ,  GPT (DH) Place Task when 
controlling for sex [F(2,80)=2.16, /? = .0 5 4 , partial r/2=.010], GPT (DH) Remove Task 
when controlling for anxiety [F(2,80)=0.64, /? = .5 3 0 , partial //2= . 0 16], GPT (NDH) Place 
Task [F (2 ,8 i)= 0 .0 7 ,/? = .9 3 1 , partial r/2=.0 0 2 ] ,  GPT (NDH) Remove Task [F (2 ,8 i)= 0 .02 , 
/? = .9 7 9 , partial ^2= .0 0 1 ] ,  GPT (NDH) contrast [F(2,8d=0. 17, /? = .8 4 0 , partial ?/2= .0 0 4 ] ,  
SST Scale Score while controlling for sex [F (2 ,8 o p 0 .5 3 , /? = .5 9 4 , partial a/2=.013] and 
IGT advantageous decks [F (2 ,8 i)= 0 .5 4 ,/? = .5 8 3 , partial rj2=.0 1 3 ] .
Six Kruskal-Wallis tests were run on the data which could not be transformed and did 
not meet parametric assumptions. These tested the hypothesis that there would be mean
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differences between cannabis use (Controls vs. Tobacco users vs. Cannabis users) and 
executive function, as measured by six error variables (see Table 3.10). There were no 
significant main effects between groups for the TMT error measure \x2(i)=3.216, 
p=. 194], percentage of set loss error on the VFT [/2(2)=2.670, p=.263], percentage of 
repetition errors on the VFT [/2(2)=0.649, p=.123], set loss errors on the DFT 
[j^ 2(2)=4.358, p=. 113], repetition errors on the DFT [^2(2)=0.178,/?=.915] and number of 
errors on the SST 1.280, p=.527]. As there were no significant main effects follow 
up post hoc tests were not run.
After correcting for multiple comparisons (j? < .01) it can be seen that the TMT Visual 
Scanning and GPT DH Contrast measre tests no longer displayed a significant main 
effect of cannabis use, however TMT Switching, DFT Switching and Switching 
Contrast did remain significant. After using a more strict correction (p < .001) only DFT 
Switching remained significant.
For the cognitive variables which showed significant ANOVA main effects, post hoc 
one-tailed Hochberg's GT2s and Tukey's HSDs were conducted to further explore the 
effects. The GT2 test was selected to account for the uneven sample sizes between the 
control/tobacco groups and the cannabis group. As the samples sizes of the tobacco and 
control group were approximately equal, Tukey's HSD was deemed appropriate for this 
comparison. Cohen's d was also calculated to examine the size of the differences 
observed between groups. Effect size interpretations were derived from Cohen (1988; 
small d~.3, moderate d~.5, large d~.8).
3.3.5.2. Age o f onset analysis
22 one-way AN(C)OVAs were run to test the hypothesis that there would be mean 
differences between the age of onset of cannabis use (Controls vs. Tobacco users vs. 
EoC users vs. LoC users) and executive function, as measured by 22 variables (see 
Table 3.11). There was a significant main effect between groups on the TMT Visual 
Scanning test while controlling for anxiety, depression and obsessions [F(3,78)=3.11, 
p=.031, partial tj2=. 107], TMT Switching while controlling for FSIQ [F(3,79)=5.65, 
p=.001, partial r]2= A ll] , TMT Switching Contrast while controlling for sex 
[F(3,79)=3.04,/?=.034, partial rj2=A03], DFT Switching while controlling for FSIQ 
[F(3,79)=5.48,/?=.002, partial ?/2=.172], DFT Switching Contrast [F(3,80)=4.55, p=.005,
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partial p2=. 146] and GPT (DH) Contrast Measure [F(3,80)=4.1 l,/?=.009, partial ;/2=.134]. 
The largest effect size produced in this analysis, the TMT Switching variable (partial 
p2=.\71), suggests that approximately 18% of the variance in TMT switching 
performance can be accounted for the smoking status of the individual.
The remaining measures did not show a significant main effect including TMT Number 
Sequencing while controlling for depression and FSIQ [F(3,78)=0.24, p=.872, partial 
;/2=.009], TMT Letter Sequencing [F(3,80)=0. 13, p=.940, partial a/2=.005], TMT Motor 
Speed while controlling for FSIQ [F(3,79)=0.61, p=.613, partial p2=.023], VFT Letter 
Fluency [F(3,80)=0.23,/?=.873, partial p2- .009], VFT Category Fluency while controlling 
for FSIQ [F(3,79)=0.81, p=.49\, partial /72=.030],VFT Switching [F(3,80)=0.99, p=A03, 
partial //2=.036], VFT Switching Contrast [F(3,80)=L40, p=.249, partial /72=.050], DFT 
Filled Dots while controlling for FSIQ [F(3,79)=0.88, p -A 5 1 , partial ;/2=.032], DFT 
Empty Dots while controlling for FSIQ [F(3,79)=0.09, p=.968, partial //2=.003], GPT 
(DH) Place Task while controlling for sex [F(3,79)=2.54, p=.062, partial >72=.088], GPT 
(DH) Remove Task while controlling for anxiety [F(3,79)=0. 47, /?=.708, partial >72=.017], 
GPT (NDH) Place Task while controlling for educational achievement [F(3,78)=0.15, 
p - .930, partial >72=.006], GPT (NDH) Remove Task [F(3,80)=0.02, p=.991, partial 
p2=.00\], GPT (NDH) Contrast Measure [F(3,80)=0.36, p=.7S\, partial /72=.013], SST 
Scaled Score while controlling for sex and educational achievement [F(3,77)=0.07, 
p - .686, partial 7/2=.019] and IGT advantageous decks [F(3,80)=0.47, p=.702, partial 
^2=.017].
Six Kruskal-Wallis tests were run to test the hypothesis that there would be mean 
differences between the age of onset of cannabis use (Controls vs. Tobacco users vs. 
EoC vs. LoC) and cognition as measured by eight variables (see Table 3.11). There was 
no significant effects for any of the error variables including TMT errors [//(3)=6.16, 
p=.104], the percentage of set loss errors on the VFT [7/(3)=5.01,p=.171], the 
percentage of repetition errors on the VFT [H(3)=0.66, p=.883], the number of set loss 
errors on the DFT [H(3)=6.25, /z=. 100], the number of repetition errors on the DFT 
[H(3)= 1.11,/?=.775], and total number of errors on the SST [//(3)= 1.45, p=.693]. As the 
Kruskal-Wallis tests were not significant follow-up Dunn's tests were not conducted.
After correcting for multiple comparisons {p < .01) it can be seen that the TMT Visual 
Scanning and Switching Contrast tests no longer displayed a significant main effect of
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the age of onset of cannabis use, however TMT Switching, DFT Switching and 
Switching Contrast, and GPT DH Contrast measure did remain significant. After using 
a more strict correction (p < .001) only TMT Switching remained significant.
3.3.5.3. Controls vs. cannabis users.
Significant differences were observed between cannabis users and controls for four of 
the cognitive variables. Cannabis users presented with lower scores on the TMT Visual 
Scanning test [f(57)=2.71,/?=.012, <7=0.69, 1-tailed Bonferroni] and the TMT Switching 
test [f(57)=3.36, p=.002, <7=0.81, 1-tailed Bonferroni] when compared to controls, 
yielding large effect sizes. The cannabis group also presented with lower scores 
compared to controls on the DFT Switching [Y(57)=4.03, pc.OOl, <7=0.97, 1-tailed 
Bonferroni] and DFT Switching Contrast |Y(57)=3.62, p=.00\, <7=0.88, 1-tailed GT2], 
both showing large effect sizes. These lower scores by the cannabis group represent 
performance deficits relative to the controls.
There were no significant differences between cannabis users and controls for the GPT 
(DH) Place Task [r(57)=0.98, p=.347, d=0.23, 1-tailed GT2] and GPT (DH) Contrast 
Measures [7(57)=0.54, p=.465, <7=0.13, 1-tailed GT2].
3.3.5.4. Tobacco users vs. cannabis users.
Significant differences were observed between cannabis users and tobacco users for 
three of the cognitive variables. The cannabis using group presented with lower scores 
on the Visual Scanning subtest of the TMT when compared to tobacco users [f(55)=2.40, 
p=.028, <7=0.55, 1-tailed Bonferroni] and the DFT Switching test [7(55)=2.42, p=.021, 
<7=0.60, 1-tailed Bonferroni] and these showed moderate to large effect sizes. Cannabis 
users took longer to complete the Place Task of the GPT (DH) [^(55)=2.71, p= .012, 
<7=0.88, 1-tailed GT2] and the Contrast Measure of the GPT (DH) [f(55)=2.93, p=.007, 
<7=0.94, 1-tailed GT2]. Both of these comparisons display large effect sizes. In all cases 
here the significant results indicate diminished performance by the cannabis group 
relative to the tobacco group.
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There were no significant differences between cannabis users and tobacco users for the 
TMT Switching test [^ (55)= 1.62, p=. 166, <4=0.41, 1-tailed Bonferroni] and DFT 
Switching Contrast [f(55)=1.99,/?=.071, <4=0.60, 1-tailed HSD] outcome measures.
3.3.5.5. Controls vs. tobacco users.
There was a significant difference between controls and tobacco users on one of the 
cognitive variables, controls took longer to complete the Contrast Measure of the GPT 
(DH) [f(50)=2.30, p=.030, <4=0.59, 1-tailed HSD] and this showed a moderate effect size. 
The longer time represents diminished performance levels by the control group relative 
to the tobacco group.
There were no significant differences between tobacco users and controls for the TMT 
Visual Scanning [4(52)=0.24, p=.500, <4=0.06, 1-tailed Bonferroni], TMT Switching test 
[4(52F 1.68, p=. 145, d - 0.41, 1-tailed Bonferroni], DFT Switching test [4(52)= 1.55, /z=. 188, 
cl-0.38, 1-tailed Bonferroni], DFT Switching Contrast [f(50)=1.49,p=.151, <4=0.40, 1- 
tailed HSD] and GPT (DH) Place Task [f(5qpl.68,p=.109, d=0.44, 1-tailed HSD] 
outcome measures.
3.3.5.6. Controls versus early cannabis users
The early onset cannabis using group presented with significantly lower scores than the 
controls on the Switching measure of the TMT [f(42)=4.12, pc.OO 1, d - 1.18, 1 -tailed 
Bonferroni] and on the Switching Contrast measure from the TMT [f(42)=2.71, p=.025, 
<4=0.83, 1-tailed Bonferroni], both of which yielded a large effect size. The early onset 
cannabis using group also presented with significantly lower scores on the Switching 
measure from the DFT [4(42)=3.27, p=.005, d=0.90, 1-tailed Bonferroni] and the 
switching contrast measure from the DFT [f(42)=3.38,/?=.004, c/=0.97, 1-tailed GT2], 
both of which yielded a large effect size.
There were no significant differences between early cannabis users and controls for the 
TMT Visual Scanning condition [4(42)=1 -94, p=. 167, <4=0.61, 1-tailed Bonferroni] and 
the GPT contrast measure [4(42)=1.39, /z=.329, <4=0.41, 1-tailed GT2].
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3.3.5.7. Controls versus late cannabis users
The late onset cannabis using group presented with significantly lower scores than the 
controls on the Visual Scanning measure of the TMT |4(42)=2.51, p=.042; d=0.75, 1- 
tailed Bonferonni], which yielded a large effect size. The late onset cannabis using 
group also presented with significantly lower scores on the Switching measure from the 
DFT |7(42)=3.42, p=.003, <7=1.00, 1-tailed Bonferroni] and the Switching Contrast 
measure from the DFT [f(42)=2.59, p=.033, d - 0.78, 1-tailed GT2], both of which yielded 
a large effect size.
There were no significant differences between early cannabis users and controls for the 
TMT Switching measure [f(42)=1.68,p=.289, <7=0.48, 1-tailed Bonferroni], TMT 
Switching Contrast measure [4(42)=0.14, p=.500, <7=0.04, 1-tailed Bonferroni], and the 
GPT Contrast Measure [7(42)=0.49, p=.499, c/=0.14, 1-tailed GT2].
3.3.5.8. Tobacco users versus early cannabis users
The early onset cannabis using group presented with significantly lower scores on the 
Switching measure from the TMT when compared to tobacco users |7(40)=2.62, p=.031; 
<7=0.80, 1-tailed Bonferroni] which both yielded a large effect size. The early onset 
cannabis group also took significantly longer to complete the Contrast Measure of the 
GPT [f(40)=3.39,p=.003; <7=1.37, 1-tailed GT2], which yielded a large effect size.
There were no significant differences between cannabis users and controls for the TMT 
Visual Scanning condition |7(40)=1.71,/?=.272, <7=0.51, 1-tailed Bonferroni], the 
Switching Contrast measure from the TMT when compared to tobacco users [7(40)=2.16, 
p=.083; <7=0.76, 1-tailed Bonferroni], the DFT Switching measure [f(40)=l .95, p=. 165, 
<7=0.56, 1-tailed Bonferroni], and the DFT Switching Contrast measure [f(40)=2.04, 
p=. 118, <7=0.70, 1-tailed Hochberg].
3.3.5.9. Tobacco users versus late cannabis users
The late onset cannabis using group did not present with deficits compared to the 
tobacco users on any of the cognitive variables.
There were no significant differences between cannabis users and controls for the TMT 
Visual Scanning condition |4(40)=2.27, p=.079, <7=0.66, 1-tailed Bonferroni], TMT
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Switching measure [f(40)=0.17, p=.500, <7=0.05, 1-tailed Bonferroni], TMT Switching 
Contrast measure [7(40)=0.56, p=.500, <7=0.18, 1-tailed Bonferroni], DFT Switching 
measure [f(40)=2.07, p=.\21, <7=0.64, 1-tailed Bonferroni], DFT Switching Contrast 
measure [f(40)=1.27, /?=.374, r/=0.47, 1-tailed Hochberg], GPT Contrast Measure 
[^ (40)= 1.54, p=.216, <7=0.59, 1-tailed Hochberg].
3.3.5.10. Early cannabis users versus late cannabis users
There were significant differences between early and late onset cannabis users for only 
one of the cognitive variables. The early onset users presented with significantly lower 
scores on the TMT Switching Contrast measure [?(3i)=2.56, p=.031, <7=0.91, 1-tailed 
Bonferroni], which yielded a large effect size.
There were no significant differences between early cannabis users and late cannabis 
users for the TMT Visual Scanning condition [7(3i)=0.49, /?=.500, d=0.17, 1-tailed 
Bonferroni], TMT Switching Measure [f(3i)=2.25, /?=.082, <7=0.79, 1-tailed Bonferroni], 
DFT Switching measure [f@i >=0.09, p=.500, <7=0.03, 1-tailed Bonferroni], DFT 
Switching Contrast measure [7(3i)=0.70, p=.449, <7=0.26, 1-tailed HSD], and GPT 
Contrast Measure [f(3i)= 1.68,/?=. 170, <7=0.75, 1-tailed HSD].
3.3.5.11. Additional ANCOVA analyses
A set of further ANCOVAs were run to control for the total amount of cannabis used. 
This was done as an earlier age of onset could potentially mean greater levels of 
cannabis use. However, these ANCOVAs were run despite the violations of at least one 
of the assumptions and therefore would be expected to have reduced power. These 
analyses are reported in Appendix A.3.11.23.
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3.3.5.12. Cannabis use variables and cognitive data 
Table 3.12.
Spearman's correlations between cannabis use variables and cognitive variables fo r  the 
whole cannabis group (n=32).
Cognitive Variable Age of onset Lifetime spliffs 
smoked
Years of 
cannabis 
smoking
Desired
Intoxication
Trail Making Task
Visual Scanning -.065 -.352* -.047 -.300*
Switching .341* -.256 -.394* -.266
Switching contrast .361* -.079 -.309* -.192
Design Fluency Task
Switching .067 -.002 -.317* -.004
Switching Contrast .209 .151 -.030 .310
Grooved Pegboard
Place task -.198 .070 .256 .204
Contrast -.372* -.076 .239 .072
Note. * (p<.05) denotes a significant correlation.
To determine whether an association existed between cannabis use variables and the 
dependant variables in which cannabis users showed impaired performance, 
correlational analyses were run for the cannabis group as a whole (N= 32). The cannabis 
use variables examined were the age-of-onset of cannabis use, number of lifetime spliffs 
smoked, number of years when using cannabis was reported and the typical desired 
level of intoxication reached on a scale from 1 (sober) to 10 (most stoned you have ever 
been).
3.3.6. Concurrent Validity of the Grooved Pegboard
The current study introduced a new measure which has yet not been published before. 
The measure is a contrast condition between the Grooved Pegboard Place task and the 
Grooved Pegboard Remove task in which the time taken to complete the latter task is 
subtracted from the time taken to complete the former task. Tables 3.13 and 3.14 show 
the correlation matrices for the Contrast Measure of the Grooved Pegboard with several 
standardised tests of motor coordination, motor speed and graphomotor speed.
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Table 3.13.
A correlation matrix o f the Contrast Measure o f the Grooved Pegboard fo r  the 
dominant hand with three other tasks measuring motor processes (N=84).
1 2 3 4 5
1. Contrast Measure
2. Place Task
3. Remove Task
4. TMT Motor Speed
.885**
.028
-.204
.367**
-.346** .390**
Table 3.14.
A correlation matrix o f the Contrast Measure o f the Grooved Pegboard fo r  the non­
dominant hand with three other tasks measuring motor processes (N=84).
1 2 3 4 5
1. Contrast Measure
2. Place Task
3. Remove Task
4. TMT Motor Speed
.889**
.111
-.211
.453**
-.296** .392**
Note. The TMT Motor Speed test is only completed with the dominant hand.
The results of the Spearman's correlations show that the Grooved Pegboard Contrast 
measure was strongly and positively correlated with Place Task with little difference 
between the dominant hand (rv=.885,p<.001, 1-tailed) and the non-dominant hand 
(rs=.889, p<.001, 1-tailed). The Contrast condition was not significantly correlated with 
the Remove Task for the dominant hand (r.v=.028, p=.401, 1-tailed) nor the non­
dominant hand (r.v=.l 11, /?=. 157, 1-tailed). It was also not correlated with the TMT 
Motor Speed test for the dominant hand (rs=~.204, p=.062, 1-tailed) nor the non­
dominant hand (/.?=-.211, p=.054, 1-tailed). While the Contrast condition was not
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correlated with the two motor speed tasks, the Place Tasks were significantly correlated 
with the dominant hand Remove Task (r.v=.367, p=.001, 1-tailed), the non-dominant 
hand Remove Task (r.v=.453, p=.001, 1-tailed), the dominant hand TMT Motor Speed 
(r.v=-.346, /?=.001, 1-tailed) and the non-dominant hand TMT Motor Speed (r.?=-.296, 
p=.006, 1-tailed). Finally the dominant hand Remove task (r.v=-.390, pc.OOl, 1-tailed) 
and non-dominant hand Remove task (rv=-.392, pc.OOl, 1-tailed) were both 
significantly correlated with the TMT Motor Speed test. All correlations with the TMT 
Motor Speed test were negative as the scoring was reversed in which higher scores 
denoted better performances, while all Grooved Pegboard variables were scored in such 
a way that meant lower scores meant better performances.
3.4. Discussion
3.4.1. Concurrent Validity of the Grooved Pegboard
The current study introduced a new neuropsychological measure and therefore 
concurrent validity tests were run to determine what processes were being measured by 
this task. The Grooved Pegboard Contrast condition for both the dominant hand and the 
non-dominant hand involved the subtraction of the time taken to complete the Remove 
task from the Place task. It is thought that both of these tasks (Place + Remve) to 
differing degrees measure motor speed (e.g. Strauss et al., 2006) and this was confirmed 
by the concurrent validity tests. Both the Place task and the Remove task correlated with 
performance on the graphomotor speed task from the TMT. Furthermore, the Place Task 
and the Remove Task correlated with each other, perhaps reflecting the overlap of 
motor speed processes involved in the respective tasks. However the Contrast condition 
only correlated with the Place task and did not correlate with the Remove Task or the 
TMT Motor Speed task which suggests that the Contrast condition does not involve 
motor speed, but rather it relates to the additional processes involved in the completion 
of the Place task beyond motor speed. As other authors have reported that the Grooved 
Pegboard Place task involves motor coordination, motor programming, visuo-executive 
cognition and motor speed (Baser & Ruff, 1997; Strauss et al., 2006; Ashendorf et al., 
2009; Bezdicek et al., 2014) the removal of this motor speed element would imply that 
the Contrast condition measures these cognitive and coordinative elements, the higher
levels of processing involved in manual dexterity beyond simple motor speed.
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3.4.2. Cognitive Data
3.4.2.1. The Trail Making Test (TMT)
Seven outcome measures from the TMT were used in the current experiment which 
included Visual Scanning, Number Sequencing, Letter Sequencing, Switching, 
Switching Contrast, Motor Speed, and the error score.
The cannabis group presented with deficits on the Visual Scanning subtest compared to 
the controls and the tobacco using group in addition to deficits on the Switching subtest 
relative to controls. After dividing the cannabis group into EoC and LoC groups it 
appeared that EoC users presented with deficits compared to controls and tobacco users 
for both the Switching and Switching Contrast variables. LoC users presented with 
deficits compared to controls on the Visual Scanning test.
There were no between-group effects on the Number Sequencing, Letter Sequencing, 
Motor Speed, or error measures for the three-group analysis or the four-group analysis.
The Visual Scanning subtest showed deficits in the LoC group when compared to the
controls. This finding was supported by previous experiments finding deficits on visual
scanning tasks by cannabis users who started using later in life (>17 years; Ehrenreich et
al., 1999). The data reported in this chapter did not support Ehrenreich et al's (1999)
findings with regards to the EoC (<16 years) as there were no significant differences
between the EoC group and the remaining three groups in current experiment. It is
likely that the deficits discovered on the Visual Scanning subtest were not due to the
later age of onset, but rather due to the lifetime number of spliffs consumed which was
slightly, albeit not significantly, higher in the LoC group (see Table 3.5). This
interpretation is firstly due to the effect becoming non-significant after controlling for
lifetime spliffs smoked and secondly due to the significant correlation between lifetime
spliffs smoked and Visual Scanning performance (see Table 3.12). There was also a
correlation between performance on the Visual Scanning subtest and the level of
intoxication the user desires to reach. This could suggest that either greater cannabis use
per session is associated with deficits in cognition, the binge hypothesis, or that a desire
for greater levels of intoxication is a product of long term cannabis use which is the
actual determinant of the deficits on this task. It is possible the discrepancies between
the current study and Ehrenreich et al (1999) were due to the abstinence period, while
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the current study enforced a 24 hours abstinence period to minimise the likelihood of 
acute intoxication or hangover effects, Ehrenreich et al's abstinence period was two 
hours to one week. If a larger proportion of these recent cannabis users, around the two 
hour abstinence mark, were in the EoC group then this could have led to the early onset 
related deficits in visual scanning. Pope et al (2003) used a more strict cannabis 
abstinence criteria of 28 days for their study. The authors administered one test of 
sustained visual attention to EoC (<16 years), LoC (>17 years) and controls, the 
Conners' Continuous Performance Test (CPT). The authors found no effect of cannabis 
use or the age of onset of cannabis use on this task in contrast to Ehrenreich et al (1999) 
and the current study. It could be that task differences led to these mixed results as the 
CPT involves searching for a target letter among letter distractors (i.e. representation 
maintained primarily in verbal working memory), while Ehrenreich et al's task involves 
searching for a target shape among spatial distractors (i.e. representation maintained 
primarily in spatial working memory), and the current task involves search for a letter 
among letter distractors, yet does not involve sustained attention as the task lasts for 
relatively little time (<60 seconds) compared to the CPT (14 minutes).
The Letter Sequencing, Number Sequencing and Motor Speed tests form part of the 
supplementary material primarily for determining if participants have a fundamental 
deficit, such as an inaccurate knowledge of the English alphabet or impaired motor 
speed. Medina et al (2007) found a general effect of cannabis on the combined Letter 
Sequencing and Number Sequencing score which was interpreted as a motor speed 
deficit. In contrast the three-group and four-group data did not replicate these findings. 
As no other tests measuring motor speed or graphomotor speed have been administered 
to cannabis users in an age of onset analysis, this chapter presents the first evidence that 
suggests these processes are not associated with the age of onset of cannabis use.
The primary executive function dependent variable, Switching, showed between group 
differences. Post-hoc tests revealed that the EoC users presented with deficits on this 
variable when compared to both the control group and the tobacco using group. The 
LoC group performed at a level comparable with tobacco users and controls on this 
task, therefore supporting the experimental hypothesis that the EoC users would be 
more vulnerable to cognitive impairments than the LoC users. The associated dependent 
variable, TMT Switching Contrast, also showed between group differences. Post-hoc
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testing revealed that the EoC group showed deficits in performance when compared to 
the control group, the tobacco group and the LoC group. This test provided the strongest 
support for the experimental hypothesis within the current experiment. While previous 
studies have used various versions of the TMT with cannabis users, only one study has 
used the TMT with an age of onset analysis (Gruber et al., 2011). The authors found 
that performance was not impaired in either the EoC or LoC users. These discrepant 
results are possibly attributable to the version of the TMT used, the current study used 
the D-KEFS version while Gruber et al (2011) used the Trails B version (Lezak, 2004). 
It is unlikely that the differences were attributable to the drug use behaviours of the 
respective samples as both studies used the same age of onset criteria for EoC users 
(<15 years) and LoC users (>16 years). Furthermore, Gruber et al's (2011) study 
reported longer periods of cannabis use than the current study by a factor of 
approximately 1.5 which suggests that if a dose-related response was also present, then 
Gruber et al's sample would be expected to present with deficits. While the TMT 
Switching data contradicts that of Gruber et al's study, the deficits of EoC users relative 
to controls, tobacco users and LoC users on the TMT Switching Contrast data is the 
first of its kind and therefore cannot be directly compared to previous research. These 
findings suggest that early onset cannabis use is associated with deficits in set switching 
abilities and the contrast test suggests that it is unlikely that a contributory factor such as 
motor speed or semantic memory was explaining these deficits. However, when 
considering the TMT error scores which showed no differences between groups it 
appears that the deficits in set switching are not so severe that participants are locked in 
one particular set, but rather that cannabis use is linked with an increased amount of 
time to successfully switch between sets.
3.4.2.2. The Verbal Fluency Test (VFT)
Six outcome measures from the VFT were used in the current experiment including 
Letter Fluency, Category Fluency, Switching, Switching contrast, the percentage of 
repetition errors and the percentage of set loss errors. There were no between group 
effects on any of these variables for the three-group analysis or the four-group analysis.
The present experiment found no between group differences on VFT Letter Fluency and 
thus supports one previous study which showed no effect of age of onset on letter 
fluency as determined by a similar FAS test (Pope et al., 2003). Despite this evidence,
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one study did not find any between group differences on an FAS test with a general 
cannabis group, yet upon splitting by age of onset, the EoC group appeared to present 
with deficits relative to the LoC group (Gruber et al., 2011). The EoC users in Gruber et 
al's (2011) study produced significantly fewer words in the time limit than did the LoC 
group, yet there were no significant differences between the EoC and the control group. 
Gruber et al (2011) and Pope et al (2003) used the same version of the FAS test and 
thus it remains unclear why this discrepancy occurred. The present study also found no 
effect of the age of onset of cannabis use on the VFT Category Fluency test. In reverse 
of the results reported above, Pope et al (2003) found that EoC users were impaired 
relative to controls on a semantic fluency test while Gruber et al (2011) found no 
differences on a semantic fluency test. While there are differences in group 
characteristics such as length of abstinence from cannabis which could explain 
differences in performance between these groups, this would not explain why one study 
found deficits in letter fluency but not semantic fluency (Gruber et al., 2011) while 
another found deficits in semantic fluency but not letter fluency (Pope et al., 2003). As 
both groups of authors administered the same test (the COW AT) these differences 
cannot be ascribed to test differences. Sample characteristics are the most likely 
explanation for these discrepancies although it is not clear what these characteristics are 
and how they differentially affected performance on the two fluency tests.
The use of the VFT Switching task and the VFT Switching Contrast measure are both 
novel tasks with regards to cannabis users and the present experiment suggests that 
performance is unaffected by the age of onset of cannabis use. As with the DFT and 
TMT, the VFT uses a switching paradigm between two different rules on the same task 
yet unlike these other tests the VFT failed to detect impairments on the switching 
contrast measure. This suggests a disassociation between the visual switching tasks and 
the verbal switching task although it is not clear whether it is this distinction in modality 
which explains the different performance between tasks. Further research needs to 
replicate this measure on cannabis users to determine whether the processes this task 
draws upon are unaffected by the age of onset of cannabis use and by cannabis use in 
general. Furthermore, there were no between group effects for the VFT percentage of 
set loss errors suggesting that the age of onset of cannabis use is not associated with 
cognitive flexibility within the verbal domain while the lack of between group effects
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for the VFT percentage of repetition errors suggests no severe verbal working memory 
impairments (Delis et al., 2001).
3.4.2.3. The Design Fluency Test (DFT)
Six outcome measures of the DFT were used in the current experiment including Filled 
Dots, Empty Dots, Switching, Switching Contrast, repetition errors, and set loss errors. 
The cannabis group presented with deficits on the DFT Switching task relative to the 
control group and presented with deficits on the DFT Switching Contrast measure 
relative to the control group and the tobacco group. After dividing the cannabis group, 
both the EoC users and LoC users displayed deficits relative to the control group. There 
were no between group effects for the remainder of the dependent variables.
The two primary executive function tests from the DFT, the Switching and Switching 
Contrast tests, both showed between group differences. Follow-up tests showed that the 
EoC and LoC groups presented with impairments relative to the controls on both of 
these two tasks. Further examination of the effect sizes suggests that the deficits across 
both tasks were approximately equal suggesting that there was not an age of onset effect 
but just a general effect of cannabis use impairing set switching in the visual domain. 
Further examination of the correlational data suggests that DFT Switching performance 
was negatively related to the number of years an individual has smoked cannabis for but 
not the age of onset or other cannabis use variables. When considering the lack of 
between group differences for the two error scores, it appears that the deficits 
discovered on the DFT Switching and DFT Switching Contrast tests were not due to 
memory impairments or perseveration. As with the TMT data it appears that the 
performance on these tasks describes a difficulty in switching sets manifested in a 
longer time to complete the switch. This is not the first evidence that the age of onset of 
cannabis use is associated with performance on set switching tasks however it is the 
first evidence of this kind derived through the use of the DFT. These deficits by both 
cannabis using groups only appeared relative to control group and not relative to the 
tobacco group. As the control group did not differ from the tobacco group on the DFT it 
unlikely that tobacco use is what was mediating these deficits. Furthermore, the tobacco 
group did differ from the whole cannabis group, possibly suggesting that the lack of 
between group differences between the tobacco group and the EoC/LoC users was due
to a lack of power associated with the cannabis group division.
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While the primary subtests of the DFT uncovered impairments, the supplementary 
subtests: Filled and Empty Dots, did not highlight group differences. This is the first use 
of a non-verbal fluency task which purportedly measures non-verbal creativity, visual 
attention, and initiation (Delis et al., 2001; Suchy et al., 2010). It appears that these two 
subtests are unrelated to cannabis use.
3.4.2.4. The Grooved Peghocird (GPT)
Six outcome measures from the GPT were used in the current experiment which 
included the Place task, the Remove task, and the Contrast measure (Contrast = Place 
time - Remove time). The two tasks were first completed with the Dominant Hand (DH) 
and then with the Non-Dominant Hand (NDH). The cannabis group presented with 
deficits compared to the tobacco group on the GPT DH Contrast Measure, while the 
control group presented with deficits compared to the tobacco group on the GPT DH 
Contrast Measure. There was a trend towards group differences on the GPT DH Place 
task (p=.054) and thus it is unclear if this represents chance variations in performance 
across groups or an underpowered analysis hiding true effects. There were no between 
group effects on any task with the non-dominant hand or the Remove task with either 
hand. The four-group analysis found that the previously determined deficits on the GPT 
DH Contrast Measure were largely due to early onset cannabis use, as only the EoC 
group displayed deficits relative to the tobacco users, while the LoC did not differ from 
any group.
Bolla et al (2002) found a positive relationship between time taken to complete the GPT 
Place task and the weekly number of joints smoked which demonstrated a dose-related 
response. The present study partially supports these previous findings as the cannabis 
users showed a trend towards impairments relative to tobacco users. In contrast, Becker 
et al (2014) found that cannabis use was unrelated GPT Place task performance. As 
Becker et al.’s study recruited cannabis users with an age of onset below 17, a 
potentially high risk group for developing cognitive and motor impairments, it is not 
clear why none were detected. With limited research and conflicting results regarding 
this particular aspect of motor control performance it is unclear as to whether cannabis 
leads to impaired performance on the GPT Place task.
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As remove task performance was not associated with cannabis use or the age of onset of 
cannabis use it appears that motor speed is not affected by cannabis use. This supports 
the findings from the TMT in which there was not an effect of cannabis use or the age 
of onset of cannabis use on the Motor Speed subtest (see Section 3.4.2.2). This 
contradicts Medina et al’s (2007) findings that motor speed was affected by use of the 
TMT composite score for Number and Letter Sequencing. Becker et al (2014) found 
that finger tapping test was not impaired in cannabis users and this test arguably a purer 
measure of motor speed than Medina et al’s measure as it does not require visual 
scanning or semantic memory. The current findings therefore support Becker et al 
(2014) that basic motor speed is unaffected by cannabis use.
The third outcome measure from the GPT is a novel modification proposed and
described for the first time within this research programme. Each individual's Remove
task time was subtracted from their Place task time to provide a Contrast Measure with
the aim of minimising the contribution of motor speed on the Place task and provide a
purer measure of the speculated cognitive component. Cannabis users in the three-group
analysis, and EoC users in the four-group analysis, showed significantly higher scores
on this Contrast Measure than the tobacco group suggesting a reduction in cognitive
efficiency. There was no difference between cannabis users and non-smoking controls,
yet the tobacco group outperformed the control group on this task. These findings
suggest that tobacco use improves motor functioning while cannabis use impairs it. As
the cannabis using group also showed high levels of tobacco use, it is feasible that this
tobacco use ameliorated the effects of the cannabis which lead to an equilibrium in task
performance, resulting in a lack of observable differences in performance between
cannabis users and non-smoking controls. These deficits become apparent however,
when comparing cannabis users with tobacco users, and when comparing tobacco users
with non-smoking controls. A mechanism for this interpretation is that cannabis users
and tobacco users were both presenting with temporarily elevated motor control due to
the acute effects of tobacco use. Self-reports show that 17 of the 27 tobacco users and
17 of the 32 cannabis users used tobacco on the day of testing. It is possible that the
consumption of tobacco acutely elevated performance on the GPT DH Contrast
Measure which explains how tobacco users outperformed controls, how tobacco users
outperformed cannabis and how no difference was uncovered between cannabis users
and controls. A meta-analysis by Heishman, Kleykamp and Singleton (2010) found that
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fine motor control was improved following acute tobacco administration on a range of 
motor tasks including the GPT supporting the acute-tobacco interpretation of the current 
data. If future research gathered more specific information about recent tobacco use 
such as the amount of hours since the last smoke or even included recent tobacco use as 
an exclusion criteria then this confounding variable could be removed.
The deficits discovered on the DH tasks were not re-discovered on the NDH tasks in the 
current study. This could be due to practice related ceiling effects occurring following 
the first two attempts with the dominant hand. This would entail that the groups, or 
specific individuals within those groups, with impaired performance improved at a 
faster rate than those whose performance was not relatively impaired. Conversely, Bolla 
et al (2002) found that non-dominant hand performance was that which was negatively 
affected by cannabis use which would suggest that cannabis use does not unilaterally 
impair motor control as different studies have now found impairments in the dominant 
and non-dominant hands. The authors do not mention if the dominant hand was tested 
and so practice effects in Bolla et al's (2002) study cannot be concluded. In contrast, 
Becker et al (2014) found that neither DH nor NDH place tasks were impaired by 
cannabis use. These three studies, including the current one, produce three conflicting 
accounts of how cannabis is related to GPT performance and therefore more research is 
needed.
3.4.2.5. The Symbol Search Test (SST)
Two outcome measures from the SST were used in the current experiment which were 
the age-scaled score from the number of correct responses, otherwise referred to as SST 
Scaled Score, and the number of errors made on this test. Unlike the three D-KEFS tests 
the error score used here is not age scaled and is just the number of errors committed. 
There were no between group differences on this variable for the three-group analysis or 
the four-group analysis.
This subtest from the WAIS-IV is a measure of visual processing speed, a task which 
requires the identification of a target abstract symbol among several non-target symbols. 
The present results suggest that the speed at which individuals discriminate and identify 
symbols is unaffected by chronic cannabis use. The present study did however discover 
cannabis related deficits on a measure of visual scanning which required visual
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processing (see section 3.4.2.2.). The Visual Scanning subtest from the TMT required 
the seeking of the target symbol (the number '3') and the discrimination between these 
target symbols and non-target symbols (other numbers and letters). As discussed, the 
finding from the SST suggests that any deficits discovered on the Visual Scanning task 
were not related to the identification and processing of the visual stimulus.
3A.2.6. The Iowa Gambling Task (IGT)
One outcome measure from the IGT was used in the current experiment which was the 
percentage of advantageous deck selections. There were no between-group effects on 
this variable for the three-group analysis or the four-group analysis.
In contrast to the current results, evidence of cognitive damage has been discovered by a 
number of previous administrations of the IGT to cannabis users and controls (Whitlow 
et al., 2004; Bolla et al., 2005; Fridberg et al., 2006; Verdejo-Garcia et al., 2007) which 
all found that cannabis use lead to impaired decision making. This is the first known 
study to study the age of onset of cannabis and there appeared to be no risk of early or 
late onset cannabis use on IGT performance.
One of the possible explanations for this deviation from consensus is down to the 
procedure employed within the present experiment. In order to test for physiological 
markers which influence decision making within the current sample, previously shown 
to be absent in patients with VMPFC damage (Bechara et al., 2005), the participants 
were attached to the Q-sensor, a portable device for measuring skin conductance 
responses. In concordance with the IGT administration procedure for physiological 
measurements, the intervals between each stimulus of the task were increased from 
500ms to 4000ms and thus encouraging a greater amount of deliberation between each 
decision. In the short time period (500ms) traditionally used with the IGT participants 
may have to rely more on an impulsive system while over the longer time period 
(4000ms) participants may have more time to draw on resources from a reflective 
system (Bechara et al., 2005). To test if cannabis use leads to an impaired impulsive 
system while an intact reflective system, future research could involve two groups of 
cannabis users; each randomly assigned to an IGT with either a short inter-stimulus 
break or a longer inter-stimulus break.
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A second explanation for the deviation from consensus is the amount of cannabis 
consumed by the different samples. As determined by either estimated lifetime cannabis 
use or years of cannabis use, the present study included a “lighter” cannabis using group 
when compared to these previous studies (Whitlow et al., 2004; Bolla et al., 2005; 
Fridberg et al., 2006; Verdejo-Garcia et al., 2007).
3.4.3. Putative Confound Data
The current sample over both analyses were matched for a large number of potential 
confounding variables including FSIQ, individual IQ subtests, depression, anxiety, 
compulsions, obsessions, sex, years of education, and educational achievement. 
Furthermore, where suitable these variables were included in ANCOVA analyses to 
control for any effects these variables may have had. The pattern of data suggests that 
the differences in cognitive performance were not due to any of these variables.
Other than cannabis use variables, the only putatively confounding variables which 
differed across the levels of the independent variables were age, alcohol use, tobacco 
use, and illegal drug use. Examination of correlation matrices between these 
confounding variables and the cognitive dependent variables in which cannabis-related 
deficits were discovered, suggested that only other drug use was correlated with a 
cognitive deficit. However, it is unlikely that other drug use was explaining these 
deficits as the level of drug use was negligible relative to the amount of cannabis use 
consumed by the group, and the relationship between other drug use and TMT visual 
scanning disappeared after controlling for cannabis use. This suggests that ‘heavier’ 
cannabis users are more likely to have used other drugs and it is their cannabis use, not 
their drug use, which is explaining the deficits in performance.
While it is possible that confounding variables not tested in the current study are 
mediating the relationships between cannabis use and cognition, the current data 
suggests that none of the 12 potentially confounding variables tested in the current study 
were mediating the deficits.
3.4.4. Strengths and Limitations
One of the primary limitations with the present experiment is the sex ratio. Although an 
equal sex ratio was achieved for the cannabis using group, there was an imbalance in
174
sex ratio for both the control and tobacco smoking groups with a greater amount of 
females taking part. Although these differences were not significant between groups the 
non-uniformity potentially biases the findings as sex differences have been found on a 
number of tasks used in the current neuropsychology battery (e.g. Bolla et al., 2002; 
Bryden & Roy, 2005). However, the current study only discovered performance related 
sex differences on two of the dependent variables and after controlling for these sex 
effects the main effect did not change. This suggests that although there were not 
identical sex ratios across groups, this confounding variable was not explaining the 
differences in group performance.
The severity and domain of cognitive impairments appears to be related to the stage of 
abstinence (Crean et al., 2010). The presence of such deficits is partially dependent on 
whether the individual is acutely intoxicated (0-6 hours), suffering residual effects (7 
hours - 20 days) or has achieved a long period of abstinence (21 days +). The present 
study used a self-report assessment to determine the most recent incident of cannabis 
use and the cannabis use group ranged from 48 hours to 6 years suggesting that the 
present study includes a mixture of residual and long-term effects. Crean et al (2010) 
described residual effects as any effects of cannabis present between 7 hours and 20 
days of abstinence, yet it is not clear how they came to this criterion. The current study 
puts an emphasis on a 'hangover' period, in which cognitive deficits may appear due to 
the intoxication the previous day. The hangover effects could be due to the lingering 
influence of cannabinoids within the bloodstream or through an indirect route including 
altered sleep patterns. The present experiment included a minimum period of 24 hour 
abstinence as hangover effects appear to not persist after 24 hours of abstinence (Pope, 
Gruber & Yurgellun-Todd, 1995). A potential limitation of the present study is that only 
self-report was used to ascertain the last use of cannabis whereas other experiments 
have included the analysis of urine samples to determine recent use (e.g. Pope et al., 
2003). Furthermore, it is not clear if the deficits which were discovered represent a short 
term impairment or long lasting damage.
3.4.5. Future Directions
The current analysis discovered deficits by the EoC and LoC group which were related
to visual scanning, set switching, and visuo-motor coordination processes. In addition to
this, the set switching tasks in which deficits were uncovered all require some level of
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visual processing, while the verbal set switching task which did not require such visual 
processes, failed to uncover deficits in the cannabis using groups. Due to this fact, it 
remains possible that a deficit relating to visual attention/scanning is mediating these 
deficits. As executive function tasks tend to recruit multiple processes and are typically 
not process pure, future research needs to clarify if performance decrements on a given 
task are a product of all contributory processes or rather reflecting a specific 
impairment. Within the context of the current experiment it needs to be determined 
whether deficits on set switching tasks are related to task set reconfiguration, visual 
attention, task set inhibition, the manipulation and maintenance of the task multiple sets 
within working memory or a non-executive process such as motor speed.
A different direction with future research concerns the outcome for the IGT. As noted 
earlier in Section 3.4.2.7 the current study did not replicate previously detected 
impairments on the IGT and a possible explanation for this is the time between stimuli 
presentations. Exploring the role of impulsive and reflective decision making processes 
by manipulating the inter-stimulus time period experimentally would provide further 
information into why cannabis users perform worse than controls on this task.
This was the first study to highlight the role of chronic cannabis intoxication levels and 
the effects that this has on cognition. The results showed that high levels of desired 
intoxication were associated with performance deficits on a measure of visual scanning. 
A method for examining this phenomenon further would be to recruit a group of 
cannabis users and divide them into those who aim to regularly achieve 'high' levels of 
intoxication with those who aim to achieve 'low' levels of intoxication, whilst matching 
the groups for cannabis use. In order to see if this suggestion receives further merit, a 
further correlational approach should be conducted to see if the findings replicate those 
within the current study. If the findings are replicated then the concept of 'cannabis 
bingeing' would be worth further exploration. This replication would help reduce the 
possibility that the correlation represents a type I error.
3.4.6. Conclusion
If the data presented from the current study are interpreted as being a result of cannabis 
use then this needs to be considered in light of the abstinence criteria. Studies with very 
low abstinence (from cannabis) timeframes (e.g. 4h>; Ehrenreich et al., 1999) would
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have trouble attributing the deficits discovered in cognition to the acute, hangover, 
withdrawal or long term effects of cannabis use. Similarly, studies with slightly longer 
abstinence timeframes (e.g. 12h>; Gruber et al., 2011) would have trouble attributing 
the deficits discovered in cognition to hangover, withdrawal or long term effects of 
cannabis use. While certain studies employed a 28 day abstinence timeframe to ensure 
that any deficits discovered were due to the long term effects of cannabis (e.g. Pope et 
al., 2003) the current study only utilised a 24 hour abstinence timeframe. This means 
that if the deficits discovered in cognition in the current study are considered a product 
of cannabis use then they could be attributable to either withdrawal effects which last 
for around two-to-three weeks (Budney et al., 2003) or due to the long term effects of 
cannabis.
In summation, the results show that the groups differ in performance on several 
neuropsychological tasks and that these overall differences are explained by cannabis 
related impairments on tasks which involve visual scanning, set switching and visuo- 
motor coordination. It also appears that early onset cannabis use was mediating some 
but not all of the deficits found in the whole cannabis group. It appears unlikely that 
these deficits were mediated by group differences in the 12  confounding variables and 
therefore it is suggested that cannabis acts directly to impair these neurocognitive 
processes, although a reverse causation explanation is also possible. While it is not clear 
if these findings can be attributed to long-term or temporary alterations in cognition, the 
current findings do support previous research (Gruber et al., 2011; Fontes et al., 2011) 
which suggests that early onset cannabis use is associated with greater cognitive deficits 
than late onset use.
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Chapter Four. Visual Search deficits in abstinent cannabis users: an eye-tracking
approach 
4.1. Introduction
This chapter describes a quasi-experiment which follows on from the conclusions 
reached in the neuropsychological study (Chapter Three). Namely, this study aimed to 
investigate whether cannabis related deficits previously found on tasks which measure 
both visual search and set switching are attributable to one, both or neither of these 
processes. This study involves a new sample of participants, the use of an eye-tracker, 
and two computerised tasks to test these hypotheses.
4.1.1. Visual Search Behaviours
The utility of visually searching is observed in many activities which are essential to 
day-to-day life. This is seen in behaviours such as driving, in which visual searching is 
critical for hazard avoidance and is found to be improved in more experienced drivers 
(Underwood, Chapman, Bowden & Crundall, 2002).
An early development in the field of visual search research was the discovery that a 
fixation location; a point at which gaze briefly stops, is dependent on the amount of 
information which can be derived from a specific area in a scene (Mackworth & 
Morandi, 1967). The authors suggested that eyes do not just search, they search 
intelligently. It appears that this intelligent eye searching can occur in the form of 
'exploratory searching'; in which non-motivated searching occurs with information from 
the scene dictating the subsequent gaze patterns (i.e. bottom-up decisions; Janiszewski, 
1998). It can also occur in the form of goal-directed searching in which motivated 
search strategies are activated in order to locate a specific piece of information in the 
visual scene (i.e. top-down decisions). These two search forms will occur in tandem as 
scene information will influence search strategies (Mackworth & Morandi, 1967) and 
prior knowledge will influence the extent to which information is gathered from the 
visual scene (Brucks, 1985).
Another key development in the field was Feature Integration Theory, which suggested 
that features of the visual scene (e.g. colour, contours etc.) are processed individually
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and pre-attentively, i.e. in parallel (Treisman & Gelade, 1980). Conversely, Feature 
Integration Theory suggests that conjunction searches involve a serial search pattern, the 
goal-directed movement of visual attention across the scene until the target is located. A 
typical conjunction search is one which involves more than one feature, i.e. searching 
for a red triangle among red circles, green triangles, and green circles. Evidence appears 
to suggest that while serial and parallel processes are dissociable, there is not a clear 
dichotomy between these two processes which deviates from early accounts of Feature 
Integration Theory (Maioli et al., 2001). In feature searches the parallel system may 
explain how objects are quickly detected independent of the number of distractors 
(Treisman & Souther, 1985), however in conjunction searches it is likely that a 
combination of parallel and serial search systems are working together (Maioli et al., 
2001 ).
There are a number of factors which determine where a visual search task is located on 
the serial-parallel continuum, and these same factors therefore influence how the task 
recruits visual attention and a focussed, goal-directed search. Feature searches which 
recruit a parallel system typically involve a target with one extra feature (e.g. target: Q, 
distractor: O) however searches in which involve one less feature, encourage a more 
serial-like strategy (e.g. target: O, distractor: Q; Treisman & Souther, 1985). 
Conjunctions (combinations of multiple features) typically encourage the recruitment of 
a search strategy nearer the serial end of the serial-parallel continuum (Maioli et al., 
2001; Treisman, 1982). An additional method for increasing search difficulty and 
inducing a serial strategy involves stimulus similarity. Maximising the visual similarity 
between target and distractor stimuli while minimising the visual similarity between 
different distractors both aid in achieving this goal (Duncan & Humphreys, 1989). 
Increasing the set size (number of stimuli per trial) will increase the difficulty during a 
serial search task, yet will have little influence on search difficulty if a solely parallel 
search process is recruited (Maioli et al., 2001; Nakayama & Martini, 2011).
The process of serially searching a visual field can be thought of as the moving of a 
spotlight of visual attention across the stimulus array. This spotlight can be increased or 
decreased in size depending on task demands, referred to as the zoom-lens model 
(Eriksen & James, 1986). Typically, the acuity will depend on the size of the spotlight 
and this has been broken down into the 2 ° area of maximum acuity within the foveal
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focus. When extended out to 5° there is reduced acuity (the parafoveal area) and then 
beyond this area there is even more degraded acuity (the peripheral area; Rayner, 1998). 
This spotlight, while linked to eye movements, is not synonymous with it. It is possible 
for a covert shift in visual attention to occur without a corresponding eye movement 
(Carusco, 2011; Nakayama & Martini, 2011; Posner, 1980).
The preparation stage of visual search, in which the target stimuli is identified and 
maintained prior to searching, typically recruits areas of the visual cortex and prefrontal 
cortex (Eimer, 2014). Once the search is initiated parallel search processes provide 
information about the whole visual scene by recruiting widespread occipital and parietal 
regions (Eimer, 2014; Leonards, Sunnaert, van Hecke & Orman, 2000). Visual 
processing resources are then allocated to a particular location within the search array of 
visual field, a process largely mediated by Frontal Eye Field (FEF) and parietal activity 
(Armstrong, Chang, & Moore, 2009; Eimer, 2014; Noudoost, Chang, Steinmetz, & 
Moore, 2010) two regions dense with CBi receptors (Eggan & Lewis, 2007). Visual 
cortical signals are mediated - to a degree - by dopamine and associated Di receptors 
within the FEF, which suggests that visual search and attentionally guided behaviours 
are mediated by dopamine (Noudoost & Moore, 2011). The identification and selection 
of a stimulus which matches the target representation maintained in working memory 
occurs last, potentially recruiting multiple occipital regions and subcortical nuclei 
including the pulvinar and thalamic reticular nucleus (Bundeson, Habekost & 
Kyllingsbaek, 2011; Eimer, 2014). Although there is temporal and functional evidence 
arguing for a dissociation of these four stages: preparation, guidance (parallel 
processing), serial processing, and selection, these stages largely recruit overlapping 
brain networks (Eimer, 2014).
Within visual search tasks there are a number of variables which describe different 
processes. The fixation count per trial is a good measure of strategic search efficiency; 
more efficient strategies will involve fewer fixations before locating the target or 
discovering that there is no target (Najemnik & Geisler, 2005). Related to this is the 
concept of inhibition o f return in which the gaze direction tends to have a preference for 
novel areas of the visual field (Najemnik & Geisler, 2005). The number of revisits to a 
previously visited area could be indicative of the competencies of a temporary spatial 
memory store (Gilchrist & Harvey, 2000) such as visuo-spatial working memory
(Baddeley & Hitch, 1974). The fixation duration refers to the amount of time spent 
between saccades. During this period a number of processes occur including extraction 
and visual processing of the information within the foveal focus, the peripheral scanning 
of neighbouring stimuli, the planning of the next saccade, and the initiation of the 
saccade (Hooge & Erkelens, 1996; Radach & Heller, 2000; Rayner, 2009; Salthouse & 
Ellis, 1980).
4.1.2. Cannabis and Visual Search Tasks
Two studies have used the same task to assess the effects of cannabis on visual search 
performance (Ehrenreich et al., 1999; Huestegge et al., 2002). The task consisted of 100 
trials, each containing 25 square stimuli. For each individual square stimulus, one of the 
four sides was missing, resulting in four possible stimuli randomised across each trial. 
The participant was asked to respond on each trial when they detected the presence or 
absence of the square stimuli with the top side missing. The earlier study administered 
the visual scanning task to controls, early onset cannabis users (<16 years old) and late 
onset cannabis users (>17 years old) and found that the early onset group had slower 
reaction times on this task than both controls and the late onset users for both target and 
non-target trials (Ehrenreich et al., 1999). A limitation of this study is that the 
abstinence period was reported at two hours to one week, suggesting a mix of acute and 
residual effects of cannabis on task performance. Huestegge et al (2002) by contrast, 
enforced a 16 hour minimum abstinence to ensure that it was only the residual effects 
which were being tested. This study recruited only one group of cannabis users, 
therefore not examining the age of onset, and a group of controls and found that the 
cannabis group were slower to respond on both target and non-target trials (Huestegge 
et al., 2 0 0 2 ).
Huestegge et al (2002) used an eye-tracking device while administering the task. This
allowed the authors to deconstruct the processes involved in task completion and to
detect where the deficits were located. The eye-tracking data showed that fixation
durations did not differ between groups, yet the cannabis group produced a greater
number of fixations per trial before determining the presence or absence of the target. In
addition to these findings, cannabis users also returned to previously inspected areas
more than controls. Further investigation using a scan path analysis suggested this is
because the cannabis users tended to follow the experimenter's instructions and perform
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a 'reading like' search of the trial, while controls opted for a more holistic strategy in 
defiance of the same instructions. Overall it appears that the reaction time differences 
between cannabis users and controls can be at least partially attributed to an inefficient 
search strategy evidenced by more fixations and more re-inspections. However, the 
former could also be attributable to the cannabis users being more obedient and 
following the experimenter's instructions, while the latter could also be attributable to 
inefficient visual working memory, as suggested by the authors.
While the findings reported by Huestegge et al (2002) can be attributed to the residual 
effects of cannabis (abstinence: 1 6 -40  hours), the findings by Ehrenreich et al (1999) 
need to be treated with caution (abstinence: 2  hours - 1 week) as the shortest abstinence 
period reflects intoxication. However, these studies provided some early evidence 
suggesting visual search behaviours are impaired in cannabis users compared to 
controls.
In a longitudinal study of cannabis abstinence, Hanson et al (2010) administered a 
number of cognitive assessments including Ruff 2 & 7 (Ruff & Allen, 1996). This test 
involves searching for target stimuli (i.e. 2 and 7) among numerical distractors for a 
serial task and then again among alphabetical distractors for a more parallel task. 
Although other tasks were administered, this was the only task which remained 
impaired in cannabis users at the end of the study. The test was administered over three 
occasions and on the last test, at three weeks of abstinence, cannabis users were still 
impaired on the accuracy score (number of errors) yet not the speed of processing score, 
suggesting that visual search accuracy is impaired due to chronic cannabis use. There 
appeared to be practice effects for both groups, but despite the improvements the 
cannabis users still had lower accuracy scores than controls.
In the neuropsychological study of the current thesis, a D-KEFS Trail Making Test 
subtest, Visual Scanning, was administered to controls and cannabis users. The findings 
of this study partially replicated the earlier work (Ehrenriech et al., 1999; Huestegge et 
al., 2002) however with a different format. The Visual Scanning test involved the search 
for a target symbol '3', among an alphanumeric array. This differs from the earlier task 
in that the target can be coded verbally, as opposed to the earlier studies which used a 
visuo-spatial target stimulus (i.e. a square). Furthermore, the earlier studies used a 
structured array while the D-KEFS task was an unstructured array of numbers and
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letters. Despite these differences cannabis users also showed impairments on this visual 
search task relative to controls, however when the cannabis group was divided in two - 
only the late group presented with impairments. This is contrary to the findings reported 
by Ehrenreich et al (1999) who found the early onset users were the ones with impaired 
performance, while using the same early/late onset criteria. As discussed in Chapter 
Three, these deficits by the late onset group are unlikely to be due to a later age of onset, 
but rather reflect other group characteristics. The use of an eye-tracking device in a 
comparable task format to the D-KEFS Visual Scanning Test would allow the 
exploration of how cannabis users are impaired on the task. By breaking down the task 
into fixation durations, fixation count and revisit count, a clearer picture could emerge 
as to how cannabinoids affect the processes involved in motivated searching 
behaviours.
4.1.3. Set Switching Behaviours
An early account of set switching was introduced into the Working Memory model 
(Baddeley & Hitch, 1974) in a later amendment of the model (Baddeley, 1998), as a 
function of the central executive. The description at this stage included switching 
between strategies on a task and attending to one stimulus while inhibiting another. Set 
switching, or one its related constructs (e.g. attentional shifting), have since been 
ubiquitous in subsequent accounts of executive function (e.g. Anderson et al., 2001; 
Banich, 2009; Delis et al., 2001; Powell et al., 2004).
Following on from the inclusion of set switching as a central executive process
(Baddeley, 1998) it has been determined that working memory is a key contributor to
performance on many commonly used assessments of set switching. On the Trail
Making Test (TMT) verbal working memory representations and maintained and
updated, as the target symbol switches back and forth through number and letters (Delis
et al., 2001). Construct validity testing has confirmed the role of working memory in the
TMT (Sanchez-Cubillo et al., 2009) by the use of correlation and regression analyses.
Inhibition has also been implicated in set switching tasks using similar methods
(Langenecker et al., 2007; Sanchez-Cubillo et al., 2009) and by the use of an n-2
paradigm. The n-2 paradigm involves a switching task in which a switching between
two tasks (A-B-A) leads to greater switch costs than switching between three tasks (A-
B-C; Mayr & Keele, 2000). This is suggestive of a residual inhibitory effect on a
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process which has previously been disengaged, a phenomenon dubbed backward 
inhibition.
The presentation modality also plays a clear role in the completion of a task. The set 
switching conditions of visual based tasks such as the D-KEFS TMT and the D-KEFS 
Design Fluency Test (DFT) both require visual scanning and visual attention resources 
(Delis et al., 2001; Sanchez-Cubillo et al., 2009; Suchy et al., 2010). In comparison, the 
set switching condition of the D-KEFS Verbal Fluency Test (VFT) recruits declarative 
memory and working memory resources, in addition to the central process of set 
switching (Delis et al., 2001). It is unlikely though that visual attention would contribute 
any unique variance to purely verbal test such as the VFT and therefore it appears that it 
is the visual processes which primarily differentiate the two categories of tests. This role 
of visual attention in the TMT, in addition to working memory and inhibitory processes 
(Delis et al., 2001) can make it difficult to determine which process(es) are impaired 
when a particular population shows impairments on the task.
4.1.4. Cannabis and Set Switching
The association between chronic cannabis use and set switching deficits remains
unclear. The TMT is a commonly used test of this construct, although different versions
are often used (e.g. Medina et al., 2007; Gruber et al., 2011) which differ in the spatial
density and arrangement of the stimuli and therefore the results cannot be completely
comparable. It is for these reasons that the differences between tasks are most likely due
to differing degrees of difficulty rather than the recruitment of different cognitive
processes. These differences in versions perhaps explain why the D-KEFS version of
the TMT (Delis et al., 2001) uncovered impairments in a group of cannabis users
(Medina et al., 2007) yet the Flalstead-Reitan battery version (Reitan & Wolfson, 1985)
did not uncover such impairments (Bolla et al., 2002; Gruber et al., 2011). Gruber et al
(2 0 1 1 ) did find a trend for impairments (pc .1 0 ) with the whole cannabis group, but after
dividing the group into early and late onset users, the trend was not present for either
group. Partially supporting the results of Medina et al (2007) and Gruber et al (2011);
the analysis in neuropsychological study (Chapter Three) found a trend for impaired
performance by cannabis users on the set switching component of the TMT (D-KEFS).
When an age of onset analysis was conducted the Set Switching subtest and switching
contrast conditions showed that early onset cannabis users were impaired relative to
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controls, late onset users and tobacco users. This is in contrast to Gruber et al (2011) 
who did not find an effect of age of onset, however this could again be due to the 
version of the TMT used. This explanation is speculative however, as the differences 
between the versions have not been directly analysed.
Two other assessments of set switching derived from the D-KEFS battery (Delis et al., 
2001) were administered in the neuropsychological study reported in Chapter Three.
The first was from the VFT in which participants were asked to switch between 
semantic categories in a semantic fluency paradigm. The second was from the DFT in 
which participants had to switch between connecting filled or empty dots while creating 
novel patterns. The cannabis users were impaired on two assessments of set switching 
from the DFT, while not impaired on any measure from the VFT (Chapter Three). This 
pattern was upheld after conducting an age of onset analysis, in which early and late 
onset cannabis users were both impaired on the DFT, yet both groups performed 
comparably with controls on the VFT.
Data reported in the neuropsychological study suggested that cannabis users' set 
switching performance was impaired on tasks (TMT, DFT) which involved both motor 
speed (Schear & Sato, 1989; Delis et al., 2001) and visual attention (Delis et al., 2001; 
Suchy et al., 2010) in addition to the key set switching process. In contrast, the VFT, on 
which performance was not impaired in cannabis users, does not have a visual or motor 
component to it. Therefore it is possible that either motor speed or visual attention 
abnormalities were explaining the poorer task performance by cannabis users relative to 
controls. It is unlikely that motor deficits were explaining these deficits as two separate 
tests to assess motor speed were unaffected in cannabis users, however visual attention 
was impaired as assessed by the Visual Scanning component of the TMT. It could be 
that the higher order process, set switching, is intact in cannabis users, and it is visual 
attention problems which are leading to the task deficits. The two options are not 
mutually exclusive, due to the impaired performance on the Set Switching Contrast 
conditions from both the TMT and DFT, it is likely that set switching processes are also 
impaired.
To the current authors’ knowledge, there is no research examining set switching tasks in 
cannabis users while using an eye-tracker. This is therefore the first study to use this 
approach.
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4.1.5. Aims and Hypotheses
The principle aim of the current study was to extract the contribution of visual search 
and executive function processes to task completion by using an eye-tracking 
methodology to better elucidate the processes diminished by cannabis use. The present 
study utilised a computerised adaptation of the TMT, containing a more process pure 
visual search component followed by a visual search and set switching component.
Based on the data collected in the neuropsychological study, it was hypothesised that 
early onset cannabis users would be impaired on the set switching component of the 
computerised task while general cannabis users would show impairments on the visual 
search component. Furthermore, it was predicted that cannabis users would have more 
fixations per trial and greater revisits as measured by the eye-tracker, in accordance with 
previous research (Huestegge et al., 2002).
4.2. Method
4.2.1. Participants
The CannaForm was completed by 182 individuals recruited by opportunity and 
purposive sampling methods and this ended up in a total of 35 participants who took 
part in the experimental stage. Individuals were approached by the experimenter on a 
university campus or at a public location in a northern English city centre and asked to 
complete a lifestyle questionnaire. Additional cannabis users were recruited using 
snowball sampling and in liaison with a local cannabis activist group. The 
administrators of the activist group put out a notification asking individuals with a 
history of cannabis use and limited other drug use to contact the email address of the 
researcher if they were interested in taking part in psychological research. After contact 
by the potential participants, the experimenter sent an electronic version of the 
information sheet to the participant and awaited confirmation that they consented to take 
part (see Appendices A.4.1.1 and A.4.1.2). The demographic information of the 
participants can be seen in Table 4.2. One cannabis user who took part in the 
neuropsychological study also took part in this study, however the rest of the 
participants were new to this study.
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Participants were excluded from the study if they met any of the following criteria: 1) 
brain trauma or history of neurological disease; 2 ) learning disabilities or genetic 
disorders which impact cognition; 3) non-native English speakers; 4) chronic alcohol 
use (>37 units per week); 5) alcohol use within the past 24 hours; 6 ) lifetime other drug 
use (>15 total uses); 7) any illegal drug use (other than cannabis) in the past week; 8 ) 
impaired vision. Inclusion criterion for the cannabis groups was at least 50 lifetime uses. 
Participants were asked to abstain from cannabis use for at least 24 hours before testing 
to ensure participants were not suffering from the acute intoxication or 'hangover' 
effects of cannabis. This was confirmed via questionnaire on the day of testing. These 
criteria were extended from the last study to include an assessment of vision due to the 
use of eye-tracking in the current study.
4.2.2. Design
The current study employed a quasi-experimental design in which participants were 
allocated to groups based on pre-existing criteria. The independent variable for the first 
analysis was labelled cannabis use and consisted of two levels: non-smoking controls, 
and cannabis users. The independent variable for the second analysis was labelled the 
age of onset of cannabis use and consisted of three levels: non-smoking controls, early 
onset cannabis users and late onset cannabis users. There were 22 Dependent Variables 
(DVs) which were the outcome measures derived from the two computerised tasks and 
the eye-tracking metrics. See Table 4.9 for the full list of dependent variables.
Separate analyses keeping the same IV were also conducted on IQ (DVs = full scale, 
verbal IQ, performance IQ) and mental health (DVs = anxiety, depression, obsessions, 
compulsions, motivation) to ascertain whether the groups were matched for intelligence 
and mental health estimates.
4.2.3. Materials
In order to assess whether an individual could be included into the study or needed to be 
excluded, the CannaForm was administered. To ensure participants task performance 
was unaffected by impaired vision, the visual spatial and object perception was assessed 
using the Visual Object Space Perception battery (VOSP; Warrington & James, 1991).
If a participant failed one or more of the four VOSP subtests then they would be
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retrospectively excluded from taking part, however no participants displayed impaired 
vision.
The Tobii T120 eye tracker was used to monitor gaze. As no suitable computerised 
version of the TMT exists and no other standardised test was available to investigate the 
hypotheses, two tasks were created for this experiment. The tasks created for use with 
the eye-tracker were the computerised analogue to the TMT Visual Scanning Task 
(hereinafter called Tobii VST) and the computerised analogue to the TMT 
Number/Letter Switching Test (hereinafter called Tobii SST). Both tasks involved the 
participant responding to the presence or absence of a target symbol in an array of 
alphanumeric distractors totalling 20 stimuli per trial (see Figure 4.1). Each trial was 
self-terminating and would only move on once the participant has responded. For the 
Tobii VST the target symbol was the letter 'F' and for the Tobii SST the target symbol 
alternated between the letter TJ' and the number '5' over consecutive trials.
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Figure 4.1. A sample target trial taken from the Tobii VST
To ensure high validity a systematic approach to task design was utilised for both tasks.
For every aspect of the stimuli: the set number, the stimuli dimensions, the entire trial
dimensions, the stimuli content (i.e. alphanumeric symbols), and the spatial density, a
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predetermined criteria was selected. These criteria were that where possible the task 
would replicate the TMT Visual Scanning test, the task would replicate previous eye- 
tracking visual search tasks (i.e. Huestegge et al., 2002), or the task would be in 
accordance with theoretical accounts of visual search and visual attention (e.g.
Najemnik & Geisler, 2005). This method ensured that similar cognitive processes to 
those recruited in the TMT Visual Scanning test would be recruited for this task and that 
a serial search strategy would be required. See the appendeces (Section A.2.2) for a 
more detailed account of the task construction.
For the Tobii SST there was an additional role of switching between two stimuli. From 
a face validity perspective there were some differences between the Tobii SST and the 
set switching task from the TMT. The Tobii SST involves switching between two 
symbols (i.e. U, 5, U, 5, etc), while the TMT version involves switching between two 
categories in which the symbols ascend through their respective categories (i.e. 1, A, 2, 
B, 3, C, etc.) The continuity of the switching symbol in the SST reduces the demand on 
working and long term memory resources during the task. To confirm face validity with 
a content validity approach described by Monsell (2003) the current analysis determined 
if there was a switch cost between the non-switch trials in the Tobii VST and the switch 
trials of the Tobii SST (see Section 4.3.6). This method confirmed that set switching 
processes were recruited by the Tobii SST. As both the Tobii VST and Tobii SST 
require response with a single button press while the TMT tasks involve a grapho-motor 
response format, the current tasks also reduce demands on the motor system.
During the Tobii VST the participants were instructed to press one button when they see 
a target symbol in the array and press a second button when they think the target symbol 
is not in the specific array. They were told to do this as fast as possible without making 
any errors. During the Tobii SST the participants were instructed that the rules had 
changed and now the target symbol would switch back and forth between trials. They 
were asked to press a button if they see target symbol (for that trial) in the array and 
press a second button when they think the target symbol is not in the specific array
In addition to the primary tasks, a number of other measures were administered to 
account for potential cofounding variables. The Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) was administered to test for anxiety and depression. 
The Clark-Beck Obsessive Compulsive Inventory (CBOCI; Clark & Beck, 2002) was
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administered to test for obsessions and compulsions. The Wechsler Abbreviated Scale 
of Intelligence (WASI; Wechsler, 1999) was administered to test for IQ estimates. In 
addition to these tasks used in the neuropsychological study, the Apathy Evaluation 
Scale (AES; Marin et al., 1991) was administered to test for motivation. The rationale 
for selecting these tasks can be found in the Methodology chapter.
Hair samples were also collected during this study and were kept in foil, sealed inside a 
plastic container.
4.2.4. Procedure
Following the recruitment process the participants were administered the CannaForm in 
one of three ways including self-report by the participants, face-to-face interview with 
the experimenter reading out the questions and over the phone interviews, with the 
experimenter reading out the questions. The method of administration was based on the 
particular recruitment strategy. Self-report and face- to-face interviews were selected 
when the individuals were approached in person by the experimenter. If the participant 
could complete the questionnaire at that point in time, an interview method was 
employed. If the participant had no free time or several participants were approached at 
once, then the self-report method was employed and the completed questionnaires were 
handed directly back to the researcher at an agreed time. The telephone interviews only 
took place when an individual responded to the notification put onto the local cannabis 
activist group’s Facebook group or associated websites. Questionnaire debriefing 
occurred after the participants had completed this stage.
Those individuals who met the inclusion criteria and who did not violate the exclusion 
criteria were contacted and a time arranged for cognitive testing. The participant arrived 
at the eye-tracking laboratory and was given the information sheet for a second time to 
ensure they were happy to continue. The order of the tasks was counterbalanced by 
blocks (IQ test, mental health questionnaires, and eye-tracking tests). After the tests and 
questionnaires were administered a hair sample (approximately lOOmg) was collected 
and placed in foil and sealed in a plastic container. Debriefing then took place. All data 
collected during the study was labelled with the participant's unique code to ensure 
anonymity and sealed in a locked cabinet.
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4.2.5. Data Analysis
The present study collected data from two categories of outcome measures: behavioural 
data and eye-tracking data. For both types of data, target trials and non-target trials were 
analysed separately. Behavioural data included Reaction Times (RTs), number of errors, 
and the time taken to complete the whole task. The first stage in preparing the RT data 
was to remove the RTs for error trials as there is normally an additional process 
involved in the trial where an error has occurred - i.e. the reason the error occurred. The 
median reaction time across the correct trials was calculated for each participant and 
then subject to the normality protocol described in earlier chapters which included 
checking for outliers, skewness statistics, kurtosis statistics, histograms, and Shapiro- 
Wilks tests. Subsequent transformations were made when the normality protocol 
suggested a variable deviated from normality and winsorising methods were used when 
outliers greater than ±3 z-scores from the mean were detected. These transformation 
methods were the square root of X (V*), base 10  logarithm of X (log  10(x)X inverse of 
X (x_1), square of X (x2) and cube of X (x3). The number of errors and total time taken 
variables did not need to be converted into median scores as the total score was used for 
each of these two variables.
In order to determine fixation metrics the Area Of Interests (AOIs) for each stimuli 
needed to be created. As stated by Goldberg and Helfman (2010; p.2) when discussing 
the process of defining the AOIs, "there are no rules or best practice guidelines to aid 
this effort." As processing can occur - albeit at a degraded level of acuity - beyond the 
foveal focus, the amount of "padding" around each stimulus needs to be considered. 
Based on the empirically discovered foveal and parafoveal focus angle (i.e. Rayner,
1998), and by observing the amount of space around each stimulus (Goldberg & 
Helfman, 2010), AOIs were given 1.2cm "padding".
The number of unique fixations was calculated by using the median number of unique 
fixations per trial across all correct trials for each participant. The unique fixations were 
taken for target trials and non-target trials separately to conform to standard protocol 
(e.g. Huestegge et al., 2002). The number of revisits was calculated by subtracting the 
number of unique fixations from the sum of the fixations per trial. Instead of taking the 
median across all trials this value was kept as a sum total across the entire task as the 
number was too low for the median analysis and would therefore have yielded a floor
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effect. It was considered to look at revisits for target trials and non-target trials however 
instead target stimuli and non-target stimuli were observed as it was thought this would 
be more informative for this metric. The fixation duration was also examined for target 
and distractor stimuli and was calculated by taking the median across every correct trial.
This process of the normality protocol and data treatment was conducted for both the 
Tobii VST and the Tobii SST. In order to control for salient confounds, a list of 12 
variables (age, sex, years of education, GCSE grades, anxiety, depression, obsessions, 
compulsions, motivation, other drug use, weekly alcohol use, and tobacco use) were 
tested for the four ANCOVA assumptions described earlier in the thesis (independence 
of treatment and covariate effects, associations between the covariate and the dependent 
variable, the association must be linear, and there must be homogeneity of regression).
If a variable could be controlled for it was analysed using the ANCOVA method. The 
remaining variables were analysed using f-tests and Mann Whitney U tests for the two 
group comparisons (controls vs. cannabis users) and analysed using ANOVAs and 
Kruskal-Wallis tests for the three group comparisons (controls vs. EoC users vs. LoC 
users) if data were parametric or non-parametric, respectively.
For demographic, drug use, mental health, and IQ data, the groups were compared with 
chi-square tests for categorical data, f-tests and Mann Whitney U tests for the two group 
comparisons (controls vs. cannabis users) and ANOVAs and Kruskal-Wallis tests for 
the three group comparisons (controls vs. EoC users vs. LoC users) if the data were 
parametric or non-parametric, respectively.
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4.3. Results
4.3.1. Demographic Data
Data from the CannaForm pertaining to demographic characteristics were collected and 
analysed to determine whether relevant factors differed between the three groups.
There were three continuous variables which potentially could be analysed through 
ANOVA method and therefore assumptions were tested for both the two-group analysis 
(see Table 4.1) and three-group analysis (see Table 4.2). The normality protocol of 
assessing histograms, the Shapiro-Wilk's test, skewness statistics and kurtosis statistics 
suggested that there were deviations from normality for the age and years of education 
variables. The five transformation methods described in section 4.2.5 were implemented 
and the normality protocol suggested that the data could not be made parametric and 
therefore Kruskal-Wallis tests were used. The educational achievement (GCSE’s) 
variable showed to be normally distributed and with no outliers and therefore was 
analysed using the ANOVA method.
Across all two-way (see Table 4.1) and three-way (see Table 4.2) analyses there were 
no between group differences suggesting that the groups were matched for sex, age, 
nationality, educational achievement, and years of education.
194
Be
tw
ee
n 
su
bj
ec
t 
eff
ec
ts 
an
d 
de
sc
rip
tiv
e 
sta
tis
tic
s 
fo
r 
the
 
th
re
e-
gr
ou
p 
de
m
og
ra
ph
ic
 
da
ta
.
oC3
CM
'•SL
CO C<5
^  aCo
o o O 3 " NO
CM t" ; i n , O O n
- Q CM 3 " o —
a>. 3
^  "cS >
CC CM O  
co, m  r~  
in  cm  o
oo
ON
O n
•n
N  T
OO I 3 "
— n °
I  «  »  §
cn ~  o
o  ^  ~  «n «ON 00
NO
in
m
+1
CM
CM
^  2  o II
W s
inm
ioo
£  m  PQ
^  ^  m
o
oo
CM
U ^
% o  PQ o
CM CM
Oo
3 ;
r n
+1
oooo
°  21-H
S 11
u
e
3 "
O oo
CM00 cn
Zl
CQ
a Z j
o zPQ oin m o
CM m
O oo o
ON 3-
c~
o
r-
NO
a  -S 
a  jo  u a 
©X)o
£a>
Q
u<n
>
a>60
3
3
feOc3J ^ sc oCD \3 toO 3
3£ y; c
.2  < 
S 2-t 3 T3
o
3
PQ
COUO
3 "
0)
CDCD
CO
■Sj
=§
193
Be
tw
ee
n 
su
bj
ec
t 
ejf
ec
ts 
an
d 
de
sc
rip
tiv
e 
sta
tis
tic
s 
fo
r 
the
 
tw
o-
gr
ou
p 
dr
ug
 
use
 
da
ta
.
a
eS
C/5t-0/033
C/5
X!3aaa
V
2  2  t-H
S 11® si U
<uW)ca
C*
CtS
c
2d
(U
<D
OX)
Ca
OC
oc
ea
’•a<u
3a
ua
>
a/
03
P
0£aS-
Q
CO CO CO
—( (N)
co co
o <N X —
C“. Os O)
o (N ■3* o i
© © © ©
© 05 © 05
oc cn (N i—i
c*~( Os 05 Os
—1 1 <N
oo
O', r o
oo ©  r-~ ©
^  OC 
CO © ©
o
O',
0 3
0 33"o
r\T " 1 '^  C\) •—i
0 3(Ni©
OS
Os
Os ©
—
X ©
^  rg o  o  03 ^  T — a- a- 
S  2 . o o o
o  o  
  O  os _ s oc
5^  ^—, (N O o  —
• NO 00 •
CO - a -  +|
0 3r- coCN
—: 03
^  <N  
CN X, 
+1
a-Io
_ o
oc O  o
3 -  r- oo
^  »n 
6  ©
o
©
©
©
05
(N
©
©
CO
d d d X
©
©
©
©
©
o
©
05
©
05
© © © © —
©
©
CO
X
oT
r -
— CO o
©
©
o
o
o
©
CN © o
— <N
o  o
o  o  o  o  
© d
o  © o  © o  ©
* 1  1
1  P H  
•C d
2  c 
o
J
X  Oo  o>H <
C /2  C/3  C/D C/D
HJ
C/2
.5 H 
E d3 ..
t/i 3d  -03  O
° -£to 3
Q H U U U U
X!
3cc
3U
to
X
a .
h   ^d  -x
o  X
E X
o  c
HX
bij
3
>, Qo i
=3 to 
o  x
X O
c
o
T3to
CD>
_to
©to
0)-a
© x
^  x° 2X 2
v -  ^n j ■=*
X  So •*
©00
X 2
0| _  C
O x
30)>oII
Xo
> o
3to50
c
1)
OX)
C3
Oo<
3
CD
E
X
H
X
X'
CD
CD£
©  X
*S 8 
£  -s<  c /3
tot)
3
<>
o2<ooc
'o c
bi) 
3
O*
CD
bt)c3
• to 3  -3
3  O  
C  - q
P 3
5  CD
©
OJ
0 3©
V
D .
3
X
’£
Eo
3
b t)
0 5  - t o
©totio
D.to
L- . o  _o
3
£I13
P4
C /2
D
H
c
3
OE
c3to
bU3L_to>3
bt) 
3
X -a
3  
3  CTL.to
C
©to
E
oc
!_o
3
3-a
CLto•—
3
Co
>to-a
3-ac
3
C
3to
Etox
3
3-ato
to
E
3i_
3
CL
L.o
X
Eo
C/3
3
3©to
bt
3
C
Xo
_ t o
-ac
3
o
CDto
3
X
C
X
3
Cc
3to
boc
■6
3
194
4.3.2. Drug Use Data
When a testing date and time was arranged the participants were asked to abstain from 
alcohol use for twenty-four hours and recreational drug use for one week prior to the 
testing time. All participants reported their last alcohol and drug use on the testing day 
which showed respective uses within the accepted timeframe for all participants. The 
aim was to recruit participants with less than 15 uses of cannabis use and tobacco use 
for the control group however this criterion was violated for three and five of the 
participants, respectively (see Table 4.3). These participants were not excluded due to 
the low level of use. It was also aimed to have less than 15 episodes of other drug use 
(total episodes of drug use; not including cannabis, alcohol or tobacco) across all three 
groups. This criterion was met for the control group however was violated for two of 
the participants from the cannabis group/early onset cannabis group (see Tables 4.3 and 
4.4). The amounts were still relatively small (16 and 45 uses) when compared to the 
amount of cannabis each participant had consumed (3,636 and 1,008 uses, respectively) 
and therefore the participants were not excluded.
The normality protocol suggested that there were deviations from normality for all of 
the drug use variables seen in Tables 4.3 and 4.4, with the exception of the desired 
cannabis intoxication level, years of cannabis use, and age of cannabis onset. The 
transformation protocol could not generate normality and therefore these variables were 
analysed using the Kruskal-Wallis test. Results of the three way analysis which were 
significant suggested follow-up comparisons were necessary to determine which groups 
differed. These post hoc tests are now discussed.
4.3.2.1 Controls vs. EoC users.
There were four significant Kruskal-Wallis tests which dictated follow-up Dunn’s 
comparisons. These tests showed that EoC users had higher levels of tobacco use than 
controls [f(23)=13.04, p=.001, a-0.69, 1-Tailed Dunn's], higher levels of cannabis use 
than controls [f(23)=17.83,/?<.001, /-0 .91, 1-Tailed Dunn's], higher levels of ecstasy use 
than controls [f(23)=8.25, p=.026, r=0.48, 1-Tailed Dunn's], and higher levels of total 
other drug use than controls [f(23)=9.33, p=.0\3, /-0 .53, 1-Tailed Dunn's].
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4.3.1.2 Controls vs. LoC users.
Further follow-up tests showed that LoC users had higher levels of cannabis use than 
controls [r(2i)= 14.72, /7<.001, /-0 .73, 1-Tailed Dunn's], however the two groups did not 
differ in total tobacco use [f(2i)=14.72, p<.00\, /-0 .73, 1-Tailed Dunn's], total ecstasy 
use [t(2d=6.96, p=.084, r=0.40, 1-Tailed Dunn's], or total other drug use [t(20=7.22, 
p=.019, r=0.40, 1-Tailed Dunn's].
4.3.1.3 EoC users vs. LoC users.
Further follow-up tests showed that the two groups did not differ on any of the four 
variables including total cannabis use |7(20)=3.1l,/?=.500, / - 0 .16, 1-Tailed Dunn's], total 
tobacco use [f(20)=8.10, p=.360, r=0.43, 1-Tailed Dunn's], total ecstasy use [f(20)= l.29, 
p=.500, /-0 .08, 1-Tailed Dunn's], or total other drug use [ (^20)=2.12, p=.500, a-0.13, 1- 
Tailed Dunn's].
In addition to the four Kruskal-Wallis test follow-ups, seven further Mann-Whitney U 
and independent r-tests were run just between the EoC and LoC using groups. This 
showed that the EoC group initiated cannabis use significantly earlier than the LoC 
group [f(20)=5.67, p<.001, d=2A\, 1-Tailed f-test], had significantly more years of 
cannabis use than the LoC group [7(20)=1.84, p~.042, d=0.86, 1-Tailed r-test] although 
there was no difference in desired levels of intoxication between the two groups 
[t{20)=0.86, p=.201, d=0.36, 1-Tailed f-test] or time since last cannabis use [f/(20)=40.00, 
p=.234, z=0.73]. There was also no differences between the two groups in total 
amphetamine use [t/(20)=59.00, p=A41, z=0.13], total cocaine use [t/(20)=54.00, p=.254, 
z=0.73], or total magic mushroom use [f/(20)=58.00, p=.423, z=0.18].
4.3.1.4 Considerations
While some of the differences between groups were statistically significant for various 
drug use variables the two tables (4.3 & 4.4) should be consulted to examine descriptive 
statistics because a statistically significant difference does not necessarily imply 
substantive or real world significance. Cannabis users were shown to use significantly 
more other drugs than controls; however this effect only represents a median difference 
of 2.50 total lifetime uses and therefore is unlikely to explain any group differences in 
cognitive performance reported in section 4.3.5.
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4.3.3. Mental Health Data
Data from the HADS (Zigmond & Snaith, 1983), the CBOCI (Clark et ah, 2005), and 
the AES (Marin et ah, 1991) were collected to determine whether the groups differed on 
measures of depression, anxiety, obsessions, compulsions, and motivation. The possible 
scores on the two HADS tests ranged from 0-21 with higher scores indicating higher 
levels of anxiety or depression. The possible scores on the CBOCI ranged from 0-42 for 
the obsessions scale and from 0-33 for the compulsions scale with higher scores 
indicating more severe symptoms of OCD. In contrast to the other two questionnaires, 
higher scores on the AES reflected greater levels of motivation (maximum possible 
score 54), while lower levels suggested apathy (minimum possible score 0).
The five variables were subject to the outlier, normality, homogeneity of variance, and 
transformation protocols. Normal, transformed, and un-transformable variables can be 
seen in Tables 4.5 and 4.6.
One of the two-group (see Table 4.5) analyses found a group difference, namely that 
cannabis users displayed significantly higher levels of anxiety than controls. In contrast, 
none of the three-group (see Table 4.6) analyses found any significant differences for 
any of the mental health variables. This suggests that the groups were matched for all 
mental health variables except anxiety within the two-group analysis.
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4.3.4. IQ Data
The estimates of IQ derived from the WASI were collected and analysed to determine 
whether the three groups differed on measures of FSIQ and each of the four subtests.
An interpretation by the test authors breaks up performance into extremely low (69 and 
below), borderline (70-79), low average (80-89), average (90-109), high average (110- 
119), superior (120-129) and very superior (130 and above) categories (Wechsler et al.,
1999). The subtest possible scores (age-scaled) are 20-73 for the Vocabulary subtest, 
24-73 for the Block Design subtest, 20-71 for the Similarities subtest, and 20-69 for the 
Matrix Reasoning subtest. Higher scores on all of the subtests indicate better 
performance.
The five variables were subject to the outlier, normality, homogeneity of variance, and 
transformation protocols. Normal, transformed, and un-transformable variables can be 
seen in Tables 4.7 and 4.8.
None of the two-group (see Table 4.7) or the three-group (see Table 4.8) analyses found 
any significant differences for any of the IQ variables. This suggests that the groups 
were matched for levels of IQ, although there was a trend for cannabis users to perform 
better on the vocabulary subtest.
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4.3.5. Cognitive Data
4.3.5.1. ANOVA Assumptions
The 22 variables were subject to the outlier, normality, homogeneity of variance, and 
transformation protocols. Normal, transformed, and un-transformable variables can be 
seen in Tables 4.9 and 4.10.
4.3.5.2. ANCOVA Assumptions
In addition to the basic ANOVA assumptions described in section 4.3.5.1 there are 
additional assumptions necessary for the ANCOVA. This analysis attempted to take 
into account the relative effects of anxiety (Eysenck et al., 2007), depression (Delis et 
ah, 2001), obsessions and compulsions (Lawrence et ah, 2006), motivation (Musty & 
Kaback, 1995), FSIQ (Ardila, Pineda & Rosseillo, 1999), alcohol use (Brown, Tapert, 
Granholm & Delis, 2000), tobacco use (Jacobsen et ah, 2005) years of education, 
educational attainment (Hooper et ah, 2004) and age (Taylor et ah, 2011) on cognitive 
test performance. The assumption of independence of treatment and covariate effects 
states that the covariate must not be significantly related to the independent variables. 
The ANOVA results from the Demographic Data, Mental Health Data and IQ Data 
analysis showed that three of these variables: anxiety, tobacco use and other drug use, 
were all related to the independent variable while the remaining variables met the first 
assumption of independence of treatment and covariate effects.
Secondly, the variables must be correlated with the given dependent variable. See 
Appendix A .4.12 for the table of correlations between potential confounding variables 
and the cognitive dependent variables. Thirdly, in such situations where a relationship is 
present between the dependent variable and the potential covariate, the relationship 
must be linear. These relationships were checked using scatter graphs. Finally, 
homogeneity of regression slopes was tested by looking for a significant interaction 
effect between the potential covariate and the independent variable. Any potential 
covariate which violated this assumption was not included in the ANCOVA.
In such cases where a potential confounding variable met all the assumptions then an 
ANCOVA was run. In situations where no potential confounding variable was related to 
the dependent variable or a violation occurred then an ANOVA was run. After checking
208
assumptions VST fixation duration on distractors was analysed while controlling for 
educational achievement and age, VST fixation duration on targets was analysed while 
controlling for compulsions, VST omissions was analysed while controlling for FSIQ 
and SST non-target reaction time was analysed while controlling for depression and 
alcohol use. The remaining variables were unrelated to the potential confounding 
variables or violated assumptions for the anlaysis.
For the two-group analysis independent Ftests were used when no covariates needed to 
be controlled. ANCOVAs were used in situations where covariates needed to be 
controlled. For the three-way analyses there was only one significant main effect (see 
Table 4.10) and therefore only one series of post-hoc tests was conducted.
4.3.53 Post-Hoc Tests
There were two significant main effects between the three groups for the number of 
revisits on target stimuli during the VST task and the number of revisits on distractors 
during the SST task. Post-hoc tests showed that early onset cannabis users made 
significantly more VST target revisits than controls [?(23)=3.94, pc.001, d= 1.41, 1-tailed 
Tukeys HSD] and late onset users |4(20)=3.32, p=.003, d - 1.30, 1-tailed Tukeys HSD] on 
the VST. In contrast, there were no differences between controls and late onset users 
[r(2i)=0.39, p=.461, r/=0.21, 1-tailed Tukeys HSD].
On the SST, post-hoc tests showed that early onset cannabis users made significantly 
more distractor revisits than controls [f(23)=2.83, p=.011, r/=1.04, 1-tailed Tukeys HSD]. 
In contrast, there were no differences between controls and late onset users [f(2i)=l .63, 
p=. 124, d=0.95, 1-tailed Tukeys HSD] or late onset users and early onset users 
[r(20)=l .08, p=.266, d - 0.56, 1-tailed Tukeys HSD] on the VST.
4.3.5.4. Correlational Analysis
In order to further explore the nature of the cannabis related impairments, the tests 
which identified cognitive impairments in cannabis users or showed a trend towards 
group differences were selected and then correlated with cannabis use variables within 
the entire cannabis using group (See Table 4.11). This showed that only one cannabis 
use variable was correlated with one dependent variable, the age of onset negatively
209
correlated with the number of revisits to target stimuli on the VST [/--.438, p=.023, 
71=22, 1-tailed].
4.3.5.5. Quartile Analysis
In order to test how performance changed over the course of the test the 80 trials for the 
Tobii VST and Tobii SST were broken down into its constituent components. The trials 
were first halved into the target trials and non-target trials to observe these effects 
separately. Secondly the 40 trials per category were broken down into quartiles 
representing 10 trials for each quartile for target and non-target trials. Of these 10 trials 
all error trials were removed so that for each participant an estimate for each quartile 
could be assessed for only the trials on which they responded correctly. These 
remaining trials formed an estimate of how each individual performed over the time 
course of the task and thus provided a measure of sustained attention as opposed to 
selective attention (e.g. Hanson et ah, 2010). The means and standard errors of these 
estimates for cannabis users and controls can be seen in Figure 4.2 for the Tobii VST 
and Figure 4.3 for the Tobii SST. This quartile analysis was not broken down into early 
and late onset users as there was not an age of onset effect on target or non-target 
reaction times.
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Table 4.11.
A table o f correlation coefficients to explore which cannabis use variables which may 
mediate the performance deficits by cannabis users
Cognitive Variable Age of 
onset
Lifetime spliffs 
smoked
Years of 
cannabis 
smoking
Desired
Intoxication
Time since 
last Use
P Rho P P Rho
Task Data
VST
Total time -.116 .077 -.152 -.136 -.039
Reaction time (T-T) -.087 .112 -.094 -.083 -.267
Reaction time (NT-T)r -.117 .104 -.189 -.304 -.146
SST
Total time -.209 .207 .295 -.157 -.130
Reaction time (T-T)IV .085 .060 -.216 .042 .195
Eye-Tracking Data
VST
Revisits on targetr -.438* .030 .280 -.315 -.273
Revisits on distractorsr -.257 .238 .083 -.324 -.151
SST
Revisits on targetL -.265 -.062 .272 -.093 -.296
Revisits on distractorsr -.207 .311 .323 -.211 -.296
Notes. P= Pearson’s correlation coefficient; Rho= Spearman’s correlation coefficient.
This analysis was performed on just the cannabis users n - 22. r=root transformed. 
IV=inverse transformation. L=log transformed.
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Figure 4.2. The mean reaction times across the four quartiles of the 
VST for target and non-target trials, for both cannabis users (can) and 
controls (cnt). Error bars represent standard errors. The * below a 
comparison indicates between group differences for that specific 
quartile.
4500.0000 Quartile Reaction Times on the SST
4000.0000
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Target (cnt) 
Non-target (cnt) 
Target (can) 
Non-target (can)
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Figure 4.3. The mean reaction times across the four quartiles of the 
SST for target and non-target trials, for both cannabis users (can) and 
controls (cnt). Error bars represent standard errors. The * below a 
comparison indicates between group differences for that specific 
quartile.
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4.3.6. Validity and Reliability
In order to test which variables of the Tobii SST recruited set switching processes a 
subtraction of a switch trial from a non-switch trial (e.g. SST total time -  VST total 
time) was conducted as described in Monsell (2003) to determine if a switch cost was 
present. As many of the variables were transformed using different transformation 
methods the transformed data could not be compared and therefore Wilcoxon tests are 
used to test all non-parametric variables while related sample Mests compared all 
parametric data. Any significant results suggest that there was a switch cost, and 
therefore set switching processes, involved for that specific cognitive variable on the 
Tobii SST.
Table 4.12.
P-valuesfor the comparisons between the Tobii SST and the Tobii VST for each 
dependent variable.
Cognitive Variable 
(SST-VST)
Controls Cannabis users 
(total group)
Task Data
Total time .023 .004
Reaction time (T-T) .254 .392
Reaction time (NT-T) .007 <.001
Omission errors .238 .272
Comission errors .079 .051
Eye-Tracking Data
Fixation duration on target .010 .003
Fixation duration on distractors .021 .056
Unique fixation count (T-T) .321 .255
Unique fixation count (NT-T) .095 .012
Revisits on target .082 .463
Revisits on distractors .050 .003
Internal reliability of the Tobii VST and Tobii SST was tested using Cronbach’s alpha 
for both the target trials and the non-target trials. Missing data were corrected using
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multiple imputations with five iterations. The median Cronbach’s alpha score across the 
five iterations was used as a pooled iteration was not possible.
The analysis showed that both tests reached levels of reliability suitable for cognitive 
testing (a >.80; Kline, 1999). The score for the target trials of the VST was in the 
“good” range (a=.84) while the score for the non-target trials of the VST was in the 
“excellent” range (a=.98). The score for the target trials o f the SST was in the “good” 
range (a=.84) while the score for the non-target trials of the SST was in the “excellent” 
range (a=.97).
4.4. Discussion
4.4.1. Validity and Reliability
The construction of the two Tobii tasks was orchestrated to ensure that visual scanning 
processes contributed to task performance. This was done by systematically creating 
task components based on previous visual search tasks (Delis et al., 2001; Huestegge et 
al., 2002) and by using concepts derived from visual search theory (e.g. Najemnik & 
Geisler, 2005). Confirming that the search strategy in both tasks that was nearer the 
serial end of the serial-parallel continuum was done by examining the reaction times 
across the trials with previous studies which have used serial and parallel tasks (Maoili 
et al., 2001). Given the number of distractors per trial and the reaction times per trial, 
these data suggests that a more serial-like search strategy with a parallel element was 
recruited, rather than a solely parallel strategy. The validity of the SST was also 
examined by a method discussed by Monsell (2003) for determining the role of set 
switching processes.
The switch cost analyses suggested a clear switch cost was present on the Tobii SST for 
the total time taken to complete the task, the reaction time for the non-target trials, the 
fixation duration time on the target stimuli, the number of unique fixations on the non­
target stimuli, and the number of revisits on the distractors. There was concordance 
between the cannabis users and the controls for this approach. This method does not 
specify what processes are involved in the switch cost however task-set reconfiguration,
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backward inhibition and working memory are likely candidates as discussed in Section 
4.1.3 of this chapter.
Results of Cronbach’s alpha tests of reliability showed that the reaction times for the 
target and non-target trials across the VST and SST were not only suitable for cognitive 
testing purposes (i.e. a>.80; Kline, 1999) but for the non-target trials the reliability 
scores were near to perfect (a=.97 & a=.98). This suggests that for each of the 
respective four groups: VST target, VST non-target, SST target, and SST non-target, 
each of the individual trials were largely measuring the same underlying cognitive 
processes as the other trials within the same test.
4.4.2. Cognitive Data
4.4.2.1. The Tobii Visual Search Task (VST)
There were 11 dependent variables derived from the VST divided between five task 
variables and six eye-tracking metrics. The cannabis users took significantly longer than 
the controls to complete the VST and had a significantly slower reaction time for the 
non-target trials, but not the target trials. While error rates were not significantly 
different between groups the cannabis users reported fewer omission errors when 
observing descriptive statistics and confidence intervals, possibly suggesting a more 
cautious strategy. The cannabis users also had significantly more revisits to the target 
stimuli than the controls. Although the effect was not significant, there was a trend 
(p<. 10) for cannabis users to have slower reaction times on the VST target trials and 
make more revisits to distractor stimuli. In the second (three-group) analysis, the only 
significant main effect was for the number of revisits to target stimuli in which early 
onset cannabis users made significantly more revisits than both controls and late onset 
users.
Of all the possible 12 putatively confounding variables which were examined, very few 
were correlated with the dependent variables. Of the ones which were, all were 
controlled for on the VST except for the influence of anxiety on the number of revisits 
to distractor stimuli, the influence of FSIQ on the number of omission errors (for the 
two group comparison only), and the influence of tobacco on the number of commission 
errors. These last two variables did not display significant differences across the groups
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however the former variable, revisits to distractor stimuli, nearly reached statistical 
significance and it could be that this was due to the higher levels of anxiety in the 
cannabis group. In contrast, all the VST variables which were significantly different 
across the groups were not correlated with any of the confounding variables and 
therefore the deficits are best explained by cannabis use. Interestingly, only one of the 
cannabis variables was associated with the dependent variables in the correlations 
analysis. The age of onset of cannabis use was negatively and moderately correlated 
with the number of revisits to the target stimuli which suggests that the earlier an 
individual starts using cannabis, the more revisits they make and thus the worse the 
performance on the task.
The current study found that cannabis users were slower to respond on non-target trials 
and there was a strong trend towards cannabis users taking longer to respond to target 
trials. This replicates the findings from Huestegge et al (2002) however the current 
study did not find that early onset cannabis users took longer to respond on these 
measures than controls and late onset users, and therefore not supporting the data by 
Ehrenreich et al (1999). This could be due to Ehrenreich et al’s much more recent 
abstinence criteria (two hours +) and therefore the effects discovered could be an acute 
intoxication effect by the early onset group driving their data. Also the cannabis users 
took longer to complete the whole VST task in the current study, supporting the slower 
findings of cannabis users on the Visual Scanning subtest of the TMT in Chapter Three 
of the current thesis.
The fixation duration data in the current study supports previous work done by 
Huestegge et al (2002) who also found no group effects on these variables. Huestegge et 
al (2002) also used a measure of total fixation count and the number of revisits to 
measure search efficiency however the current study adopted a modified approach. 
While revisits were also analysed here, the total fixation count was not analysed as the 
fixation count would also include the number of revisits. Instead the current study 
adopted the measure of the unique fixation count, which has the benefit of being 
completely separable from fixation revisits. This unique fixation count did not highlight 
any between group differences however it is not known if the same would be true for 
Huestegge et al’s data. The current study found that revisits were made more frequently
218
by the cannabis users, a finding which also supports the previous study by Huestegge et 
al (2002).
One candidate for explaining the revisits to stimuli is visuo-spatial working memory 
deficits. Theories on the role of working memory in visual search tasks have been 
controversial (Horowitz & Wolfe, 1998), however by the use of statistical models and 
dual-task paradigms a role of spatial working memory has been demonstrated (Gilchrist 
& Harvey, 2000; Woodman & Luck, 2004). As spatial working memory appears to 
have a role in visual search completion it remains a possibility that this cognitive 
domain is impaired in cannabis use which led to the deficits discovered in the current 
sample of cannabis users. This was also the interpretation made by Huestegge et al 
(2002) after their comparable finding. Related to this concept of memory deficits, is the 
concept of accuracy checking in which cannabis users may have a reduced level of 
certainty about areas they have previously checked and are re-checking the search areas. 
This explanation is partially supported by the lower, albeit not significantly different, 
levels of omission errors in the cannabis using group.
An alternate explanation for the revisits is fixation instability. In fixation stability tasks 
a participant is required to fixate on a single stationary stimuli without moving their 
gaze. Previous studies have identified that certain populations have difficulty 
maintaining stable gaze such as those with schizophrenia (Barton, Pandita, Thakkar, 
Goff & Manoach, 2008; Benson et al., 2012). Given the role of dopamine in top-down 
control of saccades and visual signals (Noudoost & Moore, 2011) and altered 
dopaminergic function in cannabis users and individuals with schizophrenia 
(Bloomfield et al., 2014), it could be that these two groups share an eye-movement 
symptom, specifically the inability to control a steady fixation without making small 
saccades from an initial fixation point. This could be easily tested by the use of a 
stability fixation test and a comparison of cannabis users and controls.
The quartile analysis suggests that the cannabis-related slower non-target trial reaction 
times and slower overall task performance are largely driven by the first half of the task, 
although the slowest target trial reaction times occurred at the end of the task. Slower 
reaction times at the start could suggest that cannabis users took longer to learn how to 
efficiently search the stimulus array (Najemnik & Geisler, 2005). Given the evidence of 
a slower first half performance on the SST as well as this VST, the association with
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cannabis appears to be robust. These findings would be compatible the accuracy 
checking explanation of revisits but not the working memory or fixation instability 
explanation. While it may it may be possible to alter a strategy by reducing the time 
spent accuracy checking, it is less likely that participants could increase their fixation 
stability or reduce their working memory deficits. It is possible however, that the 
quartile data and the revisit data do not represent the same underlying performance 
deficit, therefore a fixation instability or working memory deficit may still be viable.
The slower reaction times at the end of the task suggest an effect of sustained attention 
(Kim et al., 2006) however as this is a solitary finding over both tasks, it could represent 
a type I error. If sustained attention was impaired in cannabis users then it would be 
expected to see slower reaction times on the last quartile for target and non-target 
reaction times across both tasks, an effect which was not found.
4.4.2.2. The Tobii Switching Search Task (SST)
There were 11 dependent variables derived from the SST divided between five task 
variables and six eye-tracking metrics. The cannabis users took significantly longer than 
the controls to complete the SST and had a significantly slower reaction time for the 
target trials, but not the non-target trials. Similar to the VST, the cannabis users 
displayed marginally, albeit not significantly, fewer omission errors suggesting a more 
cautious strategy. The cannabis users also had significantly more revisits to the 
distractor stimuli than the control group. The age of onset only showed one significant 
effect -  early onset users made more revisits to distractors than controls while there was 
no difference between late onset users and controls. This result initially supported the 
age of onset hypothesis however after controlling for the effects of anxiety the effect 
was no longer significant -  albeit still suggested a trend (pc.10). There was also a trend 
for the age of onset effect on the revisits to targets variable.
The 12 confounding variables were also tested for ANCOVA assumptions and 
implemented where possible. The effects of alcohol use could not be parcelled out of 
the number of unique fixations on non-target trials however there were no between 
group differences here so this had little impact on the overall findings. In contrast, 
anxiety’s effects on the number of distractor stimuli revisits could not be controlled in 
the two group analysis. It is possible that anxiety mediated performance on this variable.
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Anxiety was also related to performance on SST non-target reaction times and could not 
be controlled for while depression and alcohol use could not be controlled for on the 
SST omission errors variable however as there were no between group differences here 
this is likely to have little impact on the overall findings.
Results of the analysis for the SST did not highlight an effect of cannabis on fixation 
duration times, a finding replicated in the previous VST task and the task by Huestegge 
et al (2002). As with the VST, the increased number of revisits by cannabis users could 
be explained by working memory deficits, increased accuracy checking or fixation 
stability deficits.
As the quartile analysis partially replicated the findings from the VST -  slower first half 
performance -  it is likely that there was a change in strategy or a learning effect. While 
this finding may be unrelated to the revisits, it would be compatible with increased 
levels of accuracy checking by the cannabis users, similar to the VST.
The purpose of introducing a switching component was to investigate whether the 
contribution of set switching processes were also impaired. To determine this all of the 
dependent variables which demonstrated a clear switch cost identified in Table 4.12 
were examined. Both the VST and SST total times were elevated in cannabis users and 
thus impaired set switching cannot be determined. The reaction times for non-target 
trials displayed a clear switch cost however counter to the predicted direction this 
variable was not impaired in cannabis users on the SST, but was on the VST. Fixation 
duration on targets also displayed a clear switch cost however this variable did not 
uncover any cannabis related deficits on the VST or SST. Finally, the revisits on 
distractors displayed a clear switch cost and this was impaired in cannabis users for the 
SST but not the VST. This mixed pattern of results suggests that the additional 
switching requirement of the SST did not lead to an increased level of deficits in 
cannabis users. Given the clear impairments on tasks the TMT, a task which recruits set 
switching processes in a visual search paradigm (Chapter Three; Medina et al., 2007) it 
was expected to see impairments on this task. It is possible that the difference in 
switching type is responsible as the current task -  the SST -  utilised a continual switch 
between two symbols while the TMT involves sequential changing the target symbol, 
increasing demands on working and long term memory. Alternatively it could be that
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previously discovered deficits on the TMT are actually due to the visual search 
requirements of the task as demonstrated in this study.
4.4.3. Putative Confound Data
The two groups (cannabis vs. controls) and the three groups (EoC vs. LoC vs. controls) 
were matched for a large number of potential confounding variables including FSIQ, 
individual IQ subtests, depression, compulsions, obsessions, motivation/apathy, sex, 
age, alcohol use, years of education, and educational achievement. In contrast, there 
were differences between cannabis users and controls in levels of anxiety, tobacco use, 
other drug use, and cannabis use variables. The levels of other drug use were negligible 
and therefore unlikely to influence cognition. Levels of tobacco use were not negligible 
however this variable was unrelated to any of the cognitive variable in which cannabis 
users had impaired performance and thus tobacco use is an unlikely factor to explain 
performance levels. It appears that the main predictors of performance deficits are the 
age of onset of cannabis use, membership within the cannabis using group, and levels of 
anxiety which were significantly higher in the cannabis group, although not in the EoC 
or LoC groups. While the age of onset of cannabis use and anxiety could only explain 
deficits on two of the variables, cannabis use in general can explain deficits on the 
majority of variables.
While anxiety has been linked with impaired attentional performance (Eysenck et al.,
2007) there is also evidence suggesting that inducing anxiety via threat of shocks can
improve certain aspects of attentional processes (Robinson, Letkiewics, Overstreet,
Ernst & Grillon, 2011). Examination of scatter-plots in the current study suggested a S -
shaped relationship between task performance and anxiety on the three variables that
anxiety was linked with. The number of revisits to distractor stimuli on the VST and
SST, and the reaction time on non-target trials during the SST were all linked with
anxiety and lower scores indicated better performance on these variables. This suggests
that as self-reported anxiety levels increased, performance improved up to a degree.
After a critical point was reached, any further increases in self-reported anxiety led to
decreases in task performance (see Appendix A.4.11). The role of anxiety mediating
some of these deficits is supported by the average levels of anxiety by each group. The
average level of anxiety in the control group (approximately 5.68) is nearer the bottom
point of the V-curve, whereas the average level of anxiety by the cannabis users
222
(approximately 8.10) is further up the slope of the V-curve, indicating diminished 
performance. While the relationship between cannabis use and anxiety is not clear 
within the current study, there is clear evidence for anxiety mediating at least three of 
the cannabis-related deficits in task performance.
4.4.4. Limitations
The current study used two tasks -  the VST and SST - have not been previously tested 
for validity or reliability. Therefore interpreting the results were more problematic than 
standardised tests with norm referenced data. To negotiate this problem the current 
study used two methods to determine validity. Firstly the tasks were developed as 
computerised analogues to a standardised and widely used neuropsychology task, the D- 
KEFS Trial Making Test (TMT). The VST maps closely on the task set out of the TMT 
Visual Scanning test while the SST has slightly more differences to its paper based 
analogue, the TMT Number-Letter Switching test. An additional measure of validity 
was accomplished by determining if a switch cost was present, a frequently used 
measure of determining the role of set switching processes in tasks (Monsell, 2003).
This test demonstrated the role of set switching in a number of the SST dependent 
variables. In order to check internal reliability, Cronbach’s alpha was calculated for the 
VST and SST and the results suggest that it is highly reliable. While these approaches 
helped determine the validity and reliability of the tasks, the lack of norm-referenced 
data means that the performances by the two groups cannot be examined relative to the 
general population.
4.4.5. Future Research
The current data showed that on tasks requiring visual search processes there is an 
increased level of revisiting to previously searched areas, a slower reaction time, and a 
slower overall performance by cannabis users. It is unclear what was mediating these 
deficits beyond the cannabis use and anxiety. If a further unknown confounding variable 
was mediating performance on these tasks then studies addressing this unknown 
confound are needed.
Given the role of visual search behaviours in everyday activities the implications of
visual deficits on such activities should be explored. Approximately 74% of adults in
Britain aged 17 or above hold a full driving licence and approximately 11% of adults
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aged 16 or above have been involved in a motor vehicle accident within the past three 
years (Department for Travel, 2013) which suggests that if cannabis could affect such a 
prevalent and dangerous activity, then evidence of this risk factor needs to be identified. 
The role of visual search has previously been implicated in driving competencies 
(Underwood et ah, 2002) and as cannabis use has been associated with impairments of 
visual search behaviours demonstrated in this study and in previous work (see Chapter 
Three; Ehrenriech et al., 1999; Hanson et ah, 2010; Huestegge et al., 2002) a 
mechanism by which chronic cannabis use can affect driving abilities has been 
discovered. Although the role of cannabis and driving performance has received much 
attention this has primarily centred on acute cannabis use (Hartman & Huestis, 2013). 
As there is now clear evidence of visual search deficiencies in abstinent cannabis users, 
this has implications for hazard perception and could be tested by using the current 
Driver and Vehicle Licensing Agency (DVLA) hazard perception test. Incorporating 
eye-tracking into such a study would allow in more in-depth analysis of how of 
individuals locate and process hazardous visual information in a driving context.
4.4.6. Summary
The main finding of this study is that cannabis use is related to slower overall visual 
search performance, slower reaction times, and that the performance decay is partially 
explained by an increased number of revisits to stimuli. Possible explanations for this 
occurrence are impaired spatial working memory in which cannabis users return to 
previously searched areas at a greater rate than controls, fixation instability in which 
cannabis users have trouble maintaining a fixation without initiating saccades or 
accuracy checking, in which cannabis users are adopt a more cautious visual search 
strategy. As the pattern of deficits in the current study could not be attributable to set 
switching the current study suggests that tasks which are thought to measure this 
process, i.e. the TMT, may in fact just be detecting visual search deficits in cannabis 
users.
This study also examined the age of onset of cannabis use and how this relates to 
cognitive performance. Of all the analyses run there was negligible evidence for an age 
of onset effect, with only two variables appearing to be related to the age of onset. 
Although this variable did appear in the predicted direction, namely that early onset
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cannabis users present with worse performance than late onset cannabis users, relative 
to controls, these isolated findings could just be type I errors.
While interpretations of cannabis-related impaired performance on cognitive tasks have 
included neurotoxicity (e.g. Meier et al., 2012), altered functional activity in the brain 
(e.g. Kanayama et al., 2004), or withdrawal effects (e.g. Schreiner & Dunn, 2012) it is 
not clear what underlying mechanism is linking cannabis use to impaired performance 
within this study. Although the lack of correlation between the time since last cannabis 
use and cognitive performance suggests the withdrawal explanation is unlikely, this 
does not provide evidence for permanent damage. The mechanism may be unclear but 
the current study provides further evidence of a link between cognitive deficits and non­
acute cannabis use.
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Chapter Five. What Mediates the Relationship between Executive Function and 
the Age of Onset of Cannabis use? Testing a New Cannabis Questionnaire
5.1. Introduction
The current research programme developed a new cannabis questionnaire, hereinafter 
called the Cannabis Use and Lifestyles Form (CannaForm). This chapter will discuss 
the development of the questionnaire and then present data on the predictors of cannabis 
use and the age of onset of cannabis use as a method of testing the CannaForm’s utility.
The proposition that cannabis use has a causal role in cognitive impairments has 
received changing levels of support since the research began. In response to a key 
publication by Solowij et al (2002), Pope (2002; p.l 173) stated that "The consensus 
across studies is strong enough to discount the likelihood that this finding can be 
explained by any combination of confounders", referring to the long term effects of 
cannabis use. Despite this claim a publication in the subsequent year reported that 
cognitive deficits in cannabis users disappeared after controlling for verbal IQ (Pope et 
al., 2003). Contrary to Pope's (2002) statement, it is clear that confounding variables 
play a large role in quasi-experimental studies (see Table 5.1). In order to understand 
the true long term effects of cannabis these variables need to be considered. The current 
study aims to test the utility of the CannaForm by testing whether lifestyle variables 
previously found to be related to executive function are related to cannabis use and 
additionally, if they are related to the age of onset of cannabis use. The relationship 
between cannabis use/lifestyle variables and executive function will not be discussed 
here, however only variables with this association will be investigated (see Eysenck et 
al., 2007; Grimley & Banner, 2008; Jacobsen et al., 2005; Romine & Reynolds., 2005; 
Yonker et al., 2005).
226
A 
tab
le 
di
sp
la
yi
ng
 
how
 
di
ffe
re
nt
 s
tu
di
es
 
ha
ve
 
ad
dr
es
se
d 
co
nf
ou
nd
in
g 
va
ria
bl
es
 
wh
en
 
ex
am
in
in
g 
co
gn
iti
on
 
in 
ca
nn
ab
is 
us
er
s
c / 3  <d<u o 
C D  9  
C  < D  
<U 00
, c d  c c
f c  <d
9o>u0)
I*
u©-=
9
<
of a,
Q B
ou
<d  a >
■i *
H
S of * 9  9  a>5  *- O Q P
oJS a>
©  C/3
s  P
O a>
°  2 W  - D
3  ^
a
so
9-a
P
01
<
ua>
9<y
O
p p p p p p p p
Q CO Q
Q
a
a
X
W
a 00
X  X  X  X  X  X  Xpq pq pq W W W PQ
s Q„ o s
XW
O
x
W
0 0  C O  0 0  0 0
00
a
00
00
a Q Q Q <z>
Q
a
00 00
a
00
a a a  a  a
00 00 00 oo
S  2  2  o  2  o  o
a  a  a  a
V O  —
Ov O  
Ov O— (N
(NOo
22
13
' x To r- ,-v ' ^  o o
(N  CO M  O— ^ o w CNOO  O  o Q
13 03 G 3 cd a
<d  <d
< D  < D  a . Oho o o
O h  O h  0 0
<u cu
< d  —  
a ,  —
o o 
0h PQ
3
Id
£o< D  
<0
-G
03
4 — 1a
03
C
o
Oh
-a
—  <d
£  s
a  p  p  ' O P
k — I X
00 ' 73, ^  w ■
U Q
X  , X  X  X  Xqq pq qq qq qq
x
pq
00
00oo
C N
o 3
X
CD
pq Q oo oo
X
pq
X
qq
a
a
00
a
a
O x x x
- pq w  pqx
pq
00
o  o  o  o  o
00 ^Od Q - dG oo oo 0C O
o
C N
O
C N
o 3  _ _ _  <
4 — i  0 3
< D  ^
<d  i )i/3
< D
C
£  a
C N
O
C N
0 3
4—>
<d
4 -1
C
o 3
U ,
a
o
C N
13
4—1CD
I n<D
D * !
C D
<d
CO
O
C N
03
4-H
( D
C / 3
< D
£
03
j C
H
O O. r ►—IT3 • - 
< D  < D  -C .3
C/3
C D  c/3  
3  < D
o 2<s- CT 0£) ..
a
a
CD
x * 2
< o  o 3
II £
x 5  pq qc
.£
< D  
>"O ‘-9
— .&
'  P  «P °is coO "TD
^  B
— 1 Uh3 O O CD •93 ^
C/3  ^
M
4 ->
C/3 M H
II .2 
00 p
CD
T D
T D
CD
T D
> £ O 2J - C  O  
C D  O
^H O
03
C D
£
( D
4—> 
4—*
03
OO "O
CD rv
4 -<  <l >
O  » - <  
C  O  
-a  c
U  - r t4_> V J9
O  o 3  
1 / 3  
C D  
G
0 2 c  ob 
II c
1 ( D  
.  < D
<  - O
127
Q
uo
tie
nt
;*
 
the
 
stu
di
es
 d
iff
er
ed
 
qu
ite
 
wi
de
ly
 
on 
th
eir
 e
xc
lu
sio
n 
cr
ite
ria
 
for
 o
th
er
 d
rug
 
us
e. 
aa
ny
 
ill
eg
al
 d
rug
 
in
clu
siv
e 
of 
ca
nn
ab
is 
ho
w
ev
er
 w
id
el
y 
di
ffe
re
nt
 c
rit
er
ia 
wa
s 
us
ed
 
ov
er 
the
se
 
stu
di
es
. 
Th
e 
m
ajo
rit
y 
of 
the
 
sta
tis
tic
al
 s
tu
di
es
 c
on
tro
lli
ng
 
for
 I
Q 
vi
ol
ate
d 
as
su
m
pt
io
ns
 f
or 
co
va
ria
te
 
te
st
s.
b y
ea
rs 
of
ed
uc
at
io
n 
did
 
no
t 
di
ffe
r 
bu
t 
sc
ho
ol
 a
ch
ie
ve
m
en
t 
did
 
di
ff
er
;c 
an
xie
ty
 
did
 
no
t 
di
ffe
r 
bu
t 
de
pr
es
sio
n 
did
 
di
ffe
r;
 d 
no 
su
bj
ec
ts 
m
et 
cr
ite
ria
 
for
 n
ic
ot
in
e 
de
pe
nd
en
ce
;e 
co
nt
ro
lli
ng
 
for
 s
ex
;f 
ca
nn
ab
is 
us
er
s 
we
re
 
ex
clu
de
d 
if 
the
y 
we
re
 
da
ily
 
to
ba
cc
o 
sm
ok
er
s 
ye
t 
the
 
gr
ou
p 
did
 
sti
ll 
use
 
to
ba
cc
o.
9ZZ
5.1.2. Lifestyle Variables
Section 1.5 of the current thesis identified a list of 12 putative confounds as a way of 
considering factors which need to be controlled when conducting quasi-experimental 
research on cannabis and cognition. This list included IQ, education, sex, mental health, 
tobacco use, brain trauma, learning disabilities, familiarity with the English language, 
alcohol use, drug use and recent alcohol/drug use. When conducting quasi-experimental 
or correlational research the number of potential confounding variables is practically 
limitless, therefore time, costs and other pragmatic considerations dictate that only the 
most salient putative confounds should be considered. Typically, putative confounds are 
associated with cannabis use in general, however this also examines if established 
confounds differ according to the age at which an individual initiates cannabis use. In 
order to assess the prevalence of confound measures, Table 5.1 shows the frequency of 
confounds considered by studies administering neuropsychological assessments of 
executive function. The methods for dealing with confounds varied widely however 
they approximately fitted into the categories of: (1) creating exclusion criteria to avoid 
the confound having an effect, (2) ’matching' the groups to distribute the effects of the 
confounding variable evenly across groups and (3) statistically accounting for the 
variable by methods such as an analysis of covariance. The different methods employed 
within each of these three categories differ in validity, and therefore it is essential that 
this is considered when comparing different studies based on the codes presented in 
Table 5.1. On occasions the groups were not matched for a particular variable (e.g. 
Education; Pope et al., 2001). In such circumstances the difference between groups is 
reported and thus the results can be interpreted in light of this confound. The following 
confounds were picked based on associations with cannabis and executive function, 
however it is the association with cannabis variables which will be discussed as that is 
the focus of this study.
5.1.2.1. Sex as a Confounding Variable
Assessing sex differences in cannabis use has produced a range of different outcomes.
Without controlling for any other variables there are no noticeable differences in trying
cannabis at least once between the two sexes (Home Office, 2008; Tu et al., 2008).
Furthermore, a logistic regression analysis which controlled for numerous other
variables found that males were 1.17 times more likely to have used cannabis at least
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once however this odds ratio was not statistically significant (McCrystal & Percy, 
2011).
Despite no sex differences being apparent for at least one use of cannabis, males are 
reportedly 2.3 times as likely to have used cannabis in the past year as females (Home 
Office, 2008) and over 1.8 times as likely to use cannabis heavily (Tu et al., 2008). Tu 
et al (2008) also found that males were more likely than females to start using cannabis 
at a younger age.
These heterogeneous cannabis use patterns across the sexes suggest that if cannabis 
does have a causal impact on cognitive integrity then it is likely that such effects will 
also be varied across the sexes. In addition to varied cannabis use behaviours, there is 
also strong evidence that male and female brain maturation trajectories are not 
synchronised. Males appear to be one to two years behind, with female frontal grey 
matter peak volumes occurring at around age 11 and males around age 12.5 (Giedd et 
al., 1999). Despite showing marginally different ages at which frontal volumes reach 
their peak (9.5 vs. 10.5), the finding of males trailing females by one to two years was 
also found by Lenroot et al (2007). There now appears to be three lines of evidence 
suggesting that males are more at risk to the effects of cannabis 1) of those who do use 
cannabis, males are more likely to use it heavily, 2) males are more likely to use 
cannabis early in life and 3) neuromaturational processes are likely to be at an earlier 
stage in males than females at the same point in time (e.g. 12 years old). These last two 
points are built on the premise that cannabis use at earlier stages in development is 
potentially more damaging to the structure and function of the brain, a position argued 
for in section 1.3.
5.7.2.2. Education as a Confounding Variable
The majority of research investigating the link between educational variables and 
cannabis use has been done outside of the UK. In Australia and New Zealand, cannabis 
use has been found to be related to school attendance and attitudes towards school 
(Jones & Heaven, 1998), while the age of onset of cannabis use has been related to high 
school completion, university enrolment and university completion (Horwood et al., 
2010). In the United States of America (USA) cannabis use has been associated with 
school drop-out rates (Mensch & Kandel, 1988; Lynskey et al., 2003a) and educational
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achievement (Novins & Mitchell, 1998). The UK has not been part of the main body of 
research within this field and as schooling systems and cannabis strains differ widely 
across countries there are problems extrapolating findings from one country to another. 
One UK based study investigating schizophrenic symptoms and cannabis in the general 
population found that individuals with undergraduate degrees or postgraduate degrees 
were less likely to have used cannabis than those with GCSEs or no educational 
qualifications (Freeman et al., 2013). A Northern Ireland based study found a trend for 
GCSE grades predicting whether or not an individual had previously used cannabis and 
thus partially supporting Freeman et aFs (2013) results (McCrystal & Percy, 2011).
All of these studies have discovered an association between cannabis use and a
particular educational variable yet establishing causation is problematic. The use of
epidemiological approaches has helped establish timelines (e.g. Lynskey et al., 2003a)
and suggests that early onset cannabis tends to precede school drop outs. Several
explanations have been proposed for how cannabis use could lead to poorer educational
outcomes including amotivation, cognitive deficits, and an early transition into ‘adult
roles’ (Lynskey & Hall, 2000). The evidence for cannabis induced amotivation is mixed
(Musty & Kaback, 1995; Barnwell, Earleywine & Wilcox, 2006) and therefore seems
the least likely route to explain the poorer educational outcomes. Lynskey and Hall
(2000) suggested that regular cannabis use could lead to the deterioration of scholastic
functioning via the acute effects of cannabis however they highlighted that there was
limited evidence of longer lasting cognitive impairments. Since this study there have
been numerous advances in this area and several studies highlight long lasting
impairments (Pope et al., 2001, 2002, 2003; Medina et al., 2007; Hanson et al., 2010).
These deficits appear in domains such as memory, attention, and executive function,
key predictors of scholastic achievement (Riding et al., 2003; Grimley & Banner, 2008).
The third explanation is that cannabis use leads to the early transition into ‘adult roles’
such as leaving school early. It also includes the social setting in which cannabis takes
place which includes surrounding themselves with ‘delinquent peers’ (Fergusson &
Horwood, 1998). The use of twin studies has helped explain some of the association
between cannabis use and education. Verweij, Huizink, Agrawal, Martin and Lynskey
(2013) recruited over 3000 mono- and di-zygotic twins to explore the influence of
environment and genes on cannabis and education. The authors found that the link
between cannabis use and school leaving was primarily due to genetic and shared-
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environmental factors, leaving little explanatory power for cognitive impairments, non­
shared environment and amotivation. In contrast, Horwood et al (2010) argue that based 
on a dose-related effect for the age of onset and frequency of use, in addition to 
controlling for numerous confounding variables, the best explanation is a causal effect 
of cannabis use on poorer educational outcomes. The authors concede that they could 
not control for genetic influences, and given the results by Verweij et al (2013) it 
appears possible that genetics are the best candidate for explaining the results.
It is also likely that the extent to which these variables are involved will depend upon 
the outcome being assessed, whether it is early school leaving (e.g. Verweij et al., 2013) 
or educational achievement (e.g. McCrystal & Percy, 2011). It is also possible that there 
is a dual causation effect implying that not only does cannabis lead to poorer 
educational outcomes, but early school leaving/lower grades leads to cannabis use 
(Lynskey & Hall, 2000).
5.1.2.3. Drugs as Confounding Variables
An early exploration into the association between cannabis and other legal and illegal
recreational drugs found that the use of other drugs was highly related to cannabis and
that the onset of use progressed from 'softer' to 'harder' drugs (Kandel, 1975). These
associations remain after controlling for other variables, for example Patton, Coffey,
Carlin, Sawyer and Lynskey (2005) found that in Australia, the use of cannabis was
highly related to the use of tobacco even after adjusting for alcohol use, physical
activity, mental health, sex, and parental smoking habits. The authors found similar
adjusted relationships between alcohol use and cannabis use, and to a lesser extent with
alcohol use and tobacco use. The widely popularised explanation for the progression of
drug use is known as the gateway hypothesis. This causal explanation is that the use of
'softer' drugs can directly lead to the use of 'harder' drugs through either
pharmacological or psychological means (Kandel et al., 2006). Despite widespread
public endorsement for the gateway hypothesis, such as commercials containing
testimonials of cannabis related gateway effects (Yzer, Cappella, Fishbein, Hornik &
Ahern, 2003), the evidence in support of the gateway hypothesis is controversial and
varies from drug-to-drug. There is still some dispute regarding which drug is the
gateway drug with tobacco (Prince vaan Leeuwen et al., 2014), alcohol (Kirby & Barry,
2012) and cannabis (Secades-Villa, Garcia-Rodriguez, Jin, Wang & Blanco, 2015)
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being prime candidates. As these studies vary in country of origin there remains the 
possibility that cultural differences result in different progression patterns through the 
drug spectrum. Such cultural differences include attitudes towards drugs and the 
availability and cost of specific drugs (Agrawal et al., 2012). Furthermore, the extent to 
which genes and upbringing affect the association depends on the individual drug. It 
appears that tobacco use and cannabis use could be highly influenced by genes (Maes et 
al., 2004; Verweij et al., 2010) while the association between cannabis use and other 
illegal drugs is only partially due to familial influences (Lynskey et al., 2003b). While a 
causal explanation is possible, the access hypothesis seems another viable alternative. 
This explanation for the high comorbidity of drug use behaviours suggests that drug 
users, by the act of purchasing an illegal drug (e.g. cannabis), have access to a wide 
range of other illegal drugs from the same source (Macoon, 2006). This would only be 
applicable to countries in which cannabis is illegal and would not be an explanatory 
factor for the link between tobacco/alcohol and illegal drugs. Although there is some 
evidence that the use of certain drugs increases the likelihood of abusing other drugs 
(e.g. Cadoni, Pisanu, Solinas, Acquas & Di Chiara, 2001) there is a lack of causal 
evidence suggesting a link between drug (A) use and drug (B) use.
5.1.2.4. Mental Health as a Confounding Variable
Cannabis use has been associated with a large number of different mental health 
diagnoses and it is the purpose of this section to identify the associations between these 
factors. Correlational and regression analyses have shown that increased use of cannabis 
use is associated with a number of mental health categories, including: depression - as 
determined by DSM-IV criteria (Rey, Sawyer, Raphael, Patton & Lynskey, 2002), 
anxiety - as determined by DMS-IV criteria (Patton et al., 2002), obsessive compulsive 
disorders - as determined by diagnostic interview (Crum & Anthony, 1993), 
schizophrenia - as determined by the International Classification of Diseases 8th revision 
(ICD-8) criteria, administered by a psychiatrist (Zammit, Allebeck, Andreasson, 
Lundberg & Lewis, 2002) and eating disorders - as determined by the Diagnostic 
Survey for Eating Disorders - Revised (DSED-R; Weiderman & Pryor, 1996). To assess 
the causal nature surrounding cannabis use and this large number of various mental 
health diagnoses is beyond the scope of this chapter, yet the primary goal was to 
highlight the association between these variables.
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In addition to the mental health of the individual, the mental health of family members 
could be a risk factor for drug use. Research has shown a link between parental mental 
health and the quality of family-child relationships via meta-analyses for fathers 
(Wilson & Durbin, 2010) and mothers (Lovejoy, Graczyk, O'Hare & Neuman, 2000). 
Butters (2002) found that poor family relations, characterised by less parental 
involvement and parental monitoring, was associated with an increase in cannabis use 
and problem cannabis use after controlling for confounds including socio-economic 
status. Furthermore, a large number of mental health conditions have a genetic 
component (Levinson, 2006; Lichentstein et al., 2009; Martin, Ressler, Binder & 
Nemeroff, 2009) and therefore young individuals with diagnosed parents may be 
displaying undiagnosed symptoms which could lead to self-medication with certain 
drugs (e.g. cannabis; Swift, Gates & Dillon, 2005). These two mechanisms could 
suggest that individuals with parents who have mental health conditions could be at an 
increased risk for cannabis use.
5.1.3. Aims and Hypotheses
The present study had three major aims. (1) To develop a new cannabis questionnaire; 
(2) to test whether a relationship exists between potential confounding variables and 
cannabis use in order to replicate previous findings; and (3) to determine whether a 
relationship exists between confounding variables and the age of onset of cannabis use. 
This will add to the literature by assessing if some confounding variables are more 
strongly associated with early onset users than late onset users. Logistic regression was 
used to investigate these relationships. It is hypothesised that all variables put into the 
analysis will be related to cannabis use and that these variables will be associated with 
early onset cannabis use greater than late onset cannabis use.
5.2. Method
5.2.1. Participants
The participants for the current survey were 329 individuals recruited by opportunity
sampling methods. The sample included 256 females (78.0%) and 72 males (22.0%),
with one participant not reporting their sex. The majority of the sample was in their late
teens and early twenties. The median age was 19.00 (interquartile range=2.00;
range= 18-50). The majority of the participants were recruited from university campus
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grounds and student accommodations. Individuals were approached by the experimenter 
and asked to complete a lifestyle questionnaire. Although a large number of non-student 
participants were recruited as part of the other stages of this research, only the 
participants recruited opportunistically were included in this analysis which left a 
sample of 100% students.
5.2.2. Design
The current study takes the form of a cross-sectional survey based design. For the first 
logistic regression analysis, the dichotomous criterion variable was whether or not an 
individual has used cannabis (coded as ‘T and ‘O’, respectively). For the second logistic 
regression, the dichotomous criterion variable was whether or not an individual initiated 
cannabis use before the age of 16 (coded as ‘I s and ‘O’, respectively). The predictor 
variables across both regression models were the years of education (continuous), 
educational achievement (continuous; total number of GCSEs grades A*-C), sex 
(dichotomous - male or female), a history of mental health or learning disorders 
(dichotomous - yes or no), estimated total lifetime tobacco use (continuous), age 
(continuous), other drug use (continuous), and number of days per week that alcohol is 
consumed (continuous).
5.2.3. CannaForm Development
The first stage in development was determining what information was required from the 
questionnaire (Rust & Golombok, 1989). Although the primary purpose of this 
questionnaire was to identify inclusion and exclusion criteria for the quasi-experimental 
studies discussed in Chapters Three and Four the CannaForm also was designed to 
answer broader questions relating to many aspects of cannabis research. As a starting 
point, the cannabis questionnaire by Solowij (1998) was examined to determine what 
sort of questions could be asked. Elaborating on this template, the primary researcher 
and his three supervisors determined which questions were kept in order to collect 
information on the following topics: age, sex, education, mental health, neurological 
health, alcohol use, tobacco use and illegal drug use. Within the bracket of illegal drug 
use, cannabis use was considered the primary research interest and therefore the sub 
topics of cannabis use were also considered: age of onset, frequency of use, length of
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use, lifetime use, recent use, methods of administration, strains of cannabis used, and 
desired intoxication levels.
Following the identification of the topics of interest, the wording of questions, the 
response format and the ordering of questions was then decided (Rust & Golombok, 
1989). Once the final draft of the first version was created, the CannaForm was piloted 
on two self-reported “heavy cannabis users” recruited opportunistically. Verbal 
feedback was given to the primary researcher and necessary alterations were made. The 
new CannaForm vl .0 (see Appendix A.2.1.1) was then used for the first study described 
in Chapters Three and Five in which 378 participants were recruited. Following 
inspection of these 378 questionnaires, certain questions were identified which needed 
altering based on responses which indicated a poor wording of the associated question, 
several questions were added based on additional information which was required, and 
redundant questions which were not needed were removed. These changes were made 
and the creation of a markers guide for the CannaForm (see Appendix A.2.1.5).
At this stage two further self-reported “heavy cannabis users” were purposively 
recruited through a local cannabis activist website to pilot the most recent version of the 
questionnaire. Minor alterations were made to the CannaForm based on suggestions 
from these cannabis users which resulted in the CannaForm v2.0 (see Appendix 
A.2.1.2). This version of the CannaForm was then used during the data collection for 
the eye-tracking study.
Throughout the whole process a number of additional changes were considered yet not 
implemented due to the ongoing data collection of a large sample reported in this 
chapter. The predetermined amalgamation of the data from the two large samples that 
completed the CannaForm v 1.0 and v2.0 necessitated that certain questions could not be 
altered throughout the process. This ensured that a question (e.g. total drug use) 
analysed in the current chapter - in which the samples were combined - was not 
answered in two different ways due to an altered question. After the data collection was 
complete all other changes were made, leading to the most up-to-date version of the 
CannaForm which has yet to be trialled (see Appendix A.2.1.3).
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5.2.4. Procedure
Following the recruitment stage, participants were administered the CannaForm in one 
of three ways including self-report by the participants, face-to-face interview with the 
experimenter reading out the questions and over the phone interviews, with the 
experimenter reading out the questions. The interview format enabled consistent 
responses as the experimenter could collect the necessary information while self- 
reporting frequently led to questions not being completed to sufficient levels of detail. 
The method of administration was based on the particular recruitment strategy. Self- 
report and face to face interviews were selected when the individuals were approached 
in person by the experimenter. If the participant could complete the questionnaire at that 
point in time, an interview method was employed. If the participant had no free time or 
a larger amount of participants were approached at once, then the self-report method 
was employed and the completed questionnaires were handed directly back to the 
researcher at an agreed time. The telephone interviews only took place when an 
individual responded to the notification put onto the local cannabis activist group’s 
Facebook group or associated websites. This mixture of methods could lead to different 
responses and inconsistent reporting as previously shown for self-report vs. interview 
methods (Tourangeau & Yan, 2007). As the CananForm has yet to be subjected to inter­
administration reliability testing it is not clear how responses would differ, however 
other questionnaires on illicit drug use typically find that individuals report marginally 
higher levels of use on self-report questionnaires as opposed to face-to-face interviews 
(Tourangeau & Yan, 2007). These limitations need to be considered when interpreting 
the results.
Each participants was then debriefed either with a paper or electronic copy of the 
debrief sheet, however selected participants were also contacted, where suitable, to take 
part in follow up experiments described in Chapter Three and Four.
5.2.5. Data Analysis
5.2.5.1. Logistic Regression
The logistic regression model was built primarily based on the Hosmer and Lemeshow 
(2000) method with additional suggestions from Field (2013) and Menard (2002). Once 
a target variable was determined (cannabis use), any predictor variables which have
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scientific interest (i.e. derived from the hypotheses) and impose a direct effect or have a 
confounding effect should be considered. Any other variables were disregarded due to 
overfitting and poorer generalizability. Once potential predictors had been identified a 
range of assumptions were explored. Firstly contingency tables were examined to check 
if there was incomplete information among the dichotomous predictor variables with the 
outcome variable (Field, 2013). If this violation occurred the categories were either 
collapsed if the interpretation was not adversely affected by this or another variable to 
assess the same underlying construct was found. Univariate logistic regression analyses 
were then run to test whether any of potential predictors were associated with the 
outcome variable (/?<.25; Hosmer & Lemeshow, 2000). The model was then built in a 
hierarchical fashion by starting with the strongest predictor and adding each subsequent 
potential predictor to determine if it added a significant proportion of explained variance 
to the model. Suggestions on model building typically encourage parsimony by not 
including non-significant predictors (Hosmer & Lemeshow, 2000; Field, 2013) and 
therefore any non-significant variables in the adjusted model were left out of the final 
model however the univariate relationship can be seen in the unadjusted model. 
Although there were multiple methods of assessing the same variable (i.e. days per 
week of alcohol use and units per week of alcohol use), only one was selected in such 
circumstances to reduce the risk of multicollinearity and overfitting, and to aim for 
parsimony. Therefore the selection of which variable was chosen, was made based on 
proportion of variance explained and theoretical importance. Once the final model was 
chosen residuals (Cook’s Distance, DF beta to the Constant and the Standardised 
Residuals) were examined based on suggestions by Field (2013) and Menard (2002). 
Any outliers identified by examining the residuals were removed, and the model was re­
run to determine if an improvement in pseudo-/?2 was noticeable. To check the 
Goodness of fit and the associated over-dispersion assumptions, the Hosmer and 
Lemeshow test was examined to determine if the observed data differed from the 
predicted data (Hosmer & Lemeshow, 2000). A non-significant chi-square from this test 
suggested a good fit of the data. Furthermore, dividing the chi-square figure by the 
association degrees of freedom provides an index to assess over-dispersion. A value 
near to 1.00 is considered normal (Menard, 2000) while a value approaching 2.00 could 
be problematic (Field, 2013). Finally, Variance Inflation Factor (VIF) and Tolerance
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statistics were observed to see if any violations of multicollinearity were present. 
Violations were apparent when VIF>10 and Tolerance <.01 (Meyers et al., 2013).
5.3. Results
5.3.1. Drug Use Data
Figure 5.1 shows the percentage of the current sample which have tried different drugs 
at least once in their lifetimes. These data should not be interpreted as being 
representative of the general population as the data sampling methods were 
opportunistic.. Figure 5.1 also shows the percentage of the sample which has used each 
drug excessively. The excessive drug use data was determined by UK guidelines on safe 
limits for alcohol: more than 14 weekly units for women and more than 21 units for 
men were considered excessive. The excessive criteria for the other drugs was largely 
arbitrary, the main distinction was to separate those who had just used a few times and 
those who had used it regularly. In this context the term excessive should not be taken 
literally as no clear guidelines have been created regarding what constitutes safe or 
excessive illegal drug use. Therefore, for tobacco and all illegal drugs excessive use was 
determined by more than 100 lifetime uses.
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Figure 5.2. Two graphs displaying the percentage of cannabis users within the current 
sample who started using cannabis at various stages and ages in life.
The majority of individuals started using cannabis at school (62.1%), college onset was 
less prevalent at 34.1%, followed by gap year at 2.3%, university at 0.8% and post­
education at 0.8% (see Figure 5.2). When considering the age of onset, it is clear that 
the majority starting using around age 16 (M= 16.02 years; SD=1.58; range= 12-21 
years).
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5.3.2. Predictors of Cannabis use - Logistic Regression Model
5.3.2.1. Building the model
As discussed in the data analysis section of the method, the current analysis used the 
Hosmer and Lemeshow (2000) method for constructing a logistic regression model. The 
criterion variable (Fir) was whether the individual had used cannabis at least once in 
their lifetime, or never at all. The potential predictors were sex, age, mental health 
(presence/absence; type), family’s mental health (presence/absence; type), 
developmental disorders (presence/absence; type), tobacco use (use/no use; quantity of 
use; dependence/no dependence), other drug use (use/no use; number of different 
drugs), alcohol use (days per week of drinking; units consumed per week), educational 
achievement (total number GSCEs; number of GCSEs grades A*-C), years in 
education, and nationality. The model building procedure led to the selection of seven 
predictor variables.
The final model included the criterion variable (H r), which was whether the individual 
had used cannabis at least once in their lifetime, or never at all. The explanatory 
variables which were considered for the model were (Xi) sex (male/female), (X 2) history 
of mental health problems (yes/no), (X 3) family history of mental health problems 
(yes/no), (X 4 ) years of education (continuous), (X 5) GCSE grades A*-C (continuous), 
(X6) history of tobacco use (yes/no) and (X 7) days of alcohol use per week (continuous).
5.3.2.2. Assumptions
There were 329 participants originally tested for the model, 48 were left out due to
missing data leaving 281. All potential predictors were associated with the outcome
variable in a univariate logistic regression model (p<.25). The hierarchical model
building procedure suggested that age, years of education and mental health were not
associated with the outcome variable. Cook’s distance, standardised residuals and DF
beta to the constant were checked and 6 cases were identified as outliers based on
criteria outlined by Field (2013). Following Hosmer and Lemeshow’s (2000)
guidelines, the cases were removed from the model and the analyses re-run. The
Negelkerke pseudo R2 was noticeably improved after the removal of these outliers and
therefore they were not re-entered into the model. As there were only five predictor
variables and now 275 cases in the final model, the assumption of overfitting was not
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violated (Meyers et al., 2013). Linearity of the logit was tested for all continuous 
variables and was not violated. Goodness of fit statistic was checked and this fell within 
the ideal range [x2(8)=9.36, p=.313] (Hosmer & Lemeshow, 2000). The dispersion value 
came to ^=1.17 and was near enough to 1.00 to suggest there were no problems 
(Menard, 2002; Field, 2013). Collinearity diagnostics were checked and tolerance levels 
were all larger than 0.1 and VIF levels were all smaller than 10, suggesting that 
collinearity assumptions were not violated (Meyers et al., 2013).
53.2.3. Running the Model
The finalised model was run in a forced entry manner. The logistic regression analysis 
showed that the combined predictor variables were significantly related to cannabis use 
|X(5)= 125.59, pc.001, Cox & Snell /?2=.367, Negelkerke /?2=.489]. Further examination 
of the variables in the equations (see Table 5.3) suggests that sex is a significant 
predictor of cannabis use with males being approximately 5.09 times as likely to use 
cannabis as females. Tobacco use is a larger predictor with individuals who have used 
tobacco being approximately 12.08 times as likely to use cannabis as those who have 
not used tobacco. Alcohol use is also a significant predictor of cannabis use with every 
additional day of alcohol use per week conferring a 1.95 times greater risk of trying 
cannabis. Educational achievement was negatively related to cannabis use, with every 
additional GCSE grade conferring a reduction in likelihood of trying cannabis with an 
odds ratio of 0.82. Individuals who reported having a family member with mental health 
problems were approximately 2.95 times as likely to use cannabis. All remaining 
variables report in Table 5.3 under the unadjusted odds ratio column were not 
significantly related to cannabis use after controlling for covariates and were therefore 
not included in the final model (Hosmer & Lemeshow, 2000, Field, 2013).
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Table 5.3.
Adjusted and unadjusted odds ratios fo r  cannabis use predictor variables.
Unadj. OR /7-value Adj. OR p  -value
Sex 3.65 (2.05, 6.50) <.001 5.09 (2.28, 11.38) <.001
Age 1.19 (1.05, 1.35) .004
Individual’s MH 1.59 (0.82,3.08) .085
Family’s MH 2.51 (1.35,4.69) .002 2.95 (1.25, 6.98) .006
Years of Ed. 1.17(1.01, 1.35) .016
GCSEs 0.84 (0.75, 0.94) .002 0.82 (0.70, 0.96) .007
Tobacco Use 9.26 (5.38, 15.91) <.001 12.08 (6.02, 24.24) <.001
Days of Alcohol Use 1.73 (1.39, 2.16) <.001 1.95 (1.42, 2.67) <.001
Disabilities 1.91 (0.72,5.05) .097
Note. 0R = odds ratio; 95% confidence intervals are reported in brackets; MH= mental 
health; Ed.= education. All p-values reported are 1-tailed.
5.3.3. Predictors of the Age of Onset of Cannabis Use - Logistic Regression Model
5.3.3.1. Analysis selection
The proposed method for analysis was going to be a multiple regression with the age of 
onset of cannabis use serving as the continuous criterion variable. Subsequent 
assumption testing suggested that normality and linearity were violated thus a multiple 
regression could not be run. As the current research programme has used an age of onset 
split of <15 and >16 years the most appropriate solution for this problem seemed to be 
converting the continuous criterion variable into a dichotomous variable using a median 
split and running a logistic regression. The disadvantages of this method is that not all 
studies use the same early/late criteria and therefore an early onset group described here 
may not the same as those described in other studies. The advantages of choosing the 
logistic regression is that it is not subject to the same assumptions which have already 
been shown to be violated, furthermore it allows continuity between the term early 
onset used in this chapter and those described in the other experimental chapters.
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5 .3 3 .2 . Building the M odel
The potential predictor variables were selected in a similar manner to the first logistic 
regression. The criterion variable (Tir) was the age at which an individual first used 
cannabis. The potential predictors were sex, age, mental health (presence/absence; 
type), family’s mental health (presence/absence; type), developmental disorders 
(presence/absence; type), tobacco use (use/no use; quantity of use; dependence/no 
dependence), other drug use (use/no use; number of different drugs), alcohol use (days 
per week of drinking; units consumed per week), educational achievement (total number 
GSCEs; number of GCSEs grades A*-C), years in education, and nationality.
The explanatory variables which were used for this analysis were: (Xi) age, (X2) sex,
(X3) GCSE grades, (X4) years of education, (X5) mental health, (X6) lifetime tobacco use, 
(X6) lifetime other drug use and (X7) weekly alcohol use.
5.3.3.3. Assumptions
There were 180 participants originally tested for the model, 31 were left out due to 
missing data leaving 149. Only three of the potential predictors were associated with the 
outcome variable in a univariate logistic regression model (p<.25). The hierarchical 
model building procedure suggested that only a history of drug use and GCSE grades 
provided a significant contribution to the model. The remaining non-significant 
predictors were left out of the final model. Cook’s distance, standardised residuals and 
DF beta to the constant were checked and 0 cases were identified as outliers based on 
criteria outlined by Field (2013). As there were only two predictor variables and now 
142 cases in the final model, the assumption of overfitting was not violated at 30:1 
(Meyers et al., 2013). Linearity of the logit was tested for all continuous variables and 
was not violated. Goodness of fit statistic was checked and this fell within the ideal 
range [x2(6)=2.55, p=.863] (Hosmer & Lemeshow, 2000). The dispersion value came to 
(/)=0.33 which suggests a slight underdispersion (Menard, 2002; Field, 2013).
Collinearity diagnostics were checked and tolerance levels were all larger than 0.1 and 
VIF levels were all smaller than 10, suggesting that collinearity assumptions were not 
violated (Meyers et al., 2013).
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5 .3 3 .4 . Running the M odel
The finalised model was run in a forced entry manner. The logistic regression analysis 
showed that the combined predictor variables were significantly related to cannabis use 
[X2(2)=8 . 13 , p= .0 \l, C ox & Snell R2=.056, Negelkerke R2=.016]. Further examination of 
the variables in the equation (see Table 5.4) suggests that drug use is a significant 
predictor of the age of onset of cannabis use with illegal (non-cannabis) drug users 
being approximately 2.32 times as likely to be an early onset cannabis user. Educational 
achievement was a significant predictor of the age of onset of cannabis use, with every 
additional GCSE grade conferring a reduction in likelihood of being an early onset user 
with an odds ratio of 0.84.
Table 5.4.
Adjusted and unadjusted odds ratios fo r  the age o f onset o f cannabis use predictor 
variables.
Unadj. OR /7-value Adj. OR /?-value
Sex 0.78 (0.38, 1.63) .258
Age 0.98 (0.89, 1.08) .340
Individual’s MH 1.35 (0.56,3.26) .253
Family’s MH 1.44 (0.65,3.18) .184
Years of Ed. 1.03 (0.86, 1.23) .382
GCSEs 0.84 (0.70, 1.02) .037 0.84 (0.69, 1.02) .036
Tobacco Use 1.03 (0.51,2.12) .463
Days of Alcohol Use 1.10(0.81, 1.48) .275
Disabilities 2.37 (0.69, 8.20) .086
Drug Use 2.39 (1.13,5.05) .011 2.32(1.09, 4.98) .015
Note. See table 5.3 for notes.
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5.4. Discussion
5.4.1. The CannaForm
The current study introduces a new cannabis questionnaire which was trialled on a large 
sample. Face validity was confirmed by self-reported heavy cannabis and other drug 
users who completed the questionnaire at two separate stages in development. The 
exclusion criteria, inclusion criteria, drug use data, and demographic data used 
throughout Chapters Three and Four, were all collected from this questionnaire. 
Furthermore, the data reported in the current chapter suggests that the CannaForm can 
be utilised to answer broader research questions relating to cannabis use.
5.4.2 The Age of Onset of Cannabis Use
The current study highlights that the majority of cannabis use occurs during the school 
years however as the median age of the participants at time of testing was 19 the non­
cannabis users may go on to use cannabis post-education later in their lives. The key 
finding was that the majority of cannabis users start using cannabis around the age of 
16, a time when in full time education. Given the well documented acute effects of 
cannabis on memory (Ranganathan & D'Souza, 2006), hangover effects of cannabis on 
a range of cognitive variables (Pope et al., 1996), and the longer lasting effects on 
learning and other cognitive variables (Schreiner & Dunn, 2012) the use of cannabis 
could interfere with educational development both in school and out (i.e. homework; 
revision etc.)
5.4.3. Lifestyle Confounds and Cannabis Use
The first logistic regression model assessed how a number of variables were related to 
the use of cannabis. The model found that being male, having a family history of mental 
health problems, having a history of tobacco use, and having a greater frequency of 
alcohol use were associated with an increased risk of using cannabis. In contrast, having 
a greater number of GCSEs was associated with a reduced risk of using cannabis. While 
age and years of education were significantly related to cannabis use in the univariate 
model, after controlling for confounding variables the significant effect was removed. 
The presence of mental health and learning disabilities was not related to cannabis use 
at any stage of the analysis. It should be noted that this was just a minimum of one use
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of cannabis, and these variables were not tested to determine if they predict regular 
cannabis use or abuse.
5.4.2.1. Sex
Previous studies observing the effects of sex on cannabis use have reported little or no 
difference between males and females (Home Office, 2009; McCrystal & Percy, 2011; 
Tu et al., 2008). In contrast to these studies the current analysis found the males were 
5.09 times more likely to use cannabis than females while controlling for a number of 
other variables seen in Table 5.3. While the Home Office (2008) and Tu et al (2008) just 
reported the unadjusted percentages, the current study controlled for alcohol use, mental 
health, tobacco use and a number of other variables. In contrast, McCrystal and Percy 
(2011) used a similar logistic regression model and thus the differences between their 
study and the current one is unlikely to be due to the controlling of confounding 
variables. The between study differences could be due to the sampling method as the 
current study primarily was opportunistic and it is possible there was a gender bias in 
this recruitment method which led to the disproportionately high percentage of cannabis 
user being male. The greater proportion of females in this study would not affect the 
outcome as the odds ratios are calculated based on the percentage of the groups (i.e. 
sex) which belong to a level of the criterion variable (e.g. cannabis use).
Tu et al (2008) also found that males were more likely to be early users of cannabis 
while the current study found no sex effects on the age of onset of cannabis use. It is 
possible that the sampling method explained these differences as the current study 
reported a disproportionately high number of females and those from university. Further 
research needs to address this question to determine if males are at a higher risk for 
initiating cannabis use at a younger age.
5.4.2.2. Education
Two educational predictor variables were utilised in the regression models: the years an 
individual has spent in education, which was only included in the cannabis use model, 
and the number of GCSE grades, which was used in both models. The years of 
education variable was not a significant predictor of cannabis use or the age of onset of 
cannabis use. In contrast, there was a clear effect of educational achievement. The
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number of GCSEs was a significant predictor of both cannabis use and early onset 
cannabis use, with increased GCSEs conferring a protective factor for both.
In contrast to the current study, three other studies have found such an association 
(Lynskey et al., 2003a; McCrystal & Percy, 2011; Verweij et al., 2013). Possible 
explanations for this lack of a relationship between years of education and cannabis use 
is that the majority of the sample were recruited from universities and thus the number 
of years in education reflects a small subset from the entire range educational 
possibilities. School drop outs, non-university attendees, post-graduates were all under­
represented within the sample. As Horwood et al (2010) identified that cannabis users 
are more likely to drop out of university than non-cannabis users it could be that such a 
relationship would have been found if a follow-up was conducted to determine how 
many of the original sample went on to complete their degrees. It is not possible to 
determine why the number of GCSEs conferred a protective risk to the age of onset of 
cannabis use from this study. Possible explanations include familial or genetic 
influences, peer influences, amotivation, and cognitive/intelligence impairments 
(Lynskey et al., 2003a; Horwood et al., 2010; Verwiej et al., 2013). Alternatively, 
another explanation which has not received any empirical investigation is whether the 
acute effects of regular cannabis use are influencing the educational problems. While 
intoxicated it would be harder to focus and absorb information due to the transient 
cognitive impairments (e.g. Hart et al., 2001). It is possible that cannabis use is a time- 
consuming hobby which reduced the amount of spare time and individual can spend 
learning. This explanation is consistent with evidence that educational achievement is 
more affected among the frequent cannabis users.
The current study assessed educational achievement by the number of GCSEs gained by 
each participant. McCrystal and Percy (2011) used a similar logistic regression model to 
that in the current study and the model included an assessment of achievement. 
McCrystal and Percy chose a categorical approach to assessing GCSE grades (A-C vs.
D & lower) while the current study used the number of GCSEs to assess achievement. 
These differing methods did yield a different outcome with the current study finding a 
significant effect while McCrystal and Percy only report a trend for an association 
between achievement and cannabis use (p<A0). This could be due to the varying 
methods of assessing this construct.
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The current study also found that a greater number of completed GCSEs was associated 
with a reduced chance of the individual being an early onset (prior to age 16) cannabis 
user. While early onset cannabis use is frequently associated with leaving school early, 
this association with GCSE grades is a novel finding in the literature. GCSE grades 
have been examined with cannabis use before (McCrystal & Percy, 2011) yet this 
association with the age of onset of cannabis use extends these findings. The use of a 
twin study, such as that done by Verweij et al (2013), could help determine whether the 
association between early onset cannabis use and educational achievement is due 
overlapping familial factors or due to a causal connection between the two variables.
5.4.2.3. Drug Use
The current study found that alcohol use and tobacco use were predictors of cannabis 
use in the first regression model. Other drug use was considered as a predictor but 
violated one of the assumptions due to it being too good of a predictor; no participants 
had used another drug without using cannabis. In the second regression model other 
drug use was included and was a significant predictor of the age of onset of cannabis 
use. Unlike the association with cannabis use, tobacco use and alcohol use were not 
related to the age of onset of cannabis use.
The association between cannabis use and other drug use (not reported in the model) 
builds on previous findings by (Agrawal et al., 2004). The association between other 
drug use and the age of onset of cannabis also supports previous research in this area 
which suggests that early onset cannabis users are more likely to use any other illegal 
drugs (Secades-Villa et al., 2014). While the current study used a dichotomous estimate 
of age of onset of early (<15 years old) and late (>16 years old) cannabis users, 
Secades-Villa et al (2014) used a continuous predictor variable. Despite these 
methodological differences both studies found that early onset use is associated with a 
greater likelihood of using other illegal drugs after controlling for confounding 
variables. Unlike Secades-Villa et al's study, a temporal sequence of drug use was not 
established for the current cohort meaning that it cannot be determined if early onset 
cannabis use preceded other drug use. This limits the ability to derive causal 
interpretations from the current data.
250
The association between tobacco use and cannabis use found in the current study 
supports previous work highlighting a link between tobacco use and cannabis use. A 
large proportion of research in this field has found associations between tobacco use and 
cannabis dependence (Prince vaan Leeuwen et al., 2014) or cannabis use and tobacco 
dependence (Patton et al., 2005) and thus the current findings do not directly support 
these findings, but rather add to them. As a small proportion of the current sample 
reported tobacco (1.9%) or cannabis (5.9%) dependence it is unlikely that it was 
dependence which was explaining the association.
The association found between alcohol frequency and cannabis use also builds on 
previous findings in the literature. Some studies have found links between alcohol use 
and cannabis use (Kirby & Barry, 2012) although the link between alcohol use and 
cannabis disorders disappears after controlling for covariates (Prince vaan Leeuwen et 
al., 2014). The current study used a different approach to measuring the association. 
Alcohol frequency was measured by the number of days per week when drinking 
alcohol and an increased frequency conferred a greater risk for cannabis use but had no 
effect on the age of onset of cannabis use.
5.4.2.4. Mental Health
The first analysis included two mental health predictors to identify the association with
cannabis use. The mental health of the individual was not included in the final model as
it was not significantly related to cannabis use however the mental health of family
members was related to cannabis use. Despite previous research highlighting a link
between multiple mental problems and cannabis use (Degenhardt et al., 2001; Rey et al.,
2002; Patton et al., 2002; Moore et al., 2007) the current study did not replicate this
relationship. This is likely due to a combination of methodological and sample
characteristics. While the current sample was young in age it is unlikely that this solely
explains the lack of association as Patton et al (2002) recruited a younger sample. The
difference emerges when considering the assessment procedure, Patton et al (2002) used
clinical interviews to assess mental health while the current study assessed whether an
individual has met with a therapist or equivalent. This leaves the possibility that a
number of individuals in the current sample may have had mental health problems but
were yet to consult professional help. Furthermore, the current study conflated all
mental health problems into one variable while other studies selectively test for specific
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conditions, as different mental health problems carry difference risk and protective odds 
ratios for the onset of cannabis use (Rey et al., 2002) this method could be hiding 
specific condition associations.
Despite the individual's mental health not being associated to cannabis use, the family's 
mental health was associated. If an individual had a family member with mental health 
problems, they were 2.95 times as likely to use cannabis after controlling for 
confounding variables. It is not clear if this association represents self-medication due to 
undiagnosed symptoms (e.g. Swift et al., 2005), an inherited genetic vulnerability for a 
particular mental health condition, or if the increased use of cannabis represents a 
product of diminished parental involvement with the child precipitated by parental 
mental health problems (e.g. Butters, 2002).
The learning disabilities variable was also included tested however no relationship with 
either cannabis use variable was found. Based on these data it seems that the 
individual's mental health, learning (dis)abilities, and familial mental health are not 
related to the age of onset of cannabis use. While this is the first study the current 
authors know of which observes relationships between learning disabilities and familial 
mental health with the age of onset of cannabis use, some research has already 
highlighted the potential link between early onset cannabis use and mental health. Green 
and Ritter (2000) found an association between early onset cannabis use (<16 years) and 
depression however this association was not significant after controlling for 
confounding variables. Building on this work, Lynskey et al (2004) found that major 
depressive disorder diagnoses were not related to early onset cannabis use (<17 years) 
however suicidal attempts were. Less is known about the age of onset of cannabis and 
other specific mental health problems reported in the CannaForm (e.g. eating disorders) 
and the current study could not contribute to this new knowledge. It was attempted to 
break down the analysis into different mental health problems however this violated the 
assumptions of incomplete data and so all mental health problems were conflated into 
one variable.
5.4.4. Limitations
The administration of the CannaForm has the potential for reduced reliability. As the 
CannaForm was completed in both a structured interview and self-report format it is
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possible that there were differences in responses which were mediated by the particular 
format (e.g. Tourangeau & Yan, 2007). The interview format allowed for questions to 
be explained in more detail, such that if a participant did not understand a question, the 
experimenter was there to help. Additionally, there is also the potential for bias with the 
interview format which is not present during the self-report format. These benefits and 
limitations of the two administration formats could influence the manner in which a 
participant responds to a particular question.
5.4.5. The Future of the CannaForm
The current chapter displayed its utility for addressing drug use behaviours. The 
development of the CannaForm has been discussed in the current chapter however there 
are changes which are to be implemented beyond this research programme.
Firstly, a reliability study in which the questionnaire will be administered and marked 
by two separate experimenters in order to test the inter-rater reliability of the 
CannaForm. Additionally, the participants will also complete the CannaForm in a self- 
report procedure which will then be compared to the structured interview approach to 
test the reliability of the CannaForm during different administration procedures. The 
Validity of the CannaForm's alcohol and drug use sections could be tested by also 
administering the Customary Drinking and Drug Use Record (Brown et al., 1998) or a 
similar questionnaire.
5.4.6. Recommendations for Confounding Variables
The current study found that a number of variables were related to cannabis use and two
were also related to the age of onset of cannabis use. These two variables were other
drug use and educational achievement. While other drug use is often controlled for in
such studies, educational achievement is not (see Table 5.1). Especially among age of
onset studies it would be advisable for studies to start controlling for this variable if it
meets the necessary assumptions to do so. For general cannabis use it would be
advisable to control for sex, family’s mental health, tobacco use, educational
achievement, and alcohol use. This is not an exhaustive list however it does represent
the first guidelines for identifying salient confounding variable within a singular study.
The benefits of this approach are that some variables may have a relationship with
cannabis use, yet not after controlling for other variables such as seen in Table 5.3.
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Chapter Six: General Discussion
6.1. Introduction
The purpose of this thesis was to extend the literature on the relationship between early 
onset cannabis use and executive function. The current chapter discussed the 
contribution of the current research to the existing literature and summarises possible 
research directions which could follow.
Table 6.1.
A table describing the three studies o f this thesis.
Study Method Main Findings
Neuropsychology Quasi-experimental, Cannabis related deficits in visual
Study neuropsychological scanning, set switching, and visuo-
(Chapter Three) tasks, questionnaires motor coordination 
Early onset cannabis related deficits 
in set switching and visuo-motor 
coordination
Eye-Tracking Quasi-experimental, eye Cannabis related deficits in visual
Study tracker, computerised scanning
(Chapter Four) tasks, questionnaires Cannabis related increases in anxiety 
Very little evidence for early onset 
cannabis related deficits
Survey Study Correlational, Cannabis use is predicted by sex
(Chapter Five) questionnaire (males at risk), the presence of 
familial mental health conditions, 
more alcohol use, tobacco use, and 
lower educational achievement 
Early onset cannabis use is predicted 
by other drug use and lower 
educational achievement
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6.2. Results
6.2.1. Summary of Results
The neuropsychological study (Chapter Three) involved the administration of a battery 
of neuropsychological tasks to cannabis users, tobacco users, and matched controls. The 
results showed that the cannabis using group performed at a significantly lower level on 
multiple tasks when compared to the tobacco users and controls. These tasks included 
the Trail Making Test (TMT) Visual Scanning test, the TMT Switching test, TMT 
Switching Contrast measure, the Grooved Pegboard Test (GPT) Contrast Measure, the 
Design Fluency Test (DFT) Switching test, and the DFT Switching Contrast test. The 
only ambiguous finding was on the GPT, in which the tobacco group out-performed the 
controls and the cannabis users while there was no difference between the cannabis 
users and controls. As cannabis users also used a large amount of tobacco this finding is 
best explained by a beneficial effect of tobacco on the GPT which hid the damaging 
effect of cannabis on this task, and made the tobacco users complete the task faster than 
the controls. This tobacco-related beneficial effect is most likely an acute and transient 
benefit by the use of tobacco just before the cognitive testing. There were no group 
differences on the remaining list of dependent variables examined in the 
neuropsychological chapter.
The second analysis of the neuropsychological study involved the same data set with a
different independent variable. The cannabis users were divided into early onset (age of
onset <15) and late onset (age of onset >16) groups while the tobacco and controls
groups remained the same. This study showed that while the late onset users displayed
some cognitive impairments, the early onset group was displaying greater and more
widespread deficits. The GPT Contrast Measure, the TMT Switching subtest, and the
TMT Switching Contrast score appeared to show a vulnerability to early onset cannabis
use. The remaining variables which highlighted cognitive impairments in cannabis users
relative to the control group or tobacco group did not show an age of onset effect.
Further correlational analyses suggested a range of cannabis variables which were
related to cognition. Earlier onset cannabis use was related to greater cognitive
impairments, greater lifetime cannabis use was related to greater cognitive impairments,
longer use of cannabis was related to greater cognitive impairments, and the desire to
reach higher levels of cannabis intoxication was related to greater cognitive
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impairments. These cannabis use variables were not related to all cognitive variables 
and some appeared more severe than others.
The eye-tracking study (Chapter Four) involved a new sample of participants and a 
focus which shifted to eye-tracking. As earlier findings from the neuropsychological 
chapter could not determine if cannabis was affecting set switching or visual processes, 
two new tasks (VST & SST) were created for use with the eye tracker to address this 
problem. While this study displayed clear main effects of cannabis use on task 
performance, there was not a clear role for the age of onset, quantity of cannabis use, or 
any other cannabis related variables. Furthermore, anxiety was found to be correlated 
with several variables in which the whole cannabis using group displayed impairments, 
and levels of anxiety were significantly higher in the cannabis group. This calls into 
question a causal role of cannabis on this task and suggests that an anxiety could have 
been mediating some, but not all, of the detected cognitive deficits.
The survey study (Chapter Six) aimed to determine what factors could be mediating the 
relationship between cannabis use, the age of onset of cannabis use, and cognition. This 
study found a range of variables related to cannabis use. Males, more frequent alcohol 
users, individuals with familial mental health problems, individuals with fewer GCSEs, 
and tobacco users were all at an increased risk of using cannabis. Other drug use was 
also related to cannabis use but could not be included in the regression model as it 
violated one of the model assumptions by being “too” related to cannabis use (i.e. no 
participants used other illegal drugs if they did not use cannabis). Despite all these 
variables which are associated with cannabis use, only fewer GCSEs and other drug use 
increased the risk of using cannabis at an early age. Most studies control for other drug 
use by means of exclusion criteria however controlling for education achievement is 
less prevalent. Given the relationship between GCSEs and the age of onset of cannabis 
use, and the previously discovered relationship between educational achievement and 
cognition (e.g. Riding, 2000; Grimley & Banner, 2008), controlling for education 
achievement where appropriate is now essential when observing the effect of the age of 
onset of cannabis use on cognition. In the neuropsychological study and the eye- 
tracking study, educational achievement and other drug use were controlled for, which 
increases the likelihood that the results can be ascribed to a causal role of cannabis use.
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6.2.2. Updated Literature
6.2.2.1. Cannabis and Cognition
The results from the two quasi-experimental studies have implications for the current 
level of understanding within four primary areas. Firstly, there is strong evidence 
presented within the thesis that cannabis use is strongly associated with cognitive 
performance and a causal link between these two variables could not be eliminated (see 
Section 6.3). This adds to the growing body of literature identifying such a relationship 
(for reviews see Crean et al., 2010; Schreiner & Dunn, 2012).
6.2.2.2. The Age o f Cannabis Onset and Cognition
Unlike the relationship between cannabis and cognition, the relationship between 
early/late onset cannabis use and cognition is sparse and inconsistent. This research 
makes a large contribution towards understanding this relationship. The 
neuropsychology study (Chapter Four) found strong support for early cannabis onset 
leading to a greater degree of cognitive deficits and this therefore supports work done 
by Gruber et al (2011) and Fontes et al (2011). The early work in this field had 
methodological limitations (i.e. Ehrenriech et al., 1999) and later work found that the 
association was removed after controlling for IQ (Pope et al., 2003) however following 
the neuropsychological study reported within this thesis, in addition to the more recent 
research (Fontes et al., 2011; Gruber et al., 2011), there is strong evidence that an early 
age of onset is associated with greater cognitive deficits. Although there was support for 
the age of onset hypothesis from the eye-tracking study, it was not as strong as that from 
the neuropsychological study.
These findings suggest that there may be a developmentally vulnerable period for 
cannabis use and although it is too early to determine for certain, it appears that some 
cognitive processes are more vulnerable than others.
6.2.23. The Specificity o f Impairment
Section 1.4 of the Literature Review discussed the evidence for cannabis impairments in 
distinct executive function components. Several components such as inhibition, 
abstract/conceptual reasoning, working memory, and strategic planning were likely to
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contribute to performance on a number of the tests used however there was no direct 
measurement of these processes and therefore they will not be discussed. The current 
thesis used four tests to measure set switching over two quasi-experimental studies. 
Using the set switching subtests from the TMT and DFT, the current study supported 
previous research identifying set switching impairments in cannabis users (Medina et 
al., 2007; Thames et al., 2014) and therefore did not support the studies which found no 
effect of cannabis on set switching (Bolla et al., 2002; Gruber et al., 2011). In contrast 
the set switching dependent variables from the VFT in the neuropsychological study 
and the SST in the eye-tracking study appeared to be unrelated to cannabis use and 
therefore supported Bolla et al (2002) and Gruber et al’s findings (2011). Furthermore, 
the set switching measures from the TMT and DFT found evidence of an age of onset 
effect, with early cannabis users displaying greater deficits than late onset users, a 
finding which does not support Gruber et al (2011) who did not find such an effect on a 
different version of the TMT. The results of the current thesis suggest set switching is 
potentially impaired, although evidence from the eye-tracking study suggests that 
deficits in visual scanning could be explaining the deficits in set switching tasks.
Verbal fluency was measured with two different tests, one of phonemic/letter fluency 
and one of semantic/category fluency. The current findings support the majority of 
previous research which found no effect of cannabis on verbal fluency performance 
(Pope et al., 2001; Medina et al., 2007; Gruber et al., 2011). Despite this Gruber et al
(2011) found that early onset cannabis users displayed impairments on the task, McHale 
and Hunt (2008) found that cannabis users were impaired on a written variant of the 
task, and Becker et al (2014) found that cannabis users outperformed controls on this 
task. The current research supports the majority of the work in this area which suggests 
cannabis use is not related to verbal fluency performance. While McHale and Hunt’s 
(2008) finding is probably explained by methodological differences as discussed in 
section 1.4.5, the remaining inconsistencies are likely due to sample characteristics 
although it is not clear what these may be.
The current test used the IGT to measure decision making abilities, the same measure 
used by all other studies described here. Despite several studies which found impaired 
performance on this task (Bolla et al., 2005; Whitlow et al., 2004) not all research has 
found these results. Becker et al (2014) found a trend towards impairments while
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Verdejo-Garcia et al (2007) found although there were no group differences, there was a 
dose-response effect as determined by correlating performance with number of spliffs 
smoked. The current study did not find any group differences between cannabis users 
and controls and is the first study to report that there was no age of onset effect.
Possible explanations for these results are discussed in section 3.4.
The neuropsychology study (Chapter Three) used two measures of non-verbal creativity 
derived from two subtests of the DFT. This is the first use of such tests within the 
cannabis-cognition literature and the results suggest that this cognitive construct is not 
associated with cannabis use or the age of onset of cannabis.
Within the current research programme there were two tests used which primarily 
measure visual scanning including a D-KEFS standardised test within the 
neuropsychological study and another created for use within the Tobii eye-tracker. Both 
tasks support findings which show that cannabis use is related to impairments in visual 
scanning abilities (Ehrenriech et al., 1999; Hanson et al., 2010; Huestegge et al., 2002). 
Despite these group differences the current study found that there was no age of onset 
effect on visual search abilities, a finding which contradicts Ehrenriech et al’s results 
(1999). The limitations of their study which have been highlighted multiple times 
suggest that the group differences which they found may not be due to the long term 
effects of cannabis, which would explain this lack of concordance.
Two categories of motor skills were tested in the current study, motor speed (GPT 
Remove and TMT Motor Speed) and visuo-motor coordination (GPT Place and GPT 
Contrast Measure). There was no effect of cannabis or the age of onset of cannabis use 
on either of these indicators of motor speed which supports previous research (Becker et 
al., 2014; Fitzgerald, Williams & Daskalakis, 2009). In contrast to these more basic 
skills, higher level visuo-motor coordination skills showed evidence of being impaired 
in cannabis users and early cannabis users relative to tobacco users but not controls. 
Possible explanations for this are discussed at length in the discussion section of 
Chapter Three. These deficits support previous research identifying a dose-response 
effect of spliffs on GPT Place performance (Bolla et al., 2002) however another two 
studies did not find differences between cannabis users and controls (Becker et al.,
2014; Fitzgerald et al., 2009). This does not contradict the findings reported in Chapter 
Three as it was the tobacco users who outperformed cannabis users. Future research
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aimed at clarifying the relationship between cannabis use and visuo-motor performance 
needs to account for tobacco use.
The final cognitive domain assessed in the current research programme was visual 
processing speed as determined by the SST. The current study found no effect of 
cannabis use or the age of onset of cannabis use on this variable. Both Meier et al
(2012) and Thames et al (2014) used a combination of the SST and a second test to 
create an information processing composite score which was found to uncover deficits 
in cannabis users in both studies thus contradicting the current findings. It could be that 
the second test used to create the composite score in these studies was the one 
uncovering deficits and the SST itself was not related to cannabis use, potentially 
supporting the current data.
6.2.2.4. Predictors o f Cannabis
The final area which the current thesis provided updated knowledge was on the 
relationship between the age of onset of cannabis use and several putative, salient 
confounding variables. The survey-based study found that early onset cannabis use was 
associated with other drug use and educational achievement. This supports previous 
work on the relationship between the age of onset of cannabis use and educational 
achievement (Lynskey et al., 2003; Horwood et al., 2010) however adds to this work by 
using GCSE performance as an indicator of educational achievement; a novel method 
due to the majority of previous research occurring outside of the UK. The current 
analysis found that sex was not related to the age of onset of cannabis use thus 
conflicting with previous research by Tu et al (2008). The findings also showed that 
early onset cannabis users are more likely to use other illegal drugs, a finding which 
supports previous results (Secades-Villa et al., 2014). As the majority of research 
regarding the predictors of cannabis use, or the age of onset of cannabis use, has been 
done outside the UK, cross-cultural differences may have an influence on such 
predictors. This could be explaining the contradictory results found between the current 
research and that of Tu et al (2008). This study was solely conducted on university 
students with a large female bias at a ratio of approximately 3:1, and this needs to be 
considered when generalising the results.
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6.2.3. Original Contributions
The first and predominant goal of the current thesis was to extend the body of 
knowledge about the relationship between the age of onset of cannabis use and 
executive function. The GPT, SST, DFT, and IGT were novel methods of assessing how 
the age of onset of cannabis use affects cognition. Furthermore, the DFT had never been 
used to examine cognitive deficits in cannabis users before, unlike these other tests. Due 
to limited evidence on the age of onset hypothesis several tests were also included for 
replication purposes which included the TMT and the VFT. Both of these tests included 
subtests, the TMT Visual Scanning test and the VFT Category Switching test, which 
were novel cognitive assessment in both fields: age of onset of cannabis and cannabis 
use in general. This battery of neuropsychological tests extended the data on the 
relationship between the age of onset of cannabis use and executive function and other 
cognitive domains.
In the eye-tracking study two new visual search tests were run and while this use of 
visual search is not an original contribution to the age of onset literature, the use of an 
eye-tracker is an original contribution as it has not been used to address the age on onset 
of cannabis use before. This means that the current thesis extended the body of 
knowledge on how the age of onset of cannabis use affects cognition by using new 
measures of already tested cognitive processes (e.g. TMT Visual Scanning test), new 
measures of un-tested cognitive processes (e.g. all DFT subtests), and new techniques 
for measuring cognitive processes (e.g. eye-tracking).
There was also a large focus on the specificity of impairments. This also required the 
use of dependent variables yet to be tested on cannabis users or early onset cannabis 
users. The use of D-KEFS tests allowed for contrast conditions to be analysed and while 
this practice is recommended by studies examining construct validity (e.g. Sanchez- 
Cubillo et al., 2009) it is not always employed by studies examining the relationship 
between cannabis use and cognition. Typically the process involves administering a test 
which measures one set of cognitive functions (e.g. VFT Category Fluency), then 
administering a second test with a small change which recruits additional cognitive 
processes (e.g. VFT Category Switching, and finally subtracting the score on test one 
from the score on test two. This approach has received support for increasing specificity 
and thus aiding the interpretation of deficits (e.g. Arbuthnott & Frank, 2000; Sanchez-
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Cubillo et al., 2009) and has been incorporated and standardised in the D-KEFS. In 
addition to using the D-KEFS, such an approach was conducted with the GPT for the 
first time in the current study. Tests of validity suggested that this approach increased 
specificity for higher cognitive/visuo-motor coordination demands of the GPT by 
reducing the involvement of basic motor skills. The eye-tracking study also used a 
similar approach by use of the Tobii VST and Tobii SST. These two tests differed by 
means of a switching component demonstrated by isolating a switch cost (i.e. Monsell, 
2003) on a number of the dependent variables. This process of comparing the group 
differences in performance on the VST and SST aided in attributing the deficits to 
specific cognitive constructs. Although this was not set out to be a primary aim of the 
research programme, the neuropsychological study and the eye-tracking study reported 
in this thesis used existing methods (e.g. TMT Switching Contrast) and contributed new 
methods (e.g. GPT Contrast Measure) for increasing specificity and aided in identifying 
which specific cognitive constructs were at risk for impairment.
The current thesis also developed and trialled a new tool for assessing cannabis use: the 
CannaForm. This new tool provides a unique and in depth assessment of cannabis use 
behaviours such as method of administration, frequency of use, how use changes over 
time, and the desired level of intoxication. While other cannabis specific questionnaires 
do exist they either lack depth (e.g. Solowij, 1998) or do not assess the desired domains 
(e.g. Heishman et al., 2001; Lee et al., 2009). General drug use questionnaires contain 
questions on cannabis use yet also lack the desired depth on cannabis use (e.g. Brown et 
al., 1998). This thesis therefore contributes a new tool specifically for research in which 
cannabis use is the focus.
6.3. Does Long Term Cannabis Use Cause Executive Function Deficits?
As discussed in Chapter Three, Hill (1965) suggested a method of determining 
causation by means of a checklist. The failure to meet one criterion does not imply 
causation is not true, and by extension, meeting the criteria does not necessarily mean 
causation is true as shown by counterfactual examples (Hofler, 2005). The list of these 
guidelines for inferring causation will now be discussed with regards to the specific 
effects found in the current studies (Chapters Three, Four and Five) and how these 
studies aid causal interpretations in the general literature.
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6.3.1. Strength of the Association
The first criterion discussed in the Methodology Chapter (Section 2.1.1) was on the 
strength of the association. This is discussed below with regards to the severity of the 
impairments however here it will be discussed with regards to causation. The effect 
sizes between the controls and the cannabis users were large as determined by general 
guidelines on interpreting effect sizes (Cohen, 1988). Although the effect sizes were 
mixed across different dependent variables for both studies (Chapters Three and Four), 
the significant results suggests moderate to large effect sizes, with the majority being 
large. When considering the age of onset of cannabis use, particularly in Chapter Three, 
the effect sizes were larger between the early onset group and the controls, than between 
the late onset group and the controls. The current findings which concern the strength of 
the association criterion lend support for the notion that the relationship between 
cannabis use and cognition is causal. This factor alone however, is not sufficient 
justification for a causal interpretation.
6.3.2. Consistency
The second criterion for causation is consistency. The neuropsychological and eye- 
tracking studies found cannabis related impairments in cognition and both found 
evidence of early onset related deficits in cognition. These early onset findings were 
much more pronounced in the first study (Chapter Three) than in the second study 
(Chapter Four). However, this adds support to the general literature on cannabis use for 
a causal interpretation as two new studies reported within the current thesis have found 
support for cannabis related impairments in cognition. The literature on general 
cannabis and cognition use is now extensive and a recent meta-analysis found a clear 
effect of cannabis use and cognitive impairments on a wide range of cognitive and 
motor faculties (Schreiner & Dunn, 2012). In contrast, there is little research on the age 
of onset of cannabis use and therefore the findings reported in the current thesis which 
address this cannabis use variable are perhaps more crucial for furthering understanding. 
Chapter Three adds further consistency to the age of onset of cannabis literature (Pope 
et al., 2003; Gruber et al., 2011; Fontes et al., 2011) while Chapter Four, the eye- 
tracking study reported in this thesis, suggests a small possibility of an age of onset 
effect however the results lack intra-study consistency as only one dependent variable 
showed an age of onset effect.
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As with the first criterion, studies reported in Chapters Three and Four meet the 
criterion of consistency for general cannabis use and to varying degrees meet the same 
criterion for early onset cannabis use. This increases the possibility that cannabis use 
and early onset cannabis use can be said to have a causal influence on cognition.
6.3.3. Specificity
The criterion of specificity suggests a specific cause should have a specific effect. The 
specific effects of cannabis appear to be wide ranging with a recent meta-analysis 
finding cannabis related deficits in attention, abstraction/executive, forgetting/retrieval, 
learning, motor, and verbal/language domains (Schreiner & Dunn, 2012). The authors 
grouped processes known to be differentially affected by cannabis use into these 
domains to aid the meta-analytic process however the effects of cannabis can be 
examined in a more precise level of specificity. An example of this grouping by the 
authors is the placing of the Iowa Gambling Task -  a measure of decision making -  into 
the “attention” domain. Comparing intra-study specificity can be done as both studies 
reported in the current thesis used multiple dependent variables which recruit over­
lapping cognitive processes.
Within the neuropsychological study there were two measures of motor speed, three 
measures of set switching, and two measures of verbal fluency. There were also 
additional measures of motor speed and visuo-motor coordination when considering 
that the GPT was completed with both hands. All measures of motor speed derived from 
the TMT and GPT suggest that cannabis use is unrelated to this domain. The three 
measures of set switching, or six if including contrast measures, were not all related to 
cannabis use. However, the set switching measures from the visual domain including 
TMT and DFT subtests were all impaired while the verbal set switching measures from 
the Verbal Fluency Test (VFT) were not impaired. Therefore there is evidence of intra­
study specificity when considering that there is a dissociation between verbal and visual 
set switching tasks. There was not a clear effect of cannabis on visuo-motor 
coordination tasks as only the dominant hand was impaired in the cannabis users on the 
GPT Contrast Measure. This could be explained by the differential recruitment of 
cognitive and motor processes over dominant and non-dominant hands on the GPT 
(Strenge, Niederberger & Seelhorst, 2002). Furthermore, the two measures of verbal
fluency; phonemic/letter fluency and semantic/category both were unrelated to cannabis
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use. The remaining tasks from the neuropsychological study included only one 
assessment of individual cognitive processes and thus intra-study specificity cannot be 
examined any further. In summary there appears to be moderate to high levels of 
specificity consistency dependent on the cognitive domain.
The eye-tracking study reported in Chapter Five included two tasks in which every 
dependent variable was replicated across both tasks. Although a number of the 
dependent variables from the Switching Search Task (SST) contained additional set 
switching processes, as demonstrated by a switch cost, every dependent variable on the 
SST would recruit comparable processes to the Visual Search Task (VST). For all of the 
variables on the VST which cannabis users displayed deficits, there were near identical 
impairments on the SST. In particular, the number of revisits to stimuli on the VST was 
replicated on the SST, although the type of stimuli revisited differed. This suggests high 
specificity of cannabis-related impairments in the eye-tracking study.
6.3.4. Temporality
The studies conducted in the current research programme were not longitudinal and thus 
it could not be determined if the deficits on the various indicators of cognitive 
performance by the cannabis users relative to controls preceded or followed the use of 
cannabis. Therefore this criterion is not met nor is it violated.
Previous epidemiological research has provided some evidence that cannabis use 
precedes cognitive impairment. Meier et al (2012) conducted a longitudinal study with 
over 1000 participants and tested IQ and cognitive function at various follow up 
sessions. The authors found that individuals who never used cannabis showed increases 
in IQ scores over the follow up sessions while those who used cannabis after the initial 
testing point showed decreases in IQ commensurate with the number of cannabis 
dependence diagnoses over the different follow-ups. This was the first large scale study 
of its kind to be conducted and future research will need to confirm the findings before a 
conclusion can be reached.
6.3.5. Biological Gradient
The neuropsychological and eye-tracking studies assessed whether a dose-related 
response led to increased levels of cognitive impairments. The current research
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programme utilised two separate measures of cannabis quantity: total lifetime cannabis 
use and years of cannabis use. Of the seven dependent variables which were found to be 
impaired in cannabis users in the neuropsychological study, four of these variables were 
significantly correlated with either lifetime cannabis use or years of cannabis use which 
therefore meets the biological gradient criterion. Surprisingly, none of the dependent 
variables which were impaired by the cannabis users in the eye-tracking study were 
significantly related to these two measures of cannabis use. This could be due to the 
smaller sample size as one of the variables had a moderate correlation coefficient with 
lifetime cannabis use and three of the variables had a moderate correlation coefficient 
with years of cannabis use. Moderate is interpreted as 0.3-0.5 for Pearson’s r or 
Spearman’s Rho. While interpretation of p -values would suggest the biological gradient 
criterion was violated for the second study, interpretation of the correlation coefficients 
would suggest the criterion was met for at least three of these variables.
6.3.6. Plausibility
Plausibility refers to whether or not a plausible mechanism can link the cause (chronic 
cannabis use) with the effect (cognitive impairments). The current research has not 
contributed to the literature regarding the plausibility of a mechanism as this is beyond 
the scope of this research. However, two possible causal mechanisms linking chronic 
cannabis and cognition have been suggested which are neurotoxicity (e.g. Lorenzetti et 
al., 2010) and neuro-dysfunction (e.g. Kanayama et al., 2004; Bloomfield et al., 2014).
A further short-term causal mechanism of withdrawal symptoms (e.g. Budney et al, 
2003) has been proposed to explain why there is a trend for impairments to be much 
greater in individual with past month cannabis use (Schreiner & Dunn, 2012). This has 
also received a certain degree of support within longitudinal data (Hanson et al., 2010) 
however these authors demonstrated that not all impairments returned to normal after 
three weeks of abstinence.
The eye-tracking study attempted to address the short term mechanism by correlating 
the dependent variables with the length of abstinence however there were no significant 
relationships. This suggested that the impaired performance in cannabis users was not 
mediated by the length of abstinence, which supports a long term damage explanation 
such as neurotoxicity induced by cannabis use.
266
In conclusion, the current thesis does not add much new evidence to the plausibility 
criterion however other research discussed in Section 1.1.5 highlights the potential for 
neurotoxicity or dopaminergic dysregulation to explain the pattern of impaired 
cognitive processes which the current research programme detected in cannabis users 
and early onset cannabis users.
6.3.7. Coherence
As a majority of this discussion has already been made in the Chapter One, this will not 
all be covered to avoid redundancy. Firstly, the current results described in the two 
quasi-experimental studies in Chapters Three and Four can be summarised as 
impairments on a certain proportion of the cognitive dependent variables, but not all. 
There were no tasks on which the cannabis users outperformed controls or tobacco 
users. Furthermore, the early onset users displayed the greatest degree of impairments 
while there was only one dependent variable in which the late onset users displayed 
greater deficits than the early users. The vast majority of the previous literature is in 
coherence with these results for the cannabis data as determined by reviews and meta­
analyses (Crean et al., 2011; Schreiner & Dunn, 2012) and the majority of the previous 
literature on early onset cannabis use is in coherence with the current early-onset data 
(Ehrenreich et al., 1999; Gruber et al., 2011; Fontes et al., 2011) while one study found 
that cognitive impairments disappeared after controlling for IQ (Pope et al., 2003).
Secondly, data from other fields lends coherence to the cognitive impairments 
discovered here. This is demonstrated by cannabis users performing worse than controls 
in educational outcomes (Horwood et al., 2010; Lynskey & Hall, 2000; Verwiej et al.,
2013). While other associations are noted with cannabis use (e.g. mental health), only 
educational deficits are noted in cannabis users which could be explained via cannabis 
induced cognitive deficits. This does not imply that cognitive impairments are the 
leading explanation of these education deficits, but rather that these educational deficits 
are coherent with the cognitive deficits.
6.3.8. Experiment
Due to ethical considerations it is not possible to conduct experimental research on the
cognitive consequences of long-term cannabis use. It is likely that this criterion, perhaps
the strongest indicator of causation, will never be explored in this area. The inability to
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meet this criterion does not imply that causation is impossible to infer as if all other 
criteria are met and replicated, then a causal interpretation could be the best explanation 
for the data. The limitations of the quasi-experimental approach can be found in the 
Methodology chapter (Section 2.1.1).
6.3.9. Analogy
This last criterion is that when a comparable cause (X2) to the one which is being 
examined (Xi) has a certain effect (Yi), the evidence required for a causal interpretation 
of Xi on Yi can be reduced. This has been critiqued as being too open for interpretation 
(Hofler, 2005) and thus any imagined analogy could potentially and erroneously lower 
the required level of evidence for a causal interpretation. While numerous recreational 
drugs other than cannabis have been shown to have a negative effect on cognitive 
functioning such as ecstasy (Hadjiefthyvoulou et al., 2011), ketamine (Morgan et al.,
2014), and cocaine (Vonmoos et al., 2013) and while there is a possibility of a shared 
indirect mechanism via neurotoxicity or dopaminergic dysfunction (Klogpanichapak, 
Govitrapong, Sharma & Ebadi, 2006; Morton, 2005; Zou et al., 2009), causation cannot 
be shown for ecstasy, ketamine, cocaine, or any other illegal drugs due to lack of true 
experimental designs. Therefore this last criterion cannot be used to infer causation as 
an appropriate analogy of cannabis’ effects on cognition is not available.
6.3.10. Other Causal Variables
During the two quasi-experimental studies described within this thesis the use of 
covariates was implemented to parcel out the effects of possible confounds. While 
cannabis use was the primary candidate for explaining the deficits reported there 
remained some possibility that non-cannabis variables were influencing performance. 
The final results were reported after controlling for all salient covariates which met 
ANCOVA assumptions however there were several cases in which covariates could not 
be controlled for and these variables differed significantly between groups. In the 
neuropsychology study alcohol use, tobacco use, and other drug use all differed 
between controls, tobacco users, and cannabis users (total or divided). While in the eye- 
tracking study anxiety, tobacco use, and other drug use differed between controls and 
cannabis users.
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In both studies the levels of other drug use were negligible, averaging less than two 
lifetime uses for each participant in contrast to the much higher levels of cannabis 
averaging around 1000 and 500 lifetime uses across the two studies. This suggests that 
other drug use is not a causal factor explaining the cognitive deficits. Tobacco use also 
differed between groups and was correlated with several of the dependent variables in 
the neuropsychological study. However cannabis users showed impairments relative to 
tobacco users while tobacco users did not differ from controls on these variables 
suggesting that tobacco was not a causal factor in these deficits. Weekly alcohol use 
was significantly higher in the cannabis group relative to the controls in the 
neuropsychological study yet was unrelated to any of the dependent variables which 
were impaired in cannabis users suggesting that alcohol use was not explaining the 
deficits. In the eye-tracking study cannabis users displayed impairments on one variable 
in which anxiety was identified as a confound. As anxiety could not be controlled for on 
this variable it is possible that cannabis users displayed these impairments due to the 
greater levels of anxiety. While the vast majority of the impaired variables over the two 
quasi-experimental studies are unlikely to be due to one of the tested confounding 
variables, this suggests anxiety is a valid candidate for explaining the number of revisits 
to distractor stimuli in the eye-tracking study. It cannot be determined in the current 
study if anxiety led to cannabis use and also caused the impairments or if cannabis 
increased anxiety which led to the impairments. Both of these interpretations are 
possibilities as the directional nature of the relationship between cannabis and anxiety 
has not been determined (Crippa et al., 2009) while anxiety has been clearly show to 
impair tasks which recruit attentional processes (Eysenck et al., 2007).
Despite anxiety possibly mediating the cannabis-related deficits on one variable, the 
majority of impaired performances by cannabis users over the neuropsychological and 
eye-tracking studies appeared to be unrelated to the potential confounds which were 
examined.
6.3.11. Summary
Considering nine of Hill’s criteria for inferring causation and when disregarding the two 
criteria which are not possible within this domain; experiment and analogy, there is 
strong evidence to suggest that the cognitive deficits described in the current thesis are 
causally related to cannabis use.
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The remaining criteria were largely met by the current studies: strength of the 
association, consistency; specificity; biological gradient; and coherence. The current 
studies did not address temporality or plausibility however these have been met by other 
research (e.g. Meier et al., 2012; Lorenzetti et al., 2010). It is worth noting that the 
biological gradient criterion, i.e. a dose-response effect, was not found for all impaired 
cognitive processes. It could be that some of the tasks in which cannabis users displayed 
impairments were not due to cannabis but rather some other confounding variable 
which was not taken into consideration. As true- as opposed to quasi-experimentation 
cannot be done, a causal effect cannot be proven. However, based on the current 
research, a causal interpretation for a proportion of the cognitive deficits discovered in 
cannabis users appears to be the best explanation. In contrast, while there is strong 
evidence meeting some of the criteria for an early onset causal theory (e.g. plausibility; 
Downer et al., 2007; Wilson et al., 2000), there is little consistency amongst the 
research due to the relatively new focus on the age of onset of cannabis use. More 
research on the age of onset of cannabis use will help determine if it has a causal, 
negative impact on cognition.
6.4. Severity of Impairments
The primary method used in quantitative, inferential analyses is the process of testing 
the null hypothesis. Null hypothesis testing involves determining whether an effect is 
notably different from the norm, such that the effects did not arise by chance. There are 
many problems with this approach, not least that any statistically significant finding 
may not actually be substantively significant (Fife-Schaw, 2006). A substantive 
significance is one which has psychological or theoretical importance. Given the 
ubiquity of the former term (statistical significance) and the rarity of the latter, it 
becomes necessary to clarify whether a significant effect discovered can be classified as 
substantive or merely statistical. It is worth noting that it is possible for a substantive 
significance to not be statistically significant.
When a statistically significant group difference is discovered in any field relating to 
cognition or executive function, it is referred to as a deficit (or impairment etc.) if 
performance is lower than the control group, or an improvement (or enhancement etc.) 
if performance is higher than the control group. These terms are common throughout 
multiple fields including, but not limited to, schizophrenia (e.g. Kopald, Mirra, Egan,
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Weinberger & Goldberg, 2012), dementia (e.g. Stopford, Thompson, Neary, Richardson 
& Snowden, 2012) and autism (e.g. Rosenthal et al., 2013). If such terminology is 
shared across these various fields without explicit clarification it has the potential for 
readers to infer that the deficits associated with cannabis use are comparable with those 
associated with schizophrenia or any other diagnosis.
This leads to the question, are the deficits in executive function associated with 
cannabis use substantively significant? A direct method of addressing the scale of the 
impairments would be to add a group of other drug users to a study already comprised 
of cannabis users and controls, to compare the between group differences in executive 
function. This would help determine which drugs cause the most damage. Further 
methods of addressing the scale of the damage would be to compare either effect sizes 
or the mean scores from standardised tests.
6.4.1. The Direct Method
Several studies have recruited cannabis users in addition to another drug using group, 
which helps determine the severity of the impairments. This allows the comparison of 
different drugs on the outcome variable of cognition. This approach has been tested 
among different illegal drugs including MDMA and cocaine (Verdejo-Garcia, Lopez- 
Torrecillas, Aguilar de Arcos & Perez-Garcia, 2005; Verdejo-Garcia et al., 2007) and 
has been able to determine the differential level of impairments and the specificity of 
these impairments across different executive function and other cognitive constructs.
The current thesis did not use this approach but instead opted to recruit cannabis users 
with little-to-no use of other recreational drugs. There were two exceptions to this; 
alcohol use and tobacco use are so prevalent among cannabis users that it is difficult to 
avoid recruiting participants with use of these two drugs. To determine if cannabis use 
caused impairments substantively greater than tobacco use the neuropsychological study 
reported in this thesis compared a control group with a tobacco using group and with 
cannabis users. While the cannabis using group displayed many cognitive deficits 
relative to controls there were no variables in which tobacco users showed deficits 
relative to controls. Alcohol, by contrast, was used as a covariate and the effects on 
cognition could be not determined as a non-alcohol using group was not recruited. 
Therefore this direct method of assessing the severity of cannabis related cognitive
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impairments only suggests that cannabis is significantly more severe than tobacco use 
and therefore other methods will have to be used to determine severity.
6.4.2. Effect Size Comparisons
The use of effect sizes could represent a useful tool for assessing the severity of 
cannabis related impairments in cognition. As previously mentioned, the use of 
statistical significance testing is ubiquitous however the reporting of effect sizes is 
much less prevalent. The use of a significance test (/?-value) does not indicate the size of 
an effect, however the aptly named effect size does accomplish this goal (Fife-Schaw, 
2006). There are multiple versions of the effect size statistic, however one of the most 
common used version - Cohen's cl - is a measurement of how two groups differ based on 
a pooled standard deviation (Cohen, 1988). Comparing the severity of impairments 
based on effect sizes is an improvement on merely reporting test statistics and />values, 
however it is vulnerable to criticism that different samples present with difference 
variances which therefore means that an effect size of d  = 0.5 in one study will not be 
identical in terms of the raw data to the same value in another.
The neuropsychological study reported in Chapter Three of the current thesis compared 
controls, tobacco users and cannabis users on a range of cognitive tests. The tests which 
reached statistical significance will be the primary discussion point here. Cannabis users 
presented with deficits on three tests compared to controls (d=~.74 to -.88) and three 
tests compared to tobacco users (d=~.60 to -.94). Based on a basic interpretation from 
Cohen (1988) who suggested guidelines for small (d~.3), moderate (r/~.5) and large 
(d~.8) effect sizes, it can be seen here that the size of the cannabis related impairments 
in cognition were large when compared to controls and moderate/large when compared 
to tobacco users. Comparing the effect sizes reported here to similar research it appears 
that the scale of the impairments are comparable (d=~.69 to -.80; Gruber et al., 2011).
Schreiner and Dunn (2012) conducted the most recent meta-analysis of cannabis use 
and cognition and found that among the significant results, effect sizes ranged from 
small to moderate (Hedge’s g=0.21-0.36). These effect sizes could be smaller for 
several reasons. Firstly, Hedge’s g is a more conservative effect size than Cohen’s d and 
this could be explaining the discrepancy (Schreiner & Dunn, 2012). The current study 
included a focus on the early onset cannabis users and thus any meta-analysis which
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specifically looked at early onset cannabis users (e.g. age of cannabis onset <16) could 
find larger effect sizes just as data from the current thesis did. At a more basic level, it is 
possible that chance characteristics of the sample recruited and described in Chapter 
Three happened to have cognitive deficits at the tail end of the distribution. It is likely 
that all three of these variables were explaining the differences in effect sizes.
When comparing cannabis use impairments to other drugs it would appear that 
ecstasy/MDMA use (c/=.40-.73; Kalechstein, de la Garza II, Mahoney, Fantegrossi & 
Newton, 2007), methamphetamine use (d=34~.66; Scott et al., 2007), and addicition to 
alcohol (recent use: r/=.33-.70; one month abstinence: r/=.27-77; one year abstinence: 
d=. 13-.30; Stavro, Pelletier & Potvin, 2012) results in greater levels of impairments 
across similar domains of cognition as determined by meta-analyses. With the exception 
of long term abstinence and recovery from alcoholism, these impairments are 
demonstrably larger than the data reported in the recent cannabis meta-analysis 
(Schreiner & Dunn, 2012). While the majority of the studies analysed within each meta­
analysis attempted to control for other drug use this was not always possible, in 
particular ecstasy and methamphetamine use is typically accompanied by other 
recreational drug use which could be explaining or contributing towards the observed 
cognitive deficits. Despite this limitation, it is notable that the cognitive deficits 
discovered in cannabis users appear to be approximately half the magnitude of those 
discovered in ecstasy users, methamphetamine users, and in alcoholics who are still 
going through treatment.
6.4.3. Standard Test Comparisons
There are numerous standardised measures available for assessing executive function, 
and although a number of studies design their own measures for use with specialist 
equipment (e.g. fMRI; eye-trackers), the neuropsychological batteries remain a popular 
choice in chronic cannabis use research. These standardised tests allow for the 
comparison of scores across multiple studies and are often norm referenced.
Within the neuropsychological study, the D-KEFS, WAIS, and WASI are all norm 
referenced across a wide age range. For the D-KEFS and the WAIS subtest, the Symbol 
Search Task (SST) the raw scores are converted into age scaled score in which 10±2 is 
the mean ± standard deviation from the normative data. The WASI Full-Scale IQ
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(FSQI), verbal IQ (VIQ), and Performance IQ (PIQ) are all age scaled in which 90-109 
is considered average. For the three cannabis using groups: the total group, the early 
onset users, and the late onset users; the scores on the D-KEFS and the SST were no 
more than one standard deviation away from the normative mean across all tests in 
which the cannabis using groups were impaired. Interestingly, the mean score of the 
early onset group scored below this cut-off of “8” on one variable in which they were 
not significantly impaired: the Switching subtest of the Verbal Fluency test.
All of the groups’ mean scores on the WASI estimates of FSIQ, VIQ, and PIQ were 
within the average range of 90-109 and therefore this suggests that on average the 
groups had normal IQ levels. Considering the cannabis users’ performance with regards 
to the normative data suggests that despite significant and large deficits in cognitive 
performance relative to controls or tobacco users, the cannabis users still maintained a 
“normal” level of cognitive functioning. It is possible that these minor deficits could 
slightly impact quality of life, as has been suggested for educational performance 
(Lynskey et al., 2003), however actually determining the contribution of long-term 
cannabis-induced cognitive deficits into real world consequences has not been 
investigated.
6.4.4. Heterogeneity of the Cannabis Use Group
The cannabis groups reported in the neuropsychological and eye-tracking studies had a 
wide range of cannabis use. Some individuals had been using regularly for a short 
period of time (months), some had been using regularly for a long period of time 
(years), and some had been using intermittently for a long period of time (years). There 
were also some individuals who “binged” at the weekend with cannabis, while others 
smoked a small amount daily. As there were multiple associations between cognitive 
performance and different cannabis use behaviours such as lifetime spliffs smoked, 
years of use, desired level of intoxication when using, and the age of onset of use, it is 
clear that the deficits were not evenly spread over the group. As all outliers in the 
analyses were winsorised it suggests that the effects were not being influenced too 
greatly by a few cases however there still is a possibility that not every individual 
suffers from cognitive impairments as a result of cannabis use, especially when 
considering that there is evidence for individuals with lower IQ to be more vulnerable to
the cognitive effects of cannabis (Pope & Yugellun-Todd, 1996).
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6.4.5. Summary of the Severity
Three different methods were adopted to try and determine the scale of the impairments 
detected in the current groups of cannabis users. The direct method suggested that 
cannabis use confers much greater risk to cognitive impairments than tobacco use. The 
effect size approach suggested that cannabis induced impairments reported in the meta­
analyses (Schreiner & Dunn, 2012) were half the magnitude of those reported in other 
drug use behaviours such as methamphetamine use, ecstasy use, and alcoholism. In 
contrast, the deficits found in the current studies were comparable to these other drug 
use behaviours.
The standardised test approach suggested that for all the neuropsychological variables 
tested, in addition to the IQ variables used for covariate purposes, cannabis users almost 
completely scored within the normal range as determined by the normative data of the 
respective tests. It is likely the large effect sizes were due to a control group which over­
performed relative to the average level which would be expected from a random 
sampling method. Overall, it appears that the cannabis-related deficits were large in 
statistical terms however the cannabis users still performed at a “normal” cognitive 
level.
6.5. Wider Implications
6.5.1. Harm Reduction
A request from the UK government to review the at-the-time current classification of 
cannabis as a Class C drug was sent to the Advisory Council on the Misuse of Drugs 
(ACMD) in 2007. The ACMD subsequently responded with a report highlighting that 
cannabis should remain a Class C drug (advice to which the government did not 
adhere), however the report also highlighted that the principle aim should be to reduce 
the harm associated with the drug (ACMD, 2008).
The present studies described in Chapter Four and Chapter Five highlight that cannabis 
use at an early age is associated with greater and more numerous executive function 
deficits than later onset users and non-smoking controls. This adds to a growing body of 
research finding similar early onset risks relating to cognition (Pope et al., 2003; Fontes 
et al., 2011; Gruber et al., 2011), psychiatric conditions such as depression (Fergussen
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& Horwood, 1997; Lynskey et al., 2004), or schizophrenia (Di Forti et al., 2015), and 
educational problems such as lower grades and less time in education (Horwood et al., 
2010).
Given the widespread risk associated with early onset cannabis use it appears the first 
step in reducing harm would be to minimise the number of individuals who start using 
cannabis early in life. Determining the success of different harm reduction strategies 
(e.g. prohibition; legalisation; education of the consequences; etc.) is beyond the scope 
of the current thesis however the current research programme does provide useful 
information about the potential dangers of long term cannabis use at an early age.
6.5.2. Education
The current thesis (Chapter Five) found that early onset cannabis use was associated 
with poorer educational achievement as indicated by the number of GCSE grades.
While a causal interpretation is not possible here it is viable that cannabis use had a 
causal influence on education. One possible mechanism for this causal influence is by 
the impairment of executive function as several researchers have identified that 
executive function predicts school grades (Grimley & Banner, 2008; Riding et al, 2003). 
Given the finding within the current thesis that executive function is impaired in 
cannabis users, and such impairments typically last for at least a month (Schreiner & 
Dunn, 2012), it is possible that regular long term cannabis use could consistently impair 
executive function to a point where education achievement is affected. This role of 
impaired cognition is likely just one very small part of the complex relationship 
between cannabis use and education with acute cannabis, covarying mental health 
problems, familial influences, and peer influences also contributing to the relationship 
(Horwood et al., 2010; Lynskey et al., 2003; Mensch & Kandel, 1988; Verwiej et al., 
2013).
While the current study could not contribute to understanding if alterations in cognitive 
faculties such as executive function are contributing to the reduced educational 
achievement in cannabis users this is discussed below as an avenue for future research. 
Regardless of the cognitive role, the use of cannabis could be a marker to highlight that 
a school student requires extra support to ensure they do not fall behind in school.
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6.6. Limitations
While several limitations specific to the individual studies are discussed in their 
respective chapters there were several overarching limitations within the current 
research which will be discussed here. Furthermore, limitations which were predicted 
and discussed in the methodology chapter will not be repeated here.
6.6.1. Methodological Critique
A problem with the CannaForm which arose was the responses on three items. Certain 
responses indicated that a large number of individuals misunderstood the question and 
therefore the responses were not counted as valid. An example of this was the question:
1. Where did you first try cannabis?
□  School Q  College [^U niversity  I I Other (please 
specify)...................
The majority of participants understood the wording of the question however a number 
took the literal interpretation, a consqeuence which was not foreseen when constructing 
the questionnaire, and typically responded with "at a festival", "in amsterdam" or "at a 
party".
This problem also arose on several questions including estimating the amount of alcohol 
used per week and the the number of A-levels obtained. As a result varying degrees of 
data was not usable for these three questions. This process allowed the develpment of 
the CannaForm to a point where it is now clear and understandable and future testing 
will be able to determine whether the improvements have been succesful.
The implication of these errors are mostly that there were missing data and assuming 
the pattern of missing data across participants was random there could be no bias as a 
result. While the large sample size of the survey (Chapter Five) meant that the loss in 
data was not problematic, the sample sizes in the quasi-experimental chapters were 
affected by this. The eye-tracking study involved the loss of data to a point were a 
different measure of alcohol use was chosen; the number of days a week when drinking 
was used to estimate alcohol use.
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6.6.2. Sample Size Critique
One of the main limitations within the current research programme was the sample size 
for the quasi-experimental studies. While the overall sample size was not small for the 
neuropsychological study the individual group sizes of the early and late onset cannabis 
groups were small (;z=16; n - 16). This was also true for the eye-tracking study (n= 12; 
>z=10) for the early and late onset groups, respectively. While cannabis using samples of 
this size are frequently reported during neuropsychological studies (e.g. Grant et al., 
2012; Gruber et al., 2011; Whitlow et al., 2004) and imaging studies (e.g. Gruber et al., 
2012; Hester et al., 2009; Tapert et al., 2007) there are still statistical implications of 
using samples of this size.
The major limitation of such sample sizes are that the results cannot be generalised to 
other cannabis users from such samples (Sturgis, 2006). Despite this limitation studies 
including small samples are necessary when dealing with specific populations in which 
few individuals meet the necessary criteria. The benefits of these studies include 
highlighting areas of future research, contributing to meta-analyses, and systematic 
reviews (Sturgis, 2006).
6.7. Future Research
6.7.1. Determining Causation
This chapter has discussed the dilemma of causation in detail and suggested how the 
current research contributes to determining the causal relationship. Future research 
should focus on several areas to help determine causation. There is substantial evidence 
for a causal link between cannabis use and cognitive deficits however the area which 
needs a greater focus is the temporality criterion. More research similar to that 
conducted by Meier et al (2012) needs to be done by looking at what comes first; 
cannabis use or cognitive deficits. The focus should be on how quantity of cannabis 
leads to cannabis deficits rather than diagnoses of dependence as done by Meier et al 
(2012) as this will allow the findings to be extrapolated out to those who use cannabis 
yet are not dependent on the drug.
In contrast to general cannabis use, a causal link between early onset cannabis use and 
cognitive deficits is not as clear. More research examining the relationship between
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these two variables will aid in meeting many of Hill’s criteria (Hill, 1965). A specific 
research focus is not necessarily recommended here as the main goal is to replicate 
previous findings in order to determine the consistency criterion of Hill’s criteria.
6.7.2. Cannabis Initiation and Cognitive Development
A possible mechanism proposed for explaining why early onset cannabis use is more 
damaging to cognition is that the exogenous chemicals in cannabis interfere with 
normal cognitive development. As discussed in section 1.3.4, different executive 
function components develop at different rates and therefore, if cannabis use does affect 
the developmental trajectory of cognition, then different executive function components 
should be differentially affected by cannabis.
Although the research on cognitive development is also in its infancy, there are some 
clear findings which can generate testable hypotheses. Due to the margin of error 
associated with determining when an individual cognitive construct, such as inhibition, 
reaches adult levels the easiest way to start would be to look at the earliest component 
to mature and the latest component to mature. Longitudinal and cross-sectional data 
suggests that working memory and the cognitive processes which underlie perseverative 
errors on the WCST mature earliest, while strategic planning matures latest (see Section
1.3.4.) If interrupted cognitive development is the mechanism behind such deficits then 
early onset cannabis users should display lower performance on strategic planning 
measures in contrast to perseveration/working memory. Perseveration has been found to 
be impaired in early onset cannabis users (Gruber et al., 2011; Fontes et al., 2011) 
although Pope et al (2003) found that late onset users were more likely to display 
deficits on this variable. No age of onset studies have examined strategic planning to 
determine if this variable would be more at risk for impairment. The main problem with 
this line of evidence is that different tasks have different levels of sensitivity and 
therefore may be more likely to detect deficits contaminating the primary hypothesis. 
This would only be problematic if the bias in task sensitivity was not random. For 
example if the tasks of processes which mature later happen to be greater in sensitivity 
than tasks of processes which mature early then this would erroneously support the 
hypothesis and thus be a type I error, while the opposite is also true which would lead to 
a type II error. There is no easy solution to this problem and it would seem prudent to
still test this hypothesis while considering the limitations of this approach.
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6.7.3. Binge Smoking Cannabis
The current research has focussed on the age of onset of cannabis use for explaining the 
pattern of deficits recorded in cannabis users however several other variables are 
suggested. One variable may be bingeing on cannabis which was measured by asking 
participants to describe the level of intoxication they like to reach when using cannabis, 
on a scale from 0-10. In the neuropsychological study this variable was found to explain 
a proportion of the deficits discovered on the TMT Visual Scanning test by cannabis 
users. However, lifetime spliffs smoked was also related to this variable and therefore it 
could be that increased level of intoxication was only an indicator for increased 
cannabis use. A similar finding was reported by Montgomery et al (2012) who found 
that spliffs used per session and lifetime cannabis use were both related to impaired 
prospective memory in cannabis users. The eye-tracking study did not replicate this 
finding and therefore the role of bingeing is not clear. If a study was designed to match 
cannabis users for total cannabis use while dividing them into two groups o f “bingers” 
and another group of frequent but low dose cannabis use, this would help determine if 
the pattern of cannabis use behaviours has any relevance for cognitive integrity.
6.7.4. Cannabis strains
Police seizures show that skunk has much greater levels of A9-THC and much lower 
levels of CBD than other strains such as hash (Potter et al., 2008). Evidence appears to 
suggest that skunk mediates a large number of the harms associated with cannabis use 
such as increased risk for schizophrenia (Di Forti et al., 2015); and that CBD appears to 
ameliorate the anxiety inducing (Niesink & van Laar, 2013) and memory impairing 
(Morgan et al., 2012) properties of A9-THC. Using a method reported by Morgan et al 
(2012) in which hair samples are used to detect levels of A9-THC and CBD, groups 
could be compared in other domains of cognition. While the strains of cannabis may 
differ over time, the length of the individuals hair will be the primary limitation to this 
method as longer hair will allow a much more detailed look into the individual’s long­
term consumption of these two cannabinoids.
6.7.5. Abstinence Induced Recovery o f Function
Given the evidence for a causal interpretation of the cannabis-cognition relationship, 
determining the mechanism for how this occurs is of importance. While several
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possibilities have been suggested such as a neurotoxic theory of cannabis-induced 
impairments an alternative and temporary explanation has recently gained support. 
Schreiner and Dunn (2012) found compelling evidence for short term impairments most 
likely explainable via a withdrawal mechanism. The authors compared a number of 
studies with the only abstinence criterion being that the subjects were not acutely 
intoxicated at the time of testing. They re-analysed all the studies after only including 
those with at least (approximately) one month of abstinence from cannabis. These 
analyses showed that impairments in cannabis users were present in the first meta­
analysis but not when the abstinence criteria was longer than one month. The limitations 
of this study are discussed in the literature review of this thesis (Section 1.4.9) however 
the implications are important. If the cognitive deficits which have been widely 
discovered in cannabis users are just due to a withdrawal effect then one of the major 
side effects of using cannabis would only be temporary as opposed to neurotoxicity in 
which damage could last much longer or even permanently.
Studies have tested this explanation with different cohorts (e.g. McHale & Hunt, 2008; 
Thames et al., 2014) however a longitudinal approach (e.g. Hanson et al., 2010) which 
includes cognitive testing after one or two days abstinence, followed by a repeated 
testing after one month of abstinence would help determine if there was a recovery of 
function as opposed to just cohort effects.
6.7.6. Ecological Validity
The range of impaired cognitive constructs within cannabis users is varied and well 
replicated (Schreiner & Dunn, 2012) however these theoretical constructs are inferred 
by performance on tasks which are lacking ecological validity. One category of research 
among cannabis users which is yet to receive sufficient attention is how these cognitive 
deficits manifest in real world activities.
One candidate topic as a real world indicator of cannabis induced cognitive impairments 
is educational performance. The relationship between cannabis use and educational 
variables is well researched (Horwood et al., 2010; Lynskey et al., 2003; Mensch & 
Kandel, 1988; Novins & Mitchell, 1998) and several mechanisms have been proposed 
to explain the association. Lynskey et al (2003) suggested a role of cannabis induced 
cognitive impairments to mediate the relationship between cannabis use and education
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however at the time there was little evidence to suggest that cannabis use had a 
substantive effect on cognition. Currently there is more evidence supporting this 
possibility and therefore the role of cannabis impacting cognition which damages 
educational achievement needs to be explored. This complex interaction is laden with 
confounding variables and determining that cannabis-induced cognitive impairments 
has a role in diminished educational performance will be problematic. An 
epidemiological approach would best answer this question, determining baseline levels 
of cognitive and educational performance in a large sample of children or teenagers 
before monitoring how these levels vary over time and change following the onset of 
cannabis use. This would need to take into account the effects of mental health, familial 
educational and drug use factors, motivation, and acute cannabis use.
Another possible avenue of future research within the ecologically valid domain is that 
of driving performance. The eye-tracking study discussed within the current thesis 
found evidence that cannabis users take longer to scan for target stimuli and take longer 
to confirm that target stimuli are not there. Furthermore, cannabis users made more 
revisits to stimuli could be due to participants moving on from an area of interest before 
fully processing the stimulus contents. The speculative implications of this within a 
driving framework is that cannabis users may take longer to identify hazards, take 
longer to determine that there is not a hazard present, and may move on from a 
particular fixation before determining for sure if there was or was not a hazard present. 
There is no direct evidence for this suggestion as the pattern of eye movements and 
visual processing may be altered in more salient circumstances such as when driving as 
opposed to in a laboratory visual search test. The first approach to determining whether 
the visual search deficits reported within the two studies of the current thesis (Chapter 
Three and Four) and in previous research (Ehrenriech et al., 1999; Hanson et al., 2010; 
Huestegge et al., 2002), have any driving implications is to test whether abstinent 
cannabis users perform worse on a standardised hazard perception test such as that used 
by the DVLA in the UK. This could be tested with an eye-tracker to determine if the 
results replicate work done in this thesis and by Huestegge et al (2002). Another driving 
concern is that cannabis users in the current study were found to be impaired relative to 
tobacco users on the GPT, a measure previously found to predict the number of driving 
errors in older adults (Dawson et al., 2010). The use of a driving simulator (e.g. Richer
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& Bergeron, 2009) or a road test (e.g. Dawson et al., 2010) could be used to test 
whether abstinent cannabis users make more driving mistakes than controls.
6.8. Summary
The thesis has aimed to elucidate the relationship between early onset cannabis use and 
executive function. Through two quasi-experimental studies reported here there is 
substantial evidence for cognitive impairments associated with cannabis use within the 
domains of visual scanning, set switching and visuo-motor coordination. While the 
neuropsychological study provided strong evidence for an age of onset effect, the eye- 
tracking study only provided partial support this hypothesis. These data suggest that 
there may be a developmental vulnerability to cannabis use prior to the age of 16. It also 
appears that other drug use and educational achievement predict an early age of onset of 
cannabis, highlighting the need to account for these variables when examining the age 
of onset effect on cognition.
While legalisation and prohibition policies are consistently changing throughout the 
world, these findings contribute to a growing body of evidence which highlights the risk 
of using cannabis during the teenage years. Whether individual political states choose to 
legalise, decriminalise, or prohibit the use and distribution of cannabis; evidence driven 
guidelines for the use of cannabis need to be made available as long as harm reduction 
is the priority.
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